Equitable (EQH) 10-K 8 Mar 19 2018 FY Annual report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 07, 2019	Jun. 29, 2018
Document and Entity Information [Abstract]
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,018
Amendment Flag	false
Entity Registrant Name	AXA Equitable Holdings, Inc.
Entity Central Index Key	1,333,986
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		521,187,924
Entity Public Float			$ 3,300

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Dec. 31, 2018	Dec. 31, 2017
Investments:
Fixed maturities available for sale, at fair value (amortized cost of $46,801 and $45,068)		$ 46,279	$ 46,941
Mortgage loans on real estate (net of valuation allowance of $7 and $8)		11,835	10,952
Real estate held for production of income	[1]	52	390
Policy loans		3,779	3,819
Other equity investments	[1]	1,334	1,392
Trading securities, at fair value		16,017	14,170
Other invested assets	[1]	2,037	4,118
Total investments		81,333	81,782
Cash and cash equivalents	[1]	4,469	4,814
Cash and securities segregated, at fair value		1,170	825
Broker-dealer related receivables		2,209	2,158
Deferred policy acquisition costs		6,745	5,919
Goodwill and other intangible assets, net		4,780	4,824
Amounts due from reinsurers		4,895	5,023
Loans to affiliates		0	1,230
GMIB reinsurance contract asset, at fair value		1,732	1,894
Current and deferred income taxes		0	84
Other assets	[1]	3,127	2,510
Separate Accounts assets		110,337	124,552
Total Assets		220,797	235,615
LIABILITIES
Policyholders’ account balances		49,923	47,171
Future policy benefits and other policyholders' liabilities		30,998	30,330
Broker-dealer related payables		431	783
Securities sold under agreements to repurchase		573	1,887
Customer related payables		3,095	2,229
Amounts due to reinsurers		1,438	1,436
Short-term and long-term debt	[1]	4,955	2,408
Loans from affiliates		0	3,622
Income taxes payable		68	0
Other liabilities	[1]	3,360	4,053
Separate Accounts liabilities		110,337	124,552
Total Liabilities		205,178	218,471
Redeemable noncontrolling interest	[1]	187	626
Equity attributable to Holdings:
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively		5	5
Capital in excess of par value		1,908	1,299
Treasury stock, at cost, 32,138,242 shares		640	0
Retained earnings		13,989	12,225
Accumulated other comprehensive income (loss)		(1,396)	(108)
Total equity attributable to Holdings		13,866	13,421
Noncontrolling interest		1,566	3,097
Total Equity		15,432	16,518
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 220,797	$ 235,615
[1]	See Note 2 for details of balances with variable interest entities.

CONSOLIDATED BALANCE SHEETS (PA

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Millions	Dec. 31, 2018	Apr. 24, 2018	Dec. 31, 2017
Fixed maturities available for sale, at fair value (amortized cost of $ and $45,068)			$ 45,256
Mortgage loans on real estate (net of valuation allowance of $8 and $8)	$ 7		$ 8
Common stock par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Common stock authorized (in shares)	2,000,000,000	2,000,000,000	2,000,000,000
Common stock issued (in shares)	561,000,000		561,000,000
Common stock outstanding (in shares)	528,861,758		561,000,000
Treasury stock (in shares)	32,138,242		0
Fixed maturities
Fixed maturities available for sale, at fair value (amortized cost of $ and $45,068)	$ 46,801		$ 45,068

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
REVENUES
Policy charges and fee income	$ 3,824	$ 3,693	$ 3,729
Premiums	1,094	1,124	1,083
Net derivative gains (losses)	(231)	214	(1,848)
Net investment income (loss)	2,693	3,082	2,665
Investment gains (losses), net:
Total other-than-temporary impairment losses	(42)	(15)	(68)
Other investment gains (losses), net	(44)	(176)	2,051
Total investment gains (losses), net	(86)	(191)	1,983
Investment management and service fees	4,268	4,093	3,749
Other income	516	445	402
Total revenues	12,078	12,460	11,763
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	2,915	4,366	3,342
Interest credited to policyholders’ account balances	1,090	995	967
Compensation and benefits	2,079	1,980	1,965
Commissions and distribution related payments	1,160	1,081	1,000
Interest expense	231	160	174
Amortization of deferred policy acquisition costs	(333)	(503)	(779)
Other operating costs and expenses	1,809	2,069	1,509
Total benefits and other deductions	9,617	11,154	9,736
Income (loss) from continuing operations, before income taxes	2,461	1,306	2,027
Income tax (expense) benefit	(307)	(49)	(378)
Net income (loss)	2,154	1,257	1,649
Less: net (income) loss attributable to the noncontrolling interest	(334)	(423)	(395)
Net income (loss) attributable to Holdings	$ 1,820	$ 834	$ 1,254
Earnings per share - common stock:
Basic (in usd per share)	$ 3.27	$ 1.49	$ 2.24
Diluted (in usd per share)	$ 3.27	$ 1.48	$ 2.24
Weighted average common shares outstanding (in millions):
Basic (in shares)	556.4	561	561
Diluted (in shares)	556.5	561	561

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 2,154	$ 1,257	$ 1,649
Other Comprehensive income (loss) net of income taxes:
Foreign currency translation adjustment	(37)	42	(18)
Change in unrealized gains (losses), net of reclassification adjustment	(1,329)	690	(274)
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	189	100	34
Total other comprehensive income (loss), net of income taxes	(1,177)	832	(258)
Comprehensive income (loss)	977	2,089	1,391
Less: Comprehensive (income) loss attributable to the noncontrolling interest	(349)	(442)	(381)
Comprehensive income (loss) attributable to Holdings	$ 628	$ 1,647	$ 1,010

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Parent	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	AOCI Attributable to Parent	Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of new ASUs | ASU 2014-09						$ 0		$ 0
Impact of new ASUs | ASU 2016-01						0	$ 0
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively			$ 5
Beginning of year at Dec. 31, 2015				$ 941	$ 0	10,137	(677)	3,108
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects						0	0
Net earnings (loss)	$ 1,254					1,254
Purchase of treasury stock					0
Capital contribution from parent				0
Purchase of AllianceBernstein Units from noncontrolling interest				0
Repurchase of AB Holding units								(128)
Net earnings (loss) attributable to noncontrolling interest								369
Dividends paid to noncontrolling interest								294
Dividends						0
Purchase of AB Units by Holdings								0
Other comprehensive income (loss)	(258)						(244)	(14)
Other				9				101
Issuance of treasury stock					0	0
End of year at Dec. 31, 2016	14,549	$ 11,407		932	0	11,391	(921)	3,142
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of new ASUs | ASU 2014-09						0		0
Impact of new ASUs | ASU 2016-01						0	0
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively			5
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects						0	0
Net earnings (loss)	834					834
Purchase of treasury stock					0
Capital contribution from parent				0
Purchase of AllianceBernstein Units from noncontrolling interest				0
Repurchase of AB Holding units								(121)
Net earnings (loss) attributable to noncontrolling interest								370
Dividends paid to noncontrolling interest								348
Dividends						0
Purchase of AB Units by Holdings								0
Other comprehensive income (loss)	832						813	19
Other				367				35
Issuance of treasury stock					0	0
End of year at Dec. 31, 2017	16,518	13,421		1,299	0	12,225	(108)	3,097
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of new ASUs | ASU 2014-09						13		19
Impact of new ASUs | ASU 2016-01						7	(7)
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively	5		$ 5
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects						89	(89)
Net earnings (loss)	1,820					1,820
Purchase of treasury stock					(648)
Capital contribution from parent				695
Purchase of AllianceBernstein Units from noncontrolling interest				17
Repurchase of AB Holding units								(95)
Net earnings (loss) attributable to noncontrolling interest								316
Dividends paid to noncontrolling interest								346
Dividends						(157)
Purchase of AB Units by Holdings								(1,525)
Other comprehensive income (loss)	(1,177)						(1,192)	15
Other				(103)				85
Issuance of treasury stock					8	(8)
End of year at Dec. 31, 2018	15,432	$ 13,866		$ 1,908	$ (640)	$ 13,989	$ (1,396)	$ 1,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively	$ 5

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Retained Earnings
Cash dividends declared per common share (in usd per share)	$ 0.26	$ 0	$ 0

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
Statement of Cash Flows [Abstract]
Net income (loss)		$ 2,154		$ 1,257		$ 1,649
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		1,090		995		967
Policy charges and fee income		(3,824)		(3,693)		(3,729)
Net derivative (gains) losses		231		(214)		1,848
Investment (gains) losses, net		86		191		(1,983)
Realized and unrealized (gains) losses on trading securities		237		(266)		63
Non-cash long term incentive compensation expense	[1]	228		247		213
Non-cash pension plan restructuring		109		0		0
Amortization and depreciation	[1]	257		399		758
Change in goodwill		0		369		0
Equity (income) loss from limited partnerships		(119)		(155)		(59)
Changes in:
Net broker-dealer and customer related receivables/payables		838		(278)		608
Reinsurance recoverable	[1]	(191)		124		24
Segregated cash and securities, net		(345)		130		(381)
Capitalization of deferred policy acquisition costs	[1]	(702)		(687)		(697)
Future policy benefits		(399)		1,097		272
Current and deferred income taxes		633		(10)		(217)
Other, net	[1]	(222)		251		428
Net cash provided by (used in) operating activities		61		(243)		(236)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available for sale		10,631		11,339		8,606
Mortgage loans on real estate		768		934		676
Trading account securities		9,340		11,231		7,841
Real estate held for the production of income		0		0		1,828
Real estate joint ventures		139		0		136
Short term investments	[1]	6,267		4,556		3,605
Other		330		228		64
Payment for the purchase/origination of:
Fixed maturities, available for sale		(12,794)		(15,166)		(10,688)
Mortgage loans on real estate		(1,642)		(2,108)		(3,278)
Trading account securities		(11,401)		(13,328)		(10,283)
Real estate		0		0		(1)
Real estate joint ventures		0		0		(51)
Short term investments	[1]	(5,058)		(4,897)		(4,090)
Other		(233)		(296)		(192)
Purchase of business, net of cash acquired		0		(130)		(21)
Cash settlements related to derivative instruments		583		(2,166)		(195)
Repayment of loans to affiliates		1,230		15		0
Issuance of loans to affiliates		0		0		(12)
Investment in capitalized software, leasehold improvements and EDP equipment		(123)		(102)		(97)
Other, net	[1]	(86)		201		384
Net cash provided by (used in) investing activities		(2,049)		(9,689)		(5,768)
Cash flows from financing activities:
Deposits		9,994		9,916		10,001
Withdrawals		(4,600)		(4,010)		(2,976)
Transfers (to) from Separate Accounts		1,724		1,486		1,432
Proceeds from loans from affiliates		0		731		0
Change in short-term financings		(1,310)		600		(176)
Change in collateralized pledged assets		31		1,044		(991)
Change in collateralized pledged liabilities		(576)		1,246		15
(Decrease) increase in overdrafts payable		3		63		(85)
Repayment of loans from affiliates		(3,000)		(56)		(1,752)
Issuance of long-term debt		4,057		0		0
Shareholder dividends paid		(157)		0		0
Purchase of AllianceBernstein Units		(1,340)		0		0
Purchases of AB Holding Units to fund long-term incentive compensation plan awards		(267)		(220)		(236)
Purchase of treasury shares		(648)		0		0
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds		(472)		120		(137)
Distribution to noncontrolling interest of consolidated subsidiaries		346		348		294
Increase (decrease) in securities sold under agreement to repurchase		(1,314)		(1,706)		227
Purchase of shares in consolidated subsidiaries		0		0		79
Purchase of shares in consolidated subsidiaries		0		(55)		0
Capital contribution from parent company		8		318		0
Other, net		(132)		(59)		4
Net cash provided by (used in) financing activities		1,655		9,070		5,111
Effect of exchange rate changes on cash and cash equivalents		(12)		22		(10)
Change in cash and cash equivalents		(345)		(840)		(903)
Cash and cash equivalents, beginning of year		4,814	[2]	5,654		6,557
Cash and cash equivalents, end of year		4,469	[2]	4,814	[2]	5,654
Supplemental cash flow information:
Interest paid		178		108		119
Income taxes (refunded) paid		57		(385)		31
Non-cash transactions:
Capital contribution from parent company		622		0		0
(Settlement) issuance of long-term debt		(202)		202		0
Transfer of assets to reinsurer		(604)		0		0
Contribution of 0.5% minority interest in AXA Financial, Inc.		65		0		0
Repayment of loans from affiliates		$ (622)		$ 0		$ 0
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 23 for further information.
[2]	See Note 2 for details of balances with variable interest entities.

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	ORGANIZATION AXA Equitable Holdings, Inc. (“Holdings” and, collectively with its consolidated subsidiaries, the “Company”) is the holding company for a diversified financial services organization. Prior to the closing of the initial public offering of shares of Holdings’ common stock on May 14, 2018 (the “IPO”), Holdings was a wholly-owned subsidiary of AXA S.A. (“AXA”), a French holding company for the AXA Group, a worldwide leader in life, property and casualty, and health insurance and asset management. AXA sold 157,837,500 of Holdings common stock to the public in the IPO. On November 20, 2018, AXA sold an additional 60,000,000 shares of Holdings common stock to the public through a secondary offering, and concurrently Holdings repurchased 30,000,000 shares of its common stock from AXA. As of December 31, 2018, AXA owns approximately 59% of the outstanding common stock of Holdings. The Company conducts operations in four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Company’s management evaluates the performance of each of these segments independently. • The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income. • The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses. • The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth Management - and distributes its institutional research products and solutions through Bernstein Research Services. The Investment Management and Research segment reflects the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”). • The Protection Solutions segment includes the Company’s life insurance and group employee benefits businesses. The life insurance business offers a variety of variable universal life, indexed universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of life, short- and long-term disability, dental and vision insurance products to small and medium-size businesses across the United States. The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes: the AXA Advisors broker-dealer business, closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB. On April 23, 2018, Holdings purchased 8,160,000 units of limited partnership in ABLP (“AB Units”) from Coliseum Reinsurance Company (“Coliseum Re”), an affiliate. In addition, Holdings acquired AXA-IM Holding US Inc., which owns 41,934,582 AB Units. As a result of these two transactions, the Company’s economic interest in AB increased to approximately 65% as of December 31, 2018 . As of December 31, 2017 the Company’s economic interest in AB was approximately 47% . The general partner of AB, AllianceBernstein Corporation (the “General Partner”), is a wholly-owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods. Prior to March 2018, Holdings owned 99.5% of AXA Financial, Inc. (“AXA Financial”). In March 2018, AXA contributed the 0.5% minority interest in AXA Financial, Inc. (“AXA Financial”) to Holdings, increasing Holdings’ ownership of AXA Financial to 100% . On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity (the “AXA Financial Merger”). As a result of the AXA Financial Merger, Holdings assumed all of AXA Financial’s liabilities, including its obligations under the $349 million aggregate principal amount of 7.0% Senior Debentures due 2028 (the “Senior Debentures”), two assumption agreements under which it legally assumed primary liability for certain employee benefit plans of AXA Equitable Life Insurance Company (“AXA Equitable Life”) and various guarantees for its subsidiaries. Holdings also replaced AXA Financial as a party to the $2 billion commercial paper program initiated by AXA and AXA Financial in June 2009. Holdings was removed as an issuer under the program in October 2018.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Significant Accounting Policies	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. Financial results in the historical consolidated financial statements may not be indicative of the results of operations, comprehensive income (loss), financial position, equity or cash flows that would have been achieved had we operated as a separate, standalone entity during the reporting periods presented. We believe that the consolidated financial statements include all adjustments necessary for a fair presentation of the results of operations of the Company. On April 24, 2018, the Company filed a Certificate of Amendment to amend its Certificate of Incorporation, authorizing the issuance of 2 billion shares of common stock, par value $0.01 per share, and effecting a 459.4752645 -for-1 common stock split, resulting in 561 million shares of common stock issued and outstanding. Prior to the Company’s IPO, all 561 million shares of the Company’s common stock were held by AXA. The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements give retroactive effect to the stock split for all periods presented. All significant intercompany transactions and balances have been eliminated in consolidation. The years “ 2018 ”, “ 2017 ” and “ 2016 ” refer to the years ended December 31, 2018 , 2017 and 2016 , respectively. Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09 This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. Adoption did not change the amounts or timing of the Company’s revenue recognition for base investment management and advisory fees, distribution revenues, shareholder servicing revenues or broker-dealer revenues. Some performance-based fees and carried-interest distributions that were recognized prior to adoption when no risk of reversal remained, in certain instances may now be recognized earlier if it is probable that significant reversal will not occur. Description Effect on the Financial Statement or Other Significant Matters ASU 2016-01 This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in a reclassification adjustment of $7 million from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $46 million common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15 Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07 This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09 This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02 Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by increasing AOCI and decreasing retained earnings by $89 million. ASU 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018, the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17 Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13 This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. ASU 2018-07 Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2017-12 The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02 This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company will adopt ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $750 million to $850 million and operating lease liabilities ranging from $950 million to $1.1 billion, respectively, for operating leases. The adoption of this standard will not have a significant impact on opening retained earnings. Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of policy related amounts and deferred income taxes. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value . Real estate held for the production of income is stated at depreciated cost less valuation allowances. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag . Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the statements of Net income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2018 , 2017 and 2016 , the carrying value of COLI was $872 million , $918 million and $889 million , respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. Cash and securities segregated primarily includes U.S. Treasury Bills segregated by AB in a special reserve bank custody account for the exclusive benefit of its brokerage customers under Rule 15c3-3 of the Exchange Act. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis . Derivatives Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include equity, currency, and interest rate futures, total return and/or other equity swaps, interest rate swaps and floors, swaptions, variance swaps and equity options, all of which may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models. Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities”. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related Credit Support Annex (“CSA”) have been executed. The Company uses derivatives to manage asset/liability risk and has designated some of those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company’s freestanding derivative positions not designated to hedge accounting relationships, including net receipts and payments, are included in “Net derivative gains (losses)” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of income (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value. Securities Repurchase and Reverse Repurchase Agreements Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date prior to maturity at a fixed and determinable price. Transfers of securities under these agreements to repurchase or resell are evaluated by the Company to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases with related forward repurchase or resale commitments. All of the Company’s securities repurchase transactions are accounted for as collateralized borrowings with the related obligations distinctly captioned in the consolidated balance sheets. Earnings from investing activities related to the cash received under the Company’s securities repurchase arrangements are reported in the consolidated statements of income (loss) as “Net investment income” and the associated borrowing cost is reported as “Interest expense.” The Company has not actively engaged in securities reverse repurchase transactions. Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used. For commercial and agricultural mortgage loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management’s judgment in determining allowance for credit losses include the following: • Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property. An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100%. In the case where the loan-to-value is in excess of 100%, the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance. • Debt service coverage ratio – Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Maturity – Mortgage loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower’s ability to refinance the debt and/or pay off the balloon balance. • Borrower/tenant related issues – Financial concerns, potential bankruptcy or words or actions that indicate imminent default or abandonment of property. • Payment status (current vs. delinquent) – A history of delinquent payments may be a cause for concern. • Property condition – Significant deferred maintenance observed during the lenders annual site inspections. • Other – Any other factors such as current economic conditions may call into question the performance of the loan. Mortgage loans also are individually evaluated quarterly by the Company’s IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. For problem mortgage loans, a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for mortgage loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan-specific portion of the loss allowance is based on the Company’s assessment as to ultimate collectability of

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Investments	INVESTMENTS Fixed Maturities The following tables provide information relating to fixed maturities classified as AFS. As a result of the adoption of “Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities” (ASU 2016-01) on January 1, 2018 (see Note 2), equity securities are no longer classified and accounted for as available-for-sale securities. Available-for-Sale Securities by Classification Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value OTTI in AOCI (4) (in millions) December 31, 2018: Fixed Maturities: Corporate (1) $ 30,572 $ 406 $ 800 $ 30,178 $ — U.S. Treasury, government and agency 14,004 295 470 13,829 — States and political subdivisions 415 47 1 461 — Foreign governments 524 19 13 530 — Residential mortgage-backed (2) 225 10 1 234 — Asset-backed (3) 612 1 12 601 2 Redeemable preferred stock 449 15 18 446 — Total at December 31, 2018 $ 46,801 $ 793 $ 1,315 $ 46,279 $ 2 December 31, 2017: Fixed Maturities: Corporate (1) $ 24,480 $ 1,031 $ 65 $ 25,446 $ — U.S. Treasury, government and agency 17,759 1,000 251 18,508 — States and political subdivisions 422 67 — 489 — Foreign governments 395 29 5 419 — Residential mortgage-backed (2) 797 22 1 818 — Asset-backed (3) 745 5 1 749 2 Redeemable preferred stock 470 43 1 512 — Total Fixed Maturities 45,068 2,197 324 46,941 2 Equity securities 188 2 — 190 — Total at December 31, 2017 $ 45,256 $ 2,199 $ 324 $ 47,131 $ 2 _____________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in income (loss) in accordance with current accounting guidance. The contractual maturities of AFS fixed maturities at December 31, 2018 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) December 31, 2018: Due in one year or less $ 2,598 $ 2,603 Due in years two through five 9,396 9,444 Due in years six through ten 16,501 16,327 Due after ten years 17,020 16,624 Subtotal 45,515 44,998 Residential mortgage-backed securities 225 234 Asset-backed securities 612 601 Redeemable preferred stock 449 446 Total at December 31, 2018 $ 46,801 $ 46,279 The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities for the years ended December 31, 2018 , 2017 and 2016 : For the Years Ended December 31, 2018 2017 2016 (in millions) Proceeds from sales $ 8,523 $ 8,213 $ 5,036 Gross gains on sales $ 180 $ 107 $ 212 Gross losses on sales $ (215 ) $ (259 ) $ (60 ) Total OTTI $ (42 ) $ (15 ) $ (68 ) Non-credit losses recognized in OCI — — — Credit losses recognized in net income (loss) $ (42 ) $ (15 ) $ (68 ) The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments 2018 2017 (in millions) Balances at January 1, $ (18 ) $ (239 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 2 236 Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired (42 ) (14 ) Additional impairments this period on securities previously impaired — (1 ) Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at December 31, $ (58 ) $ (18 ) _____________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: As of December 31, 2018 2017 (in millions) AFS Securities: Fixed maturities: With OTTI loss $ — $ 2 All other (522 ) 1,871 Equity securities — 2 Net Unrealized Gains (Losses) $ (522 ) $ 1,875 Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized, and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 2 $ — $ (1 ) $ — $ 1 Net investment gains (losses) arising during the period (1 ) — — — (1 ) Reclassification adjustment: Included in Net income (loss) (1 ) — — — (1 ) Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — — — — — Deferred income taxes — — — — — Policyholders’ liabilities — — 1 — 1 Balance, December 31, 2018 $ — $ — $ — $ — $ — Balance, January 1, 2017 $ 19 $ 1 $ (10 ) $ (4 ) $ 6 Net investment gains (losses) arising during the period (18 ) — — — (18 ) Reclassification adjustment Included in Net income (loss) 1 — — — 1 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — 4 4 Policyholders’ liabilities — — 9 — 9 Balance, December 31, 2017 $ 2 $ — $ (1 ) $ — $ 1 _______________ (1) Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss. All Other Net Unrealized Investment Gains (Losses) in AOCI Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1,871 $ (358 ) $ (238 ) $ (397 ) $ 878 Net investment gains (losses) arising during the period (2,470 ) — — — (2,470 ) Reclassification adjustment: Included in Net income (loss) 77 — — — 77 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 458 — — 458 Deferred income taxes (2) — — — 501 501 Policyholders’ liabilities — — 165 — 165 Balance, December 31, 2018 $ (522 ) $ 100 $ (73 ) $ 104 $ (391 ) Balance, January 1, 2017 $ 528 $ (45 ) $ (192 ) $ (102 ) $ 189 Net investment gains (losses) arising during the period 1,329 — — — 1,329 Reclassification adjustment: Included in Net income (loss) 14 — — — 14 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (313 ) — — (313 ) Deferred income taxes — — — (295 ) (295 ) Policyholders’ liabilities — — (46 ) — (46 ) Balance, December 31, 2017 $ 1,871 $ (358 ) $ (238 ) $ (397 ) $ 878 ______________ (1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss. (2) Includes a $113 million income tax benefit from the impact of adoption of ASU 2018-02. The following tables disclose the fair values and gross unrealized losses of the 1,700 issues at December 31, 2018 and the 752 issues at December 31, 2017 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) December 31, 2018: Fixed Maturities: Corporate $ 8,964 $ 313 $ 8,244 $ 487 $ 17,208 $ 800 U.S. Treasury, government and agency 1,077 53 4,306 417 5,383 470 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 29 1 29 1 Asset-backed 563 11 13 1 576 12 Redeemable preferred stock 165 13 33 5 198 18 Total $ 10,878 $ 393 $ 12,720 $ 922 $ 23,598 $ 1,315 December 31, 2017: Fixed Maturities: Corporate $ 2,903 $ 23 $ 1,331 $ 42 $ 4,234 $ 65 U.S. Treasury, government and agency 2,718 6 4,506 245 7,224 251 States and political subdivisions 20 — — — 20 — Foreign governments 11 — 73 5 84 5 Residential mortgage-backed 62 — 76 1 138 1 Asset-backed 15 1 12 — 27 1 Redeemable preferred stock 10 — 13 1 23 1 Total $ 5,739 $ 30 $ 6,011 $ 294 $ 11,750 $ 324 The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.7% of total investments. The largest exposures to a single issuer of corporate securities held at December 31, 2018 and 2017 were $226 million and $207 million , respectively. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At December 31, 2018 and 2017 , respectively, approximately $1,268 million and $1,372 million , or 2.7% and 3.0% , of the $46,801 million and $45,068 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized (losses) and gains of $(31) million and $5 million at December 31, 2018 and 2017 , respectively. At December 31, 2018 and 2017 , respectively, the $922 million and $294 million of gross unrealized losses of twelve months or more were concentrated in corporate and U.S. Treasury, government and agency securities. In accordance with the policy described in Note 2 , the Company concluded that an adjustment to income for OTTI for these securities was not warranted at either December 31, 2018 or 2017 . At December 31, 2018 , the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. The Company does not originate, purchase or warehouse residential mortgages and is not in the mortgage servicing business. At December 31, 2018 , the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $2 million . At December 31, 2018 and 2017 , respectively, the fair value of the Company’s trading account securities was $16,017 million and $14,170 million . Also at December 31, 2018 and 2017 , respectively, trading account securities included the General Account’s investment in Separate Accounts which had carrying values of $49 million a nd $50 million . Mortgage Loans The payment terms of mortgage loans may from time to time be restructured or modified. At December 31, 2018 and 2017, the carrying values of problem commercial mortgage loans on real estate that had been classified as non-accrual loans were $19 million and $19 million , respectively. Valuation Allowances for Mortgage Loans: The change in the valuation allowance for credit losses for commercial mortgage loans during the years ended December 31, 2018 , 2017 and 2016 was as follows: Commercial Mortgage Loans 2018 2017 2016 (in millions) Allowance for credit losses: Beginning Balance, January 1 $ 8 $ 8 $ 6 Charge-offs — — — Recoveries (1 ) — (2 ) Provision — — 4 Ending Balance, December 31 $ 7 $ 8 $ 8 Ending Balance, December 31 Individually Evaluated for Impairment $ 7 $ 8 $ 8 There were no allowances for credit losses for agricultural mortgage loans in 2018 , 2017 and 2016 . The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at December 31, 2018 and 2017 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Total Mortgage Loans Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 1.5x to 1.2x to 1.0x to Less than (in millions) December 31, 2018: Commercial Mortgage Loans (1) 0% - 50% $ 797 $ 21 $ 247 $ 24 $ — $ — $ 1,089 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,965 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,147 Agricultural Mortgage Loans (1) 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans (1) 0% - 50% $ 1,079 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,700 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,359 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,842 December 31, 2017: Commercial Mortgage Loans (1) 0% - 50% $ 759 $ — $ 320 $ 74 $ — $ — $ 1,153 50% - 70% 4,088 682 1,066 428 145 — 6,409 70% - 90% 169 110 196 272 50 — 797 90% plus — — 27 — — — 27 Total Commercial Mortgage Loans $ 5,016 $ 792 $ 1,609 $ 774 $ 195 $ — $ 8,386 Agricultural Mortgage Loans (1) 0% - 50% $ 272 $ 149 $ 275 $ 515 $ 316 $ 30 $ 1,557 50% - 70% 111 46 227 359 221 49 1,013 70% - 90% — — — 4 — — 4 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 383 $ 195 $ 502 $ 878 $ 537 $ 79 $ 2,574 Total Mortgage Loans (1) 0% - 50% $ 1,031 $ 149 $ 595 $ 589 $ 316 $ 30 $ 2,710 50% - 70% 4,199 728 1,293 787 366 49 7,422 70% - 90% 169 110 196 276 50 — 801 90% plus — — 27 — — — 27 Total Mortgage Loans $ 5,399 $ 987 $ 2,111 $ 1,652 $ 732 $ 79 $ 10,960 ______________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually. The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2018 and 2017 , respectively. Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) December 31, 2018: Commercial $ — $ — $ 27 $ 27 $ 9,120 $ 9,147 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,747 $ 11,842 $ 40 December 31, 2017: Commercial $ 27 $ — $ — $ 27 $ 8,359 $ 8,386 $ — Agricultural 49 3 22 74 2,500 2,574 22 Total Mortgage Loans $ 76 $ 3 $ 22 $ 101 $ 10,859 $ 10,960 $ 22 The following table provides information relating to impaired mortgage loans at December 31, 2018 and 2017 , respectively. Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) December 31, 2018: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans 2 2 — — — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (7 ) $ 27 $ — December 31, 2017: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans — — — — — Total $ — $ — $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (8 ) $ 27 $ 2 Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (8 ) $ 27 $ 2 ___________ (1) Represents a five-quarter average of recorded amortized cost. Derivatives and Offsetting Assets and Liabilities The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers without any basis risk due to market exposures, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. The Company implemented a strategy to hedge a portion of the credit exposure in its General Account investment portfolio by buying protection through a swap. These are swaps on the “super senior tranche” of the investment grade CDX index. Under the terms of these swaps, the Company pays quarterly fixed premiums that, together with any initial amount paid or received at trade inception, serve as premiums paid to hedge the risk arising from multiple defaults of bonds referenced in the CDX index. These credit derivatives have terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net derivative gains (losses). In 2016, the Company implemented a program to mitigate its duration gap using total return swaps for which the reference U.S. Treasury securities are sold to the swap counterparty under arrangements economically similar to repurchase agreements. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. Under this program, the Company derecognized approximately $3,905 million of U.S. Treasury securities for which the Company received proceeds of approximately $3,905 million at inception of the total return swap contract. Under the terms of these swaps, the Company retains ongoing exposure to the total returns of the underlying U.S. Treasury securities in exchange for a financing cost. At December 31, 2018, the aggregate fair value of U.S. Treasury securities derecognized under this program was approximately $3,690 million . Reported in Other invested assets in the Company’s balance sheet at December 31, 2018 is approximately $24 million , representing the fair value of the total return swap contracts. Derivatives used to hedge currency fluctuations on affiliated loans The Company uses foreign exchange derivatives to reduce exposure to currency fluctuations that may arise from non-U.S.-dollar denominated financial instruments. The Company had a currency swap contract with AXA to hedge foreign exchange exposure from affiliated loans, which matured in March 2018. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At December 31, 2018 Fair Value Gains (Losses) Reported In Earnings (Loss) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (6): Equity contracts: Futures $ 11,143 $ 2 $ 3 $ 541 Swaps 7,796 143 168 715 Options 21,821 2,133 1,164 (899 ) Interest rate contracts: Swaps 27,116 634 196 (656 ) Futures 11,792 — — 112 Credit contracts: Credit default swaps 1,376 20 3 (2 ) Other freestanding contracts: Foreign currency contracts 2,184 35 22 6 Margin — 18 5 — Collateral — 8 1,581 — Embedded Derivatives: GMIB reinsurance contracts (6) — 1,732 — (162 ) GMxB derivative features liability (3) (6) — — 5,614 (775 ) SCS, SIO, MSO and IUL indexed features (5) (6) — — 715 889 Net derivative investment gains (loss) (231 ) Cross currency swaps (2) (4) — — — 9 Balances, December 31, 2018 $ 83,228 $ 4,725 $ 9,471 $ (222 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Other assets or Other liabilities in the consolidated balance sheets. (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) Reported in Other income in the consolidated statements of income (loss). (5) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (6) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). Derivative Instruments by Category At December 31, 2017 Fair Value Gains (Losses) Reported In Earnings (Loss) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (6): Equity contracts: Futures $ 6,716 $ 1 $ 2 $ (1,297 ) Swaps 7,623 4 201 (1,413 ) Options 22,223 3,456 1,457 1,265 Interest rate contracts: Swaps 26,769 604 193 863 Futures 20,675 — — 293 Credit contracts: Credit default swaps 2,131 35 3 19 Other freestanding contracts: Foreign currency contracts 1,423 19 10 (39 ) Margin — 24 4 — Collateral — 4 2,123 — Embedded Derivatives: GMIB reinsurance contracts (6) — 1,894 — 174 GMxB derivative features liability (3) (6) — — 4,451 1,652 SCS, SIO, MSO and IUL indexed features (5) (6) — — 1,786 (1,303 ) Net derivative gains (loss) 214 Cross currency swaps (2) (4) 354 5 — 40 Balances, December 31, 2017 $ 87,914 $ 6,046 $ 10,230 $ 254 _________________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Other assets or Other liabilities in the consolidated balance sheets. (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) Reported in Other income in the consolidated statements of income (loss). (5) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (6) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at December 31, 2018 are exchange-traded and net settled daily in cash. At December 31, 2018 , the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000 and Emerging Market indices, having initial margin requirements of $279 million , (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $71 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $25 million . Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At December 31, 2018 and 2017, respectively, the Company held $1,581 million and $2,123 million in cash and securities collateral delivered by trade counterparties

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill represents the excess of purchase price over the estimated fair value of identifiable net assets acquired in a business combination. The Company tests goodwill for recoverability each annual reporting period at December 31 and at interim periods if facts or circumstances are indicative of potential impairment. The Company managed its business under two operating segments through third quarter 2017, each deemed to be reporting units for purpose of its goodwill impairment assessments. Effective January 1, 2017, the Company early adopted the new goodwill guidance that eliminates Step 2 from the impairment model and continues to limit the measure of goodwill impairment to the carrying amount of the reporting unit’s goodwill. As a result, the Company recognized an impairment loss of $369 million during first quarter 2017, representing all of the goodwill assigned to its Financial Advisory/Insurance reporting unit for which recoverability previously had been supported by a Step 2 assessment. The carrying value of goodwill assigned to the Company’s Investment Management reporting unit totaled $4,570 million at both December 31, 2018 and 2017 , resulting from its investment in AB as well as direct strategic acquisitions of AB, including its purchase of Sanford C. Bernstein, Inc. For purpose of testing this goodwill for impairment, the Company applied a discounted cash flow valuation technique to measure the fair value of the reporting unit, sourcing the underlying cash flows and assumptions from AB’s current business plan projections and adjusting the result to reflect the noncontrolling interest in AB as well as incremental taxes at the Company level as related to the form and structure of its investment in AB. At December 31, 2018 and 2017 , the Company’s annual testing resulted in no impairment of this goodwill, as the fair value of the reporting unit exceeded its carrying amount at each respective date. In the fourth quarter 2017 , the Company recast its Financial Advisory/Insurance segment into multiple operating segments as described in Note 19 , Business Segment Information. Accordingly, goodwill previously attributed to the Financial Advisory/Insurance segment in reporting periods prior thereto was reassigned to the reporting units affected using a relative fair value allocation approach in accordance with the relevant accounting guidance. Goodwill resulting from the Company’s investment in AB was reassigned to the Company’s Investment Management and Research segment and the resulting reporting unit redefined. Immediately prior thereto, the Company determined there were no indications of potential goodwill impairment that would require quantitative assessment prior to its annual testing. Information regarding goodwill by reporting segment and Corporate and Other is as follows: Individual Retirement Group Retirement Protection Solutions Corporate and Other Subtotal Investment Management and Research Total (in millions) 2016 Goodwill, beginning of year $ 53 $ 122 $ 139 $ 55 $ 369 $ 4,548 $ 4,917 Goodwill acquired during year — — — — — 22 22 Impairment losses recognized during the year — — — — — — — Goodwill, end of year, net $ 53 $ 122 $ 139 $ 55 $ 369 $ 4,570 $ 4,939 2017 Goodwill acquired during year $ — — — — — — — Impairment losses recognized during the year (53 ) (122 ) (139 ) (55 ) (369 ) — (369 ) Goodwill, end of year, net $ — $ — $ — $ — $ — $ 4,570 $ 4,570 2018 Goodwill acquired during year $ — $ — $ — $ — $ — $ — $ — Impairment losses recognized during the year — — — — — — — Goodwill, end of year, net $ — $ — $ — $ — $ — $ 4,570 $ 4,570 At December 31, 2018 and 2017 , respectively, net deferred sales commissions from AB totaled $17 million and $30 million and are included within other assets. The estimated amortization expense of deferred sales commissions, based on the December 31, 2018 net asset balance for each of the next five years is $10 million , $5 million , $3 million , $0 million and $0 million . The Company tests the deferred sales commission asset for impairment quarterly by comparing undiscounted future cash flows to the recorded value, net of accumulated amortization. Each quarter, significant assumptions used to estimate the future cash flows are updated to reflect management’s consideration of current market conditions on expectations made with respect to future market levels and redemption rates. As of December 31, 2018 and 2017 , the Company determined that the deferred sales commission asset was not impaired. The gross carrying amount of AB-related intangible assets was $909 million at both December 31, 2018 and 2017 , and the accumulated amortization of these intangible assets was $702 million and $659 million at December 31, 2018 and 2017 , respectively. Amortization expense for AB-related intangible assets totaled $43 million , $44 million and $42 million for 2018 , 2017 and 2016 , respectively. Estimated annual amortization expense for each of the next five years is approximately $43 million , $36 million , $20 million , $19 million and $16 million , respectively. On June 20, 2014, AB acquired an 81.7% ownership interest in CPH Capital Fondsmaeglerselskab A/S (“CPH”), a Danish asset management firm that managed approximately $3,000 million in global core equity assets for institutional investors, for a cash payment of $64 million and a contingent consideration payable of $9 million based on projected assets under management levels over a three-year measurement period. Also recognized on the date of acquisition were $58 million of goodwill, $24 million of finite-lived intangible assets related to separately-managed account relationships, and $4 million of indefinite-lived intangible assets related to an acquired fund’s investment contract. Redeemable noncontrolling interest of $17 million was recorded as related to the fair value of CPH not purchased by AB. During 2017 and 2018 , AB purchased additional shares of CPH, bringing its ownership interest to 96.8% as of December 31, 2018 . The acquisitions described above did not have a significant impact on the Company’s consolidated revenues or net income. As a result, supplemental pro forma information has not been provided. Additional information regarding the contingent payment obligations associated with these and other acquisitions made by AB is included in Note 7 , Fair Value Disclosures. Capitalized Software Capitalized software, net of accumulated amortization, amounted to $181 million and $162 million at December 31, 2018 and 2017 , respectively, and is recorded in Other assets. Amortization of capitalized software in 2018 , 2017 and 2016 was $49 million , $51 million and $56 million , respectively, recorded in other Operating costs and expenses in the consolidated statements of income (loss).

CLOSED BLOCK

CLOSED BLOCK	12 Months Ended
	Dec. 31, 2018
Closed Block Disclosure [Abstract]
Closed Block	CLOSED BLOCK As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders. Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) represents the expected maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. As of January 1, 2001, the Company has developed an actuarial calculation of the expected timing of the Closed Block’s earnings. If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block. Many expenses related to Closed Block operations, including amortization of DAC, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block. Summarized financial information for the Company’s Closed Block is as follows: As of December 31, 2018 2017 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,709 $ 6,958 Policyholders’ dividend obligation — 19 Other liabilities 47 271 Total Closed Block liabilities 6,756 7,248 Assets Designated To The Closed Block: Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923) 3,672 4,070 Mortgage loans on real estate, net of valuation allowance of $- and $- 1,824 1,720 Policy loans 736 781 Cash and other invested assets 76 351 Other assets 179 182 Total assets designated to the Closed Block 6,487 7,104 Excess of Closed Block liabilities over assets designated to the Closed Block 269 144 Amounts included in Accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders' dividend obligation of $- and $19 8 138 Maximum future income to be recognized from closed block assets and liabilities $ 277 $ 282 The Company’s Closed Block revenues and expenses follow : Years ended December 31, 2018 2017 2016 (in millions) Revenues: Premiums and other income $ 194 $ 224 $ 212 Net investment income (loss) 291 314 349 Investment gains (losses), net (3 ) (20 ) (1 ) Total revenues 482 518 560 Benefits and Other Deductions: Policyholders’ benefits and dividends 471 537 522 Other operating costs and expenses 3 2 4 Total benefits and other deductions 474 539 526 Net income, before income taxes 8 (21 ) 34 Income tax (expense) benefit (3 ) (36 ) (12 ) Net income (losses) $ 5 $ (57 ) $ 22 A reconciliation of the Company’s policyholders’ dividend obligation follows: December 31, 2018 2017 (in millions) Balance, beginning of year $ 19 $ 52 Unrealized investment gains (losses) (19 ) (33 ) Balance, end of year $ — $ 19

DAC AND POLICYHOLDER BONUS INTE

DAC AND POLICYHOLDER BONUS INTEREST CREDITS	12 Months Ended
	Dec. 31, 2018
Contractholder Bonus Interest Credits [Abstract]
DAC and Policyholder Bonus Interest Credits	DAC AND POLICYHOLDER BONUS INTEREST CREDITS Changes in the deferred policy acquisition cost asset for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 5,919 $ 6,049 $ 6,047 Capitalization of commissions, sales and issue expenses 701 687 697 Amortization: Impact of assumptions updates and model changes 286 112 (201 ) All other (619 ) (615 ) (578 ) Total amortization (333 ) (503 ) (779 ) Change in unrealized investment gains and losses 458 (314 ) 84 Balance, end of year $ 6,745 $ 5,919 $ 6,049 Changes in the deferred asset for policyholder bonus interest credits for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 473 $ 504 $ 534 Policyholder bonus interest credits deferred 4 7 13 Amortization charged to income (51 ) (38 ) (43 ) Balance, end of year $ 426 $ 473 $ 504

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value Disclosures	FAIR VALUE DISCLOSURES The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and liabilities measured at fair value on a recurring basis are summarized below. At December 31, 2018 and December 31, 2017 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 28,992 $ 1,186 $ 30,178 U.S. Treasury, government and agency — 13,829 — 13,829 States and political subdivisions — 422 39 461 Foreign governments — 530 — 530 Residential mortgage-backed (2) — 234 — 234 Asset-backed (3) — 82 519 601 Redeemable preferred stock 167 279 — 446 Total fixed maturities, available-for-sale 167 44,368 1,744 46,279 Other equity investments 11 — 74 85 Trading securities 446 15,507 64 16,017 Other invested assets: Short-term investments — 515 — 515 Assets of consolidated VIEs/VOEs 92 259 27 378 Swaps — 426 — 426 Credit default swaps — 17 — 17 Futures (1 ) — — (1 ) Options — 968 — 968 Total other invested assets 91 2,185 27 2,303 Cash equivalents 3,482 — — 3,482 Segregated securities — 1,170 — 1,170 GMIB reinsurance contracts asset — — 1,732 1,732 Separate Accounts assets 106,994 2,747 374 110,115 Total Assets $ 111,191 $ 65,977 $ 4,015 $ 181,183 Level 1 Level 2 Level 3 Total (in millions) Liabilities GMxB derivative features’ liability $ — $ — $ 5,614 $ 5,614 SCS, SIO, MSO and IUL indexed features’ liability — 715 — 715 Liabilities of consolidated VIEs and VOEs — 7 — 7 Contingent payment arrangements — — 7 7 Total Liabilities $ — $ 722 $ 5,621 $ 6,343 ____________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 24,296 $ 1,150 $ 25,446 U.S. Treasury, government and agency — 18,508 — 18,508 States and political subdivisions — 449 40 489 Foreign governments — 419 — 419 Residential mortgage-backed (2) — 818 — 818 Asset-backed (3) — 208 541 749 Redeemable preferred stock 184 327 1 512 Total fixed maturities, available-for-sale 184 45,025 1,732 46,941 Other equity investments 13 — 34 47 Trading securities 485 13,647 38 14,170 Other invested assets Short-term investments — 1,730 — 1,730 Assets of consolidated VIEs/VOEs 1,060 215 27 1,302 Swaps — 222 — 222 Credit default swaps — 33 — 33 Futures (2 ) — — (2 ) Foreign currency contract (4) — 5 — 5 Options — 1,999 — 1,999 Total other invested assets 1,058 4,204 27 5,289 Cash equivalents 3,608 — — 3,608 Segregated securities — 825 — 825 GMIB reinsurance contracts asset — — 1,894 1,894 Separate Accounts assets 121,000 2,997 349 124,346 Total Assets $ 126,348 $ 66,698 $ 4,074 $ 197,120 Liabilities GMxB derivative features’ liability $ — $ — $ 4,451 $ 4,451 SCS, SIO, MSO and IUL indexed features’ liability — 1,786 — 1,786 Liabilities of consolidated VIEs and VOEs 670 22 — 692 Contingent payment arrangements — — 15 15 Total Liabilities $ 670 $ 1,808 $ 4,466 $ 6,944 ___________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Reported in Other assets in the consolidated balance sheets. The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. The net fair value of the Company’s freestanding derivative positions as disclosed in Note 3 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Account assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature. Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products such as the SCS and EQUI-VEST variable annuity products, and in the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have 1, 3, 5, or 6-year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g. holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, asset-backed securities are classified as Level 3. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the GMIBNLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity separate account funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $112 million and $8 million at December 31, 2018 and 2017 , respectively, to recognize incremental counterparty non-performance risk and reduced the fair value of its GMIB reinsurance contract liabilities by $41 million and $24 million at December 31, 2018 and 2017 , respectively to recognize its own incremental non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2010, 2014 and 2016 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon revenue and discount rate projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. The Company’s Level 3 liabilities also include contingent payment arrangements associated with a Renewal Rights Agreement (the “Renewal Rights Agreement”) that transitions certain group employee benefits policies beginning January 1, 2017 from an insurer exiting such business to MONY Life Insurance Company of America (“MLOA”). The fair value of the contingent payments liability associated with this transaction is measured and adjusted each reporting period through final settlement using projected premiums from these policies, net of potential surrenders and terminations, and applying a risk-adjusted discount factor ( 8.6% at December 31, 2018 ) to the resulting cash flows. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3 and primarily consist of corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. In 2018 , AFS fixed maturities with fair values of $28 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $89 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.8% of total equity at December 31, 2018 . In 2017 , AFS fixed maturities with fair values of $5 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $7 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.1% of total equity at December 31, 2017 . The table below presents a reconciliation for all Level 3 assets and liabilities at December 31, 2018 , 2017 and 2016 respectively: Level 3 Instruments Fair Value Measurements Corporate State and Foreign Commercial Asset- (in millions) Balance, January 1, 2018 $ 1,150 $ 40 $ — $ — $ 541 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 8 — — — — Investment gains (losses), net (9 ) — — — — Subtotal (1 ) — — — — Other comprehensive income (loss) (21 ) (1 ) — — (9 ) Purchases 334 — — — 17 Sales (337 ) (1 ) — — (30 ) Transfers into Level 3 (1) 89 1 — — — Transfers out of Level 3 (1) (28 ) — — — — Balance, December 31, 2018 $ 1,186 $ 39 $ — $ — $ 519 Balance, January 1, 2017 $ 857 $ 42 $ — $ 373 $ 120 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 4 — — (2 ) — Investment gains (losses), net 1 — — (95 ) 15 Subtotal 5 — — (97 ) 15 Other comprehensive income (loss) 4 (1 ) — 78 (7 ) Purchases 615 — — — 434 Sales (333 ) (1 ) — (354 ) (21 ) Transfers into Level 3 (1) 7 — — — — Transfers out of Level 3 (1) (5 ) — — — — Balance, December 31, 2017 $ 1,150 $ 40 $ — $ — $ 541 Balance, January 1, 2016 $ 430 $ 45 $ 1 $ 535 $ 41 Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net 2 — — (71 ) — Other comprehensive income (loss) 8 (2 ) — 14 1 Purchases 574 — — — 96 Sales (144 ) (1 ) — (91 ) (9 ) Transfers into Level 3 (1) 25 — — — — Transfers out of Level 3 (1) (38 ) — (1 ) (14 ) (9 ) Balance, December 31, 2016 $ 857 $ 42 $ — $ 373 $ 120 Redeem- able Preferred Stock Other Equity Invest- ments GMIB Reinsur- ance Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrange- ment (in millions) Balance, January 1, 2018 $ 1 $ 99 $ 1,894 $ 349 $ (4,451 ) $ (15 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — (3 ) — 26 — — Net derivative gains (losses), excluding non-performance risk — — (131 ) — (1,272 ) — Non-performance risk (5) — — (33 ) — 497 — Subtotal — (3 ) (164 ) 26 (775 ) — Other comprehensive income (loss) — 15 — — — — Purchases (2) — 62 46 5 (412 ) — Sales (3) (1 ) (3 ) (44 ) (1 ) 24 — Settlements (4) — — — (5 ) — 6 Change in estimate — — — — — 2 Activity related to consolidated VIEs/VOEs — (6 ) — — — — Transfers into Level 3 (1) — 6 — — — — Transfers out of Level 3 (1) — (5 ) — — — — Balance, December 31, 2018 $ — $ 165 $ 1,732 $ 374 $ (5,614 ) $ (7 ) Balance, January 1, 2017 $ 1 $ 88 $ 1,735 $ 313 $ (5,731 ) $ (25 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 29 — — Net derivative gains (losses), excluding non-performance risk — — 171 — 1,809 — Non-performance risk (5) — — 3 — (157 ) — Subtotal — — 174 29 1,652 — Other comprehensive income(loss) — 14 — — — — Purchases (2) — 22 48 13 (393 ) — Sales (3) — (3 ) (63 ) (2 ) 21 — Settlements (4) — — — (4 ) — 10 Activity related to consolidated VIEs/VOEs — (22 ) — — — — Transfers into Level 3 (1) — — — — — — Transfers out of Level 3 (1) — — — — — — Balance, December 31, 2017 $ 1 $ 99 $ 1,894 $ 349 $ (4,451 ) $ (15 ) Redeem- able Preferred Stock Other Equity Invest- ments GMIB Reinsur- ance Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrange- ment (in millions) Balance, January 1, 2016 $ — $ 81 $ 1,829 $ 313 $ (5,534 ) $ (31 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 19 — — Net derivative gains (losses), excluding non-performance risk — — (75 ) — 417 — Non-performance risk (5) — — (2 ) — (281 ) — Subtotal — — (77 ) 19 136 — Other comprehensive income (loss) — (1 ) — — — — Purchases (2) 1 4 48 10 (356 ) (18 ) Sales (3) — — (65 ) — 23 — Activity related to consolidated VIEs/VOEs — 60 — (7 ) — 24 Transfers into Level 3 (1) — — — 1 — — Transfers out of Level 3 (1) — (56 ) — (23 ) — — Balance, December 31, 2016 $ 1 $ 88 $ 1,735 $ 313 $ (5,731 ) $ (25 ) ___________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) For contingent payment arrangements, it represents payments under the arrangement. (5) The Company’s non-performance risk is recorded through Net derivative gains (losses). The table below details changes in unrealized gains (losses) for 2018 , 2017 and 2016 by category for Level 3 assets and liabilities still held at December 31, 2018 , 2017 and 2016 respectively. Earnings (Loss) Investment Gains Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ (19 ) State and political subdivisions — — (1 ) Commercial mortgage-backed — — — Asset-backed — — (6 ) Subtotal — — (26 ) GMIB reinsurance contracts — (164 ) — Separate Accounts assets (1) 26 — — GMxB derivative features liability — (775 ) — Total $ 26 $ (939 ) $ (26 ) Earnings (Loss) Investment Gains Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2017: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 5 State and political subdivisions — — (1 ) Commercial mortgage-backed — — — Asset-backed — — 1 Subtotal — — 5 GMIB reinsurance contracts — 174 — Separate Accounts assets (1) 29 — — GMxB derivative features liability — 1,652 — Total $ 29 $ 1,826 $ 5 Held as of December 31, 2016: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 11 State and political subdivisions — — (2 ) Commercial mortgage-backed — — 10 Asset-backed — — 1 Subtotal — — 20 GMIB reinsurance contracts — (77 ) — Separate Accounts assets (1) 20 — — GMxB derivative features liability — 136 — Total $ 20 $ 59 $ 20 ______________ (1) There is an investment expense that offsets this investment gain (loss). The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of December 31, 2018 and 2017 , respectively. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 99 Matrix pricing model Spread over Benchmark 15 - 580 bps 109 bps 881 Market EBITDA multiples 4.1x - 37.8x 12.1x Other equity investments 35 Discounted cash flow Earnings multiple 9.4x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve Discount factor 248bps GMIB reinsurance contract asset 1,732 Discounted cash flow Lapse rates 1% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk 189 bps Assumed GMIB Reinsurance Contracts 183 Discounted cash flow Lapse rates 1.1% - 11.2% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 0.5% - 11.0% Quantitative Information about Level 3 Fair Value Measurements at December 31, 2017 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 53 Matrix pricing model Spread over the industry-specific benchmark yield curve 0 bps-565 bps 125 bps 789 Market comparable companies EBITDA multiples 5.3x - 27.9x 12.9x Other equity investments 38 Discounted cash flow Earnings multiple 10.8x Separate Accounts assets 326 Third party appraisal Capitalization rate 4.6% 1 Discounted cash flow Spread over U.S. Treasury curve 243 bps GMIB reinsurance contract asset 1,894 Discounted Cash flow Lapse rates 1.0% - 6.3% Liabilities: GMIBNLG 4,149 Discounted cash flow Non-performance risk 1.0% Assumed GMIB Reinsurance Contracts 194 Discounted cash flow Lapse rates 1.1% - 13.3% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.9% - 5.7% GIB (27 ) Discounted cash flow Lapse rates 0.9% - 5.7% GMAB 5 Discounted cash flow Lapse rates 0.5% - 11.0% Excluded from the tables above at December 31, 2018 and 2017 , respectively, are approximately $915 million and $973 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an incr

INSURANCE LIABILITIES

INSURANCE LIABILITIES	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Insurance Liabilities	INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following: • Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); • Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); • Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; • Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or • Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. Liabilities for Variable Annuity Contracts with GMDB and GMIB Features and no GMIBNLG Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and no GMIBNLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No GMIBNLG Feature For the Years ended December 31, 2018 , 2017 and 2016 GMDB GMIB Direct Assumed Ceded Direct Assumed Ceded (in millions) Balance at January 1, 2016 $ 2,969 $ 135 $ (98 ) $ 3,842 $ 268 $ (1,829 ) Paid guarantee benefits (357 ) (33 ) 15 (281 ) (20 ) 65 Other changes in reserve 552 19 (7 ) 241 10 27 Balance at December 31, 2016 3,164 121 (90 ) 3,802 258 (1,737 ) Paid guarantee benefits (354 ) (21 ) 14 (151 ) (59 ) 63 Other changes in reserve 1,249 (5 ) (32 ) 1,101 (4 ) (220 ) Balance at December 31, 2017 4,059 95 (108 ) 4,752 195 (1,894 ) Paid guarantee benefits (393 ) (24 ) 16 (153 ) (12 ) 44 Other changes in reserve 993 11 (21 ) (856 ) 1 118 Balance at December 31, 2018 $ 4,659 $ 82 $ (113 ) $ 3,743 $ 184 $ (1,732 ) Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features liability, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7 . Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct and assumed variable annuity contracts in force with GMDB and GMIB features as of December 31, 2018 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features As of December 31, 2018 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,035 $ 102 $ 61 $ 184 $ 14,382 Separate Accounts 41,463 8,382 2,903 30,406 83,154 Total Account Values $ 55,498 $ 8,484 $ 2,964 $ 30,590 $ 97,536 Net Amount at Risk, gross $ 418 $ 791 $ 2,291 $ 20,587 $ 24,087 Net Amount at Risk, net of amounts reinsured $ 418 $ 772 $ 1,615 $ 20,587 $ 23,392 Average attained age of policyholders (in years) 51.4 67.0 73.6 69.0 55.3 Percentage of policyholders over age 70 10.0 % 43.0 % 65.5 % 49.9 % 18.8 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 251 $ 270 Separate Accounts — — 19,407 33,428 52,835 Total Account Values $ — $ — $ 19,426 $ 33,679 $ 53,105 Net Amount at Risk, gross $ — $ — $ 994 $ 9,156 $ 10,150 Net Amount at Risk, net of amounts reinsured $ — $ — $ 309 $ 8,268 $ 8,577 Average attained age of policyholders (in years) N/A N/A 68.9 68.8 68.8 Weighted average years remaining until annuitization N/A N/A 1.7 0.5 0.6 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Assumed Variable Annuity Contracts with GMDB and GMIB Features As of December 31, 2018 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rates) Variable annuity contracts with GMDB features Reinsured Account Values $ 873 $ 5,004 $ 257 $ 1,600 $ 7,734 Net Amount at Risk assumed $ 10 $ 608 $ 26 $ 397 $ 1,041 Average attained age of policyholders (in years) 67 72 77 75 73 Percentage of policyholders over age 70 43.5 % 62.5 % 78.6 % 75.5 % 63.6 % Range of contractually specified interest rates N/A N/A 3%-10% 5%-10% 3%-10% Variable annuity contracts with GMIB features Reinsured Account Values $ 846 $ 43 $ 229 $ 1,124 $ 2,242 Net Amount at Risk assumed $ 2 $ 1 $ 46 $ 313 $ 362 Average attained age of policyholders (in years) 72 74 72 69 70 Percentage of policyholders over age 70 63.2 % 64.5 % 58.8 % 50.4 % 56.4 % Range of contractually specified interest rates (1) N/A N/A 3.3%-6.5% 6%-6% 3.3%-6.5% ___________ (1) In general, for policies with the highest contractual interest rate shown (10%), the rate applied only for the first 10 years after issue, which has now elapsed. For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance Agreements” in Note 10 . Separate Account Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total Account Values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds As of December 31, 2018 2017 GMDB GMIB GMDB GMIB (in millions) Investment type: Equity $ 35,541 $ 15,759 $ 41,658 $ 19,676 Fixed income 5,173 2,812 5,469 3,110 Balanced 41,588 33,974 46,577 38,398 Other 852 290 968 314 Total $ 83,154 $ 52,835 $ 94,672 $ 61,498 Hedging Programs for GMDB, GMIB, GIB and Other Features Beginning in 2003, the Company established a program intended to hedge certain risks associated first with the GMDB feature and, beginning in 2004, with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net investment income (loss) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies – GMIBNLG The GMIBNLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The GMIBNLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the liabilities for GMIBNLG liabilities, reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below. Direct Liability (1) (in millions) Balance at January 1, 2016 $ 1,247 Other changes in reserves 64 Balance at December 31, 2016 1,311 Paid guarantee benefits (24 ) Other changes in reserves (578 ) Balance at December 31, 2017 709 Paid guarantee benefits (23 ) Other changes in reserves 126 Balance at December 31, 2018 $ 812 __________ (1) There were no amounts of reinsurance ceded in any period presented.

REINSURANCE AGREEMENTS

REINSURANCE AGREEMENTS	12 Months Ended
	Dec. 31, 2018
Reinsurance Disclosures [Abstract]
Reinsurance Agreements	REINSURANCE AGREEMENTS The Company assumes and cedes reinsurance with other insurance companies. The Company evaluates the financial condition of its reinsurers to minimize its exposure to significant losses from reinsurer insolvencies. Ceded reinsurance does not relieve the originating insurer of liability. The following table summarizes the effect of reinsurance: Years Ended December 31, 2018 2017 2016 (in millions) Direct premiums $ 1,012 $ 1,038 $ 998 Reinsurance assumed 214 225 231 Reinsurance ceded (132 ) (139 ) (146 ) Net premiums $ 1,094 $ 1,124 $ 1,083 Policy charges and fee income ceded $ 418 $ 381 $ 393 Policyholders’ benefits ceded $ 580 $ 657 $ 871 Interest credited to policyholders’ account balances ceded $ 50 $ 46 $ 51 Ceded Reinsurance The Company reinsures most of its new variable life, UL and term life policies on an excess of retention basis. The Company generally retains on a per life basis up to $25 million for single lives and $30 million for joint lives with the excess 100% reinsured. The Company also reinsures risk on certain substandard underwriting risks and in certain other cases. Effective February 1, 2018, AXA Equitable Life entered into a coinsurance reinsurance agreement (the “Coinsurance Agreement”) to cede 90% of its single premium deferred annuities (“SPDA”) products issued between 1978-2001 and its Guaranteed Growth Annuity (“GGA”) single premium deferred annuity products issued between 2001-2014. As a result of this agreement, AXA Equitable Life transferred securities with a market value of $604 million and cash of $31 million to equal the statutory reserves of approximately $635 million . As the risks transferred by AXA Equitable Life to the reinsurer under the Coinsurance Agreement are not considered insurance risks and therefore do not qualify for reinsurance accounting, AXA Equitable Life applied deposit accounting. Accordingly, AXA Equitable Life recorded the transferred assets of $635 million as a deposit asset recorded in Other assets, net of the ceding commissions paid to the reinsurer. At December 31, 2018 and 2017 , the Company had reinsured with non-affiliates in the aggregate approximately 2.9% and 3.5% , respectively, of its current exposure to the GMDB obligation on annuity contracts in-force and, subject to certain maximum amounts or caps in any one period, approximately 15.5% and 16.8% of its current liability exposure, respectively, resulting from the GMIB feature. For additional information, see Note 8. Based on management’s estimates of future contract cash flows and experience, the estimated net fair values of the ceded GMIB reinsurance contracts, considered derivatives, were $1,732 million and $1,894 million at December 31, 2018 and 2017 , respectively. The estimated fair values decreased $162 million and $93 million during 2018 and 2016, respectively, and increased $159 million during 2017 . At December 31, 2018 and 2017 , third-party reinsurance recoverables related to insurance contracts amounted to $4,895 million and $5,023 million , respectively. Additionally, $2,796 million and $2,962 million of the amounts due from reinsurers relates to two reinsurers, Zurich Insurance Company, Ltd. ( AA- rating by S&P) and Protective Life Insurance Company ( AA- rating by S&P). At December 31, 2018 and 2017 , amounts due to reinsurers were $1,438 million and $1,436 million , respectively. Included in this balance were policy loans ceded to RGA Reinsurance Company of $1,211 million and $1,212 million , respectively and policy loans ceded to Protective Life of $125 million and $128 million , respectively. The Company cedes substantially all of its group health business to a third-party insurer. Insurance liabilities ceded totaled $62 million and $71 million at December 31, 2018 and 2017 , respectively. The Company also cedes a portion of its extended term insurance and paid-up life insurance and substantially all of its individual disability income business through various coinsurance agreements. Assumed Reinsurance In addition to the sale of insurance products, the Company currently assumes risk from professional reinsurers. The Company also has a run-off portfolio of assumed reinsurance liabilities at ACS Life. The Company assumes accident, life, health, annuity (including products covering GMDB and GMIB benefits), aviation, special risk and space risks by participating in or reinsuring various reinsurance pools and arrangements. Reinsurance assumed reserves were $1,095 million and $1,111 million (including assumed GMIB reserves that have an estimated net fair value of $183 million and $194 million ) at December 31, 2018 and 2017 , respectively. For reinsurance agreements with affiliates, see “Related Party Transactions” in Note 12 .

REVENUE RECOGNITION

REVENUE RECOGNITION	12 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenue Recognition	REVENUE RECOGNITION See “Revenue Recognition” in Note 2 descriptions of revenues presented in the table below. The adoption of ASC 606 had no material impact on revenue recognition in 2018 . The table below presents the revenues recognized for the years ended December 31, 2018 , 2017 and 2016 , disaggregated by category: Years ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 2,877 $ 2,730 $ 2,487 Performance-based fees 118 95 33 Research services 439 450 480 Distribution services 723 701 651 Shareholder services 76 75 78 Other 19 18 17 Total investment management and service fees $ 4,252 $ 4,069 $ 3,746 Other income $ 479 $ 423 $ 385

SHORT-TERM AND LONG-TERM DEBT

SHORT-TERM AND LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Short-term and Long-term Debt	SHORT-TERM AND LONG-TERM DEBT Short-term and long-term debt consists of the following: As of December 31, 2018 2017 (in millions) Short-term debt: AB revolving credit facility (with interest rates of 3.4% and 2.4%) $ 25 $ 75 AB commercial paper (with interest rates of 2.7% and 1.6%) 521 491 AXA Financial commercial paper — 1,291 Total short-term debt 546 1,857 Long-term debt: Senior Notes (5.0%, due 2048) 1,480 — Senior Notes (4.35%, due 2028) 1,486 — Senior Notes (3.9%, due 2023) 794 — Delayed Draw Term Loan (one-month LIBOR + 1.125%, due 2021) 300 — Senior Debentures, 7.0%, due 2028 349 349 AXA Equitable non-recourse mortgage debt (with interest rate of 4.1%) — 82 AXA Equitable non-recourse mortgage debt (with interest rate of 3.9%) — 120 Total long-term debt 4,409 551 Total short-term and long-term debt $ 4,955 $ 2,408 As of December 31, 2018, the Company is in compliance with all debt covenants. Short-term Debt AB Commercial Paper As of December 31, 2018 and 2017 , AB had $521 million and $491 million , respectively, in commercial paper outstanding with weighted average interest rates of approximately 2.7% a nd 1.6% , respectively. The commercial paper is short term in nature, and as such, recorded value is estimated to approximate fair value (and considered a Level 2 security in the fair value hierarchy). Average daily borrowings of commercial paper during the years ended December 31, 2018 and 2017 were $350 million and $482 million , respectively, with weighted average interest rates of approximately 2.0% and 1.2% , respectively. AXA Financial Commercial Paper In June 2009, AXA Financial and AXA initiated a commercial paper program on a private placement basis under which AXA Financial or AXA could issue short-term unsecured notes in an aggregate amount not to exceed $2 billion outstanding at any time. The obligations of AXA Financial under the program were guaranteed by AXA. At December 31, 2017, $1.3 billion was outstanding with an interest rate of 1.6% . Holdings, as successor to AXA Financial after the AXA Financial Merger, was removed as an issuer under this program in October 2018. AB Revolver On December 1, 2016, AB entered into a $200 million , unsecured 364 -day senior revolving credit facility (the “AB Revolver”) with a leading international bank and the other lending institutions that may be party thereto. On November 16, 2018, AB amended and restated the AB Revolver, extending the maturity date from November 28, 2018 to November 16, 2021. There were no other significant changes included in the amendment. The AB Revolver is available for AB’s and SCB LLC’s business purposes, including the provision of additional liquidity to meet funding requirements primarily related to SCB LLC’s operations. Both AB and SCB LLC can draw directly under the AB Revolver and management expects to draw on the AB Revolver from time to time. AB has agreed to guarantee the obligations of SCB LLC under the AB Revolver. The AB Revolver contains affirmative, negative and financial covenants which are identical to those of the AB Credit Facility described below. As of December 31, 2018 and 2017 , AB had $25 million and $75 million outstanding under the AB Revolver, respectively, with interest rates of 3.4% and 2.4% , respectively. Average daily borrowings for 2018 and 2017 were $19 million and $21 million , respectively, with weighted average interest rates of 2.8% and 2.0% , respectively. Long-term Debt Holdings Senior Notes On April 20, 2018, Holdings issued $800 million aggregate principal amount of 3.9% Senior Notes due 2023 , $1.5 billion aggregate principal amount of 4.35% Senior Notes due 2028 and $1.5 billion aggregate principal amount of 5.0% Senior Notes due 2048 (together, the “Notes”). These amounts are recorded net of original issue discount and issuance costs. Under the Registration Rights Agreement associated with the Notes, Holdings agreed to use reasonable best efforts to cause a registration statement to be filed with the SEC that, upon effectiveness, would permit holders of the notes to exchange them for new notes containing identical terms except for the restrictions on transfer contained in the original notes. The offer to exchange the notes was completed on January 23, 2019. As of December 31, 2018 , Holdings had outstanding $349 million aggregate principal amount of 7.0% Senior Debentures due 2028 (the “Senior Debentures”). As discussed above, on October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity. As a result of the AXA Financial Merger, Holdings assumed AXA Financial’s obligations under the Senior Debentures . The Notes and Senior Debentures contain customary affirmative and negative covenants, including a limitation on certain liens and a limit on the Company’s ability to consolidate, merge or sell or otherwise dispose of all or substantially all of its assets. The Notes and Senior Debentures also include customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding Notes and Senior Debentures may be accelerated. At December 31, 2018, the Company was not in breach of any of the covenants. Credit Facilities Holdings Two-Year Delayed Draw Term Loan In February 2018, Holdings entered into a $3.9 billion two -year senior unsecured delayed draw term loan agreement which was terminated in April 2018. Holdings Three-Year Delayed Draw Term Loan On May 4, 2018, Holdings borrowed $300 million under a $500 million three -year senior unsecured delayed draw term loan agreement and terminated the remaining $200 million capacity at the date of the IPO. Holdings Revolving Credit Facility In February 2018, Holdings entered into a $2.5 billion five-year senior unsecured revolving credit facility with a syndicate of banks. The revolving credit facility has a sub-limit of $1.5 billion for the issuance of letters of credit to support the life insurance business reinsured by EQ AZ Life Re and the third-party GMxB variable annuity business reinsured by CS Life RE Company (“CS Life RE”). At December 31, 2018 , the Company had $125 million and $600 million of undrawn letters of credit issued out of the $1.5 billion sub-limit for ACS Life and AXA Equitable Life, respectively, as beneficiaries. Bilateral Letter of Credit Facilities In February 2018, the Company entered into bilateral letter of credit facilities, each guaranteed by Holdings, with an aggregate principal amount of approximately $1.9 billion , with the following counterparties: • JP Morgan Chase Bank, N.A. ( $150 million ) • Citibank Europe PLC ( $175 million ) • Barclays Bank PLC ( $150 million ) • HSBC Bank USA, National Association ( $150 million ) • Credit Agricole Corporate and Investment Bank ( $400 million ) • Landesbank Hessen-Thuringen Girozentrale ( $300 million ) • Commerzbank AG, New York Branch ( $325 million ) • Natixis, New York Branch ( $250 million ) These facilities support the life insurance business reinsured by EQ AZ Life Re. As of December 31, 2018 , $1.9 billion of undrawn letters of credit were issued under these facilities, each of which matures on February 16, 2023. AB Revolving Credit Facility On September 27, 2018, AB amended and restated the existing $1.0 billion committed, unsecured senior revolving credit facility (the “AB Credit Facility”) with a group of commercial banks and other lenders, reducing the principal amount to $800 million and extending the maturity to September 27, 2023. The credit facility provides for possible increases in the principal amount by up to an aggregate incremental amount of $200 million . Any such increase is subject to the consent of the affected lenders. The AB Credit Facility is available for AB and SCB LLC for business purposes, including the support of AB’s commercial paper program. Both AB and SCB LLC can draw directly under the AB Credit Facility and AB management expects to draw on the AB Credit Facility from time to time. AB has agreed to guarantee the obligations of SCB LLC under the AB Credit Facility. The AB Credit Facility contains affirmative, negative and financial covenants, which are customary for facilities of this type, including, among other things, restrictions on dispositions of assets, restrictions on liens, a minimum interest coverage ratio and a maximum leverage ratio. As of December 31, 2018 , AB was in compliance with these covenants. The AB Credit Facility also includes customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or lender’s commitments may be terminated. Also, under such provisions, upon the occurrence of certain insolvency- or bankruptcy-related events of default, all amounts payable under the AB Credit Facility would automatically become immediately due and payable, and the lender’s commitments would automatically terminate. As of December 31, 2018 and 2017 , AB and SCB LLC had no amounts outstanding under the AB Credit Facility. During the years ended the December 31, 2018 and 2017 , AB and SCB LLC did not draw upon the AB Credit Facility. In addition, SCB LLC currently has three uncommitted lines of credit with three financial institutions. Two of these lines of credit permit borrowing up to an aggregate of approximately $175 million , with AB named as an additional borrower, while the other line has no stated limit. As of December 31, 2018 and 2017 , SCB LLC had no bank loans outstanding. Average daily borrowings of bank loans during 2018 and 2017 were $3 million and $5 million , respectively, with weighted average interest rates of approximately 1.6% and 1.4% , respectively. Termination of AXA Financial’s Participation in AXA Facilities On the date of the IPO, AXA Financial terminated its participation in the following credit facilities guaranteed by AXA: (i) J.P. Morgan Chase Bank $250 million multi-currency revolving credit facility; (ii) Citibank $300 million multi-currency credit facility; (iii) Bank of America Merrill Lynch $300 million multi-currency revolving credit facility; and (iv) club deal unsecured revolving credit facility with a number of lending institutions for $1.3 billion . Also, AXA Financial, AXA RE Arizona Company (“ AXA RE Arizona”) and CS Life RE terminated their participation in an unsecured revolving credit facility guaranteed by AXA totaling €1.6 billion (or its equivalent in optional currencies) with a number of major European lending institutions. On April 25, 2018, AXA Equitable Life (as successor to AXA RE Arizona) canceled its $1.5 billion revolving credit facility with AXA. In the second quarter of 2018, AXA RE Arizona terminated its participation in the following credit facilities guaranteed by AXA: (i) $700 million letter of credit facility agreement with Commerzbank; (ii) $2.5 billion letter of credit facility agreement with Citibank Europe Plc; and (iii) $200 million letter of credit facility agreement with JP Morgan Europe Limits. AXA RE Arizona also terminated its participation in a $250 million letter of credit facility agreement with Helaba Landesbank Hessen-Th ü r ingen.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial or operating decisions. The Company has entered into a number of related party transactions with AXA and its subsidiaries that are not part of the Company (collectively, “AXA Affiliates”) and other related parties that are described herein. Since transactions with related parties may raise potential or actual conflicts of interest between the related party and the Company, Holdings has implemented a related party transaction policy that requires related party transactions to be reviewed and approved by independent Audit Committee members. Pre-IPO Transactions with AXA Affiliates As former wholly-owned subsidiaries of AXA, Holdings and its subsidiaries have historically entered into various transactions with AXA Affiliates. General Services Agreements with AXA Affiliates Prior to the IPO, Holdings entered into cost-sharing and general service agreements with various AXA Affiliates pursuant to which the parties provided general corporate services (IT, human resources, legal, finance, etc.) to each other. Loans to AXA Affiliates As of December 31, 2018 2017 (in millions) Loans to Affiliates: Loans to AXA: 2007 Senior Unsecured Note, 5.7%, due 2020 $ — $ 700 2008 Senior Unsecured Note, 5.4%, due 2020 — 200 Unsecured Loan to AXA IM Holding US, three-month LIBOR +1.5%, due 2025 — 185 Unsecured Loan to Colisée Re. 4.75%, due 2028 — 145 Total Loans to Affiliates $ — $ 1,230 In December 2015, AXA IM Holding US received a $185 million three-month LIBOR plus 1.5% unsecured loan from AXA Financial. The loan was repaid on April 23, 2018. In December 2013, Colisée Re received a $145 million 4.75% loan from Holdings. The loan was repaid on March 26, 2018. In September 2007, AXA received a $700 million 5.7% Senior Unsecured Note from Holdings. In January 2018, AXA pre-paid $50 million of the note. In April 2018, AXA pre-paid the remainder of this note. In December 2008, AXA received a $500 million 5.4% term loan from AXA Financial. In December 2014, AXA repaid $300 million on this term loan. In January 2018, AXA pre-paid an additional $150 million of the loan. In April 2018, AXA pre-paid the remainder of this loan. Loans from AXA Affiliates As of December 31, 2018 2017 (in millions) Loans from Affiliates: AXA S.A. term loan, three- month LIBOR +1.06%, due 2024 $ — $ 1,007 AXA Japan Subordinated Notes, floating rate of LIBOR +1.20%, due 2020 — 770 AXA Belgium €300 million EURIBOR +0.06%, due 2018 — 391 AXA S.A. loan, LIBOR + 1.44%, due 2022 — 366 Coliseum Reinsurance Company, 4.75%, due 2028 — 387 AXA America Corporate Solutions, Inc., 1.85%, due 2018 — 110 Foreign Exchange impact of AXA Belgium loan — (31 ) AXA S.A. loan, LIBOR + 0.439%, due 2018 — 622 Total Loans From Affiliates $ — $ 3,622 In March 2010, AXA Financial issued subordinated notes to AXA Life Insurance Company Ltd., in the amount of $770 million (“AXA Japan Subordinated Notes”). The AXA Japan Subordinated Notes have a maturity date of March 30, 2020 and a floating interest rate of LIBOR plus 1.2% , which resets semiannually on March 30 and September 30. The notes were repaid on April 20, 2018. The 2018, 2017 and 2016 interest cost related to the AXA Japan Subordinated Notes totaled approximately $12 million , $19 million and $16 million , respectively. In October 2012, AXA Financial issued a note denominated in Euros in the amount of €300 million or $391 million to AXA Belgium S.A. (“AXA Belgium”). This note had an interest rate of Europe Interbank Offered Rate (“EURIBOR”) plus 1.15% and a maturity date of October 23, 2017. Concurrently, AXA Financial entered into a swap with AXA, covering the exchange rate on both the interest and principal payments related to this note. The interest rate on the swap was 6-month LIBOR plus 1.48% . In October 2017, the note was extended to March 30, 2018. The extended note has a floating interest rate of one-month EURIBOR plus 0.06% . Concurrently, AXA Financial entered into a swap with AXA covering the exchange rate on both the interest and principal payments related to the extended note until March 30, 2018. Both the loan and the swap were repaid on March 29, 2018. The 2018, 2017 and 2016 interest cost related to this loan totaled approximately $2 million , $12 million and $9 million , respectively. In 2013, Holdings received $242 million and $145 million 4.75% loans from Coliseum Reinsurance Company. The loans have maturity dates in December 2028. The loans were repaid on April 20, 2018. The 2018, 2017 and 2016 interest cost related to these loans totaled approximately $6 million , $18 million and $18 million , respectively. In December 2014, AXA Financial issued a $2,727 million , three-month LIBOR plus 1.06% margin term loan to AXA. The loan has a maturity date of December 18, 2024. In June 2015, AXA Financial repaid $520 million and during 2016 repaid an additional $1,200 million of this loan. The outstanding balance on this loan at December 31, 2017 was $1,007 million . The interest cost related to this loan totaled approximately $10 million , $23 million , and $23 million in 2018, 2017, and 2016, respectively. On April 20, 2018, the remainder of this loan was repaid. In 2015, AXA America Holdings, Inc. received a $366 million , three-month LIBOR plus 1.44% loan from AXA. The loan has a maturity date of October 8, 2022. This loan was repaid on April 20, 2018. The 2018, 2017 and 2016 interest cost related to this loan totaled approximately $6 million , $9 million and $8 million , respectively. In 2017, Holdings repaid a $56 million 1.39% loan from AXA America Corporate Solutions, Inc. (“AXA CS”) originally made in 2015 and received a $100 million loan and a $10 million loan from AXA CS. The loans have interest rates of 1.86% and 1.76% , respectively, and were repaid on their maturity of February 5, 2018. The 2018, 2017 and 2016 interest cost related to these loans totaled approximately $2 million , $2 million and $1 million , respectively. Reinsurance Assumed from AXA Affiliates AXA Global Life retrocedes a quota share portion of certain life and health risks of various AXA affiliates to AXA Equitable Life and MLOA on a one-year term basis. Also, AXA Life Insurance Company Ltd. cedes a portion of its variable deferred annuity business to AXA Equitable Life. Premiums earned in 2018 , 2017 and 2016 were $8 million , $8 million and $9 million , respectively. Claims and expenses paid in 2018 , 2017 and 2016 were $3 million , $2 million and $2 million , respectively. Reinsurance Ceded to AXA Affiliates AXA Equitable Life has entered into a stop loss reinsurance agreement with AXA Global Life to protect AXA Equitable Life with respect to a deterioration in its claim experience following the occurrence of an extreme mortality event. AXA Equitable Life has accepted certain retrocession policies through reinsurance agreements with various reinsurers. AXA Equitable Life retrocedes to AXA Global Life the excess of its first retention layer. Certain of our subsidiaries have entered into a Life Catastrophe Excess of Loss Reinsurance Agreement with a number of subscribing reinsurers, including AXA Global Life. AXA Global Life participates in 5% of the pool, pro-rata, across the upper and lower layers. Premiums and expenses paid for the above agreements in 2018 , 2017 and 2016 were $4 million , $4 million and $4 million , respectively. On September 12, 2018 AXA Group acquired XL Catlin. The Company had previously ceded part of our disability income business to XL Catlin and as of December 31, 2018 , the reserves ceded were $93 million . Revolving Credit Facility with AXA AXA previously provided a $1.5 billion revolving credit facility to AXA RE Arizona. On April 25, 2018, AXA Equitable Life (as successor to AXA RE Arizona) canceled this facility. AXA Guarantees AXA previously guaranteed some of the Company’s borrowings. As of June 12, 2018, AXA no longer provides any such guarantees. Other Transactions with AXA Affiliates In 2016, AXA Financial invested in ASV Capital B FPCI, a French Professional Private Equity Fund managed by AXA Strategic Ventures SAS. As of December 31, 2018 and 2017 , the fair value of the investment in the fund was $23 million and $7 million , respectively. In September 2017, AXA Equitable FMG made a €30 million capital commitment to ASV Diversified, a French Special Limited Partnership investing in venture funds specialized in both early stage and growth startups with new technologies and business models relevant to AXA’s business. This fund is managed by AXA Strategic Ventures SAS. As of December 31, 2018 and 2017, €0.8 million and €0.5 million in capital had been called, respectively. In December 2017, AXA Tech paid approximately $18 million to AXA US Holdings Inc., a U.S. subsidiary of AXA, which is not a subsidiary of Holdings, in exchange for AXA US Holdings Inc. assuming certain liabilities pertaining to its servicing of AXA companies within the United States and in Latin America valued at approximately $18 million , including costs and expenses associated with providing infrastructure services to AXA and its subsidiaries. Reorganization Transactions with AXA Affiliates Prior to the IPO, the Company engaged in a number of reorganization transactions with AXA Affiliates. Disposition of AXA CS Holdings formerly held 78.99% of the shares of AXA CS. AXA CS and its subsidiaries have been excluded from the historical Consolidated Financial Statements since they were operated independently from the other Holdings subsidiaries. In March 2018, Holdings sold its AXA CS shares to AXA for $630 million . In anticipation of this sale, in the fourth quarter of 2017, AXA made a short-term loan of $622 million to Holdings with interest calculated at three-month LIBOR plus 0.439% margin. Holdings’ repayment obligation to AXA in respect of this loan was set off against the purchase price for the AXA CS shares, and AXA paid Holdings the $8 million balance in cash. The net result of the sale was a decrease in Loans from affiliates of $622 million , an increase in cash of $8 million , and an increase in capital in excess of par of $630 million . Disposition of Real Estate Joint Ventures In March 2018, AXA Equitable Life sold its interest in two consolidated real estate joint ventures to AXA France for a total purchase price of approximately $143 million . Acquisition of Noncontrolling Interest of AXA Financial In March 2018, AXA contributed the 0.5% noncontrolling interest in AXA Financial to Holdings, resulting in AXA Financial becoming a wholly-owned subsidiary of Holdings. The contribution is reflected as a $66 million capital contribution. Acquisition of Additional AB Units On April 23, 2018, Holdings purchased: (i) 100% of the shares of AXA-IM Holding U.S. Inc., which owns 41,934,582 AB Units, for a purchase price of $1,113 million and (ii) 8,160,000 AB Units held by Coliseum Re for $217 million . On December 20, 2018, Holdings purchased 254,675 AB Holdings units from a former AB executive. As a result of these two transactions, Holdings ownership of AB increased to approximately 65% , Noncontrolling interest decreased by $29 million , Capital in excess of par increased by $17 million and taxes payable increased by $174 million . Acquisition of 30.3% of AXA Venture Partners SAS On May 7, 2018, Holdings made a capital contribution of approximately $3 million to AXA Venture Partners SAS in exchange for approximately 30.3% of the shares of AXA Venture Partners SAS and certain rights and protections as a shareholder of the company, including the right to appoint two members of the management committee as well as consent rights over significant transactions. Post-IPO Transactions with AXA Affiliates Prior to the IPO, Holdings and AXA entered into a number of agreements governing certain post-IPO transactions. Transitional Services Agreement Holdings and AXA entered into a Transitional Services Agreement, dated as of May 4, 2018 (the “TSA”), regarding the continued provision of services between the Company and AXA and its subsidiaries on a transitional basis. The TSA replaced existing cost-sharing and general service agreements with various AXA subsidiaries and governs the following types of services: • services AXA or its subsidiaries (other than the Company) receive pursuant to a contract with a third-party service provider, which AXA or its subsidiaries then provide to the Company on a pass-through basis; • services the Company receives pursuant to a contract with a third-party service provider, which the Company then provides to AXA or its subsidiaries (excluding the Company) on a pass-through basis; • certain services the Company receives directly from AXA or its subsidiaries (excluding the Company); and • certain services the Company provides directly to AXA or its subsidiaries (excluding the Company). The fees for each service vary and may be based on costs, usage, previously established rates or other factors. Generally, all services other than specified long-term services will be provided until the third anniversary of the date of a change in control of Holdings, unless the service recipient elects to terminate the service earlier upon 180 days written notice. The specified long-term services will be provided until specific end dates listed in the TSA. In addition to the above, AXA allocates a portion of its corporate overhead expenses to the Company. Expenses associated with overhead costs were $34 million , $35 million and $26 million , in 2018 , 2017 and 2016 , respectively. Trademark License Agreement On May 4, 2018, AXA and Holdings entered into a Trademark License Agreement (the “TLA”) that replaced the existing sub-licensing agreement between AXA Financial and AXA (the “Former TLA”). Under the TLA, AXA grants the Company a limited license to use certain trademarks (the “Licensed Marks”), including the name “AXA” and domain names, in the United States and Canada (the “Territory”). Under the TLA, the Company is obligated to pay AXA consideration for the grant of the license based on the same formula that applied under the Former TLA which takes into account the Company’s revenue (excluding certain items) and a notoriety index for the Licensed Marks in the Territory. AXA may terminate the TLA upon a change in control of Holdings. After the termination of the TLA, the Company will be able to continue to use the Licensed Marks for a transition period, but the Company will be required to use reasonable best efforts to transition to other trademarks. Tax Sharing Agreement Holdings entered into a tax sharing agreement with AXA and AXA Investment Managers S.A. (“AXA IM SA”) on March 28, 2018 related to the sale of AXA-IM Holding U.S. Inc. and AXA CS, described above. The agreement generally allocates responsibility for the taxes of AXA-IM Holding U.S. Inc. and AXA CS to the seller of the applicable entity for taxable periods predating the sale and to the buyer of such entity for taxable periods postdating the sale, except that any taxes arising in connection with the sale transactions as a result of an adjustment by a taxing authority will instead be borne 90% by the seller and 10% by the buyer (or, if that taxes are attributable to any action or inaction of the seller or the buyer, 100% by the responsible party). Share Repurchase from AXA On November 20, 2018, Holdings repurchased approximately 30 million shares of its common stock from AXA at a total cost of approximately $592 million under the $800 million share repurchase authorization and pursuant to a share repurchase agreement. The repurchased common stock was recorded as treasury stock in the consolidated balance sheets. See Note 20 for more information. Investment Management and Administrative Services Provided by AXA Equitable FMG to Related Trusts AXA Equitable FMG provides investment management and administrative services to EQAT, VIP Trust, 1290 Funds and the Other AXA Trusts, all of which are considered related parties. Investment management and service fees earned are calculated as a percentage of assets under management and are recorded as revenue as the related services are performed. Investment Management and Related Services Provided by AB to Related Mutual Funds AB provides investment management and related services to mutual funds sponsored by AB. Revenues earned by AB from providing these services were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Investment management and services fees $ 1,207 $ 1,148 $ 999 Distribution revenues 404 398 372 Other revenues - shareholder servicing fees 74 73 76 Other revenues - other 7 7 6 Total $ 1,692 $ 1,626 $ 1,453 Expenses and Revenues for 2018, 2017 and 2016 The table below summarizes the expenses reimbursed to/from the Company and the fees received/paid by the Company in connection with certain services described above for the years ended December 31, 2018 , 2017 and 2016 . Years Ended December 31, 2018 2017 2016 (in millions) Expenses paid or accrued for: General services provided by AXA affiliates $ 146 $ 141 $ 118 Investment management services provided by AXA IM, AXA REIM, and AXA Rosenberg 2 5 15 Investment management services provided by AXA Strategic Ventures Corporation (“ASV Corp”) 2 2 2 Guarantees and credit facility 1 9 12 Total $ 151 $ 157 $ 147 Revenue received or accrued for: Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts $ 727 $ 720 $ 674 General services provided to AXA affiliates 6 27 29 Total $ 733 $ 747 $ 703

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Employee Benefit Plans	EMPLOYEE BENEFIT PLANS As a result of the AXA Financial Merger, Holdings assumed all of AXA Financial’s liabilities, including its obligations under two assumption agreements pursuant to which it legally assumed primary liability for certain employee benefit plans of AXA Equitable Life. Holdings also succeeded AXA Financial as the sponsor of the MONY Life Retirement Income Security Plan for Employees. Pension Plans Holdings and AXA Equitable Life Retirement Plans AXA Equitable Life sponsors the AXA Equitable 401(k) Plan, a qualified defined contribution plan for eligible employees and financial professionals. The plan provides for both a company contribution and a discretionary profit-sharing contribution. Expenses associated with this 401(k) Plan were $36 million , $28 million and $28 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. Holdings sponsors the MONY Life Retirement Income Security Plan for Employees and AXA Equitable Life sponsors the AXA Equitable Retirement Plan (the “AXA Equitable Life QP”), both of which are qualified defined benefit plans covering eligible employees and financial professionals. These pension plans are non-contributory, and their benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period. Holdings and AXA Equitable Life also sponsor certain nonqualified defined benefit plans, including the AXA Equitable Excess Retirement Plan, that provide retirement benefits in excess of the amount permitted under the tax law for the qualified plans. Effective December 31, 2015, primary liability for the obligations of AXA Equitable Life under the AXA Equitable Life QP was transferred from AXA Equitable Life to AXA Financial pursuant to an assumption agreement (the “Assumption Agreement”). As a result of the AXA Financial Merger, Holdings assumed the obligations of AXA Financial under the Assumption Agreement. AXA Equitable Life remains secondarily liable for its obligations under the AXA Equitable Life QP and would recognize such liability in the event Holdings does not perform under the terms of the Assumption Agreement. On March 13, 2018, the Company signed a binding agreement with a third-party insurer to purchase two single premium, non-participating group annuity contracts with the intent of settling certain retiree liabilities under the MONY Life Retirement Income Security Plan for Employees and the AXA Equitable Life QP. Payment of the preliminary contribution amounts for the group annuity contracts was funded from plan assets on March 20, 2018, securing the third-party insurer’s irrevocable assumption of certain benefits obligations and commitment to issue the group annuity contracts. The annuity purchase transaction and consequent transfer of $254 million of the plans’ obligations to retirees or 10% of the aggregate pension benefit obligations resulted in a partial settlement of the plans. The Company remeasured the plans’ assets and obligations on March 20, 2018, as required in the event of an accounting settlement. For the year end December 31, 2018, the Company recognized a pre-tax settlement loss of $109 million , largely attributable to recognition of a pro rata portion of the plans’ unamortized net actuarial losses accumulated in other comprehensive income and routine lump-sum distributions totaling $36 million made from the AXA Equitable Life QP and the MONY Life Retirement Income Security Plan for Employees. Holdings and AXA Equitable Life use a December 31 measurement date for their pension plans. AB Retirement Plans AB maintains the Profit Sharing Plan for Employees of AB, a tax-qualified retirement plan for U.S. employees. Employer contributions under this plan are discretionary and generally are limited to the amount deductible for federal income tax purposes. AB also maintains a qualified, non-contributory, defined benefit retirement plan covering current and former employees who were employed by AB in the United States prior to October 2, 2000 (the “AB Plan”). Benefits under the AB Plan are based on years of credited service and average final base salary. AB uses a December 31 measurement date for the AB Plan. Contributions and Funding Policy The Company’s funding policy for its qualified pension plans is to satisfy its funding obligations each year in an amount not less than the minimum required by the Employee Retirement Income Security Act of 1974 (“ERISA”), as amended by the Pension Protection Act of 2006 (the “Pension Act”), and not greater than the maximum the Company can deduct for federal income tax purposes. For 2018 , no cash contributions were made by Holdings or AXA Equitable Life to their respective qualified pension plans. Based on the funded status of the plans at December 31, 2017 , AB contributed $5 million to th e AB Plan during 2018 . AB currently estimates that it will contribute $4 million to the AB Plan during 2019 . No minimum funding contributions under ERISA are required to be made to the Holdings and AXA Equitable Life plans, and management does not expect to make any discretionary contributions to those plans during 2019 . Net Periodic Pension Expense Components of net periodic pension expense for the Company’s qualified and non-qualified plans were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 8 $ 10 $ 11 Interest cost 103 105 108 Expected return on assets (163 ) (173 ) (177 ) Actuarial (gain) loss 1 1 1 Net amortization 98 126 133 Impact of settlement 109 — — Net periodic pension expense $ 156 $ 69 $ 76 Changes in Projected Benefit Obligation (“PBO”) Changes in the PBO of the Company’s qualified and non-qualified plans were comprised of: 2018 2017 (in millions) Projected benefit obligation, beginning of year $ 3,455 $ 3,442 Service cost — — Interest cost 103 105 Actuarial (gains)/losses (1) (204 ) 144 Benefits paid (190 ) (236 ) Plan amendments and curtailments — — Settlements (290 ) — Projected benefit obligation, end of year $ 2,874 $ 3,455 _____________ (1) Actuarial gains and losses are a product of changes in the discount rate as shown below. The following table discloses the change in plan assets and the funded status of the Company’s qualified pension plans and non-qualified pension plans: 2018 2017 (in millions) Pension plan assets at fair value, beginning of year $ 2,839 $ 2,679 Actual return on plan assets (53 ) 357 Contributions 5 4 Benefits paid (184 ) (201 ) Annuity purchases (266 ) — Pension plan assets at fair value, end of year 2,341 2,839 PBO 2,874 3,455 Excess of PBO over pension plan assets, end of year $ (533 ) $ (616 ) Accrued pension costs of $(533) million and $(616) million at December 31, 2018 and 2017 , respectively, were recognized in the accompanying consolidated balance sheets to reflect the funded status of these plans. The aggregate PBO/accumulated benefit obligation (“ABO”) and fair value of pension plan assets for plans with PBOs/ABOs in excess of their assets were $2,874 million and $2,341 million , respectively, at December 31, 2018 and $3,455 million and $2,839 million , respectively, at December 31, 2017 . Unrecognized Net Actuarial (Gain) Loss The following table discloses the amounts included in AOCI at December 31, 2018 and 2017 that have not yet been recognized as components of net periodic pension cost. As of December 31, 2018 2017 (in millions) Unrecognized net actuarial (gain) loss $ 1,123 $ 1,315 Unrecognized prior service cost (credit) 1 1 Total $ 1,124 $ 1,316 Pension Plan Assets The fair values of qualified pension plan assets are measured and ascribed to levels within the fair value hierarchy in a manner consistent with the fair values of the Company’s invested assets that are measured at fair value on a recurring basis. See Note 7 for a description of the fair value hierarchy. The following table discloses the allocation of the fair value of total qualified pension plan assets at December 31, 2018 and 2017 : As of December 31, 2018 2017 Fixed maturities 50.3 % 46.2 % Equity securities 22.9 33.9 Equity real estate 17.7 13.9 Cash and short-term investments 3.4 1.4 Other 5.7 4.6 Total 100.0 % 100.0 % Qualified pension plan assets are invested with the primary objective of return, giving consideration to prudent risk. Guidelines regarding the allocation of plan assets are established by the respective Investment Committees for the plans and are designed with a long-term investment horizon. At December 31, 2018 , the qualified pension plans continued their investment allocation strategy to target a 50%- 50% mix of long-duration bonds and “return-seeking” assets, including public equities, real estate, hedge funds, and private equity. The following tables disclose the fair values of qualified pension plan assets and their level of observability within the fair value hierarchy at December 31, 2018 and 2017 , respectively. Level 1 Level 2 Level 3 Total (in millions) December 31, 2018: Fixed Maturities: Corporate $ — $ 677 $ — $ 677 U.S. Treasury, government and agency — 467 — 467 States and political subdivisions — 23 — 23 Foreign governments — 2 — 2 Commercial mortgage-backed — — 1 1 Common and preferred equity 424 78 — 502 Mutual funds 53 — — 53 Private real estate investment trusts 1 — — 1 Cash and cash equivalents 34 — — 34 Short-term investments — 22 — 22 Total assets in the fair value hierarchy 512 1,269 1 1,782 Investments measured at Net Asset Value — — — 559 Investments at fair value $ 512 $ 1,269 $ 1 $ 2,341 Level 1 Level 2 Level 3 Total (in millions) December 31, 2017: Fixed Maturities: Corporate $ — $ 792 $ 2 $ 794 U.S. Treasury, government and agency — 471 — 471 States and political subdivisions — 26 — 26 Foreign governments — 5 — 5 Commercial mortgage-backed — — 1 1 Common and preferred equity 730 98 — 828 Mutual funds 99 — — 99 Commercial paper — 44 — 44 Private real estate investment trusts 2 — — 2 Cash and cash equivalents 12 — — 12 Short-term investments — 27 — 27 Total assets in the fair value hierarchy 843 1,463 3 2,309 Investments measured at Net Asset Value — — — 530 Investments at fair value $ 843 $ 1,463 $ 3 $ 2,839 The following table lists investments for which net asset value (“NAV”) is calculated; NAV is used as a practical expedient to determine the fair value of these investments at December 31, 2018 and 2017 . Practical Expedient Disclosure as of December 31, 2018 and 2017 Investment Fair Value Redemption Frequency (If currently eligible) Redemption Notice Period Unfunded Commitments (in millions) December 31, 2018: Private Equity Fund $ 64 N/A (1)(2) N/A $ 33 Private Real Estate Investment Trust 402 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 12 Total $ 559 December 31, 2017: Private Equity Fund $ 61 N/A (1)(2) N/A $ 29 Private Real Estate Investment Trust 376 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 34 Total $ 530 ______________ (1) Cannot sell or transfer ownership interest without prior written consent to transfer, and by meeting several criteria (e.g., does not adversely affect other investors). (2) Cannot sell interest in the vehicle without prior written consent of the managing member. (3) March, June, September and December. The table below presents a reconciliation for all Level 3 fair values of qualified pension plan assets at December 31, 2018 , 2017 and 2016 , respectively: Level 3 Instruments Fair Value Measurements Private Real Estate Investment Trusts Other Equity Investments Fixed Maturities Total (in millions) Balance, January 1, 2018 $ — $ — $ 3 $ 3 Actual return on plan assets: Relating to assets still held at December 31, 2018 — — — — Relating to assets sold during 2018 — — — — Purchases/Issues — — — — Sales/Settlements — — (1 ) (1 ) Transfers into/out of Level 3 — — — — Balance, December 31, 2018 $ — $ — $ 2 $ 2 Balance, January 1, 2017 $ — $ — $ 5 $ 5 Actual return on plan assets: Relating to assets still held at December 31, 2017 — — — — Relating to assets sold during 2017 — — — — Purchases/Issues — — — — Sales/Settlements — — (2 ) (2 ) Transfers into/out of Level 3 — — — — Balance, December 31, 2017 $ — $ — $ 3 $ 3 Balance, January 1, 2016 $ — $ — $ 8 $ 8 Actual return on plan assets: Relating to assets still held at December 31, 2016 — — — — Relating to assets sold during 2016 — — — — Purchases/Issues — — — — Sales/Settlements — — (1 ) (1 ) Transfers into/out of Level 3 — — (2 ) (2 ) Balance, December 31, 2016 $ — $ — $ 5 $ 5 At December 31, 2018 , assets classified as Level 1, Level 2 and Level 3 comprise approximately 21.9% , 54.2% and 0.0% , respectively, of qualified pension plan assets. At December 31, 2017 , assets classified as Level 1, Level 2 and Level 3 comprised approximately 29.7% , 51.5% and 0.1% , respectively, of qualified pension plan assets. There are no significant concentrations of credit risk arising within or across categories of qualified pension plan assets. Assumptions Discount Rate The benefits obligations and related net periodic costs of the Company’s qualified and non-qualified pension plans are measured using discount rate assumptions that reflect the rates at which the plans’ benefits could be effectively settled. Projected nominal cash outflows to fund expected annual benefits payments under each of the plans are discounted using a published high-quality bond yield curve as a practical expedient for a matching bond approach. Beginning in 2014, the Company uses the Citigroup Pension Above-Median-AA Curve (the “Citigroup Curve”) for this purpose. The Company has concluded that an adjustment to the Citigroup Curve is not required after comparing the projected benefit streams of the plans to the cash flows and duration of the reference bonds. Mortality In October 2016, the Society of Actuaries (“SOA”) released MP-2016, its second annual update to the “gold standard” mortality projection scale issued by the SOA in 2014, reflecting three additional years of historical U.S. population historical mortality data (2012 through 2014). Similar to its predecessor (MP-2015), MP-2016 indicated that, while mortality data continued to show longer lives, longevity was increasing at a slower rate and lagging behind that previously suggested both by MP-2015 and MP-2014. The Company considered this new data as well as observations made from current practice regarding how to best estimate improved trends in life expectancies and concluded to continue using the RP-2000 base mortality table projected on a full generational basis with Scale BB mortality improvements for purposes of measuring and reporting its consolidated defined benefit plan obligations at December 31, 2018 . Interest Cost Beginning January 1, 2016, the Company adopted a spot rate/full yield curve approach for measuring the interest cost component of expense for each of its defined benefit plans, thereby reducing 2016 benefits expense by approximately $76 million . The following table discloses assumptions used to measure the Company’s pension benefit obligations and net periodic pension cost at and for the years ended December 31, 2018 and 2017 . As of December 31, 2018 2017 Discount rates: AXA Equitable Life QP 4.07% 3.4% AXA Equitable Excess Retirement Plan 4.01% 3.32% MONY Life Retirement Income Security Plan for Employees 4.2% 3.5% AB Qualified Retirement Plan 3.9% 4.55% Other defined benefit plans 3.75%-4.10% 3.00%-3.43% Periodic cost 3.00%-3.50% 3.17%-3.98% Cash balance interest crediting rate for pre-April 1, 2012 accruals 4.00% 4.00% Cash balance interest crediting rate for post-April 1, 2012 accruals 2.50% 1.25% Rates of compensation increase: Benefit obligation 5.99% 5.99% Periodic cost 6.34% 6.38% Expected long-term rates of return on pension plan assets (periodic cost) 6.75% 6.75% The expected long-term rate of return assumption on plan assets is based upon the target asset allocation of the plan portfolio and is determined using forward-looking assumptions in the context of historical returns and volatilities for each asset class. Prior to 1987, participants’ benefits under the AXA Equitable Life QP were funded through the purchase of non-participating annuity contracts from AXA Equitable Life. Benefit payments under these contracts were approximately $6 million and $6 million for 2018 and 2017 , respectively. Post-Retirement Benefits The Company eliminated any subsidy for post-retirement medical and dental coverage for individuals retiring on or after May 1, 2012. The Company continues to contribute to the cost of post-retirement medical and dental coverage for certain individuals who retired prior to May 1, 2012 based on years of service and age, subject to rights reserved in the plans to change or eliminate these benefits. The Company funds these post-retirement benefits on a pay-as-you-go basis. The Company sponsors the AXA Equitable Executive Survivor Benefits Plan (the “ESB Plan”) which provides post-retirement life insurance benefits to eligible executives. Eligible executives may choose up to four levels of coverage with each level providing a benefit equal to the executive’s compensation, subject to an overall $25 million cap. Aside from the ESB Plan, the Company does not currently offer post-retirement life insurance benefits but continues to provide post-retirement life insurance benefits to certain active and retired employees who were eligible for such benefits under discontinued plans. For 2018 and 2017 , post-retirement benefits payments were $46 million and $38 million , respectively, net of employee contributions. The Company uses a December 31 measurement date for its post-retirement plans. Components of Net Post-retirement Benefits Costs Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 2 $ 2 $ 2 Interest cost 16 16 16 Net amortization 9 6 7 Net Periodic Post-Retirement Benefits Costs $ 27 $ 24 $ 25 Changes in the accumulated benefits obligation of the Company’s post-retirement plans recognized in the accompanying consolidated financial statements are described in the following table: Accumulated Post-Retirement Benefits Obligation December 31, 2018 2017 (in millions) Accumulated post-retirement benefits obligation, beginning of year $ 537 $ 539 Service cost 2 2 Interest cost 16 16 Contributions and benefits paid (46 ) (38 ) Actuarial (gains) losses (18 ) 18 Accumulated post-retirement benefits obligation, end of year $ 491 $ 537 The post-retirement medical plan obligations of the Company are offset by an anticipated subsidy from Medicare Part D, which is assumed to increase with the healthcare cost trend. Assumed Healthcare Cost Trend Rates used to Measure the Expected Cost of Benefits December 31, 2018 2017 Following year 10.2% 6.9% Ultimate rate to which cost increase is assumed to decline 4.3% 4.2% Year in which the ultimate trend rate is reached 2099 2097 The following table discloses the amounts included in AOCI at December 31, 2018 and 2017 that have not yet been recognized as components of net periodic post-retirement benefits cost: December 31, 2018 2017 (in millions) Unrecognized net actuarial (gains) losses $ 116 $ 143 Unrecognized prior service (credit) — — Total $ 116 $ 143 The assumed discount rates for measuring the post-retirement benefit obligations at December 31, 2018 and 2017 were determined in substantially the same manner as described above for measuring the pension benefit obligations. The following table discloses the range of discrete single equivalent discount rates and related net periodic cost at and for the years ended December 31, 2018 and 2017 . December 31, 2018 2017 Discount rates: Benefit obligation 3.52%-3.89% 2.80%-3.52% Periodic cost 3.00%-3.50% 3.17%-3.98% The Company provides post-employment medical and life insurance coverage for certain disabled former employees. The accrued liabilities for these post-employment benefits were $10 million and $11 million , respectively, at December 31, 2018 and 2017 . Components of net post-employment benefits costs follow: Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 2 $ 2 $ 2 Interest cost — — — Net amortization (1 ) (2 ) — Net periodic post-employment benefits costs $ 1 $ — $ 2 The following table provides an estimate of future benefits expected to be paid in each of the next five years, beginning January 1, 2019 , and in the aggregate fr the five years thereafter. These estimates are based on the same assumptions used to measure the respective benefit obligations at December 31, 2018 and include benefits attributable to estimated future employee service. Postretirement Benefits Health Pension Benefits Life Insurance Gross Estimate Payment Estimated Medicare Part D Subsidy Net Estimate Payment (in millions) 2019 $ 221 $ 26 $ 16 $ 3 $ 13 2020 223 26 15 3 12 2021 220 26 14 3 11 2022 216 25 13 3 10 2023 209 25 12 3 9 Years 2024-2028 2,926 541 100 9 91

SHARE-BASED COMPENSATION PROGRA

SHARE-BASED COMPENSATION PROGRAMS	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based Compensation Programs	SHARE-BASED COMPENSATION PROGRAMS Compensation costs for 2018 , 2017 and 2016 for share-based payment arrangements as further described herein are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Performance Shares (1) $ 11 $ 45 $ 37 Stock Options 2 1 1 AXA Shareplan — 13 19 Restricted Stock Unit Awards (2) 215 185 154 Other Compensation Plans (3) — 3 2 Total Compensation Expenses $ 228 $ 247 $ 213 ________________ (1) Reflects change to performance share retirement rules. Specifically, individuals who retire at any time after the grant date will continue to vest in their 2017 performance shares while individuals who retire prior to March 1, 2019 will forfeit all 2018 performance shares. (2) Reflects a $24 million adjustment for awards in 2018 with graded vesting, service-only conditions from the graded to the straight-line attribution method. (3) Includes stock appreciation rights and employee stock purchase plans. Retirement and Protection Businesses In 2017 and prior years, equity awards for employees, financial professionals and directors in our retirement and protection (“R&P”) businesses were available under the umbrella of AXA’s global equity program. Accordingly, equity awards granted in 2017 and prior years were linked to AXA’s stock. Following the IPO, Holdings has granted and will continue to grant equity awards under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan (the “Omnibus Plan”) which was adopted by Holdings on April 25, 2018. Awards under the Omnibus Plan are linked to Holdings’ common stock. As of December 31, 2018 , the common stock reserved and available for issuance under the Omnibus Plan was 5.5 million shares. 2018 Equity Awards All 2018 equity awards for R&P employees, financial professionals and directors were granted under the Omnibus Plan with the exception of the Holdings restricted stock units (“Holdings RSUs”) granted to financial professionals on May 17, 2018. Accordingly, all grants discussed in this section will be settled in shares of Holdings’ common stock except for the RSUs granted to financial professionals which will be settled in cash. As described below, Holdings made various grants of equity awards linked to the value of Holdings’ common stock in 2018 . For awards with graded vesting schedules and service-only vesting conditions, including Holdings RSUs and other forms of share-based payment awards, the Company applies a straight-line expense attribution policy for the recognition of compensation cost. Actual forfeitures with respect to the 2018 grants were considered immaterial in the recognition of compensation cost. Transaction Incentive Awards On May 9, 2018, coincident with the IPO, Holdings granted one-time “Transaction Incentive Awards” to executive officers and certain other R&P employees in the form of 0.7 million Holdings RSUs. Fifty percent of the Holdings RSUs will vest based on service over a two -year period from the IPO date (the “Service Units”), and fifty percent will vest based on service and a market condition (the “Performance Units”). The market condition is based on share price growth of at least 130% or 150% within a two or five -year period, respectively. If the market condition is not achieved, 50% of the Performance Units may still vest based on five years of continued service and the remaining Performance Units will be forfeited. The $7 million aggregate grant-date fair value of the 0.4 million Service Units was measured at the $20 IPO price of a Holdings share and will be charged to compensation expense over the stated requisite service periods. The grant-date fair value of half of the Performance Units , or 0.2 million Holdings RSUs, was also measured at th e $20 IPO price for a Holdings share as employees are still able to vest in these awards even if the share price growth targets are not achieved. The resulting $4 million for these awards will be c harged to compensation expense over the five -year requisite service period. The grant-date fair value of $16.47 was used to value the remaining half of the Performance Units that are subject to risk of forfeiture for non-achievement of the Holdings share price conditions. The grant date fair value was measured using a Monte Carlo simulation from which a five -year requisite service period was derived, representing the median of the distribution of stock price paths on which the market condition is satisfied, over which the total $3 million compensation expense will be recognized. In 2018 , the Company recognized compensation expense associated with the Transaction Incentive Awards of approximately $6 million . Special IPO Grant Also, on May 9, 2018, Holdings made a grant of 0.4 million Holdings RSUs to R&P employees and financial professionals, or 50 restricted stock units to each eligible individual, that cliff vested on November 9, 2018. The grant-date fair value of the award was measured using the $20 IPO price for a Holdings share and the resulting $7 million has been recognized as compensation expense over the six-month service period ending November 9, 2018. Annual Awards Under 2018 Equity Program Annual awards under Holdings’ 2018 equity program consisted of a mix of equity vehicles including Holdings RSUs, Holdings stock options and Holdings performance shares. If Holdings pays any ordinary dividend in cash, all outstanding Holdings RSUs and performance shares will accrue dividend equivalents in the form of additional Holdings RSUs or performance shares to be settled or forfeited consistent with the terms of the related award. Holdings RSUs On May 17, 2018, Holdings gra nted 1.3 million Holdings RSUs to R&P employees that vest ratably in equal annual installments over a three -year period on each of the first three anniversaries of March 1, 2018. The fair value of the award was measured using the closing price of the Holdings share on the grant date, and the re sulting $27 million will be rec ognized as compensation expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. Also, on May 17, 2018, Holdings granted an award of 0.5 million cash-settled Holdings RSUs to eligible R&P financial professionals that vest ratably in equal installments over a three -year period on each of the first three anniversaries of March 1, 2018. The cash payment for each RSU will equal the average closing price for a Holdings share on the NYSE over the 20 trading days immediately preceding the vesting date. These awards are liability-classified and require fair value remeasurement based upon the price of a Holdings share at the close of each reporting period. In 2018 , the Company recognized expense associated with the annual awards of approximately $4 million . Holdings Stock Options On June 11, 2018, Holdings granted 1.0 million Holdings stock options to R&P employees. These options expire on March 1, 2028 and have a three -year graded vesting schedule, with one-third vesting on each of the three anniversaries of March 1, 2018. The exercise price for the options is $21.34 , which was the closing price of a Holdings share on the grant date. The weighted average grant date fair value per option was estimated at $4.61 using a Black-Scholes options pricing model. Key assumptions used in the valuation included expected volatility of 25.4% based on historical selected peer data, a weighted average expected term of 5.7 years as determined by the simplified method, an expected dividend yield of 2.44% based on Holdings’ expected annualized dividend, and a risk-free interest rate of 2.83% . The total fair value of these options of approximately $5 million will be charged to expense over the shorter of the vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In 2018 , the Company recognized expense associated with the June 11, 2018 option grant of approximately $2 million . Holdings Performance Shares On May 17, 2018, Holdings granted 0.4 million unearned Holdings performance shares to R&P employees, subject to performance conditions and a cliff-vesting term ending March 1, 2021. The performance shares consist of two distinct tranches; one based on the Company’s return-on-equity targets (the “ROE Performance Shares”) and the other based on the Holdings’ relative total shareholder return targets (the “TSR Performance Shares”), each comprising approximately one-half of the award. Participants may receive from 0% to 200% of the unearned performance shares granted. The grant-date fair value of the ROE Performance Shares will be established once the 2019 and 2020 Non-GAAP ROE target are determined and approved. The grant-date fair value of the TSR Performance Shares was measured at $23.17 using a Monte Carlo approach. Under the Monte Carlo approach, stock returns were simulated for Holdings and the selected peer companies to estimate the payout percentages established by the conditions of the award. The resulting $5 million aggregate grant-date fair value of the unearned TSR Performance Shares will be recognized as compensation expense over the shorter of the cliff-vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In 2018 , the Company recognized expense associated with the TSR Performance Share awards of approximately $2 million . Director Awards On May 17, 2018, Holdings granted 0.03 million unrestricted Holdings shares to non-officer directors of Holdings, AXA Equitable Life and MLOA. The fair value of these awards was measured using the $21.68 closing price of Holdings shares on the grant date. As these awards were immediately vested, their aggregate fair value of $0.6 million was immediately recognized as compensation expense. Funding of Awards The Company used common stock held in Treasury to fund the delivery of th e 0.03 million unrestricted Holdings shares granted to the non-officer directors in the second quarter of 2018. Holdings may issue new shares or use common stock held in Treasury for the other outstanding awards linked to Holdings’ common stock. Prior Equity Award Grants and Settlements Prior to adoption of the Omnibus Plan, R&P employees were granted AXA ordinary share options under the AXA Stock Option Plan for AXA Financial Employees and Associates (the “Stock Option Plan”). There is no limitation in the Stock Option Plan on the number of shares that may be issued pursuant to option or other grants. R&P employees were also granted AXA performance shares under the AXA International Performance Shares Plan established for each year (the “Performance Share Plan”) and R&P financial professionals were granted performance units under the AXA Advisors Performance Unit Plan established for each year. The fair values of these prior awards are measured at the grant date by reference to the closing price of the AXA ordinary share, and the result, as adjusted for achievement of performance targets and pre-vesting forfeitures, generally is attributed over the shorter of the requisite service period, the performance period, if any, or to the date at which retirement eligibility is achieved and subsequent service no longer is required for continued vesting of the award. Remeasurements of fair value for subsequent price changes until settlement are made only for performance unit awards that are settled in cash. The fair value of performance units earned and reported in Other liabilities in the consolidated balance sheets at December 31, 2018 and 2017 was $32 million and $45 million , respectively. Approximately 2.0 million outstanding performance units and shares are at risk to achievement of 2017 performance criteria, primarily representing all of the performance shares granted June 19, 2015 and the second tranche of performance shares granted March 24, 2014, for which cumulative average 2017-2019 and 2016-2018 performance targets will determine the number of performance units and shares earned under those awards, respectively. 2017 and 2016 Performance Unit Grants On June 21, 2017 and June 6, 2016, under the terms of the AXA Advisors Performance Unit Plan, approximately 0.6 million and 0.7 million performance units, respectively, were granted to R&P financial professionals. The performance units will be cash settled and are remeasured until settlement of the awards. The performance units will be earned based on meeting pre-established performance metrics tied to achievement of specific sales and earnings goals. For all awards, the number of performance units earned may vary between 0% and 130% of the number of performance units at stake. As a result of the market decline during 2018, the remeasurement associated with 2017 and 2016 performance unit grants resulted in a reduction to compensation expense of $4 million . For the years ended 2017 and 2016, the expense was $15 million and $10 million , respectively. 2017 Performance Shares Grant On June 21, 2017, under the terms of the 2017 Performance Share Plan, AXA awarded approximately 1.7 million unearned performance shares to R&P employees. For employees other than employees of AXA Tech, the extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and the retirement and protection businesses are achieved will determine the number of performance shares earned. For employees of AXA Tech, the extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and AXA Group Management Services (a group of AXA’s central functions and internal service companies) are achieved will determine the number of performance shares earned. For all R&P employees, the number of performance shares earned may vary between 0% and 130% of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the fourth anniversary of the award date. The plan will settle in AXA ordinary shares to all participants. In 2018 and 2017 , the expense associated with the June 21, 2017 grant of performance shares was approximately $6 million and $14 million , respectively. 2016 Performance Shares Grant On June 6, 2016, under the terms of the 2016 Performance Share Plan, AXA awarded approximately 1.9 million unearned performance shares to R&P employees. For R&P employees other than employees of AXA Tech, the extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and the retirement and protection businesses are achieved will determine the number of performance shares earned. For employees of AXA Tech, the extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and AXA Group Management Services (a group of AXA’s central functions and internal service companies) are achieved will determine the number of performance shares earned. For all R&P employees, the number of performance shares earned may vary between 0% and 130% of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the fourth anniversary of the award date. The plan will settle in AXA ordinary shares to all participants. In 2018 , 2017 and 2016 , the expense associated with the June 6, 2016 grant of performance shares was approximately $5 million , $6 million and $15 million , respectively. 2017 Stock Options Grant On June 21, 2017, 0.5 million options to purchase AXA ordinary shares were granted to R&P employees under the terms of the Stock Option Plan at an exercise price of €23.92 . All of those options have a five-year graded vesting schedule, with one-third vesting on each of the third, fourth, and fifth anniversaries of the grant date. Of the total options awarded on June 21, 2017, 0.3 million are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on June 21, 2017 have a ten-year term. The weighted average grant date fair value per option award was estimated at €1.78 using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 25.05% , a weighted average expected term of 8.8 years , an expected dividend yield of 6.53% and a risk-free interest rate of 0.59% . The total fair value of these options (net of expected forfeitures) of approximately $1 million is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. In 2018 and 2017 , the Company recognized expenses associated with the June 21, 2017 grant of options of approximately $0.1 million and $0.6 million , respectively. 2016 Stock Options Grant On June 6, 2016, 0.6 million options to purchase AXA ordinary shares were granted to R&P employees under the terms of the Stock Option Plan at an exercise price of € 21.52 . All of those options have a five-year graded vesting schedule, with one-third vesting on each of the third, fourth, and fifth anniversaries of the grant date. Of the total options awarded on June 6, 2016, 0.3 million are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on June 6, 2016 have a ten -year term. The weighted average grant date fair value per option award was estimated at € 1.85 using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 26.60% , a weighted average expected term of 8.1 years, an expected dividend yield of 6.50% and a risk-free interest rate of 0.33% . The total fair value of these options (net of expected forfeitures) of approximately $1 million is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. In 2018 , 2017 and 2016 the Company recognized expenses associated with the June 6, 2016 grant of options of approximately $0.1 million , $0.1 million and $0.6 million , respectively. Settlement of 2014 Grants in 2018 In June 2018, share distributions totaling approximately $22 million were made to active and former R&P employees in settlement of 0.8 million performance shares earned under the terms of the second tranche of the 2014 Performance Share Plan. In April 2018, cash distributions of approximately $7 million were made to active and former R&P financial professionals in settlement of 0.2 million performance units earned under the terms of the second tranche of the AXA Advisor Performance Unit Plan 2014. Settlement of 2014 Grants in 2017 On March 24, 2017, share distributions totaling approximately $21 million were made to active and former R&P employees in settlement of 2.3 million performance shares earned under the terms of the 2014 Performance Share Plan. On April 7, 2017, cash distributions of approximately $6 million were made to active and former R&P financial professionals in settlement of 0.2 million performance units earned under the terms of the first tranche of the AXA Advisor Performance Unit Plan 2014. Other Grants Prior to the IPO, non-officer directors of Holdings and certain subsidiaries were granted restricted AXA ordinary shares (prior to 2011, AXA ADRs) and unrestricted AXA ordinary shares (prior to March 15, 2010, AXA ADRs) annually under The Equity Plan for Directors. The Company has also granted AXA restricted stock units (“AXA RSUs”) to certain R&P executives. The AXA RSUs are phantom AXA ordinary shares that, once vested, entitle the recipient to a cash payment based on the average closing price of the AXA ordinary share over the twenty trading days immediately preceding the vesting date. Investment Management and Research Employees and directors in our Investment Management and Research business participate in several unfunded long-term incentive compensation plans maintained by AB. Awards under these plans are linked to AB Holding Units. Under the AB 2017 Long Term Incentive Plan (“2017 Plan”), which was adopted at a special meeting of AB Holding Unitholders held on September 29, 2017, the following forms of awards may be granted to AB employees and Directors: (i) restricted AB Holding Units or phantom restricted AB Holding Units (a “phantom” award is a contractual right to receive AB Holding Units at a later date or upon a specified event); (ii) options to buy AB Holding Units; and (iii) other AB Holding Unit-based awards (including, without limitation, AB Holding Unit appreciation rights and performance awards). The 2017 Plan will expire on September 30, 2027, and no awards under the 2017 Plan will be made after that date. Under the 2017 Plan, the aggregate number of AB Holding Units with respect to which awards may be granted is 60 million , including no more than 30 million newly-issued AB Holding Units. AB engages in open-market purchases of AB Holding Units to help fund anticipated obligations under its long-term incentive compensation plans and for other corporate purposes. During 2018 and 2017 , AB purchased 9.3 million AB Holding Units for $268 million and $220 million , respectively. These amounts reflect open-market purchases of 6.5 million and 5.2 million AB Holding Units for $183 million and $117 million , respectively, with the remainder relating to purchases of AB Holding Units from AB employees to allow them to fulfill statutory tax withholding requirements at the time of distribution of long-term incentive compensation awards, offset by AB Holding Units purchased by AB employees as part of a distribution reinvestment election. During 2018 , and 2017, AB granted 8.7 million and 8.6 million restricted AB Holding units to AB employees and directors, respectively. During 2018 and 2017 , AB Holding issued 0.9 million and 1.2 million AB Holding Units, respectively, upon exercise of options to buy AB Holding Units. AB Holding used the proceeds of $17 million and $20 million , respectively, received from employees as payment in cash for the exercise price to purchase the equivalent number of newly-issued AB Holding Units. As of December 31, 2018 , no options to buy AB Holding Units had been granted and 14.4 million AB Holding Units, net of withholding tax requirements, were subject to other AB Holding Unit awards made under the 2017 Plan or an equity compensation plan with similar terms that was canceled in 2017. AB Holding Unit-based awards (including options) in respect of 45.6 million AB Holding Units were available for grant as of December 31, 2018 . Summary of Stock Option Activity A summary of activity in the AXA and the Company option plans during 2018 follows: Options Outstanding EQH Shares AB Holding Units AXA Ordinary Shares AXA ADRs (2) Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Number Weighted Number Weighted Options Outstanding at January 1, 2018 — $ — 3,082 $ 52.37 5,402 € 17.36 35 $ 20.98 Options granted 1,035 $ 21.34 — $ — — € — — $ — Options exercised — $ — (889 ) $ 18.66 (565 ) € 11.80 — $ — Options forfeited, net (41 ) $ 21.34 — $ — — € — — $ — Options expired — $ — (1,522 ) $ 85.09 (1,225 ) € 17.45 (10 ) $ 35.25 Options Outstanding at December 31, 2018 994 $ 21.34 671 $ 22.83 3,612 € 18.20 25 $ 15.37 Aggregate Intrinsic Value (1) $ — $ 3 € 2,383 $ 151 Weighted Average Remaining Contractual Term (in years) 9.16 1.60 4.50 0.58 Options Exercisable at December 31, 2018 — $ — 635 $ 22.84 2,147 € 15.27 25 $ 15.37 Aggregate Intrinsic Value (1) $ — $ 3 € 7,698 $ 151 Weighted Average Remaining Contractual Term (in years) — 1.50 2.45 0.58 __________ (1) Aggregate intrinsic value, presented in thousands, is calculated as the excess of the closing market price on December 31, 2018 of the respective underlying shares over the strike prices of the option awards. For awards with strike prices higher then market prices, intrinsic value is shown as zero. (2) AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity. For the purpose of estimating the fair value of stock option awards, the Company applies the Black-Scholes model and attributes the result over the requisite service period using the graded-vesting method. A Monte-Carlo simulation approach was used to model the fair value of the conditional vesting feature of the awards of options to purchase Holdings and AXA ordinary shares. Shown below are the relevant input assumptions used to derive the fair values of options awarded in 2018 , 2017 and 2016 , respectively. EQH Shares AB Holding Units (1) AXA Ordinary Shares (2) 2018 2018 2017 2016 2018 2017 2016 Dividend yield 2.44 % NA NA 7.10 % NA 6.53 % 6.50 % Expected volatility 25.40 % NA NA 31.00 % NA 25.05 % 26.6 % Risk-free interest rates 2.83 % NA NA 1.30 % NA 0.59 % 0.33 % Expected life in years 9.7 NA NA 6.0 NA 8.8 8.1 Weighted average fair value per option at grant date $ 4.61 NA NA $ 2.75 NA $ 2.01 $ 2.06 _____________ (1) There were no options to buy AB Holding Units awarded during 2018 and 2017. As such, the input assumptions for 2018 and 2017 are not applicable. (2) There were no options to buy AXA Ordinary Shares awarded during 2018. As such, the input assumptions for 2018 are not applicable. As of December 31, 2018 , approximately $1 million of unrecognized compensation cost related to AXA unvested stock option awards, net of estimated pre-vesting forfeitures, is expected to be recognized by the Company over a weighted average period of 2.2 years. As of December 31, 2018 , approximately $3 million of unrecognized compensation cost related to Holdings unvested stock option awards, net of estimated pre-vesting forfeitures, is expected to be recognized by the Company over a weighted average period of 0.8 years. Options The fair value of AXA stock options is calculated using the Black-Scholes option pricing model. The expected AXA dividend yield is based on market consensus. AXA share price volatility is estimated on the basis of implied volatility, which is checked against an analysis of historical volatility to ensure consistency. The risk-free interest rate is based on the Euro Swap Rate curve for the appropriate term. The effect of expected early exercise is taken into account through the use of an expected life assumption based on historical data. The fair value of AB Holding Unit options is calculated using the Black-Scholes option pricing model. The expected cash distribution yield is based on the average of our distribution yield over the past four quarters. The volatility factor represents historical AB Holding Units price volatility over the same period as the expected term. The risk-free interest rate is based on the U.S. Treasury bond yield for the appropriate expected term. The expected term was calculated using the simplified method, due to the lack of sufficient historical data. Restricted Awards The market price of a Holdings share is used as the basis for the fair value measure of a Holdings RSU. For purposes of determining compensation cost for stock-settled Holdings RSUs, fair value is fixed at the grant date until settlement, absent modification to the terms of the award. For liability-classified cash-settled Holdings RSUs, fair value is remeasured at the end of each reporting period. For 2018 , 2017 and 2016 , respectively, the Company recognized compensation costs of $215 million , $185 million and $154 million for outstanding restricted stock and AXA RSUs. The fair values of awards made under these programs are measured at the grant date by reference to the closing price of the unrestricted shares, and the result generally is attributed over the shorter of the requisite service period, the performance period, if any, or to the date at which retirement eligibility is achieved and subsequent service no longer is required for continued vesting of the award. Remeasurements of fair value for subsequent price changes until settlement are made only for AXA RSUs. At December 31, 2018 , approximately 2.3 million restricted Holdings and AXA ordinary share awards remain unvested. Unrecognized compensation cost related to these awards totaled approximately $30 million , net of estimated pre-vesting forfeitures, and is expected to be recognized over a weighted average period of 1.2 years. At December 31, 2018 , approximately 20.2 million AB Holding Unit awards remain unvested. Unrecognized compensation cost related to these awards totaled approximately $87 million , net of estimated pre-vesting forfeitures, is expected to be recognized over a weighted average period of 3.6 years. The following table summarizes restricted Holdings share and AXA ordinary share activity for 2018 . Shares of Holdings Restricted Stock Weighted Average Grant Date Fair Value Shares of AXA Restricted Stock Weighted Average Grant Date Fair Value Unvested as of January 1, 2018 — $ — 93,720 $ 21.07 Granted 2,877,011 $ 20.83 — $ — Cancelled 92,526 $ 21.21 208 $ 26.64 Vested 511,575 $ 21.09 39,528 $ 21.99 Unvested as of December 31, 2018 2,272,910 $ 21.00 53,984 $ 20.38 Employee Stock Purchase Plans AXA Shareplan 2017 In 2017 , eligible employees of participating subsidiaries were offered the opportunity to purchase newly issued AXA ordinary shares, subject to plan limits, under the terms of AXA Shareplan 2017 . Eligible employees could have reserved a share purchase during the reservation period from August 28, 2017 through September 8, 2017 and could have canceled their reservation or elected to make a purchase for the first time during the retraction/subscription period from October 13, 2017 through October 17, 2017 . The U.S. dollar purchase price was determined by applying the U.S. dollar/Euro forward exchange rate on October 11, 2017 to the discounted formula subscription price in Euros. Investment Option A permitted participants to purchase AXA ordinary shares at a 20% formula discounted price of € 20.19 per share. Investment Option B permitted partic ipants to purchase AXA ordinary shares at an 8.98% formula discounted price of € 22.96 per share on a leveraged basis with a guaranteed return of initial investment plus a portion of any appreciation in the undiscounted value of the total shares purchased. For purposes of determining the amount of any appreciation, the AXA ordinary share price will be measured over a fifty-two week peri od preceding the scheduled end date of AXA Shareplan 2018 , which is July 1, 2022. All subscriptions became binding and irrevocable on October 17, 2017 . The Company recognized compensation expense of $13 million and $19 million in the years ended December 31, 2017 and 2016, respectively, in connection with each respective year’s offering of AXA stock under the AXA Shareplan, representing the aggregate discount provided to participants for their purchase of AXA stock under each of those plans, as adjusted for the post-vesting, five -year holding period. The Company participants in AXA Shareplan 2017 and 2016 primarily invested under Investment Option B for the purchase of approximately of 4 million and 6 million AXA ordinary shares, respectively . Holdings Stock Purchase Plan During 2018, Holdings introduced the AXA Equitable Holdings, Inc. Stock Purchase Program (“SPP”). Participants are able to contribute up to 100% of their eligible compensation and receive a matching contribution in cash equal to 15% of their payroll contribution, which will be used to purchase Holdings shares. Purchases will be made on the last trading day of each month at the prevailing market rate.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES Income from operations before income taxes included income from domestic operations of $2,305 million , $1,163 million and $1,908 million for the years ended December 31, 2018 , 2017 and 2016 , and income from foreign operations of $156 million , $143 million and $119 million for the years ended December 31, 2018 , 2017 and 2016 . Approximately $37 million , $30 million and $30 million of the Company’s income tax expense is attributed to foreign jurisdictions for the years ended December 31, 2018 , 2017 and 2016 . A summary of the income tax (expense) benefit in the consolidated statements of income (loss) follows: Years Ended December 31, 2018 2017 2016 (in millions) Income tax (expense) benefit: Current (expense) benefit $ 508 $ 119 $ (169 ) Deferred (expense) benefit (815 ) (168 ) (209 ) Total $ (307 ) $ (49 ) $ (378 ) The Federal income taxes attributable to consolidated operations are different from the amounts determined by multiplying the earnings before income taxes and noncontrolling interest by the expected Federal income tax rate of 21% , 35% and 35% for 2018 , 2017 and 2016 , respectively. The sources of the difference and their tax effects are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Expected income tax (expense) benefit $ (516 ) $ (457 ) $ (710 ) Noncontrolling interest 54 138 125 Non-taxable investment income (loss) 105 255 177 Tax audit interest (22 ) (14 ) (32 ) State income taxes (18 ) (16 ) (108 ) Tax settlements/uncertain tax position release — 228 181 Change in tax law 104 (32 ) — Intangibles (3 ) (138 ) (9 ) Other (11 ) (13 ) (2 ) Income tax (expense) benefit $ (307 ) $ (49 ) $ (378 ) The Tax Cuts and Jobs Act (the “Tax Reform Act”) was enacted on December 22, 2017. The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the application of U.S. GAAP in situations where a company does not have the necessary information available to complete its accounting for certain income tax effects of the Tax Reform Act. In accordance with SAB 118, the Company determined reasonable estimates for certain effects of the Tax Reform Act and recorded those estimates as provisional amounts in the 2017 financial statements. The accounting for the income tax effects of the Tax Reform Act has been completed. The components of change in tax law are as follows: • An income tax benefit of $69 million from the revaluation of deferred tax assets and liabilities that existed at the time of enactment. The calculation of cumulative temporary differences has been refined. • An income tax expense of $17 million related to the decrease in federal tax benefit allowable for audit interest as a result of lower corporate tax rates. • An income tax benefit of $35 million to reverse the sequestration fee applied to a portion of accumulated minimum tax credits in the 2017 financial statements. The Internal Revenue Service has since clarified that refundable minimum tax credits are not subject to sequestration. • During the fourth quarter of 2018, the Company adopted the Internal Revenue Service’s directive related to the calculation of tax reserves for variable annuity contracts. As a result of adoption of the directive, the Company released audit interest accrued for uncertainties in the calculation of variable annuity tax reserves. Additionally, due to adoption of the directive, certain tax credits became unavailable for utilization. The impact on the Company’s financial statements was a benefit of $17 million . During the second quarter of 2017 , the Company agreed to the Internal Revenue Service’s Revenue Agent’s Report for its consolidated 2008 and 2009 Federal corporate income tax returns. The impact on the Company’s financial statements and unrecognized tax benefits was a tax benefit of $228 million . The Company’s financial statements include a tax expense of $129 million related to non-deductible goodwill due to the Company’s early adoption of revised goodwill impairment guidance in the first quarter of 2017 . During the first quarter of 2016 , the Company agreed to the Internal Revenue Service’s Revenue Agent’s Report for MONY Life’s consolidated amended 2004-2007 Federal and consolidated 2008 and 2009 Federal corporate income tax returns. The impact on the Company’s statement of income (loss) is an income tax benefit of $21 million . Also during 2016 , the Company released an unrecognized tax benefit related to the loss generated by the sale of MONY Life Insurance Company. The benefit recorded in the Company’s financial statements was $160 million . The components of the net deferred income taxes are as follows: As of December 31, 2018 2017 Assets Liabilities Assets Liabilities (in millions) Compensation and related benefits $ 312 $ — $ 328 $ — Net operating loss 90 — 35 — Reserves and reinsurance 321 — 1,460 — DAC — 1,175 — 850 Unrealized investment gains (losses) 108 — — 373 Investments 124 — — 891 Tax credits 149 — 528 — Other — 208 170 — Total $ 1,104 $ 1,383 $ 2,521 $ 2,114 The Company has Federal tax net operating loss carry forwards of $429 million and $167 million , which will expire at various dates from 2030 through 2034, for the years ending December 31, 2018 and 2017 , respectively. Realization is dependent on generating sufficient taxable income prior to expiration of the loss carry forwards. Although realization is not assured, management believes it is more likely than not that all of the deferred tax asset will be realized. The Company had $140 million and $528 million of AMT credits for the years ended December 31, 2018 and 2017 , respectively, which are expected to be refunded or utilized against future taxable income. The Company provides income taxes on the unremitted earnings of non-U.S. corporate subsidiaries except to the extent that such earnings are indefinitely reinvested outside the United States. As of December 31, 2018 , $29 million of undistributed earnings of non-U.S. corporate subsidiaries were permanently invested outside the United States. At existing applicable income tax rates, additional taxes of approximately $8 million would need to be provided if such earnings are remitted. A reconciliation of unrecognized tax benefits (excluding interest and penalties) follows: 2018 2017 2016 (in millions) Balance at January 1, $ 477 $ 729 $ 802 Additions for tax positions of prior years 91 28 99 Reductions for tax positions of prior years (29 ) (247 ) (172 ) Additions for tax positions of current year — — — Settlements with tax authorities — (33 ) — Balance at December 31, $ 539 $ 477 $ 729 Unrecognized tax benefits that, if recognized, would impact the effective rate $ 407 $ 317 $ 485 The Company recognizes accrued interest and penalties related to unrecognized tax benefits in tax expense. Interest and penalties included in the amounts of unrecognized tax benefits at December 31, 2018 and 2017 were $75 million and $83 million , respectively. For 2018 , 2017 and 2016 , respectively, there were $(8) million , $(43) million and $25 million in interest expense (benefit) related to unrecognized tax benefits. It is reasonably possible that the total amount of unrecognized tax benefits will change within the next 12 months due to the conclusion of IRS proceedings and the addition of new issues for open tax years. The possible change in the amount of unrecognized tax benefits cannot be estimated at this time. As of December 31, 2018 , tax years 2010 and subsequent remain subject to examination by the IRS.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances for the past three years follow: December 31, 2018 2017 2016 (in millions) Unrealized gains (losses) on investments (1) (3) $ (394 ) $ 830 $ 140 Defined benefit pension plans (2) (968 ) (955 ) (1,055 ) Foreign currency translation adjustments (72 ) (35 ) (77 ) Total accumulated other comprehensive income (loss) (1,434 ) (160 ) (992 ) Less: Accumulated other comprehensive (income) loss attributable to the noncontrolling interest 38 52 71 Accumulated other comprehensive income (loss) attributable to Holdings $ (1,396 ) $ (108 ) $ (921 ) ______________ (1) 2018 includes a $113 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (2) 2018 includes a $202 million increase to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (3) 2018 includes a $ 7 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2016-01. The components of OCI for the past three years, net of tax, follow: Years Ended December 31, 2018 2017 2016 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the year $ (1,952 ) $ 910 $ (227 ) (Gains) losses reclassified into net income (loss) during the year (1) 60 10 (55 ) Net unrealized gains (losses) on investments (1,892 ) 920 (282 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other 563 (230 ) 8 Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(356), $262 and $(164)) (1,329 ) 690 (274 ) Change in defined benefit plans: Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost (2) 189 100 34 Change in defined benefit plans (net of deferred income tax expense (benefit) of $50, $51 and $19) 189 100 34 Foreign currency translation adjustments: Foreign currency translation gains (losses) arising during the year (37 ) $ 42 $ (18 ) (Gains) losses reclassified into net income (loss) during the year — — — Foreign currency translation adjustment (37 ) 42 (18 ) Total other comprehensive income (loss), net of income taxes (1,177 ) 832 (258 ) Less: Other comprehensive (income) loss attributable to noncontrolling interest (15 ) (19 ) 14 Other comprehensive income (loss) attributable to Holdings $ (1,192 ) $ 813 $ (244 ) ______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $13 million , $5 million and $29 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. (2) These AOCI components are included in the computation of net periodic costs (see “Employee Benefit Plans” in Note 13 ). Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of December 31, 2018 , the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date to be up to approximately $95 million . For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable Life, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable Life implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable Life’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following AXA Equitable Life’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 and is pending in Connecticut Superior Court, Judicial District of Stamford. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to AXA Equitable Life’s COI rate increase. In early 2016, AXA Equitable Life raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by AXA Equitable Life in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek; (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal actions challenging the COI rate increase are also pending against AXA Equitable Life and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Two actions are also pending against AXA Equitable Life in New York state court. AXA Equitable Life is vigorously defending each of these matters. Debt Maturities The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2018: Calendar Year 2020 2021 2022 2023 2024 and thereafter Long-term debt $ — $ 300 $ — $ 800 $ 3,350 Leases The Company has entered into operating leases for office space and certain other assets, principally information technology equipment and office furniture and equipment. Future minimum payments under non-cancelable operating leases for 2019 and the four successive years are $212 million , $186 million , $181 million , $166 million , $155 million and $293 million thereafter. Minimum future sublease rental income on these non-cancelable operating leases for 2019 and the four successive years is $59 million , $46 million , $44 million , $41 million , $40 million and $27 million thereafter. Rent expense, which is amortized on a straight-line basis over the life of the lease, was $143 million , $143 million , $140 million , respectively, for the years ended December 31, 2018 , 2017 and 2016 , net of sublease income of $12 million , $16 million , $16 million , respectively, for the years ended December 31, 2018 , 2017 and 2016 . Obligations under Funding Agreements Entering into FHLBNY membership, borrowings and funding agreements requires the ownership of FHLBNY stock and the pledge of assets as collateral. The Company has purchased FHLBNY stock of $190 million and pledged collateral with a carrying value of $6.1 billion , as of December 31, 2018 . The Company issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. The Company issues long term funding agreements to the FHLBNY and uses the funds for spread lending purposes. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Derivative and offsetting assets and liabilities” included in Note 3. The table below summarizes the Company’s activity of funding agreements with the FHLBNY. Outstanding balance at end of period Maturity of Outstanding balance Issued during the period Repaid during the period (in millions) December 31, 2018: Short-term FHLBNY funding agreements $ 1,490 Less than one month $ 7,980 $ 6,990 Long-term FHLBNY funding agreements 1,621 Less than four years — — 98 Less than five years — — 781 Greater than five years — — Total long-term funding agreements 2,500 — — Total FHLBNY funding agreements at December 31, 2018 (1) $ 3,990 $ 7,980 $ 6,990 December 31, 2017: Short-term FHLBNY funding agreements $ 500 Less than one month $ 6,000 $ 6,000 Long-term FHLBNY funding agreements 1,244 Less than four years 324 — 377 Less than five years 303 — 879 Greater than five years 135 — Total long-term funding agreements 2,500 762 — Total FHLBNY funding agreements at December 31, 2017 (1) $ 3,000 $ 6,762 $ 6,000 ____________ (1) The $11 million and $14 million difference between the funding agreements carrying value shown in fair value table for 2018 and 2017 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. Restructuring As part of the Company’s on-going efforts to reduce costs and operate more efficiently, from time to time, management has approved and initiated plans to reduce headcount and relocate certain operations. In 2018 , 2017 and 2016 respectively, the Company recorded $7 million , $29 million and $21 million pre-tax charges related to severance and lease costs. The restructuring costs are included in other operating expenses and liabilities on the balance sheet and in other liabilities on the income statement. On May 2, 2018, AB announced that they will establish their corporate headquarters in, and relocate approximately 1,050 jobs currently located in the New York metro area to, Nashville, TN. During the transition period, which began in 2018 and is expected to continue through 2024, AB expects to incur transition costs of approximately $155 million to $165 million . These costs include employee relocation, severance, recruitment, and overlapping compensation and occupancy costs. AB incurred $10 million of transition costs in 2018 . Guarantees and Other Commitments The Company provides certain guarantees or commitments to affiliates and others. At December 31, 2018 , these arrangements include commitments by the Company to provide equity financing of $952 million (including $304 million with affiliates and $12 million on consolidated VIEs) to certain limited partnerships and real estate joint ventures under certain conditions. Management believes the Company will not incur material losses as a result of these commitments. The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote. Holdings had $606 million of commitments under existing mortgage loan agreements at December 31, 2018 . AXA Equitable Life, USFL and MLOA receive statutory reserve credits for reinsurance treaties with EQ AZ Life Re to the extent EQ AZ Life Re holds assets in an irrevocable trust (the “EQ AZ Life Re Trust”). As of December 31, 2018 , EQ AZ Life Re holds $1.6 billion of assets in the EQ AZ Life Re Trust December 31, 2018 and letters of credit of $2.5 billion that are guaranteed by Holdings. Under the reinsurance transactions, EQ AZ Life Re is permitted to transfer assets from the EQ AZ Life Re Trust under certain circumstances. The level of statutory reserves held by EQ AZ Life Re fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or additional letters of credit be secured, which could adversely impact EQ AZ Life Re’s liquidity. AXA Corporate Solutions receives statutory reserve credits for reinsurance treaties with CS Life RE to the extent CS Life RE holds assets in an irrevocable trust (the “CS Life RE Trust”). As of December 31, 2018 , CS Life RE holds $0.3 billion of assets in the CS Life RE Trust and letters of credit of $125 million that are guaranteed by Holdings. Under the reinsurance transactions, CS Life RE is permitted to transfer assets from the CS Life RE Trust under certain circumstances. The level of statutory reserves held by CS Life RE fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or additional letters of credit be secured, which could adversely impact CS Life RE’s liquidity. In addition, CS Life RE utilizes derivative instruments that are collectively managed in an effort to reduce the economic impact of unfavorable changes to GMDB and GMIB reserves. The use of such instruments is accompanied by agreements which specify the circumstances under which the parties are required to pledge collateral related to the decline in the estimated fair value of specified instruments. Moreover, under the terms of a majority of the transactions, payments to counterparties related to the change in fair value of the instruments may be required. The amount of collateral pledged, and the amount of payments required to be made pursuant to such transactions may increase under certain circumstances, which could adversely impact CS Life RE’s liquidity.

INSURANCE GROUP STATUTORY FINAN

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2018
Insurance Group Statutory Financial Information [Abstract]
Insurance Group Statutory Financial Information	INSURANCE GROUP STATUTORY FINANCIAL INFORMATION For 2018 , 2017 and 2016 , respectively, AXA Equitable Life’s, MLOA’s, USFL’s, AXA Equitable L&A’s and ACS Life’s combined statutory Net income (loss) totaled $3.0 billion , $0.9 billion and $0.7 billion . Combined statutory Surplus, Capital stock and Asset Valuation Reserve (“AVR”) totaled $8.4 billion and $9.2 billion at December 31, 2018 and 2017 , respectively. At December 31, 2018 , AXA Equitable Life, MLOA, USFL, AXA Equitable L&A and ACS Life, in accordance with various government and state regulations, had $77 million of securities on deposit with such government or state agencies. In 2018 , AXA Equitable Life paid to its direct parent which subsequently distributed such amount to Holdings an ordinary shareholder dividend of $1.1 billion . Also in 2018, AXA Equitable Life transferred its interests in ABLP, AB Holding and the General Partner to Alpha Units Holdings, Inc., a newly formed subsidiary, and distributed the shares of that subsidiary to its direct parent which subsequently distributed such shares to Holdings (the “AB Ownership Transfer”). The AB Ownership transfer was considered an extraordinary dividend of $1.7 billion representing the equity value of Alpha Units Holdings, Inc. In connection with the AB Ownership Transfer, AXA Equitable Life paid an extraordinary cash dividend of $572 million and issued a surplus note to Holdings in the same amount. AXA Equitable Life repaid the outstanding principal balance of the surplus note in March 2019. In 2017 , AXA Equitable Life did not pay shareholder dividends and in 2016 , AXA Equitable Life paid $1.1 billion in shareholder dividends. Dividend Restrictions As domestic insurance subsidiaries regulated by insurance laws of their respective domiciliary states, AXA Equitable Life, MLOA, USFL, AXA Equitable Life and Annuity (“AXA Equitable L&A”) and ACS Life are subject to restrictions as to the amounts they may pay as dividends and amounts they may repay of surplus notes to Holdings . With respect to AXA Equitable Life, a New York domiciled insurance subsidiary which is also the Company’s primary insurance subsidiary, New York insurance law provides that a stock life insurer may not, without prior approval of the New York State Department of Financial Services (“NYDFS”), pay a dividend to its stockholders exceeding an amount calculated under one of two standards (the “Standards”). The first standard allows payment of an ordinary dividend out of the insurer’s earned surplus (as reported on the insurer’s most recent annual statement) up to a limit calculated pursuant to a statutory formula, provided that the NYDFS is given notice and opportunity to disapprove the dividend if certain qualitative tests are not met (the “Earned Surplus Standard”). The second standard allows payment of an ordinary dividend up to a limit calculated pursuant to a different statutory formula without regard to the insurer’s earned surplus. Dividends exceeding these prescribed limits require the insurer to file a notice of its intent to declare the dividends with the NYDFS and prior approval or non-disapproval from the NYDFS. In applying the Standards, AXA Equitable Life could pay ordinary dividends up to approximately $1.0 billion during 2019 or, if the amount under the Earned Surplus Standard was limited to the amount of AXA Equitable Life’s positive unassigned funds as reported on its 2019 annual statement, $2.1 billion . However, in connection with the AB Ownership Transfer, AXA Equitable Life agreed with the NYDFS that it would not seek a dividend of greater than $1.0 billion under the Earned Surplus Standard during 2019. Prescribed and Permitted Accounting Practices At December 31, 2018 and for the year then ended, for AXA Equitable Life, MLOA, USFL and AXA Equitable L&A there were no differences in Net income (loss) and Capital and surplus resulting from practices prescribed and permitted by NYDFS, the Arizona Department of Insurance (the “AID”) and those prescribed by NAIC Accounting Practices and Procedures effective at December 31, 2018 . At December 31, 2018 , ACS Life had a difference in Capital and surplus based on the investment valuation of the Captive reinsurance subsidiary which follows a special purpose framework for Statutory reporting as agreed to with the AID from practices prescribed and permitted by the Delaware Department of Insurance and those prescribed by NAIC Accounting Practices and Procedures effective at December 31, 2018 . The impact of this permitted practice increased the statutory surplus and AVR of ACS Life by $86 million and $103 million at December 31, 2018 and 2017 , respectively. ACS Life’s risk-based capital would have triggered a regulatory event without the use of this permitted practice in 2016. AXA Equitable Life, USFL and MLOA cede a portion of their statutory reserves to EQ AZ Life Re, a captive reinsurer, as part of the Company’s capital management strategy. EQ AZ Life Re prepares financial statements in a special purpose framework for statutory reporting. Differences between Statutory Accounting Principles and U.S. GAAP Accounting practices used to prepare statutory financial statements for regulatory filings of stock life insurance companies differ in certain instances from U.S. GAAP. The differences between statutory surplus and capital stock determined in accordance with Statutory Accounting Principles (“SAP”) and total equity under U.S. GAAP are primarily: (a) the inclusion in SAP of an AVR intended to stabilize surplus from fluctuations in the value of the investment portfolio; (b) future policy benefits and policyholders’ account balances under SAP differ from U.S. GAAP due to differences between actuarial assumptions and reserving methodologies; (c) certain policy acquisition costs are expensed under SAP but deferred under U.S. GAAP and amortized over future periods to achieve a matching of revenues and expenses; (d) under SAP, Federal income taxes are provided on the basis of amounts currently payable with limited recognition of deferred tax assets while under U.S. GAAP, deferred taxes are recorded for temporary differences between the financial statements and tax basis of assets and liabilities where the probability of realization is reasonably assured; (e) the valuation of assets under SAP and U.S. GAAP differ due to different investment valuation and depreciation methodologies, as well as the deferral of interest-related realized capital gains and losses on fixed income investments; (f) the valuation of the investment in AB and AB Holding under SAP reflects a portion of the market value appreciation rather than the equity in the underlying net assets as required under U.S. GAAP; (g) reporting the surplus notes as a component of surplus in SAP but as a liability in U.S. GAAP; (h) computer software development costs are capitalized under U.S. GAAP but expensed under SAP; (i) certain assets, primarily prepaid assets, are not admissible under SAP but are admissible under U.S. GAAP; and (j) cost of reinsurance which is recognized as expense under SAP and amortized over the life of the underlying reinsured policies under U.S. GAAP.

BUSINESS SEGMENT INFORMATION

BUSINESS SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Business Segment Information	BUSINESS SEGMENT INFORMATION The Company has four reportable segments: Individual Retirement, Group Retirement, Investment Management and Research and Protection Solutions. The Company changed its segment presentation in the fourth quarter 2017. The segment disclosures are based on the intention to provide the users of the financial statements with a view of the business from the Company’s perspective. As a result, the Company determined that it is more useful for a user of the financial statements to assess the historical performance on the basis which management currently evaluates the business. The reportable segments are based on the nature of the business activities, as they exist as of the initial filing date. These segments reflect the manner by which the Company’s chief operating decision maker views and manages the business. A brief description of these segments follows: • The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income. • The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses. • The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels- Institutional, Retail and Private Wealth Management-and distributes its institutional research products and solutions through Bernstein Research Services. • The Protection Solutions segment includes our life insurance and group employee benefits businesses. Our life insurance business offers a variety of variable universal life, universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of dental, vision, life, and short- and long-term disability and other insurance products to small and medium-size businesses across the United States. Measurement Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments. In the first quarter of 2018, the Company revised its Operating earnings definition as it relates to the treatment of certain elements of the profitability of its variable annuity products with indexed-linked features to align to the treatment of its variable annuity products with GMxB features. In addition, adjustments for variable annuity products with index-linked features previously included within Other adjustments in the calculation of Non-GAAP Operating Earnings are now included with the adjustments for variable annuity products with GMxB features in the broader adjustment category, Variable annuity product features. In order to improve the consistency and comparability of the financial statements, management revised the Notes to the Consolidated Financial Statements for the years ended December 31, 2017 and 2016 to include the revisions discussed herein. Operating earnings is calculated by adjusting each segment’s Net income (loss) attributable to Holdings for the following items: • Items related to Variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features, the effect of benefit ratio unlock adjustments and changes in the fair value of the embedded derivatives reflected within variable annuity products’ net derivative results; • Investment (gains) losses, which includes other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances; • Goodwill impairment, which includes a write-down of goodwill in 2017. • Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation; • Other adjustments, which includes restructuring costs related to severance, lease write-offs related to non-recurring restructuring activities, and separation costs; and • Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period, permanent differences due to goodwill impairment and the Tax Reform Act. Revenues derived from any customer did not exceed 10% of revenues for the years ended December 31, 2018 , 2017 and 2016 . The table below presents operating earnings (loss) by segment and Corporate and Other and a reconciliation to Net income (loss) attributable to Holdings for the years ended December 31, 2018 , 2017 and 2016 , respectively: Years Ended December 31, 2018 2017 2016 (in millions) Net income (loss) attributable to Holdings $ 1,820 $ 834 $ 1,254 Adjustments related to: Variable annuity product features (70 ) 1,107 2,143 Investment (gains) losses 86 191 (1,983 ) Goodwill impairment — 369 — Net actuarial (gains) losses related to pension and other postretirement benefit obligations 215 135 140 Other adjustments (1) 299 119 (7 ) Income tax expense (benefit) related to above adjustments (111 ) (644 ) (93 ) Non-recurring tax items (73 ) (76 ) (63 ) Non-GAAP Operating Earnings $ 2,166 $ 2,035 $ 1,391 Operating earnings (loss) by segment: Individual Retirement $ 1,555 $ 1,252 $ 1,167 Group Retirement 389 283 167 Investment Management and Research 381 211 161 Protection Solutions 197 502 77 Corporate and Other (2) (356 ) (213 ) (181 ) _______________ (1) Other adjustments include separation costs of $213 million in 2018 and $93 million in 2017. (2) Includes interest expense of $223 million , $138 million and $161 million , in 2018 , 2017 and 2016 , respectively. Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to Total revenues by excluding the following items: • Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features; • Investment gains (losses), which include other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses, and valuation allowances; and • Other adjustments, which includes investment income (loss) from certain derivative instruments, excluding derivative instruments used to hedge risks associated with interest margins on interest sensitive life and annuity contracts and freestanding and embedded derivatives associated with products with GMxB features. The table below presents segment revenues for the years ended December 31, 2018 , 2017 and 2016 . Years Ended December 31, 2018 2017 2016 (in millions) Segment revenues: Individual Retirement (1) $ 4,054 $ 4,374 $ 3,703 Group Retirement (1) 1,019 942 801 Investment Management and Research (2) 3,411 3,216 2,933 Protection Solutions (1) 3,232 3,057 3,129 Corporate and Other (1) 1,148 1,212 1,256 Adjustments: Variable annuity product features (643 ) (214 ) (2,132 ) Investment gains (losses) (86 ) (191 ) 1,983 Other adjustments to segment revenues (57 ) 64 90 Total revenues $ 12,078 $ 12,460 $ 11,763 _____________ (1) Includes investment expenses charged by AB of approximately $67 million , $68 million and $60 million for 2018 , 2017 and 2016 , respectively, for services provided to the Company. (2) Inter-segment investment management and other fees of approximately $94 million , $96 million and $86 million for 2018 , 2017 and 2016 , respectively, are included in segment revenues of the Investment Management and Research segment. The table below presents total assets by segment as of December 31, 2018 and 2017 : December 31, 2018 2017 (in millions) Total assets by segment: Individual Retirement (1) $ 105,532 $ 121,824 Group Retirement (1) 38,874 38,419 Investment Management and Research 10,294 10,057 Protection Solutions (1) 44,633 43,205 Corporate and Other 21,464 22,110 Total assets $ 220,797 $ 235,615 ________ (1) Amounts for December 31, 2017 as previously reported were: Individual Retirement of $121,713 million , Group Retirement of $38,578 million and Protection Solutions of $43,157 million .

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Equity	EQUITY Dividends to Shareholders On August 10, 2018, our Board of Directors declared a cash dividend on Holdings’ common stock of $0.13 per share, payable on August 30, 2018 to shareholders of record on August 23, 2018. On November 9, 2018, our Board of Directors declared a cash dividend on Holdings’ common stock of $0.13 per share, payable on December 3, 2018 to shareholders of record on November 26, 2018. The payment of any future dividends will be at the discretion of our Board of Directors and will depend on various factors. Share Repurchase Program On August 10, 2018, Holdings’ Board of Directors authorized a share repurchase program. Under the program, Holdings may purchase up to $500 million of its common stock beginning August 16, 2018 and expiring on March 31, 2019. On November 9, 2018, Holdings’ Board of Directors approved a $300 million increase to Holdings’ share repurchase program, bringing the total authorization to $800 million . Holdings may choose to suspend or discontinue the repurchase program at any time. The repurchase program does not obligate Holdings to purchase any particular number of shares. As of December 31, 2018 , the Company repurchased approximately 32.5 million shares of its common stock at a total cost of approximately $648 million . The repurchased common stock was recorded as treasury stock in the consolidated balance sheets. As of December 31, 2018 , the Company reissued approximately 0.4 million shares of its treasury stock. The timing and amount of share repurchases are determined by management based upon market conditions and other considerations, and repurchases may be effected in the open market, through derivative, accelerated repurchase and other negotiated transactions and through prearranged trading plans complying with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Numerous factors could affect the timing and amount of any future repurchases under the share repurchase authorization, including increased capital needs of the Company due to changes in regulatory capital requirements, opportunities for growth and acquisitions, and the effect of adverse market conditions on the segments.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE Basic earnings per share (“EPS”) is calculated by dividing net income (loss) attributable to Holdings common shareholders by the weighted-average number of common shares outstanding during the period. Diluted EPS is calculated by dividing the net income (loss) attributable to Holdings common shareholders, adjusted for the incremental dilution from AB, by the weighted-average number of common shares outstanding for the period plus the shares representing the dilutive effect of share-based awards. On April 24, 2018, a 459.4752645 -for-1 stock split of the common stock of Holdings was effected. All applicable share data, per share amounts and related information in the consolidated financial statements and notes thereto have been adjusted retroactively to give effect to the stock split. The following table presents the reconciliation of the numerator for the basic and diluted net income per share calculations: Years Ended December 31, 2018 2017 2016 (in millions) Net income (loss) attributable to Holdings common shareholders: Net income (loss) attributable to Holdings common shareholders (basic): $ 1,820 $ 834 $ 1,254 Less: Incremental dilution from AB (1) — 1 — Net income (loss) attributable to Holdings common shareholders (diluted): $ 1,820 $ 833 $ 1,254 ______________ (1) The incremental dilution from AB represents the impact of AB’s dilutive units on the Company’s diluted earnings per share and is calculated based on the Company’s proportionate ownership interest in AB. The following table presents the weighted average shares used in calculating basic and diluted earnings per common share: Years Ended December 31, 2018 2017 2016 (in millions) Weighted Average Shares: Weighted average common stock outstanding for basic earnings per common share 556.4 561.0 561.0 Effect of dilutive securities: Employee stock awards 0.1 — — Weighted average common stock outstanding for diluted earnings per common share 556.5 561.0 561.0 For the year ended December 31, 2018 , approximately 2.7 million shares of outstanding stock awards were not included in the computation of diluted earnings per share because their effect was anti-dilutive. The following table presents both basic and diluted income (loss) per share for each period presented: Years Ended December 31, 2018 2017 2016 (in U.S. dollars per share) Net income (loss) attributable to Holdings per common share: Basic $ 3.27 $ 1.49 $ 2.24 Diluted $ 3.27 $ 1.48 $ 2.24

REVISION OF PRIOR PERIOD FINANC

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]
Revision of Prior Period Financial Statements	During the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to the financial statements of any period. These have been corrected in the comparative consolidated statements of cash flows for the year ended December 31, 2017 contained elsewhere in this filing. The following table presents line items for the consolidated statement of cash flows for the year ended December 31, 2017 that have been affected by the revisions. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Year Ended December 31, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Non-cash long term incentive compensation expense $ 185 $ 62 $ — $ 247 Amortization and depreciation (104 ) 503 — 399 Distributions from joint ventures and limited partnerships 140 (140 ) — — Equity (income) loss from limited partnerships — (155 ) — (155 ) Changes in: — Reinsurance recoverable — 124 124 Capitalization of deferred policy acquisition costs (184 ) (503 ) — (687 ) Future policy benefits 1,599 — (502 ) 1,097 Current and deferred income taxes 767 — (777 ) (10 ) Other, net 127 109 15 251 Net cash provided by (used in) operating activities $ 1,021 $ — $ (1,264 ) $ (243 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short term investments — 4,555 — 4,555 Payment for the purchase/origination of: Short-term investments — (4,897 ) — (4,897 ) Change in short-term investments (342 ) 342 — — Net cash provided by (used in) investing activities $ (9,689 ) $ — $ — $ (9,689 ) Cash flows from financing activities: Policyholders’ account balances: Deposits 10,591 — (675 ) 9,916 Withdrawals (6,140 ) — 2,130 (4,010 ) Transfers (to) from Separate Accounts 1,677 — (191 ) 1,486 Net cash provided by (used in) financing activities $ 7,806 $ — $ 1,264 $ 9,070 Change in cash and cash equivalents $ (840 ) $ — $ — $ (840 ) Cash and cash equivalents, end of year $ 4,814 $ — $ — $ 4,814

QUARTERLY FINANCIAL INFORMATION

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Quarterly Financial Information (Unaudited)	QUARTERLY FINANCIAL INFORMATION (UNAUDITED) The unaudited quarterly financial information for the years ended December 31, 2018 and 2017 are summarized in the table below: Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2018 Total revenues $ 2,874 $ 2,966 $ 1,083 $ 5,155 Total benefits and other deductions 2,446 2,644 1,701 2,826 Income (loss) before income taxes 428 322 (618 ) 2,329 Income tax (expense) benefit (91 ) (61 ) 175 (330 ) Net income (loss) 337 261 (443 ) 1,999 Less: Net (income) loss attributable to the noncontrolling interest (123 ) (97 ) (53 ) (61 ) Net Income (Loss) Attributable to Holdings $ 168 $ 164 $ (496 ) $ 1,938 Earnings per share - common stock: Basic $ 0.30 $ 0.29 $ (0.89 ) $ 3.57 Diluted $ 0.30 $ 0.29 $ (0.89 ) $ 3.57 Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2017 Total revenues $ 2,844 $ 3,888 $ 2,806 $ 2,922 Total benefits and other deductions 2,991 3,258 2,759 2,146 Income (loss) before income taxes (147 ) 630 47 776 Income tax (expense) benefit (37 ) 78 59 (149 ) Net income (loss) (184 ) 708 106 627 Less: Net (income) loss attributable to the noncontrolling interest (93 ) (90 ) (96 ) (144 ) Net Income (Loss) Attributable to Holdings $ (277 ) $ 618 $ 10 $ 483 Earnings per share - common stock: Basic $ (0.49 ) $ 1.10 $ 0.02 $ 0.86 Diluted $ (0.50 ) $ 1.10 $ 0.02 $ 0.86 Net Income (Loss) Volatility The fluctuation in the Company’s quarterly Net income (loss) during 2018 and 2017 is not due to any specific events or transactions, but instead is driven primarily by the impact of changes in market conditions on the Company’s liabilities associated with GMxB features embedded in its variable annuity products, partially offset by derivatives the Company has in place to mitigate the movement in those liabilities. As those derivatives do not qualify for hedge accounting treatment, volatility in Net income (loss) result from the changes in value of the derivatives being recognized in the period in which they occur, with offsetting changes in the liabilities being partially recognized in the current period. Revisions of Prior Period Interim Consolidated Financial Statements The Company’s third quarter 2018 financial statements were revised to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements for the three and six months ended March 31, 2018 and June 30, 2018, respectively, as well as the three and six months ended March 31, 2017 and June 30, 2017. The table below presents the impacts of these revisions to the quarterly financial information presented above. As Previously Reported Impact of Revisions As Revised (in millions) Three Months Ended June 30, 2018 Total revenues $ 2,962 $ 4 $ 2,966 Total benefits and other deductions 2,648 (4 ) 2,644 Net income (loss) $ 255 $ 6 $ 261 Three Months Ended March 31, 2018 Total revenues $ 2,835 $ 39 $ 2,874 Total benefits and other deductions 2,465 (19 ) 2,446 Net income (loss) $ 291 $ 46 $ 337 Three Months Ended June 30, 2017 Total revenues $ 3,882 $ 6 $ 3,888 Total benefits and other deductions 3,268 (10 ) 3,258 Net income (loss) $ 698 $ 10 $ 708 Three Months Ended March 31, 2017 Total revenues $ 2,830 $ 14 $ 2,844 Total benefits and other deductions 2,997 (6 ) 2,991 Net income (loss) $ (197 ) $ 13 $ (184 ) uring the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s historical consolidated statements of cash flows. The Company has determined that these mis-classifications were not material to the financial statements for any period. These misclassifications will be corrected in the comparative consolidated statements of cash flows for the three, six and nine months ended March 31, 2019, June 30, 2019 and September 30, 2019 that will appear in the Company’s first, second and third quarter 2019 Form 10-Q filings, respectively. The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2018 (in millions) Net income (loss) $ 291 $ — $ 46 $ 337 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances — Policy charges and fee income (972 ) — 6 (966 ) Net derivative (gains) losses 281 — (45 ) 236 Amortization of deferred sales commission 7 (7 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (20 ) 184 (5 ) 159 Distributions from joint ventures and limited partnerships 25 (25 ) — — Equity (income) loss from limited partnerships — (38 ) — (38 ) Changes in: Reinsurance recoverable 32 — (3 ) 29 Capitalization of deferred policy acquisition costs 15 (172 ) — (157 ) Future policy benefits (254 ) — 6 (248 ) Current and deferred income taxes 103 — 12 115 Other, net (255 ) 63 — (192 ) Net cash provided by (used in) operating activities $ (264 ) $ — $ 17 $ (247 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Real estate joint ventures $ — $ — $ 140 $ 140 Short-term investments 876 — 77 953 Cash settlements related to derivative instruments (54 ) — (620 ) (674 ) Other, net (371 ) — 60 (311 ) Net cash provided by (used in) investing activities $ 459 $ — $ (343 ) $ 116 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,532 $ — $ (491 ) $ 2,041 Withdrawals (1,384 ) — 284 (1,100 ) Transfers (to) from Separate Accounts (102 ) — 533 431 Net cash provided by (used in) financing activities $ 1,074 $ — $ 326 $ 1,400 Change in cash and cash equivalents $ 1,277 $ — $ — $ 1,277 Cash and Cash Equivalents, end of period $ 6,091 $ — $ — $ 6,091 The following table presents line items for the consolidated statement of cash flows for the six months ended June 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2018 (in millions) Net income (loss) $ 546 $ — $ 52 $ 598 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,959 ) $ — 29 $ (1,930 ) Net derivative (gains) losses 354 — (72 ) 282 Amortization of deferred sales commission 13 (13 ) — — Amortization of reinsurance cost 10 (10 ) — — Amortization and depreciation $ (32 ) $ 380 $ 11 $ 359 Distributions from joint ventures and limited partnerships 44 (44 ) — — Equity (income) loss from limited partnerships — (59 ) — (59 ) Changes in: Reinsurance recoverable 20 — 9 29 Capitalization of deferred policy acquisition costs 14 (357 ) — (343 ) Future policy benefits (171 ) — (15 ) (186 ) Current and deferred income taxes 224 — (42 ) 182 Other, net (180 ) 103 — (77 ) Net cash provided by (used in) operating activities $ (314 ) $ — $ (28 ) $ (342 ) Cash flows from investing activities: Real estate joint ventures — 139 — 139 Other 261 (139 ) — 122 Cash settlements related to derivative instruments $ (333 ) $ — $ (637 ) $ (970 ) Other, net 419 — 61 480 Net cash provided by (used in) investing activities $ 1,807 $ — $ (576 ) $ 1,231 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,567 $ — $ (1,141 ) $ 4,426 Withdrawals (2,750 ) — 572 (2,178 ) Transfers (to) from Separate Accounts (307 ) — 1,173 866 Net cash provided by (used in) financing activities $ 532 $ — $ 604 $ 1,136 Change in cash and cash equivalents 2,019 — — 2,019 Cash and Cash Equivalents, end of period $ 6,833 $ — — $ 6,833 The following table presents line items for the consolidated statement of cash flows for the nine months ended September 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2018 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission $ 18 $ (18 ) $ — $ — Amortization of reinsurance cost 17 (17 ) — — Amortization and depreciation (57 ) $ 210 $ — $ 153 Distribution from joint ventures and limited partnerships 63 (63 ) — — Equity (income) loss from limited partnerships — (82 ) — (82 ) Changes in: Reinsurance recoverable 92 — (2 ) 90 Capitalization of deferred policy acquisition costs (338 ) (175 ) — (513 ) Future policy benefits (620 ) — (44 ) (664 ) Current and deferred income taxes 249 — (56 ) 193 Other, net (139 ) 145 — 6 Net cash provided by (used in) operating activities $ (34 ) $ — $ (102 ) $ (136 ) Cash flows from investing activities: Real estate joint ventures $ — $ 139 $ — $ 139 Other 335 (139 ) — 196 Cash settlements related to derivative instruments $ (609 ) $ — $ (668 ) $ (1,277 ) Other, net 319 — (5 ) 314 Net cash provided by (used in) investing activities $ (1,057 ) $ — $ (673 ) $ (1,730 ) Cash flows from financing activities: Deposits $ 8,372 $ — $ (1,719 ) $ 6,653 Withdrawals (4,170 ) — 846 (3,324 ) Transfers (to) from Separate Accounts (335 ) — 1,648 1,313 Net cash provided by (used in) financing activities $ 1,063 $ — $ 775 $ 1,838 Change in cash and cash equivalents (37 ) — — (37 ) Cash and Cash Equivalents, end of period $ 4,777 $ — $ — $ 4,777 The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2017 (in millions) Net income (loss) $ (197 ) $ — $ 13 $ (184 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (956 ) — 17 (939 ) (Income) loss related to derivative instruments 235 — (31 ) 204 Amortization of deferred sales commission 9 (9 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (42 ) 128 (4 ) 82 Equity (income) loss from limited partnerships — (40 ) — (40 ) Distributions from joint ventures and limited partnersh 26 (26 ) — — Changes in: Net broker-dealer and customer related receivables/payables 297 — (10 ) 287 Reinsurance recoverable 27 — 3 30 Capitalization of deferred policy acquisition costs (55 ) (114 ) (169 ) Future policy benefits 296 — 52 348 Current and deferred income taxes 252 — (256 ) (4 ) Other, net (71 ) 66 — (5 ) Net cash provided by (used in) operating activities $ 72 $ — $ (216 ) $ (144 ) Cash flows from investing activities: Change in short-term investments 573 — (308 ) 265 Cash settlements related to derivative instruments (1,400 ) — 22 (1,378 ) Other, net (191 ) — 76 (115 ) Net cash provided by (used in) investing activities $ (2,899 ) $ — $ (210 ) $ (3,109 ) Cash flows from financing activities: Policyholders’ account balances: — Deposits 2,790 — (144 ) 2,646 Withdrawals (1,342 ) — 376 (966 ) Transfers (to) from Separate Accounts 186 — 194 380 Net cash provided by (used in) financing activities $ 2,630 $ — $ 426 $ 3,056 Change in cash and cash equivalents $ (189 ) $ — $ — $ (189 ) Cash and cash equivalents, end of period $ 5,465 $ — $ — $ 5,465 The following tables present line items for the consolidated statement of cash flows for the six months ended June 30, 2017 that has been affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2017 (in millions) Net income (loss) $ 501 $ — $ 23 $ 524 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,891 ) $ — $ 34 $ (1,857 ) Net derivative (gains) losses (494 ) — (54 ) (548 ) Amortization of reinsurance cost 7 (7 ) — — Amortization of deferred sales commission 17 (17 ) — — Amortization and depreciation (60 ) 203 (5 ) 138 Equity (income) loss from limited partnerships — (66 ) — (66 ) Distribution from joint ventures and limited partnerships 53 (53 ) — — Changes in: — Reinsurance recoverable 40 — 9 49 Capitalization of deferred policy acquisition costs (168 ) (179 ) — (347 ) Future policy benefits 1,516 — (169 ) 1,347 Current and deferred income taxes 123 — (210 ) (87 ) Other, net 333 119 — 452 Net cash provided by (used in) operating activities $ 666 $ — $ (372 ) $ 294 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,537 ) $ — $ 34 $ (1,503 ) Other, net 179 — (173 ) 6 Net cash provided by (used in) investing activities $ (5,067 ) $ — $ (139 ) $ (5,206 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 4,401 — $ 766 $ 5,167 Withdrawals (1,724 ) — (158 ) (1,882 ) Transfers (to) from Separate Accounts 826 — (97 ) 729 Net cash provided by (used in) financing activities $ 4,923 $ — $ 511 $ 5,434 Change in cash and cash equivalents 533 — — 533 Cash and Cash Equivalents, end of period $ 6,187 $ — $ — $ 6,187 The following tables present line items for the consolidated statement of cash flows for the nine months ended September 30, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission 25 (25 ) — — Amortization of reinsurance cost 11 (11 ) — — Amortization and depreciation $ (121 ) $ 399 $ — $ 278 Equity (income) loss from limited partnerships — (103 ) — (103 ) Distribution from joint ventures and limited partnerships 94 (94 ) — — Changes in: — Reinsurance recoverable 115 — 10 125 Capitalization of deferred policy acquisition costs (150 ) (363 ) — (513 ) Future policy benefits 1,587 — (10 ) 1,577 Current and deferred income taxes 498 — (546 ) (48 ) Other, net 253 197 15 465 Net cash provided by (used in) operating activities $ 1,044 $ — $ (531 ) $ 513 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,722 ) $ — $ 50 $ (1,672 ) Other, net (133 ) — (230 ) (363 ) Net cash provided by (used in) investing activities $ (6,568 ) $ — $ (180 ) $ (6,748 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 6,135 $ — $ 1,283 $ 7,418 Withdrawals (2,765 ) — (114 ) (2,879 ) Transfers (to) from Separate Accounts 1,617 — (458 ) 1,159 Net cash provided by (used in) financing activities $ 6,299 $ — $ 711 $ 7,010 Change in cash and cash equivalents 792 — — 792 Cash and Cash Equivalents, end of period $ 6,446 $ — $ — $ 6,446

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS Accelerated Share Repurchase Agreement In January 2019, Holdings entered into an Accelerated Share Repurchase agreement (the “ASR”) with a third-party financial institution to repurchase an aggregate of $150 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a prepayment of $150 million and received initial delivery of 6,956,522 shares. The ASR is scheduled to terminate during the first quarter of 2019, at which time additional shares may be delivered or returned depending on the daily volume-weighted average price of Holdings’ common stock. Cash Dividend Declared On February 14, 2019, Holdings’ Board of Directors declared a quarterly cash dividend of $0.13 per share of common stock, payable on March 15, 2019 to all stockholders of based on fourth quarter earnings record as of the close of business on March 5, 2019. Share Repurchase Program On February 27, 2019, Holdings’ Board of Directors authorized a $800 million share repurchase program. Under this authorization, Holdings, may, from time to time through December 31, 2019, purchase shares of its common stock through various means. Holdings may choose to suspend or discontinue the repurchase program at any time. The repurchase program does not obligate Holdings to purchase any particular number of shares. AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan”) In November 2018, our Board and AXA, as our then controlling stockholder, adopted the 2019 Plan, which became effective January 1, 2019, with a total of 5.2 million shares of common stock reserved for issuance thereunder. On February 25, 2019, the Compensation Committee of Holdings’ Board of Directors approved an amendment to the 2019 Plan increasing the amount of shares of Holdings’ common stock available for issuance in connection with equity awards granted under the Plan by two million shares. The holder of a majority of the outstanding shares of our common stock executed a written consent approving the increase on February 28, 2019.

SCHEDULE I - SUMMARY OF INVESTM

SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
Schedule I - Summary of Investments - Other than Investments in Related Parties	SCHEDULE I SUMMARY OF INVESTMENTS — OTHER THAN INVESTMENTS IN RELATED PARTIES AS OF DECEMBER 31, 2018 Cost (1) Fair Value Carrying Value (in millions) Fixed Maturities: U.S. government, agencies and authorities $ 14,004 $ 13,829 $ 14,004 State, municipalities and political subdivisions 415 461 415 Foreign governments 524 530 524 Public utilities 5,101 5,046 5,101 All other corporate bonds 25,471 25,132 25,471 Residential mortgage-backed 225 234 225 Asset-backed 612 601 612 Redeemable preferred stocks 449 446 449 Total fixed maturities 46,801 46,279 46,801 Mortgage loans on real estate (2) 11,842 11,494 11,835 Real estate held for the production of income 52 52 52 Policy loans 3,779 4,183 3,779 Other equity investments 1,293 1,334 1,334 Trading securities 16,211 16,017 16,017 Other invested assets 2,037 2,037 2,037 Total Investments $ 82,015 $ 81,396 $ 81,855 ______________ (1) Cost for fixed maturities represents original cost, reduced by repayments and write-downs and adjusted for amortization of premiums or accretion of discount; cost for equity securities represents original cost reduced by write-downs; cost for other limited partnership interests represents original cost adjusted for equity in earnings and reduced by distributions. (2) Carrying value for mortgage loans on real estate represents original cost adjusted for amortization of premiums or accretion of discount and reduced by valuation allowance.

SCHEDULE II - PARENT COMPANY

SCHEDULE II - PARENT COMPANY	12 Months Ended
	Dec. 31, 2018
Condensed Financial Information Disclosure [Abstract]
Schedule II - Parent Company	SCHEDULE II BALANCE SHEETS (PARENT COMPANY) DECEMBER 31, 2018 AND 2017 2018 2017 (in millions, except share amounts) ASSETS Investment in consolidated subsidiaries $ 16,743 $ 13,772 Fixed maturities available-for-sale, at fair value (amortized cost of $337) 336 — Other equity investments 23 — Other invested assets 80 — Total investments 17,182 13,772 Cash and cash equivalents 407 44 Goodwill and other intangible assets, net 1,265 — Loans to affiliates 572 1,045 Income taxes receivable — 72 Other assets 766 1 Total Assets $ 20,192 $ 14,934 LIABILITIES Short-term and long-term debt 4,408 — Employee benefits liabilities 1,184 — Loans from affiliates 600 1,484 Income taxes payable 16 — Accrued liabilities 118 29 Total Liabilities 6,326 1,513 EQUITY ATTRIBUTABLE TO HOLDINGS Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively 5 5 Capital in excess of par value 1,908 1,299 Treasury stock, at cost, 32,138,242 shares (640 ) — Retained earnings 13,989 12,225 Accumulated other comprehensive income (loss) (1,396 ) (108 ) Total equity attributable to Holdings 13,866 13,421 Total Liabilities and Equity Attributable to Holdings $ 20,192 $ 14,934 The financial information of AXA Equitable Holdings, Inc. should be read in conjunction with the Consolidated Financial Statements and Notes thereto. AXA EQUITABLE HOLDINGS, INC. SCHEDULE II STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) (PARENT COMPANY) YEARS ENDED DECEMBER 31, 2018 , 2017 , AND 2016 2018 2017 2016 (in millions) REVENUES Equity in income (losses) from continuing operations of consolidated subsidiaries $ 2,404 $ 863 $ 1,293 Net investment income (loss) 30 8 7 Investment gains (losses), net (8 ) — — Other income (1 ) — — Total revenues 2,425 871 1,300 EXPENSES Interest expense 214 31 27 Other operating costs and expenses 123 22 26 Total expenses 337 53 53 Income (loss) from continuing operations, before income taxes 2,088 818 1,247 Income tax (expense) benefit (268 ) 16 7 Net income (loss) attributable to Holdings 1,820 834 1,254 Other comprehensive income (loss) (1,192 ) 816 (276 ) Total comprehensive income (loss) attributable to Holdings $ 628 $ 1,647 $ 1,010 The financial information of AXA Equitable Holdings, Inc. should be read in conjunction with the Consolidated Financial Statements and Notes thereto. AXA EQUITABLE HOLDINGS, INC. SCHEDULE II STATEMENTS OF CASH FLOWS (PARENT COMPANY) YEARS ENDED DECEMBER 31, 2018 , 2017 , AND 2016 2018 2017 2016 (in millions) Net income (loss) attributable to Holdings $ 1,820 $ 834 $ 1,254 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Equity in net (earnings) loss of subsidiaries (2,404 ) (863 ) (1,293 ) Amortization and depreciation — — — Changes in: Current and deferred income taxes 111 (14 ) (6 ) Dividends from subsidiaries 1,838 20 — Other, net (264 ) 24 27 Net cash provided by (used in) operating activities $ 1,101 $ 1 $ (18 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Fixed maturities, available-for-sale 18 — — Short-term investments 1,038 Payment for the purchase/origination of: Fixed maturities, available-for-sale (355 ) — — Short-term investments (1,113 ) Other (16 ) — — Repayment of loans to affiliates 1,045 — — Issuance of loans to affiliates (572 ) (900 ) — Increase in cash and cash equivalents from merger of AXA Financial, Inc. 381 — — Purchase of shares of consolidated subsidiaries — (55 ) — Other, net (5 ) — — Net cash provided by (used in) investing activities $ 421 $ (955 ) $ — Cash flows from financing activities: Issuance of long-term debt 4,057 — — Proceeds from loans from affiliates 800 731 — Repayments of loans from affiliates (200 ) (56 ) — Shareholder dividends paid (157 ) — — Purchase of AllianceBernstein Units (1,340 ) — — Purchase of treasury shares (648 ) — — Capital contribution from parent company 8 318 — Capital contribution to subsidiaries (3,679 ) — — Net cash provided by (used in) financing activities $ (1,159 ) $ 993 $ — Change in cash and cash equivalents 363 39 (18 ) Cash and cash equivalents, beginning of year 44 5 23 Cash and cash equivalents, end of year $ 407 $ 44 $ 5 Non-cash transactions: Goodwill and intangible assets $ 1,079 $ — $ — Equity investments $ 8 $ — $ — Other assets $ 774 $ — $ — Settlement of long-term debt $ (349 ) $ — $ — Employee benefit plans $ (1,168 ) $ — $ — Other liabilities $ (20 ) $ — $ — The financial information of AXA Equitable Holdings, Inc. should be read in conjunction with the Consolidated Financial Statements and Notes thereto. AXA EQUITABLE HOLDINGS, INC. NOTES TO PARENT COMPANY FINANCIAL STATEMENTS 1) BASIS OF PRESENTATION The financial information of Holdings should be read in conjunction with the Consolidated Financial Statements and Notes thereto. AXA, the ultimate parent company of Holdings, is the holding company for the AXA Group, a worldwide leader in life, property and casualty and health insurance, and asset management. 2) LOANS TO AFFILIATES In 2018, AXA Equitable received a $572 million loan from Holdings. The loan has an interest rate of 3.75% and matures in December 2019. In 2013, Colisee Re received a $145 million loan from Holdings. The loan had an interest rate of 4.75% and a maturity date in December 2028. The loan was repaid on April 23, 2018. 3) LOANS FROM AFFILIATES In March 2010 AXA Financial issued Subordinated Notes to AXA Life Insurance Company LTD in the amount of $770 million . This loan was repaid on April 20, 2018 In December 2014, AXA Financial received a $2,727 million , three-month LIBOR plus 1.06% margin term loan from AXA. AXA Financial repaid $520 million of this loan in June 2015 and repaid an additional $1,200 million of this loan in 2016. On April 20, 2018, the remainder of this loan was repaid. In 2015, Holdings received a $366 million , three-month LIBOR plus 1.44% loan from AXA. This loan was repaid on April 20, 2018. In December 2013, Coliseum Re issued $242 million and $145 million of 4.75% Senior Unsecured Notes to Holdings. These loans were repaid on March 26, 2018. In 2017, Holdings received a $ 100 million and $ 10 million loan from AXA CS. The loans have interest rates of 1.86% and 1.76% , respectively, and were repaid on their maturity date of February 5, 2018. In December 2017, Holdings received a $622 million , three-month LIBOR plus 0.439% margin term loan from AXA. The loan was repaid on April 20, 2018. In April 2018, Holdings received a $800 million loan from AXA Equitable. The loan has an interest rate of 3.69% and matures in April 2021. In December 2018, Holdings repaid $200 million of this loan. Interest cost related to these loans totaled $48 million , $77 million and $71 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. 4) RELATED PARTY TRANSACTIONS Disposition of AXA CS Holdings formerly held 78.99% of the shares of AXA CS, which holds certain AXA U.S. P&C business. AXA CS and its subsidiaries have been excluded from the historical Consolidated Financial Statements since they were operated independently from the other Holdings subsidiaries. In March 2018, Holdings sold its AXA CS shares to AXA for $630 million . In anticipation of this sale, in the fourth quarter of 2017, AXA made a short-term loan of $622 million to Holdings with interest calculated at three-month LIBOR plus 0.439% margin. Holdings’ repayment obligation to AXA in respect of this loan was set off against the purchase price for the AXA CS shares, and AXA paid Holdings the $8 million balance in cash. The net result of the sale was a decrease in Loans from affiliates of $622 million , an increase in cash of $8 million , and an increase in capital in excess of par of $630 million . Acquisition of Noncontrolling Interest of AXA Financial In March 2018, AXA contributed the 0.5% noncontrolling interest in AXA Financial to Holdings, resulting in AXA Financial becoming a wholly-owned subsidiary of Holdings. The contribution is reflected as a $66 million capital contribution. Acquisition of Additional AB Units On April 23, 2018, Holdings purchased: (i) 100% of the shares of AXA-IM Holding U.S. Inc., which owns 41,934,582 AB Units, for a purchase price of $1,113 million and (ii) 8,160,000 AB Units held by Coliseum Re for $217 million . As a result of these two transactions, Holdings ownership of AB increased to approximately 65% , Noncontrolling interest decreased by $29 million , Capital in excess of par increased by $17 million and taxes payable increased by $174 million . Pre-IPO Transactions with AXA Affiliates As former wholly-owned subsidiaries of AXA, Holdings and its subsidiaries have historically entered into various transactions with AXA Affiliates. General Services Agreements with AXA Affiliates Prior to the IPO, Holdings entered into cost-sharing and general service agreements with various AXA Affiliates pursuant to which the parties provided general corporate services (IT, human resources, legal, finance, etc.) to each other. 5) AXA FINANCIAL MERGER On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity (the “AXA Financial Merger”). As a result of the AXA Financial Merger, Holdings assumed all of AXA Financial’s assets and liabilities, including its obligations under the Senior Debentures, two assumption agreements under which it legally assumed primary liability for certain employee benefit plans of AXA Equitable Life and various guarantees for its subsidiaries. Holdings also replaced AXA Financial as a party to the $2 billion commercial paper program initiated by AXA and AXA Financial in June 2009. Holdings was removed as an issuer under the program in October 2018. The following table discloses the assets and liabilities that Holdings assumed at the date of the merger. As of October 1, 2018 Assets Liabilities (in millions) Cash and cash equivalents $ 381 Goodwill and other intangibles assets, net 1,079 Other equity investments 13 Other assets 777 Total Assets $ 2,250 Employee benefit liabilities $ 1,168 Long-term debt 349 Income taxes payable 2,106 Other liabilities 20 Total Liabilities $ 3,643 6) INCOME TAXES Holdings and certain of its consolidated subsidiaries and affiliates file a consolidated federal income tax return. Holdings has tax sharing agreements with certain of its subsidiaries and generally will either receive or pay these subsidiaries for utilization of the subsidiaries’ tax benefits or expense. Holdings settles these amounts annually.

SCHEDULE III - SUPPLEMENTARY IN

SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Schedule III - Supplementary Insurance Information	SCHEDULE III SUPPLEMENTARY INSURANCE INFORMATION AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2018 Individual Retirement Group Retirement Investment Management and Research Protection Solutions Corporate and Other Total (in millions) Deferred policy acquisition costs $ 3,229 $ 657 $ — $ 2,706 $ 153 $ 6,745 Policyholders’ account balances 20,798 11,617 — 13,989 3,519 49,923 Future policy benefits and other policyholders' liabilities 16,076 6 — 4,556 10,360 30,998 Policy charges and premium revenue 2,124 271 — 2,103 420 4,918 Net investment income (loss) (1) 497 552 36 903 474 2,462 Policyholders’ benefits and interest credited 590 294 — 2,308 813 4,005 Amortization of deferred policy acquisition costs 183 (8 ) — 161 (3 ) 333 All other operating expenses (2) 764 325 2,538 561 1,091 5,279 ____________ (1) Net investment income (loss) is allocated to segments. Includes net derivative gains (losses). (2) Operating expenses are allocated to segments. AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2017 Individual Retirement Group Retirement Investment Management and Research Protection Solutions Corporate and Other Total (in millions) Deferred policy acquisition costs (1) $ 2,988 $ 519 $ — $ 2,352 $ 60 $ 5,919 Policyholders’ account balances 19,414 11,318 — 13,908 2,531 47,171 Future policy benefits and other policyholders' liabilities 15,202 2 — 5,444 9,682 30,330 Policy charges and premium revenue 2,116 248 — 1,995 458 4,817 Net investment income (loss) (2) 1,292 523 118 850 513 3,296 Policyholders’ benefits and interest credited 2,728 282 — 1,432 919 5,361 Amortization of deferred policy acquisition costs 114 25 — 374 (10 ) 503 All other operating expenses (3) 881 463 2,517 734 695 5,290 ____________ (1) Amounts previously reported for Individual Retirement, Group Retirement and Protection Solutions were: $2,877 million , $678 million and $2,304 million , respectively. (2) Net investment income (loss) is allocated to segments. Includes net derivative gains (losses). (3) Operating expenses are allocated to segments. FOR THE YEAR ENDED DECEMBER 31, 2016 Individual Retirement Group Retirement Investment Management and Research Protection Solutions Corporate and Other Total (in millions) Policy charges and premium revenue $ 1,980 $ 217 $ — $ 2,156 $ 459 $ 4,812 Net investment income (loss) (1) (1,060 ) 431 133 763 550 817 Policyholders’ benefits and interest credited 1,195 268 — 1,940 906 4,309 Amortization of deferred policy acquisition costs 139 50 — 551 39 779 All other operating expenses (2) 818 296 2,306 600 628 4,648 ____________ (1) Net investment income (loss) is allocated to segments. Includes net derivative gains (losses). (2) Operating expenses are allocated to segments.

SCHEDULE IV - REINSURANCE

SCHEDULE IV - REINSURANCE	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV - Reinsurance	SCHEDULE IV REINSURANCE (1) AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2018 , 2017 AND 2016 Gross Amount Ceded to Other Companies Assumed from Other Companies Net Amount Percentage of Amount Assumed to Net (in millions) 2018 Life insurance in-force $ 488,431 $ 69,255 $ 31,249 $ 450,425 6.9 % Premiums: Life insurance and annuities $ 963 $ 100 $ 204 $ 1,067 19.1 % Accident and health 49 32 10 27 37.0 % Total Premiums $ 1,012 $ 132 $ 214 $ 1,094 19.6 % 2017 Life insurance in-force $ 483,010 $ 73,049 $ 31,886 $ 441,847 7.2 % Premiums: Life insurance and annuities $ 984 $ 103 $ 216 $ 1,097 19.7 % Accident and health 54 36 9 27 33.3 % Total Premiums $ 1,038 $ 139 $ 225 $ 1,124 20.0 % 2016 Life insurance in-force $ 485,888 $ 77,306 $ 30,688 $ 439,270 7.0 % Premiums: Life insurance and annuities $ 937 $ 106 $ 222 $ 1,053 21.1 % Accident and health 61 40 9 30 30.0 % Total Premiums $ 998 $ 146 $ 231 $ 1,083 21.3 % __________ (1) Includes amounts related to the discontinued group life and health business.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. Financial results in the historical consolidated financial statements may not be indicative of the results of operations, comprehensive income (loss), financial position, equity or cash flows that would have been achieved had we operated as a separate, standalone entity during the reporting periods presented. We believe that the consolidated financial statements include all adjustments necessary for a fair presentation of the results of operations of the Company. On April 24, 2018, the Company filed a Certificate of Amendment to amend its Certificate of Incorporation, authorizing the issuance of 2 billion shares of common stock, par value $0.01 per share, and effecting a 459.4752645 -for-1 common stock split, resulting in 561 million shares of common stock issued and outstanding. Prior to the Company’s IPO, all 561 million shares of the Company’s common stock were held by AXA. The accompanying Consolidated Financial Statements and Notes to the Consolidated Financial Statements give retroactive effect to the stock split for all periods presented. All significant intercompany transactions and balances have been eliminated in consolidation. The years “ 2018 ”, “ 2017 ” and “ 2016 ” refer to the years ended December 31, 2018 , 2017 and 2016 , respectively.
Adoption of New and Future Accounting Pronouncements	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09 This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. Adoption did not change the amounts or timing of the Company’s revenue recognition for base investment management and advisory fees, distribution revenues, shareholder servicing revenues or broker-dealer revenues. Some performance-based fees and carried-interest distributions that were recognized prior to adoption when no risk of reversal remained, in certain instances may now be recognized earlier if it is probable that significant reversal will not occur. Description Effect on the Financial Statement or Other Significant Matters ASU 2016-01 This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in a reclassification adjustment of $7 million from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $46 million common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15 Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07 This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09 This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02 Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by increasing AOCI and decreasing retained earnings by $89 million. ASU 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018, the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17 Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13 This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. ASU 2018-07 Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2017-12 The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02 This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company will adopt ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $750 million to $850 million and operating lease liabilities ranging from $950 million to $1.1 billion, respectively, for operating leases. The adoption of this standard will not have a significant impact on opening retained earnings.
Investments	Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of policy related amounts and deferred income taxes. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value . Real estate held for the production of income is stated at depreciated cost less valuation allowances. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag . Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the statements of Net income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2018 , 2017 and 2016 , the carrying value of COLI was $872 million , $918 million and $889 million , respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. Cash and securities segregated primarily includes U.S. Treasury Bills segregated by AB in a special reserve bank custody account for the exclusive benefit of its brokerage customers under Rule 15c3-3 of the Exchange Act. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis .
Derivatives	Derivatives Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include equity, currency, and interest rate futures, total return and/or other equity swaps, interest rate swaps and floors, swaptions, variance swaps and equity options, all of which may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models. Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities”. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related Credit Support Annex (“CSA”) have been executed. The Company uses derivatives to manage asset/liability risk and has designated some of those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company’s freestanding derivative positions not designated to hedge accounting relationships, including net receipts and payments, are included in “Net derivative gains (losses)” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of income (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value.
Securities Repurchase and Reverse Repurchase Agreements	Securities Repurchase and Reverse Repurchase Agreements Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date prior to maturity at a fixed and determinable price. Transfers of securities under these agreements to repurchase or resell are evaluated by the Company to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases with related forward repurchase or resale commitments. All of the Company’s securities repurchase transactions are accounted for as collateralized borrowings with the related obligations distinctly captioned in the consolidated balance sheets. Earnings from investing activities related to the cash received under the Company’s securities repurchase arrangements are reported in the consolidated statements of income (loss) as “Net investment income” and the associated borrowing cost is reported as “Interest expense.” The Company has not actively engaged in securities reverse repurchase transactions.
Commercial and Agricultural Mortgage Loans on Real Estate (mortgage loans)	Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used. For commercial and agricultural mortgage loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management’s judgment in determining allowance for credit losses include the following: • Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property. An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100%. In the case where the loan-to-value is in excess of 100%, the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance. • Debt service coverage ratio – Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Maturity – Mortgage loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower’s ability to refinance the debt and/or pay off the balloon balance. • Borrower/tenant related issues – Financial concerns, potential bankruptcy or words or actions that indicate imminent default or abandonment of property. • Payment status (current vs. delinquent) – A history of delinquent payments may be a cause for concern. • Property condition – Significant deferred maintenance observed during the lenders annual site inspections. • Other – Any other factors such as current economic conditions may call into question the performance of the loan. Mortgage loans also are individually evaluated quarterly by the Company’s IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. For problem mortgage loans, a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for mortgage loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan-specific portion of the loss allowance is based on the Company’s assessment as to ultimate collectability of loan principal and interest. Valuation allowances for a non-performing loan are recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral if the loan is collateral dependent. The valuation allowance for mortgage loans can increase or decrease from period to period based on such factors. Impaired mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Changes in the present value attributable to changes in the amount or timing of expected cash flows are reported as investment gains or losses. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is doubtful. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely.
Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses)	Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the valuation allowances are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date
Recognition of Insurance Income and Related Expenses	Recognition of Insurance Income and Related Expenses Deposits related to universal life (“UL”) and investment-type contracts are reported as deposits to policyholders’ account balances. Revenues from these contracts consist of fees assessed during the period against policyholders’ account balances for mortality charges, policy administration charges and surrender charges. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policyholders’ account balances. Premiums from participating and non-participating traditional life and annuity policies with life contingencies generally are recognized in income when due. Benefits and expenses are matched with such income so as to result in the recognition of profits over the life of the contracts. This match is accomplished by means of the provision for liabilities for future policy benefits and the deferral and subsequent amortization of DAC. For contracts with a single premium or a limited number of premium payments due over a significantly shorter period than the total period over which benefits are provided, premiums are recorded as revenue when due with any excess profit deferred and recognized in income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments. Premiums from individual health contracts are recognized as income over the period to which the premiums relate in proportion to the amount of insurance protection provided.
DAC	DAC Acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance business, reflecting incremental direct costs of contract acquisition with independent third parties or employees that are essential to the contract transaction, as well as the portion of employee compensation, including payroll fringe benefits and other costs directly related to underwriting, policy issuance and processing, medical inspection, and contract selling for successfully negotiated contracts including commissions, underwriting, agency and policy issue expenses, are deferred. In each reporting period, DAC is amortized to Amortization of deferred policy acquisition costs of the accrual of imputed interest on DAC balances. DAC is subject to recoverability testing at the time of policy issue and loss recognition testing at the end of each accounting period. After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings . Amortization Policy In accordance with the guidance for the accounting and reporting by insurance enterprises for certain long-duration contracts and participating contracts and for realized gains and losses from the sale of investments, current and expected future profit margins for products covered by this guidance are examined regularly in determining the amortization of DAC. DAC associated with certain variable annuity products is amortized based on estimated assessments, with DAC on the remainder of variable annuities, UL and investment-type products amortized over the expected total life of the contract group as a constant percentage of estimated gross profits arising principally from investment results, Separate Accounts fees, mortality and expense margins and surrender charges based on historical and anticipated future experience, embedded derivatives and changes in the reserve of products that have indexed features such as SCS IUL and MSO, updated at the end of each accounting period. When estimated gross profits are expected to be negative for multiple years of a contract life, DAC is amortized using the present value of estimated assessments. The effect on the amortization of DAC of revisions to estimated gross profits or assessments is reflected in earnings (loss) in the period such estimated gross profits or assessments are revised. A decrease in expected gross profits or assessments would accelerate DAC amortization. Conversely, an increase in expected gross profits or assessments would slow DAC amortization. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. A significant assumption in the amortization of DAC on variable annuities and, to a lesser extent, on variable and interest-sensitive life insurance relates to projected future separate account performance. Management sets estimated future gross profit or assessment assumptions related to separate account performance using a long-term view of expected average market returns by applying a Reversion to the Mean (“RTM”) approach, a commonly used industry practice. This future return approach influences the projection of fees earned, as well as other sources of estimated gross profits. Returns that are higher than expectations for a given period produce higher than expected account balances, increase the fees earned resulting in higher expected future gross profits and lower DAC amortization for the period. The opposite occurs when returns are lower than expected. In applying this approach to develop estimates of future returns, it is assumed that the market will return to an average gross long-term return estimate, developed with reference to historical long-term equity market performance. Management has set limitations as to maximum and minimum future rate of return assumptions, as well as a limitation on the duration of use of these maximum or minimum rates of return. At December 31, 2018 , the average gross short-term and long-term annual return estimate on variable and interest-sensitive life insurance and variable annuities was 7.0% ( 4.7% net of product weighted average Separate Accounts fees), and the gross maximum and minimum short-term annual rate of return limitations were 15.0% ( 12.7% net of product weighted average Separate Accounts fees) and 0.0% ( (2.3)% net of product weighted average Separate Accounts fees), respectively. The maximum duration over which these rate limitations may be applied is five years. This approach will continue to be applied in future periods. These assumptions of long-term growth are subject to assessment of the reasonableness of resulting estimates of future return assumptions. In addition, projections of future mortality assumptions related to variable and interest-sensitive life products are based on a long-term average of actual experience. This assumption is updated periodically to reflect recent experience as it emerges. Improvement of life mortality in future periods from that currently projected would result in future deceleration of DAC amortization. Conversely, deterioration of life mortality in future periods from that currently projected would result in future acceleration of DAC amortization. Other significant assumptions underlying gross profit estimates for UL and investment type products relate to contract persistency and General Account investment spread. For participating traditional life policies (substantially all of which are in the Closed Block), DAC is amortized over the expected total life of the contract group as a constant percentage based on the present value of the estimated gross margin amounts expected to be realized over the life of the contracts using the expected investment yield. At December 31, 2018, the average rate of assumed investment yields, excluding policy loans, for the Company was 4.7% grading to 4.3% over six years. Estimated gross margins include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve and expected annual policyholder dividends. The effect on the accumulated amortization of DAC of revisions to estimated gross margins is reflected in earnings in the period such estimated gross margins are revised. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. Many of the factors that affect gross margins are included in the determination of the Company’s dividends to these policyholders. DAC adjustments related to participating traditional life policies do not create significant volatility in results of operations as the Closed Block recognizes a cumulative policyholder dividend obligation expense in “Policyholders’ dividends,” for the excess of actual cumulative earnings over expected cumulative earnings as determined at the time of demutualization. DAC associated with non-participating traditional life policies are amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are estimated at the date of policy issue and are consistently applied during the life of the contracts. Deviations from estimated experience are reflected in income (loss) in the period such deviations occur. For these contracts, the amortization periods generally are for the total life of the policy. DAC related to these policies are subject to recoverability testing as part of the Company’s premium deficiency testing. If a premium deficiency exists, DAC are reduced by the amount of the deficiency or to zero through a charge to current period earnings (loss). If the deficiency exceeds the DAC balance, the reserve for future policy benefits is increased by the excess, reflected in earnings (loss) in the period such deficiency occurs. For some products, policyholders can elect to modify product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. These transactions are known as internal replacements. If such modification substantially changes the contract, the associated DAC is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed . Reinsurance For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC and recognized as a component of other expenses on a basis consistent with the way the acquisition costs on the underlying reinsured contracts would be recognized. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as Premiums ceded (assumed); and Amounts due from reinsurers (Amounts due to reinsurers) are established. Amounts currently recoverable under reinsurance agreements are included in Amounts due from reinsurers and amounts currently payable are included in Amounts due to reinsurers . Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. Premiums, Policy charges and fee income and Policyholders’ benefits include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in GMIB reinsurance contract asset, at fair value with changes in estimated fair value reported in Net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in Other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. For reinsurance contracts other than those accounted for as derivatives, reinsurance recoverable balances are calculated using methodologies and assumptions that are consistent with those used to calculate the direct liabilities.
Policyholder Bonus Interest Credits	Policyholder Bonus Interest Credits Policyholder bonus interest credits are offered on certain deferred annuity products in the form of either immediate bonus interest credited or enhanced interest crediting rates for a period of time. The interest crediting expense associated with these policyholder bonus interest credits is deferred and amortized over the lives of the underlying contracts in a manner consistent with the amortization of DAC. Unamortized balances are included in Other assets in the consolidated balance sheets and amortization is included in Interest credited to policyholders’ account balances in the consolidated statements of income (loss).
Policyholder's Account Balances and Future Policy Benefits	Policyholders’ Account Balances and Future Policy Benefits Policyholders’ account balances relate to contracts or contract features where the Company has no significant insurance risk. This liability represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. For participating traditional life insurance policies, future policy benefit liabilities are calculated using a net level premium method on the basis of actuarial insurance assumptions equal to guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Terminal dividends are accrued in proportion to gross margins over the life of the contract. For non-participating traditional life insurance policies, future policy benefit liabilities are estimated using a net level premium method on the basis of actuarial assumptions as to mortality, persistency and interest established at policy issue. Assumptions established at policy issue as to mortality and persistency are based on the Company’s experience that, together with interest and expense assumptions, includes a margin for adverse deviation. Benefit liabilities for traditional annuities during the accumulation period are equal to accumulated policyholders’ fund balances and, after annuitization, are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 5.0% to 6.3% (weighted average of 5.1% ) for approximately 99.1% of life insurance liabilities and from 1.6% to 5.5% (weighted average of 4.8% ) for annuity liabilities. Individual health benefit liabilities for active lives are estimated using the net level premium method and assumptions as to future morbidity, withdrawals and interest. Benefit liabilities for disabled lives are estimated using the present value of benefits method and experience assumptions as to claim terminations, expenses and interest. While management believes its disability income (“DI”) reserves have been calculated on a reasonable basis and are adequate, there can be no assurance reserves will be sufficient to provide for future liabilities. When the liabilities for future policy benefits plus the present value of expected future gross premiums for a product are insufficient to provide for expected future policy benefits and expenses for that product, DAC is written off and thereafter, if required, a premium deficiency reserve is established by a charge to earnings. Funding agreements are also reported in Policyholders’ account balances in the consolidated balance sheets. As a member of the Federal Home Loan Bank of New York (“FHLBNY”), the Company has access to collateralized borrowings. The Company may also issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require the Company to pledge qualified mortgage-backed assets and/or government securities as collateral. The Company has issued and continues to offer certain variable annuity products with guaranteed minimum death benefits (“GMDB”) and/or contain a guaranteed minimum living benefit (“GMLB,” and together with GMDB, the “GMxB features”) which, if elected by the policyholder after a stipulated waiting period from contract issuance, guarantees a minimum lifetime annuity based on predetermined annuity purchase rates that may be in excess of what the contract account value can purchase at then-current annuity purchase rates. This minimum lifetime annuity is based on predetermined annuity purchase rates applied to a guaranteed minimum income benefit (“GMIB”) base. The Company previously issued certain variable annuity products with and guaranteed income benefit (“GIB”) features, guaranteed withdrawal benefit for life (“GWBL”), guaranteed minimum withdrawal benefit (“GMWB”) and guaranteed minimum accumulation benefit (“GMAB”) features. The Company has also assumed reinsurance for products with GMxB features. Reserves for products that have GMIB features, but do not have no-lapse guarantee features, and products with GMDB features are determined by estimating the expected value of death or income benefits in excess of the projected contract accumulation value and recognizing the excess over the estimated life based on expected assessments (i.e., benefit ratio). The determination of this estimated liability is based on models that involve numerous estimates and subjective judgments, including those regarding expected market rates of return and volatility, contract surrender and withdrawal rates, mortality experience, and, for contracts with the GMIB feature, GMIB election rates. Assumptions regarding separate account performance used for purposes of this calculation are set using a long-term view of expected average market returns by applying a RTM approach, consistent with that used for DAC amortization. There can be no assurance that actual experience will be consistent with management’s estimates. Products that have a GMIB feature with a no-lapse guarantee rider (“GMIBNLG”), GIB, GWBL, GMWB and GMAB features and the assumed products with GMIB features (collectively “GMxB derivative features”) are considered either freestanding or embedded derivatives and discussed below under (“Embedded and Freestanding Insurance Derivatives”). After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings. Premium deficiency reserves have been recorded for the group single premium annuity business, certain interest-sensitive life contracts, structured settlements, individual disability income and major medical. Additionally, in certain instances the policyholder liability for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. This pattern of profits followed by losses is exhibited in our VISL business and is generated by the cost structure of the product or secondary guarantees in the contract. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. We accrue for these Profits Followed by Losses ("PFBL") using a dynamic approach that changes over time as the projection of future losses change.
Embedded and Freestanding Insurance Derivatives	Embedded and Freestanding Insurance Derivatives Reserves for products considered either embedded or freestanding derivatives are measured at estimated fair value separately from the host variable annuity product, with changes in estimated fair value reported in Net derivative gains (losses). The estimated fair values of these derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees attributable to the guarantee. The projections of future benefits and future fees require capital markets and actuarial assumptions, including expectations concerning policyholder behavior. A risk-neutral valuation methodology is used under which the cash flows from the guarantees are projected under multiple capital market scenarios using observable risk-free rates. Additionally, the Company cedes and assumes reinsurance of products with GMxB features, which are considered either an embedded or freestanding derivative, and measured at fair value. The GMxB reinsurance contract asset and liabilities’ fair values reflect the present value of reinsurance premiums and recoveries and risk margins over a range of market-consistent economic scenarios. Changes in the fair value of embedded and freestanding derivatives are reported in Net derivative gains (losses). Embedded derivatives in direct and assumed reinsurance contracts are reported in Future policyholders’ benefits and other policyholders’ liabilities and embedded derivatives in ceded reinsurance contracts are reported in the GMIB reinsurance contract asset, at fair value in the consolidated balance sheets . Embedded and freestanding insurance derivatives fair values are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits is attributed to the embedded derivative. The percentage of fees included in the fair value measurement is locked-in at inception. Fees above those amounts represent “excess” fees and are reported in Policy charges and fee income.
Policyholders Dividends	Policyholders’ Dividends The amount of policyholders’ dividends to be paid (including dividends on policies included in the Closed Block) is determined annually by the board of directors of the issuing insurance company. The aggregate amount of policyholders’ dividends is related to actual interest, mortality, morbidity and expense experience for the year and judgment as to the appropriate level of statutory surplus to be retained by the Company.
Separate Accounts	Separate Accounts Generally, Separate Accounts established under New York State and Arizona State Insurance Law are not chargeable with liabilities that arise from any other business of the Company. Separate Accounts assets are subject to General Account claims only to the extent Separate Accounts assets exceed separate accounts liabilities. Assets and liabilities of the Separate Account represent the net deposits and accumulated net investment earnings (loss) less fees, held primarily for the benefit of policyholders, and for which the Company does not bear the investment risk. Separate Accounts assets and liabilities are shown on separate lines in the consolidated balance sheets. Assets held in Separate Accounts are reported at quoted market values or, where quoted values are not readily available or accessible for these securities, their fair value measures most often are determined through the use of model pricing that effectively discounts prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to policyholders of such Separate Accounts are offset within the same line in the consolidated statements of income (loss). For 2018 , 2017 and 2016 , investment results of such Separate Accounts were losses of $7.3 billion , and gains of $17.0 billion and $8.3 billion , respectively. Deposits to Separate Accounts are reported as increases in Separate Accounts assets and liabilities and are not reported in revenues or expenses. Mortality, policy administration and surrender charges on all policies including those funded by Separate Accounts are included in revenues. The Company reports the General Account’s interests in Separate Accounts as Other trading in the consolidated balance sheets.
Broker-Dealer Revenues, Receivables and Payables	Broker-Dealer Revenues, Receivables and Payables AXA Advisors and certain of the Company’s other subsidiaries provide investment management, brokerage and distribution services for affiliates and third parties. Third-party revenues earned from these services are reported in Other income in the Company’s consolidated statement of income (loss). Receivables from and payables to clients include amounts due on cash and margin transactions. Securities owned by customers are held as collateral for receivables; such collateral is not reflected in the consolidated financial statements.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill recorded by the Company represents the excess of purchase price over the estimated fair value of identifiable net assets of companies acquired in a business combination and relates principally to the acquisition of SCB Inc., an investment research and management company formerly known as Sanford C. Bernstein Inc. (“Bernstein Acquisition”) and the purchase of units of the limited partnership interest in ABLP (“AB Units”). The Company tests goodwill for recoverability each annual reporting period at December 31 and at interim periods if facts or circumstances are indicative of potential impairment. Effective January 1, 2017, the Company early-adopted new guidance that eliminated Step 2 testing from the goodwill impairment model and continued to limit the measurement of any goodwill impairment to the carrying value of the reporting unit’s goodwill. The Company’s intangible assets primarily relate to the Bernstein Acquisition and purchases of AB Units and reflect amounts assigned to acquired investment management contracts based on their estimated fair values at the time of acquisition, less accumulated amortization. These intangible assets generally are amortized on a straight-line basis over their estimated useful life, ranging from six to twenty years. All intangible assets are periodically reviewed for impairment as events or changes in circumstances indicate that the carrying value may not be recoverable. If the carrying value exceeds fair value, impairment tests are performed to measure the amount of the impairment loss, if any.
Internal-use Software	Internal-use Software Capitalized internal-use software, included in Other assets in the consolidated balance sheets, is amortized on a straight-line basis over the estimated useful life of the software that ranges between three and five years. Capitalized amounts are periodically tested for impairment in accordance with the guidance on impairment of long-lived assets. An immediate charge to earnings is recognized if capitalized software costs no longer are deemed to be recoverable. In addition, service potential is periodically reassessed to determine whether facts and circumstances have compressed the software’s useful life such that acceleration of amortization over a shorter period than initially determined would be required.
Short-term and Long-term Debt	Short-term and Long-term Debt Liabilities for short-term and long-term debt are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issue costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within Interest expense in the consolidated statements of income (loss). Short-term debt represents debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. See Note 11 for additional information regarding short-term and long-term debt.
Income Taxes	Income Taxes The Company and certain of its consolidated subsidiaries and affiliates file a consolidated federal income tax return. The Company provides for federal and state income taxes currently payable, as well as those deferred due to temporary differences between the financial reporting and tax bases of assets and liabilities. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income tax assets and liabilities are recognized based on the difference between financial statement carrying amounts and income tax bases of assets and liabilities using enacted income tax rates and laws. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred tax assets will not be realized. Under accounting for uncertainty in income taxes guidance, the Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the consolidated financial statements. Tax positions are then measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement. ABLP is a private partnership for federal income tax purposes and, accordingly, is not subject to federal and state corporate income taxes. However, ABLP is subject to a 4.0% New York City unincorporated business tax (“UBT”). AB Holding is subject to a 3.5% federal tax on partnership gross income from the active conduct of a trade or business. Domestic corporate subsidiaries of AB are subject to federal, state and local income taxes. Foreign corporate subsidiaries are generally subject to taxes in the foreign jurisdictions where they are located. The Company provides federal and state income taxes on the undistributed earnings of non-U.S. corporate subsidiaries except to the extent that such earnings are permanently invested outside the United States.
Recognition of Investment Management and Service Fees and Related Expenses	Recognition of Investment Management and Service Fees and Related Expenses Investment management, advisory and service fees Investment management and service fees principally include the Investment Management and Research segment’s investment advisory and service fees, distribution revenues and institutional research services revenue. Investment advisory and service base fees, generally calculated as a percentage, referred to as basis points (“BPs”), of assets under management, are recorded as revenue as the related services are performed. Certain investment advisory contracts, including those associated with hedge funds, provide for a performance-based fee, in addition to or in lieu of a base fee which is calculated as either a percentage of absolute investment results or a percentage of the investment results in excess of a stated benchmark over a specified period of time. Investment management and administrative service fees are also earned by AXA Equitable Funds Management Group, LLC (“AXA Equitable FMG”) and reported in the Individual Retirement, Group Retirement and Protection Solutions segments as well as certain asset-based fees associated with insurance contracts. AB provides asset management services by managing customer assets and seeking to deliver returns to investors. Similarly, AXA Equitable FMG provides investment management and administrative services, such as fund accounting and compliance services, to AXA Premier VIP Trust (“VIP Trust”), EQ Advisors Trust (“EQAT”) and 1290 Funds as well as two private investment trusts established in the Cayman Islands, AXA Allocation Funds Trust and AXA Offshore Multimanager Funds Trust (collectively, the “Other AXA Trusts”). The contracts supporting these revenue streams create a distinct, separately identifiable performance obligation for each day the assets are managed for the performance of a series of services that are substantially the same and have the same pattern of transfer to the customer. Accordingly, these investment management, advisory, and administrative service base fees are recorded over time as services are performed and entitle the Company to variable consideration. Base fees, generally calculated as a percentage of assets under management (“AUM”), are recognized as revenue at month-end when the transaction price no longer is variable and the value of the consideration is determined. These fees are not subject to claw back and there is minimal probability that a significant reversal of the revenue recorded will occur. Certain investment advisory contracts of AB, including those associated with hedge funds or other alternative investments, provide for a performance-based fee (including carried interest), in addition to a base advisory fee, calculated either as a percentage of absolute investment results or a percentage of investment results in excess of a stated benchmark over a specified period of time. These performance-based fees are forms of variable consideration and, therefore, are excluded from the transaction price until it becomes probable there will not be significant reversal of the cumulative revenue recognized. At each reporting date, the Company evaluates constraining factors surrounding the variable consideration to determine the extent to which, if any, revenues associated with the performance-based fee can be recognized. Constraining factors impacting the amount of variable consideration included in the transaction price include contractual claw-back provisions, the length of time of the uncertainty, the number and range of possible amounts, the probability of significant fluctuations in the fund’s market value and the level in which the fund’s value exceeds the contractual threshold required to earn such a fee and the materiality of the amount being evaluated. Prior to adoption of the new revenue recognition guidance on January 1, 2018, the Company recognized performance-based fees at the end of the applicable measurement period when no risk of reversal remained and carried-interest distributions received as deferred revenues until no risk of reversal remained. Sub-advisory and sub-administrative expenses associated with these services are calculated and recorded as the related services are performed in Other operating costs and expense in the consolidated statements of income (loss) as the Company is acting in a principal capacity in these transactions and, as such, reflects these revenues and expenses on a gross basis. Research services Research services revenue principally consists of brokerage transaction charges received by Sanford C. Bernstein & Co. LLC (“SCB LLC”), Sanford C. Bernstein Limited (“SCBL”) and AB’s other sell side subsidiaries for providing equity research services to institutional clients. Brokerage commissions for trade execution services and related expenses are recorded on a trade-date basis when the performance obligations are satisfied. Generally, the transaction price is agreed upon at the point of each trade and based upon the number of shares traded or the value of the consideration traded. Research revenues are recognized when the transaction price is quantified, collectability is assured and significant reversal of such revenue is not probable. Distribution services Revenues from distribution services include fees received as partial reimbursement of expenses incurred in connection with the sale of certain AB sponsored mutual funds and the 1290 Funds and for the distribution primarily of EQAT and VIP Trust shares to separate accounts in connection with the sale of variable life and annuity contracts. The amount and timing of revenues recognized from performance of these distribution services often is dependent upon the contractual arrangements with the customer and the specific product sold as further described below. Most open-end management investment companies, such as U.S. funds and the EQAT and VIP Trusts and the 1290 Funds, have adopted a plan under Rule 12b-1 of the Investment Company Act that allows for certain share classes to pay out of assets, distribution and service fees for the distribution and sale of its shares (“12b-1 Fees”). These open-end management investment companies have such agreements with the Company, and the Company has selling and distribution agreements pursuant to which it pays sales commissions to the financial intermediaries that distribute the shares. These agreements may be terminated by either party upon notice (generally 30 days) and do not obligate the financial intermediary to sell any specific amount of shares. The Company records 12b-1 fees monthly based upon a percentage of the net asset value (“NAV”) of the funds. At month-end, the variable consideration of the transaction price is no longer constrained as the NAV can be calculated and the value of consideration is determined. These services are separate and distinct from other asset management services as the customer can benefit from these services independently of other services. The Company accrues the corresponding 12b-1 fees paid to sub-distributors monthly as the expenses are incurred. The Company is acting in a principal capacity in these transactions; as such, these revenues and expenses are recorded on a gross basis in the consolidated statements of income (loss). AB sponsored mutual funds offer back-end load shares in limited instances and charge the investor a contingent deferred sales charge (“CDSC”) if the investment is redeemed within a certain period. The variable consideration for these contracts is contingent upon the timing of the redemption by the investor and the value of the sales proceeds. Due to these constraining factors, the Company excludes the CDSC fee from the transaction price until the investor redeems the investment. Upon redemption, the cash consideration received for these contractual arrangements is recorded as a reduction of unamortized deferred sales commissions. AB’s Luxembourg subsidiary, the management company for most of its non-U.S. funds, earns a management fee which is accrued daily and paid monthly, at an annual rate, based on the average daily net assets of the fund. With respect to certain share classes, the management fee also may contain a component paid to distributors and other financial intermediaries and service providers to cover shareholder servicing and other administrative expenses (also referred to as an “All-in-Fee”). Based on the conclusion that asset management is distinct from distribution, the Company allocates a portion of the investment and advisory fee to distribution revenues for the servicing component based on standalone selling prices. Other revenues Also reported as Investment management and service fees in the Company’s consolidated statements of income (loss) are other revenues from contracts with customers, primarily consisting of shareholder servicing fees, mutual fund reimbursements and other brokerage income. Shareholder services, including transfer agency, administration and record-keeping are provided by AB to company-sponsored mutual funds. The consideration for these services is based on a percentage of the NAV of the fund or a fixed-fee based on the number of shareholder accounts being serviced. The revenues are recorded at month-end when the constraining factors involved with determining NAV or the numbers of shareholders’ accounts are resolved. Other income Revenues from contracts with customers reported as Other Income in the Company’s consolidated statements of income (loss) primarily consist of advisory account fees and brokerage commissions from the Company’s subsidiary broker-dealer operations and sales commissions from the Company’s general agent for the distribution of non-affiliate insurers’ life insurance and annuity products. These revenues are recognized at month-end when constraining factors, such as AUM and product mix, are resolved and the transaction pricing no longer is variable such that the value of consideration can be determined.
Deferred Sales Commissions, Net	Deferred Sales Commissions, Net Commissions paid to financial intermediaries in connection with the sale of shares of open-end AB sponsored mutual funds sold without a front-end sales charge (“back-end load shares”) are capitalized as deferred sales commissions and amortized over periods not exceeding five and one-half years for U.S. fund shares and four years for non-U.S. fund shares, the periods of time during which the deferred sales commissions are generally recovered. These commissions are recovered from distribution services fees received from those funds and from contingent deferred sales commissions (“CDSC”) received from shareholders of those funds upon the redemption of their shares. CDSC cash recoveries are recorded as reductions of unamortized deferred sales commissions when received. Since January 31, 2009, AB sponsored U.S. mutual funds have not offered back-end load shares to new investors. Likewise, as of December 31, 2016, AB sponsored Non-U.S. Funds are no longer offering back-end load shares, except in isolated instances. Management periodically reviews the deferred sales commission asset for impairment as events or changes in circumstances indicate that the carrying value may not be recoverable. If these factors indicate impairment in value, a comparison is made of the carrying value to the undiscounted cash flows expected to be generated by the asset over its remaining life. If it is determined the deferred sales commission asset is not fully recoverable, the asset will be deemed impaired and a loss will be recorded in the amount by which the recorded amount of the asset exceeds its estimated fair value.
Accounting and Consolidation of VIE's	Accounting and Consolidation of VIEs For all new investment products and entities developed by the Company (other than Collateralized Debt Obligations (“CDOs”)), the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then identifies the primary beneficiary of the VIE. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity. Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships. The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate. At December 31, 2018 and 2017 , respectively, the Company held approximately $1.2 billion and $1.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheet as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these nonconsolidated VIEs are approximately $166.1 billion and $160.2 billion at December 31, 2018 and 2017, respectively. The Company ’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion and $1.1 billion and approximately $940 million and $769 million of unfunded commitments at December 31, 2018 and 2017 , respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. At December 31, 2018 , the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable Life Insurance Company (“AXA Equitable Life”) and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheet at December 31, 2018 , are total assets of $36 million related to this VIE, primarily resulting from the consolidated presentation of $36 million of Real estate held for production of income. In addition, Real estate held for production of income reflects $16 million as related to two non-consolidated joint ventures at December 31, 2018 . At December 31, 2017 , the Company consolidated three real estate joint ventures for which it was identified as primary beneficiary under the VIE model. Two of the joint ventures are owned 95% by the Company and 5% by the venture partner. The third consolidated entity is jointly owned by AXA Equitable and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheets at December 31, 2017 are total assets of $393 million related to these VIEs, primarily resulting from the consolidated presentation of $372 million of real estate held for production of income. Also resulting from the Company’s consolidated presentation of these VIEs are total liabilities of $229 million at December 31, 2017 including long term debt in the amount of $203 million . In addition, Real estate held for production of income reflects $18 million as related to two non-consolidated joint ventures at December 31, 2017 . Included in the Company’s consolidated balance sheet at December 31, 2018 and 2017 , respectively, are assets of $236 million and $1.5 billion , liabilities of $5 million and $696 million , and redeemable non-controlling interests of $118 million and $596 million associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets are assets of $152 million and $58 million , liabilities of $17 million and $2 million , and redeemable non-controlling interests of $28 million and $0 million from consolidation of AB-sponsored investment funds under the VOE model. The assets of these consolidated funds are presented within Other invested assets and cash and cash equivalents, and liabilities of these consolidated funds are presented with other liabilities on the face of the Company’s consolidated balance sheet at December 31, 2018 ; ownership interests not held by the Company relating to consolidated VIEs and VOEs are presented either as redeemable or non-redeemable noncontrolling interest, as appropriate. The Company is not required to provide financial support to these company-sponsored investment funds, and only the assets of such funds are available to settle each fund’s own liabilities. As of December 31, 2018 , the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $44.3 billion and the Company ’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $6 million at December 31, 2018 . The Company has no further commitments to or economic interest in these VIEs.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09 This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. Adoption did not change the amounts or timing of the Company’s revenue recognition for base investment management and advisory fees, distribution revenues, shareholder servicing revenues or broker-dealer revenues. Some performance-based fees and carried-interest distributions that were recognized prior to adoption when no risk of reversal remained, in certain instances may now be recognized earlier if it is probable that significant reversal will not occur. Description Effect on the Financial Statement or Other Significant Matters ASU 2016-01 This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in a reclassification adjustment of $7 million from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $46 million common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15 Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07 This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09 This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02 Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by increasing AOCI and decreasing retained earnings by $89 million. ASU 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018, the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17 Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13 This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. ASU 2018-07 Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2017-12 The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02 This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company will adopt ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $750 million to $850 million and operating lease liabilities ranging from $950 million to $1.1 billion, respectively, for operating leases. The adoption of this standard will not have a significant impact on opening retained earnings. The reclassification adjustments for the years ended December 31, 2017 and 2016 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and distribution plan payments, and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item. Years Ended December 31, 2017 2016 Individual Retirement Group Retirement Protection Solutions Consoli- dated Individual Retirement Group Retirement Protection Solutions Consoli- dated (in millions) Reductions to expense line items: Compensation and benefits $ 71 $ 30 $ 56 $ 157 $ 72 $ 28 $ 54 $ 154 Commissions and distribution plan payments 328 55 140 523 347 54 135 537 Other operating costs and expenses 2 1 4 7 2 — 4 6 Total reductions $ 401 $ 86 $ 200 $ 687 $ 421 $ 82 $ 193 $ 697 Increase to expense line item: Amortization of deferred policy acquisition costs $ 401 $ 86 $ 200 $ 687 $ 421 $ 82 $ 193 $ 697 The following table lists investments for which net asset value (“NAV”) is calculated; NAV is used as a practical expedient to determine the fair value of these investments at December 31, 2018 and 2017 . Practical Expedient Disclosure as of December 31, 2018 and 2017 Investment Fair Value Redemption Frequency (If currently eligible) Redemption Notice Period Unfunded Commitments (in millions) December 31, 2018: Private Equity Fund $ 64 N/A (1)(2) N/A $ 33 Private Real Estate Investment Trust 402 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 12 Total $ 559 December 31, 2017: Private Equity Fund $ 61 N/A (1)(2) N/A $ 29 Private Real Estate Investment Trust 376 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 34 Total $ 530 ______________ (1) Cannot sell or transfer ownership interest without prior written consent to transfer, and by meeting several criteria (e.g., does not adversely affect other investors). (2) Cannot sell interest in the vehicle without prior written consent of the managing member. (3) March, June, September and December.

INVESTMENTS (Tables)

INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Debt Securities, Available-for-sale	The contractual maturities of AFS fixed maturities at December 31, 2018 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) December 31, 2018: Due in one year or less $ 2,598 $ 2,603 Due in years two through five 9,396 9,444 Due in years six through ten 16,501 16,327 Due after ten years 17,020 16,624 Subtotal 45,515 44,998 Residential mortgage-backed securities 225 234 Asset-backed securities 612 601 Redeemable preferred stock 449 446 Total at December 31, 2018 $ 46,801 $ 46,279 The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities for the years ended December 31, 2018 , 2017 and 2016 : For the Years Ended December 31, 2018 2017 2016 (in millions) Proceeds from sales $ 8,523 $ 8,213 $ 5,036 Gross gains on sales $ 180 $ 107 $ 212 Gross losses on sales $ (215 ) $ (259 ) $ (60 ) Total OTTI $ (42 ) $ (15 ) $ (68 ) Non-credit losses recognized in OCI — — — Credit losses recognized in net income (loss) $ (42 ) $ (15 ) $ (68 ) Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value OTTI in AOCI (4) (in millions) December 31, 2018: Fixed Maturities: Corporate (1) $ 30,572 $ 406 $ 800 $ 30,178 $ — U.S. Treasury, government and agency 14,004 295 470 13,829 — States and political subdivisions 415 47 1 461 — Foreign governments 524 19 13 530 — Residential mortgage-backed (2) 225 10 1 234 — Asset-backed (3) 612 1 12 601 2 Redeemable preferred stock 449 15 18 446 — Total at December 31, 2018 $ 46,801 $ 793 $ 1,315 $ 46,279 $ 2 December 31, 2017: Fixed Maturities: Corporate (1) $ 24,480 $ 1,031 $ 65 $ 25,446 $ — U.S. Treasury, government and agency 17,759 1,000 251 18,508 — States and political subdivisions 422 67 — 489 — Foreign governments 395 29 5 419 — Residential mortgage-backed (2) 797 22 1 818 — Asset-backed (3) 745 5 1 749 2 Redeemable preferred stock 470 43 1 512 — Total Fixed Maturities 45,068 2,197 324 46,941 2 Equity securities 188 2 — 190 — Total at December 31, 2017 $ 45,256 $ 2,199 $ 324 $ 47,131 $ 2 _____________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in income (loss) in accordance with current accounting guidance.
Fixed Maturities Credit Loss Impairments	Fixed Maturities - Credit Loss Impairments 2018 2017 (in millions) Balances at January 1, $ (18 ) $ (239 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 2 236 Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired (42 ) (14 ) Additional impairments this period on securities previously impaired — (1 ) Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at December 31, $ (58 ) $ (18 ) _____________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: As of December 31, 2018 2017 (in millions) AFS Securities: Fixed maturities: With OTTI loss $ — $ 2 All other (522 ) 1,871 Equity securities — 2 Net Unrealized Gains (Losses) $ (522 ) $ 1,875
Unrealized Gain (Loss) On Investments With Other Than Temporary Impairment	The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized, and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 2 $ — $ (1 ) $ — $ 1 Net investment gains (losses) arising during the period (1 ) — — — (1 ) Reclassification adjustment: Included in Net income (loss) (1 ) — — — (1 ) Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — — — — — Deferred income taxes — — — — — Policyholders’ liabilities — — 1 — 1 Balance, December 31, 2018 $ — $ — $ — $ — $ — Balance, January 1, 2017 $ 19 $ 1 $ (10 ) $ (4 ) $ 6 Net investment gains (losses) arising during the period (18 ) — — — (18 ) Reclassification adjustment Included in Net income (loss) 1 — — — 1 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — 4 4 Policyholders’ liabilities — — 9 — 9 Balance, December 31, 2017 $ 2 $ — $ (1 ) $ — $ 1 _______________ (1) Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss.
Other Net Unrealized Investment Gains Losses In Accumulated Other Comprehensive Income	. All Other Net Unrealized Investment Gains (Losses) in AOCI Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1,871 $ (358 ) $ (238 ) $ (397 ) $ 878 Net investment gains (losses) arising during the period (2,470 ) — — — (2,470 ) Reclassification adjustment: Included in Net income (loss) 77 — — — 77 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 458 — — 458 Deferred income taxes (2) — — — 501 501 Policyholders’ liabilities — — 165 — 165 Balance, December 31, 2018 $ (522 ) $ 100 $ (73 ) $ 104 $ (391 ) Balance, January 1, 2017 $ 528 $ (45 ) $ (192 ) $ (102 ) $ 189 Net investment gains (losses) arising during the period 1,329 — — — 1,329 Reclassification adjustment: Included in Net income (loss) 14 — — — 14 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (313 ) — — (313 ) Deferred income taxes — — — (295 ) (295 ) Policyholders’ liabilities — — (46 ) — (46 ) Balance, December 31, 2017 $ 1,871 $ (358 ) $ (238 ) $ (397 ) $ 878 ______________ (1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss. (2) Includes a $113 million income tax benefit from the impact of adoption of ASU 2018-02.
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following tables disclose the fair values and gross unrealized losses of the 1,700 issues at December 31, 2018 and the 752 issues at December 31, 2017 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) December 31, 2018: Fixed Maturities: Corporate $ 8,964 $ 313 $ 8,244 $ 487 $ 17,208 $ 800 U.S. Treasury, government and agency 1,077 53 4,306 417 5,383 470 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 29 1 29 1 Asset-backed 563 11 13 1 576 12 Redeemable preferred stock 165 13 33 5 198 18 Total $ 10,878 $ 393 $ 12,720 $ 922 $ 23,598 $ 1,315 December 31, 2017: Fixed Maturities: Corporate $ 2,903 $ 23 $ 1,331 $ 42 $ 4,234 $ 65 U.S. Treasury, government and agency 2,718 6 4,506 245 7,224 251 States and political subdivisions 20 — — — 20 — Foreign governments 11 — 73 5 84 5 Residential mortgage-backed 62 — 76 1 138 1 Asset-backed 15 1 12 — 27 1 Redeemable preferred stock 10 — 13 1 23 1 Total $ 5,739 $ 30 $ 6,011 $ 294 $ 11,750 $ 324
Allowance for Credit Losses on Financing Receivable	The change in the valuation allowance for credit losses for commercial mortgage loans during the years ended December 31, 2018 , 2017 and 2016 was as follows: Commercial Mortgage Loans 2018 2017 2016 (in millions) Allowance for credit losses: Beginning Balance, January 1 $ 8 $ 8 $ 6 Charge-offs — — — Recoveries (1 ) — (2 ) Provision — — 4 Ending Balance, December 31 $ 7 $ 8 $ 8 Ending Balance, December 31 Individually Evaluated for Impairment $ 7 $ 8 $ 8
Debt Service Coverage Ratio	The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at December 31, 2018 and 2017 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Total Mortgage Loans Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 1.5x to 1.2x to 1.0x to Less than (in millions) December 31, 2018: Commercial Mortgage Loans (1) 0% - 50% $ 797 $ 21 $ 247 $ 24 $ — $ — $ 1,089 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,965 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,147 Agricultural Mortgage Loans (1) 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans (1) 0% - 50% $ 1,079 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,700 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,359 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,842 December 31, 2017: Commercial Mortgage Loans (1) 0% - 50% $ 759 $ — $ 320 $ 74 $ — $ — $ 1,153 50% - 70% 4,088 682 1,066 428 145 — 6,409 70% - 90% 169 110 196 272 50 — 797 90% plus — — 27 — — — 27 Total Commercial Mortgage Loans $ 5,016 $ 792 $ 1,609 $ 774 $ 195 $ — $ 8,386 Agricultural Mortgage Loans (1) 0% - 50% $ 272 $ 149 $ 275 $ 515 $ 316 $ 30 $ 1,557 50% - 70% 111 46 227 359 221 49 1,013 70% - 90% — — — 4 — — 4 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 383 $ 195 $ 502 $ 878 $ 537 $ 79 $ 2,574 Total Mortgage Loans (1) 0% - 50% $ 1,031 $ 149 $ 595 $ 589 $ 316 $ 30 $ 2,710 50% - 70% 4,199 728 1,293 787 366 49 7,422 70% - 90% 169 110 196 276 50 — 801 90% plus — — 27 — — — 27 Total Mortgage Loans $ 5,399 $ 987 $ 2,111 $ 1,652 $ 732 $ 79 $ 10,960 ______________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
Age Analysis Of Past Due Mortgage Loans	The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2018 and 2017 , respectively. Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) December 31, 2018: Commercial $ — $ — $ 27 $ 27 $ 9,120 $ 9,147 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,747 $ 11,842 $ 40 December 31, 2017: Commercial $ 27 $ — $ — $ 27 $ 8,359 $ 8,386 $ — Agricultural 49 3 22 74 2,500 2,574 22 Total Mortgage Loans $ 76 $ 3 $ 22 $ 101 $ 10,859 $ 10,960 $ 22
Impaired Mortgage Loans	The following table provides information relating to impaired mortgage loans at December 31, 2018 and 2017 , respectively. Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) December 31, 2018: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans 2 2 — — — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (7 ) $ 27 $ — December 31, 2017: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans — — — — — Total $ — $ — $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (8 ) $ 27 $ 2 Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (8 ) $ 27 $ 2 ___________ (1) Represents a five-quarter average of recorded amortized cost.
Schedule of Derivative Instruments	The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At December 31, 2018 Fair Value Gains (Losses) Reported In Earnings (Loss) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (6): Equity contracts: Futures $ 11,143 $ 2 $ 3 $ 541 Swaps 7,796 143 168 715 Options 21,821 2,133 1,164 (899 ) Interest rate contracts: Swaps 27,116 634 196 (656 ) Futures 11,792 — — 112 Credit contracts: Credit default swaps 1,376 20 3 (2 ) Other freestanding contracts: Foreign currency contracts 2,184 35 22 6 Margin — 18 5 — Collateral — 8 1,581 — Embedded Derivatives: GMIB reinsurance contracts (6) — 1,732 — (162 ) GMxB derivative features liability (3) (6) — — 5,614 (775 ) SCS, SIO, MSO and IUL indexed features (5) (6) — — 715 889 Net derivative investment gains (loss) (231 ) Cross currency swaps (2) (4) — — — 9 Balances, December 31, 2018 $ 83,228 $ 4,725 $ 9,471 $ (222 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Other assets or Other liabilities in the consolidated balance sheets. (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) Reported in Other income in the consolidated statements of income (loss). (5) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (6) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). Derivative Instruments by Category At December 31, 2017 Fair Value Gains (Losses) Reported In Earnings (Loss) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (6): Equity contracts: Futures $ 6,716 $ 1 $ 2 $ (1,297 ) Swaps 7,623 4 201 (1,413 ) Options 22,223 3,456 1,457 1,265 Interest rate contracts: Swaps 26,769 604 193 863 Futures 20,675 — — 293 Credit contracts: Credit default swaps 2,131 35 3 19 Other freestanding contracts: Foreign currency contracts 1,423 19 10 (39 ) Margin — 24 4 — Collateral — 4 2,123 — Embedded Derivatives: GMIB reinsurance contracts (6) — 1,894 — 174 GMxB derivative features liability (3) (6) — — 4,451 1,652 SCS, SIO, MSO and IUL indexed features (5) (6) — — 1,786 (1,303 ) Net derivative gains (loss) 214 Cross currency swaps (2) (4) 354 5 — 40 Balances, December 31, 2017 $ 87,914 $ 6,046 $ 10,230 $ 254 _________________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Other assets or Other liabilities in the consolidated balance sheets. (3) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (4) Reported in Other income in the consolidated statements of income (loss). (5) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (6) Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
Offsetting Assets And Liabilities	The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2018 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets (1) Total Derivatives $ 2,993 $ 2,945 $ 48 Other financial instruments 1,989 — 1,989 Other invested assets $ 4,982 $ 2,945 $ 2,037 Liabilities (2) Total Derivatives $ 3,142 $ 2,945 $ 197 Other financial liabilities 3,163 — 3,163 Other liabilities $ 6,305 $ 2,945 $ 3,360 Securities sold under agreement to repurchase (3) $ 571 $ — $ 571 ________________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Excludes expense of $2 million in securities sold under agreement to repurchase. The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2017 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2017 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets (1) Total Derivatives $ 4,147 $ 3,993 $ 154 Other financial instruments 3,964 — 3,964 Other invested assets $ 8,111 $ 3,993 $ 4,118 Total Derivatives, not subject to an ISDA Master Agreement (4) $ 5 $ — $ 5 Liabilities (2) Total Derivatives $ 3,993 $ 3,993 $ — Other financial liabilities 4,053 — 4,053 Other liabilities $ 8,046 $ 3,993 $ 4,053 Securities sold under agreement to repurchase (3) $ 1,882 $ 2,009 $ (127 ) __________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Excludes expense of $5 million included in Securities sold under agreements to repurchase on the consolidated balance sheets. (4) This amount is reflected in Other assets.
Collateral Arrangements By Counterparty Not Offset In Consolidated Balance Sheets	The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018 : Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Cash Net (in millions) Assets (1) Total Derivatives $ 1,411 $ — $ (1,363 ) $ 48 Other financial instruments 1,989 — — 1,989 Other invested assets $ 3,400 $ — $ (1,363 ) $ 2,037 Liabilities (2) Total Derivatives $ 197 $ — $ — $ 197 Other financial liabilities 3,163 — — 3,163 Other liabilities $ 3,360 $ — $ — $ 3,360 Securities sold under agreement to repurchase (3) (4) (5) $ 571 $ (588 ) $ — $ (17 ) ______________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Excludes expense of $2 million in securities sold under agreement to repurchase. (4) US Treasury and agency securities are in fixed maturities available for sale on consolidated balance sheet. (5) Cash is in Cash and cash equivalents on consolidated balance sheet The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2017 : Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2017 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash Net Amount (in millions) Assets (1) Total derivatives $ 2,253 $ — $ (2,099 ) $ 154 Other financial instruments 3,964 — — 3,964 Other invested assets $ 6,217 $ — $ (2,099 ) $ 4,118 Liabilities (2) Other financial liabilities $ 4,053 $ — $ — $ 4,053 Other liabilities $ 4,053 $ — $ — $ 4,053 Securities sold under agreement to repurchase (3) (4) (5) $ 1,882 $ (1,988 ) $ (21 ) $ (127 ) __________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Excludes expense of $5 million in securities sold under agreement to repurchase. (4) U.S. Treasury and agency securities are in fixed maturities available for sale on consolidated balance sheets. (5) Cash is included in Cash and cash equivalents on consolidated balance sheets.
Transfer Of Financial Assets Accounted For As Sales	The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2017 . Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2017 Remaining Contractual Maturity of the Agreements Overnight and Up to 30 days 30-90 days Greater Than Total (in millions) Securities sold under agreement to repurchase (1): U.S. Treasury and agency securities $ — $ 1,882 $ — $ — $ 1,882 Total $ — $ 1,882 $ — $ — $ 1,882 ____________ (1) Excludes expense of $5 million in securities sold under agreements to repurchase on the consolidated balance sheets. The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018 : Repurchase Agreement Accounted for as Secured Borrowings December 31, 2018 Remaining Contractual Maturity of the Agreements Overnight and Up to 30 days 30-90 days Greater Than Total (in millions) Securities sold under agreement to repurchase (1) U.S. Treasury and agency securities $ — $ 571 $ — $ — $ 571 Total $ — $ 571 $ — $ — $ 571 ______________ (1) Excludes expense of $2 million in securities sold under agreement to repurchase.
Investment Income	The following table breaks out Net investment income (loss) by asset category: Years Ended December 31, 2018 2017 2016 (in millions) Fixed maturities $ 1,725 $ 1,629 $ 1,723 Mortgage loans on real estate 494 454 397 Real estate held for the production of income (6 ) 2 19 Other equity investments 147 186 168 Policy loans 215 221 225 Repurchase agreements — — 1 Trading securities 105 553 144 Other investment income 85 109 67 Gross investment income (loss) 2,765 3,154 2,744 Investment expenses (1) (72 ) (72 ) (79 ) Net Investment Income (Loss) $ 2,693 $ 3,082 $ 2,665 ______________ (1) Investment expenses includes expenses related to the management of the two buildings sold in 2016 .
Trading Securities	The table below shows a breakdown of Net investment income from trading account securities during the years ended December 31, 2018 , 2017 and 2016 : Net Investment Income (Loss) from Trading Securities Years Ended December, 31 2018 2017 2016 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (223 ) $ 247 $ (51 ) Net investment gains (losses) recognized on securities sold during the period (14 ) 19 (12 ) Unrealized and realized gains (losses) on trading securities (237 ) 266 (63 ) Interest and dividend income from trading securities 342 287 207 Net investment income (loss) from trading securities $ 105 $ 553 $ 144
Realized Gain (Loss) on Investments	Investment Gains (Losses), Net Investment gains (losses), net including changes in the valuation allowances and OTTI are as follows: Years ended December, 31 2018 2017 2016 (in millions) Fixed maturities $ (75 ) $ (194 ) $ 83 Mortgage loans on real estate — 2 (2 ) Real estate held for the production of income — — 1,880 Other equity investments — 2 (2 ) Other (11 ) (1 ) 24 Investment gains (losses), net $ (86 ) $ (191 ) $ 1,983

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Information regarding goodwill by reporting segment and Corporate and Other is as follows: Individual Retirement Group Retirement Protection Solutions Corporate and Other Subtotal Investment Management and Research Total (in millions) 2016 Goodwill, beginning of year $ 53 $ 122 $ 139 $ 55 $ 369 $ 4,548 $ 4,917 Goodwill acquired during year — — — — — 22 22 Impairment losses recognized during the year — — — — — — — Goodwill, end of year, net $ 53 $ 122 $ 139 $ 55 $ 369 $ 4,570 $ 4,939 2017 Goodwill acquired during year $ — — — — — — — Impairment losses recognized during the year (53 ) (122 ) (139 ) (55 ) (369 ) — (369 ) Goodwill, end of year, net $ — $ — $ — $ — $ — $ 4,570 $ 4,570 2018 Goodwill acquired during year $ — $ — $ — $ — $ — $ — $ — Impairment losses recognized during the year — — — — — — — Goodwill, end of year, net $ — $ — $ — $ — $ — $ 4,570 $ 4,570

CLOSED BLOCK (Tables)

CLOSED BLOCK (Tables)	12 Months Ended
	Dec. 31, 2018
Closed Block Disclosure [Abstract]
Schedule of Closed Block Assets and Liabilities	Summarized financial information for the Company’s Closed Block is as follows: As of December 31, 2018 2017 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,709 $ 6,958 Policyholders’ dividend obligation — 19 Other liabilities 47 271 Total Closed Block liabilities 6,756 7,248 Assets Designated To The Closed Block: Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923) 3,672 4,070 Mortgage loans on real estate, net of valuation allowance of $- and $- 1,824 1,720 Policy loans 736 781 Cash and other invested assets 76 351 Other assets 179 182 Total assets designated to the Closed Block 6,487 7,104 Excess of Closed Block liabilities over assets designated to the Closed Block 269 144 Amounts included in Accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders' dividend obligation of $- and $19 8 138 Maximum future income to be recognized from closed block assets and liabilities $ 277 $ 282
Closed Block Operations, Net Results	The Company’s Closed Block revenues and expenses follow : Years ended December 31, 2018 2017 2016 (in millions) Revenues: Premiums and other income $ 194 $ 224 $ 212 Net investment income (loss) 291 314 349 Investment gains (losses), net (3 ) (20 ) (1 ) Total revenues 482 518 560 Benefits and Other Deductions: Policyholders’ benefits and dividends 471 537 522 Other operating costs and expenses 3 2 4 Total benefits and other deductions 474 539 526 Net income, before income taxes 8 (21 ) 34 Income tax (expense) benefit (3 ) (36 ) (12 ) Net income (losses) $ 5 $ (57 ) $ 22
Closed Block Dividend Obligation	A reconciliation of the Company’s policyholders’ dividend obligation follows: December 31, 2018 2017 (in millions) Balance, beginning of year $ 19 $ 52 Unrealized investment gains (losses) (19 ) (33 ) Balance, end of year $ — $ 19

DAC AND POLICYHOLDER BONUS IN_2

DAC AND POLICYHOLDER BONUS INTEREST CREDITS (Tables)	12 Months Ended
	Dec. 31, 2018
Contractholder Bonus Interest Credits [Abstract]
Contractholder Bonus Interest Credits	Changes in the deferred policy acquisition cost asset for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 5,919 $ 6,049 $ 6,047 Capitalization of commissions, sales and issue expenses 701 687 697 Amortization: Impact of assumptions updates and model changes 286 112 (201 ) All other (619 ) (615 ) (578 ) Total amortization (333 ) (503 ) (779 ) Change in unrealized investment gains and losses 458 (314 ) 84 Balance, end of year $ 6,745 $ 5,919 $ 6,049 Changes in the deferred asset for policyholder bonus interest credits for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 473 $ 504 $ 534 Policyholder bonus interest credits deferred 4 7 13 Amortization charged to income (51 ) (38 ) (43 ) Balance, end of year $ 426 $ 473 $ 504

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 28,992 $ 1,186 $ 30,178 U.S. Treasury, government and agency — 13,829 — 13,829 States and political subdivisions — 422 39 461 Foreign governments — 530 — 530 Residential mortgage-backed (2) — 234 — 234 Asset-backed (3) — 82 519 601 Redeemable preferred stock 167 279 — 446 Total fixed maturities, available-for-sale 167 44,368 1,744 46,279 Other equity investments 11 — 74 85 Trading securities 446 15,507 64 16,017 Other invested assets: Short-term investments — 515 — 515 Assets of consolidated VIEs/VOEs 92 259 27 378 Swaps — 426 — 426 Credit default swaps — 17 — 17 Futures (1 ) — — (1 ) Options — 968 — 968 Total other invested assets 91 2,185 27 2,303 Cash equivalents 3,482 — — 3,482 Segregated securities — 1,170 — 1,170 GMIB reinsurance contracts asset — — 1,732 1,732 Separate Accounts assets 106,994 2,747 374 110,115 Total Assets $ 111,191 $ 65,977 $ 4,015 $ 181,183 Level 1 Level 2 Level 3 Total (in millions) Liabilities GMxB derivative features’ liability $ — $ — $ 5,614 $ 5,614 SCS, SIO, MSO and IUL indexed features’ liability — 715 — 715 Liabilities of consolidated VIEs and VOEs — 7 — 7 Contingent payment arrangements — — 7 7 Total Liabilities $ — $ 722 $ 5,621 $ 6,343 ____________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 24,296 $ 1,150 $ 25,446 U.S. Treasury, government and agency — 18,508 — 18,508 States and political subdivisions — 449 40 489 Foreign governments — 419 — 419 Residential mortgage-backed (2) — 818 — 818 Asset-backed (3) — 208 541 749 Redeemable preferred stock 184 327 1 512 Total fixed maturities, available-for-sale 184 45,025 1,732 46,941 Other equity investments 13 — 34 47 Trading securities 485 13,647 38 14,170 Other invested assets Short-term investments — 1,730 — 1,730 Assets of consolidated VIEs/VOEs 1,060 215 27 1,302 Swaps — 222 — 222 Credit default swaps — 33 — 33 Futures (2 ) — — (2 ) Foreign currency contract (4) — 5 — 5 Options — 1,999 — 1,999 Total other invested assets 1,058 4,204 27 5,289 Cash equivalents 3,608 — — 3,608 Segregated securities — 825 — 825 GMIB reinsurance contracts asset — — 1,894 1,894 Separate Accounts assets 121,000 2,997 349 124,346 Total Assets $ 126,348 $ 66,698 $ 4,074 $ 197,120 Liabilities GMxB derivative features’ liability $ — $ — $ 4,451 $ 4,451 SCS, SIO, MSO and IUL indexed features’ liability — 1,786 — 1,786 Liabilities of consolidated VIEs and VOEs 670 22 — 692 Contingent payment arrangements — — 15 15 Total Liabilities $ 670 $ 1,808 $ 4,466 $ 6,944 ___________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Reported in Other assets in the consolidated balance sheets.
Reconciliation of Assets and Liabilities at Level 3	Level 3 Instruments Fair Value Measurements Corporate State and Foreign Commercial Asset- (in millions) Balance, January 1, 2018 $ 1,150 $ 40 $ — $ — $ 541 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 8 — — — — Investment gains (losses), net (9 ) — — — — Subtotal (1 ) — — — — Other comprehensive income (loss) (21 ) (1 ) — — (9 ) Purchases 334 — — — 17 Sales (337 ) (1 ) — — (30 ) Transfers into Level 3 (1) 89 1 — — — Transfers out of Level 3 (1) (28 ) — — — — Balance, December 31, 2018 $ 1,186 $ 39 $ — $ — $ 519 Balance, January 1, 2017 $ 857 $ 42 $ — $ 373 $ 120 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 4 — — (2 ) — Investment gains (losses), net 1 — — (95 ) 15 Subtotal 5 — — (97 ) 15 Other comprehensive income (loss) 4 (1 ) — 78 (7 ) Purchases 615 — — — 434 Sales (333 ) (1 ) — (354 ) (21 ) Transfers into Level 3 (1) 7 — — — — Transfers out of Level 3 (1) (5 ) — — — — Balance, December 31, 2017 $ 1,150 $ 40 $ — $ — $ 541 Balance, January 1, 2016 $ 430 $ 45 $ 1 $ 535 $ 41 Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net 2 — — (71 ) — Other comprehensive income (loss) 8 (2 ) — 14 1 Purchases 574 — — — 96 Sales (144 ) (1 ) — (91 ) (9 ) Transfers into Level 3 (1) 25 — — — — Transfers out of Level 3 (1) (38 ) — (1 ) (14 ) (9 ) Balance, December 31, 2016 $ 857 $ 42 $ — $ 373 $ 120 Redeem- able Preferred Stock Other Equity Invest- ments GMIB Reinsur- ance Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrange- ment (in millions) Balance, January 1, 2018 $ 1 $ 99 $ 1,894 $ 349 $ (4,451 ) $ (15 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — (3 ) — 26 — — Net derivative gains (losses), excluding non-performance risk — — (131 ) — (1,272 ) — Non-performance risk (5) — — (33 ) — 497 — Subtotal — (3 ) (164 ) 26 (775 ) — Other comprehensive income (loss) — 15 — — — — Purchases (2) — 62 46 5 (412 ) — Sales (3) (1 ) (3 ) (44 ) (1 ) 24 — Settlements (4) — — — (5 ) — 6 Change in estimate — — — — — 2 Activity related to consolidated VIEs/VOEs — (6 ) — — — — Transfers into Level 3 (1) — 6 — — — — Transfers out of Level 3 (1) — (5 ) — — — — Balance, December 31, 2018 $ — $ 165 $ 1,732 $ 374 $ (5,614 ) $ (7 ) Balance, January 1, 2017 $ 1 $ 88 $ 1,735 $ 313 $ (5,731 ) $ (25 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 29 — — Net derivative gains (losses), excluding non-performance risk — — 171 — 1,809 — Non-performance risk (5) — — 3 — (157 ) — Subtotal — — 174 29 1,652 — Other comprehensive income(loss) — 14 — — — — Purchases (2) — 22 48 13 (393 ) — Sales (3) — (3 ) (63 ) (2 ) 21 — Settlements (4) — — — (4 ) — 10 Activity related to consolidated VIEs/VOEs — (22 ) — — — — Transfers into Level 3 (1) — — — — — — Transfers out of Level 3 (1) — — — — — — Balance, December 31, 2017 $ 1 $ 99 $ 1,894 $ 349 $ (4,451 ) $ (15 ) Redeem- able Preferred Stock Other Equity Invest- ments GMIB Reinsur- ance Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrange- ment (in millions) Balance, January 1, 2016 $ — $ 81 $ 1,829 $ 313 $ (5,534 ) $ (31 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 19 — — Net derivative gains (losses), excluding non-performance risk — — (75 ) — 417 — Non-performance risk (5) — — (2 ) — (281 ) — Subtotal — — (77 ) 19 136 — Other comprehensive income (loss) — (1 ) — — — — Purchases (2) 1 4 48 10 (356 ) (18 ) Sales (3) — — (65 ) — 23 — Activity related to consolidated VIEs/VOEs — 60 — (7 ) — 24 Transfers into Level 3 (1) — — — 1 — — Transfers out of Level 3 (1) — (56 ) — (23 ) — — Balance, December 31, 2016 $ 1 $ 88 $ 1,735 $ 313 $ (5,731 ) $ (25 ) ___________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) For contingent payment arrangements, it represents payments under the arrangement. (5) The Company’s non-performance risk is recorded through Net derivative gains (losses). The table below details changes in unrealized gains (losses) for 2018 , 2017 and 2016 by category for Level 3 assets and liabilities still held at December 31, 2018 , 2017 and 2016 respectively. Earnings (Loss) Investment Gains Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ (19 ) State and political subdivisions — — (1 ) Commercial mortgage-backed — — — Asset-backed — — (6 ) Subtotal — — (26 ) GMIB reinsurance contracts — (164 ) — Separate Accounts assets (1) 26 — — GMxB derivative features liability — (775 ) — Total $ 26 $ (939 ) $ (26 ) Earnings (Loss) Investment Gains Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2017: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 5 State and political subdivisions — — (1 ) Commercial mortgage-backed — — — Asset-backed — — 1 Subtotal — — 5 GMIB reinsurance contracts — 174 — Separate Accounts assets (1) 29 — — GMxB derivative features liability — 1,652 — Total $ 29 $ 1,826 $ 5 Held as of December 31, 2016: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 11 State and political subdivisions — — (2 ) Commercial mortgage-backed — — 10 Asset-backed — — 1 Subtotal — — 20 GMIB reinsurance contracts — (77 ) — Separate Accounts assets (1) 20 — — GMxB derivative features liability — 136 — Total $ 20 $ 59 $ 20 ______________ (1) There is an investment expense that offsets this investment gain (loss).
Quantitative Information About Level 3 Fair Value Measurement	The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of December 31, 2018 and 2017 , respectively. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 99 Matrix pricing model Spread over Benchmark 15 - 580 bps 109 bps 881 Market EBITDA multiples 4.1x - 37.8x 12.1x Other equity investments 35 Discounted cash flow Earnings multiple 9.4x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve Discount factor 248bps GMIB reinsurance contract asset 1,732 Discounted cash flow Lapse rates 1% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk 189 bps Assumed GMIB Reinsurance Contracts 183 Discounted cash flow Lapse rates 1.1% - 11.2% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 0.5% - 11.0% Quantitative Information about Level 3 Fair Value Measurements at December 31, 2017 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 53 Matrix pricing model Spread over the industry-specific benchmark yield curve 0 bps-565 bps 125 bps 789 Market comparable companies EBITDA multiples 5.3x - 27.9x 12.9x Other equity investments 38 Discounted cash flow Earnings multiple 10.8x Separate Accounts assets 326 Third party appraisal Capitalization rate 4.6% 1 Discounted cash flow Spread over U.S. Treasury curve 243 bps GMIB reinsurance contract asset 1,894 Discounted Cash flow Lapse rates 1.0% - 6.3% Liabilities: GMIBNLG 4,149 Discounted cash flow Non-performance risk 1.0% Assumed GMIB Reinsurance Contracts 194 Discounted cash flow Lapse rates 1.1% - 13.3% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.9% - 5.7% GIB (27 ) Discounted cash flow Lapse rates 0.9% - 5.7% GMAB 5 Discounted cash flow Lapse rates 0.5% - 11.0%
Fair Value Disclosure Financial Instruments Not Carried At Fair Value	The carrying values and fair values at December 31, 2018 and 2017 for financial instruments not otherwise disclosed in Note 3 are presented in the table below. Carrying Fair Value Level 1 Level 2 Level 3 Total (in millions) December 31, 2018: Mortgage loans on real estate $ 11,835 $ — $ — $ 11,494 $ 11,494 Policyholders’ liabilities: Investment contracts 2,127 — — 2,174 2,174 FHLBNY funding agreements 4,002 — 3,956 — 3,956 Short-term and long-term debt 4,955 — 4,749 — 4,749 Policy loans 3,779 — — 4,183 4,183 Separate Accounts liabilities 7,406 — — 7,406 7,406 December 31, 2017: Mortgage loans on real estate $ 10,952 $ — $ — $ 10,912 $ 10,912 Loans to affiliates 1,230 — 1,230 — 1,230 Policyholders’ liabilities: Investment contracts 2,224 — — 2,329 2,329 FHLBNY funding agreements 3,014 — 3,020 — 3,020 Short-term and long-term debt 2,408 — 2,500 — 2,500 Loans from affiliates 3,622 — 3,622 — 3,622 Policy loans 3,819 — — 4,754 4,754 Separate Accounts liabilities 7,537 — — 7,537 7,537

INSURANCE LIABILITIES (Tables)

INSURANCE LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Variable Annuity Contracts- GMDB GMIB	ariable annuity contracts with GMDB and GMIB features and no GMIBNLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No GMIBNLG Feature For the Years ended December 31, 2018 , 2017 and 2016 GMDB GMIB Direct Assumed Ceded Direct Assumed Ceded (in millions) Balance at January 1, 2016 $ 2,969 $ 135 $ (98 ) $ 3,842 $ 268 $ (1,829 ) Paid guarantee benefits (357 ) (33 ) 15 (281 ) (20 ) 65 Other changes in reserve 552 19 (7 ) 241 10 27 Balance at December 31, 2016 3,164 121 (90 ) 3,802 258 (1,737 ) Paid guarantee benefits (354 ) (21 ) 14 (151 ) (59 ) 63 Other changes in reserve 1,249 (5 ) (32 ) 1,101 (4 ) (220 ) Balance at December 31, 2017 4,059 95 (108 ) 4,752 195 (1,894 ) Paid guarantee benefits (393 ) (24 ) 16 (153 ) (12 ) 44 Other changes in reserve 993 11 (21 ) (856 ) 1 118 Balance at December 31, 2018 $ 4,659 $ 82 $ (113 ) $ 3,743 $ 184 $ (1,732 )
Guaranteed Minimum Death Benefit Reinsurance Ceded	The liability for the GMxB derivative features liability, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7 .
Schedule of Net Amount of Risk by Product and Guarantee	direct and assumed variable annuity contracts in force with GMDB and GMIB features as of December 31, 2018 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features As of December 31, 2018 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,035 $ 102 $ 61 $ 184 $ 14,382 Separate Accounts 41,463 8,382 2,903 30,406 83,154 Total Account Values $ 55,498 $ 8,484 $ 2,964 $ 30,590 $ 97,536 Net Amount at Risk, gross $ 418 $ 791 $ 2,291 $ 20,587 $ 24,087 Net Amount at Risk, net of amounts reinsured $ 418 $ 772 $ 1,615 $ 20,587 $ 23,392 Average attained age of policyholders (in years) 51.4 67.0 73.6 69.0 55.3 Percentage of policyholders over age 70 10.0 % 43.0 % 65.5 % 49.9 % 18.8 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 251 $ 270 Separate Accounts — — 19,407 33,428 52,835 Total Account Values $ — $ — $ 19,426 $ 33,679 $ 53,105 Net Amount at Risk, gross $ — $ — $ 994 $ 9,156 $ 10,150 Net Amount at Risk, net of amounts reinsured $ — $ — $ 309 $ 8,268 $ 8,577 Average attained age of policyholders (in years) N/A N/A 68.9 68.8 68.8 Weighted average years remaining until annuitization N/A N/A 1.7 0.5 0.6 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5%
Schedule of Fair Value of Separate Accounts by Major Category of Investment	Investment in Variable Insurance Trust Mutual Funds As of December 31, 2018 2017 GMDB GMIB GMDB GMIB (in millions) Investment type: Equity $ 35,541 $ 15,759 $ 41,658 $ 19,676 Fixed income 5,173 2,812 5,469 3,110 Balanced 41,588 33,974 46,577 38,398 Other 852 290 968 314 Total $ 83,154 $ 52,835 $ 94,672 $ 61,498
No Lapse Guarantee Liabilities	The change in the liabilities for GMIBNLG liabilities, reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below. Direct Liability (1) (in millions) Balance at January 1, 2016 $ 1,247 Other changes in reserves 64 Balance at December 31, 2016 1,311 Paid guarantee benefits (24 ) Other changes in reserves (578 ) Balance at December 31, 2017 709 Paid guarantee benefits (23 ) Other changes in reserves 126 Balance at December 31, 2018 $ 812 __________ (1) There were no amounts of reinsurance ceded in any period presented.

REINSURANCE AGREEMENTS (Tables)

REINSURANCE AGREEMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Reinsurance Disclosures [Abstract]
Schedule Of Effect Of Reinsurance	The following table summarizes the effect of reinsurance: Years Ended December 31, 2018 2017 2016 (in millions) Direct premiums $ 1,012 $ 1,038 $ 998 Reinsurance assumed 214 225 231 Reinsurance ceded (132 ) (139 ) (146 ) Net premiums $ 1,094 $ 1,124 $ 1,083 Policy charges and fee income ceded $ 418 $ 381 $ 393 Policyholders’ benefits ceded $ 580 $ 657 $ 871 Interest credited to policyholders’ account balances ceded $ 50 $ 46 $ 51

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenues Recognized, Disaggregated by Category	The table below presents the revenues recognized for the years ended December 31, 2018 , 2017 and 2016 , disaggregated by category: Years ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 2,877 $ 2,730 $ 2,487 Performance-based fees 118 95 33 Research services 439 450 480 Distribution services 723 701 651 Shareholder services 76 75 78 Other 19 18 17 Total investment management and service fees $ 4,252 $ 4,069 $ 3,746 Other income $ 479 $ 423 $ 385

SHORT-TERM AND LONG-TERM DEBT (

SHORT-TERM AND LONG-TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Short-term and Long-term Debt	Short-term and long-term debt consists of the following: As of December 31, 2018 2017 (in millions) Short-term debt: AB revolving credit facility (with interest rates of 3.4% and 2.4%) $ 25 $ 75 AB commercial paper (with interest rates of 2.7% and 1.6%) 521 491 AXA Financial commercial paper — 1,291 Total short-term debt 546 1,857 Long-term debt: Senior Notes (5.0%, due 2048) 1,480 — Senior Notes (4.35%, due 2028) 1,486 — Senior Notes (3.9%, due 2023) 794 — Delayed Draw Term Loan (one-month LIBOR + 1.125%, due 2021) 300 — Senior Debentures, 7.0%, due 2028 349 349 AXA Equitable non-recourse mortgage debt (with interest rate of 4.1%) — 82 AXA Equitable non-recourse mortgage debt (with interest rate of 3.9%) — 120 Total long-term debt 4,409 551 Total short-term and long-term debt $ 4,955 $ 2,408

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Investment Management and Related Services Provided by AB to Related Mutual Funds AB provides investment management and related services to mutual funds sponsored by AB. Revenues earned by AB from providing these services were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Investment management and services fees $ 1,207 $ 1,148 $ 999 Distribution revenues 404 398 372 Other revenues - shareholder servicing fees 74 73 76 Other revenues - other 7 7 6 Total $ 1,692 $ 1,626 $ 1,453 Loans to AXA Affiliates As of December 31, 2018 2017 (in millions) Loans to Affiliates: Loans to AXA: 2007 Senior Unsecured Note, 5.7%, due 2020 $ — $ 700 2008 Senior Unsecured Note, 5.4%, due 2020 — 200 Unsecured Loan to AXA IM Holding US, three-month LIBOR +1.5%, due 2025 — 185 Unsecured Loan to Colisée Re. 4.75%, due 2028 — 145 Total Loans to Affiliates $ — $ 1,230 The table below summarizes the expenses reimbursed to/from the Company and the fees received/paid by the Company in connection with certain services described above for the years ended December 31, 2018 , 2017 and 2016 . Years Ended December 31, 2018 2017 2016 (in millions) Expenses paid or accrued for: General services provided by AXA affiliates $ 146 $ 141 $ 118 Investment management services provided by AXA IM, AXA REIM, and AXA Rosenberg 2 5 15 Investment management services provided by AXA Strategic Ventures Corporation (“ASV Corp”) 2 2 2 Guarantees and credit facility 1 9 12 Total $ 151 $ 157 $ 147 Revenue received or accrued for: Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts $ 727 $ 720 $ 674 General services provided to AXA affiliates 6 27 29 Total $ 733 $ 747 $ 703 Loans from AXA Affiliates As of December 31, 2018 2017 (in millions) Loans from Affiliates: AXA S.A. term loan, three- month LIBOR +1.06%, due 2024 $ — $ 1,007 AXA Japan Subordinated Notes, floating rate of LIBOR +1.20%, due 2020 — 770 AXA Belgium €300 million EURIBOR +0.06%, due 2018 — 391 AXA S.A. loan, LIBOR + 1.44%, due 2022 — 366 Coliseum Reinsurance Company, 4.75%, due 2028 — 387 AXA America Corporate Solutions, Inc., 1.85%, due 2018 — 110 Foreign Exchange impact of AXA Belgium loan — (31 ) AXA S.A. loan, LIBOR + 0.439%, due 2018 — 622 Total Loans From Affiliates $ — $ 3,622

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs	Components of net post-employment benefits costs follow: Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 2 $ 2 $ 2 Interest cost — — — Net amortization (1 ) (2 ) — Net periodic post-employment benefits costs $ 1 $ — $ 2 Components of Net Post-retirement Benefits Costs Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 2 $ 2 $ 2 Interest cost 16 16 16 Net amortization 9 6 7 Net Periodic Post-Retirement Benefits Costs $ 27 $ 24 $ 25 Components of net periodic pension expense for the Company’s qualified and non-qualified plans were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Service cost $ 8 $ 10 $ 11 Interest cost 103 105 108 Expected return on assets (163 ) (173 ) (177 ) Actuarial (gain) loss 1 1 1 Net amortization 98 126 133 Impact of settlement 109 — — Net periodic pension expense $ 156 $ 69 $ 76
Schedule of Accumulated and Projected Benefit Obligations	Changes in the accumulated benefits obligation of the Company’s post-retirement plans recognized in the accompanying consolidated financial statements are described in the following table: Accumulated Post-Retirement Benefits Obligation December 31, 2018 2017 (in millions) Accumulated post-retirement benefits obligation, beginning of year $ 537 $ 539 Service cost 2 2 Interest cost 16 16 Contributions and benefits paid (46 ) (38 ) Actuarial (gains) losses (18 ) 18 Accumulated post-retirement benefits obligation, end of year $ 491 $ 537 Changes in the PBO of the Company’s qualified and non-qualified plans were comprised of: 2018 2017 (in millions) Projected benefit obligation, beginning of year $ 3,455 $ 3,442 Service cost — — Interest cost 103 105 Actuarial (gains)/losses (1) (204 ) 144 Benefits paid (190 ) (236 ) Plan amendments and curtailments — — Settlements (290 ) — Projected benefit obligation, end of year $ 2,874 $ 3,455 _____________ (1) Actuarial gains and losses are a product of changes in the discount rate as shown below. The following table discloses the change in plan assets and the funded status of the Company’s qualified pension plans and non-qualified pension plans: 2018 2017 (in millions) Pension plan assets at fair value, beginning of year $ 2,839 $ 2,679 Actual return on plan assets (53 ) 357 Contributions 5 4 Benefits paid (184 ) (201 ) Annuity purchases (266 ) — Pension plan assets at fair value, end of year 2,341 2,839 PBO 2,874 3,455 Excess of PBO over pension plan assets, end of year $ (533 ) $ (616 )
Schedule of Health Care Cost Trend Rates	Assumed Healthcare Cost Trend Rates used to Measure the Expected Cost of Benefits December 31, 2018 2017 Following year 10.2% 6.9% Ultimate rate to which cost increase is assumed to decline 4.3% 4.2% Year in which the ultimate trend rate is reached 2099 2097
Schedule of Net Periodic Benefit Cost Not yet Recognized	The following table discloses the amounts included in AOCI at December 31, 2018 and 2017 that have not yet been recognized as components of net periodic post-retirement benefits cost: December 31, 2018 2017 (in millions) Unrecognized net actuarial (gains) losses $ 116 $ 143 Unrecognized prior service (credit) — — Total $ 116 $ 143 The following table discloses the amounts included in AOCI at December 31, 2018 and 2017 that have not yet been recognized as components of net periodic pension cost. As of December 31, 2018 2017 (in millions) Unrecognized net actuarial (gain) loss $ 1,123 $ 1,315 Unrecognized prior service cost (credit) 1 1 Total $ 1,124 $ 1,316
Schedule of Allocation of Plan Assets	The following table discloses the allocation of the fair value of total qualified pension plan assets at December 31, 2018 and 2017 : As of December 31, 2018 2017 Fixed maturities 50.3 % 46.2 % Equity securities 22.9 33.9 Equity real estate 17.7 13.9 Cash and short-term investments 3.4 1.4 Other 5.7 4.6 Total 100.0 % 100.0 %
Schedule of Fair Values of Plan Assets Within Fair Value Hierarchy	The following tables disclose the fair values of qualified pension plan assets and their level of observability within the fair value hierarchy at December 31, 2018 and 2017 , respectively. Level 1 Level 2 Level 3 Total (in millions) December 31, 2018: Fixed Maturities: Corporate $ — $ 677 $ — $ 677 U.S. Treasury, government and agency — 467 — 467 States and political subdivisions — 23 — 23 Foreign governments — 2 — 2 Commercial mortgage-backed — — 1 1 Common and preferred equity 424 78 — 502 Mutual funds 53 — — 53 Private real estate investment trusts 1 — — 1 Cash and cash equivalents 34 — — 34 Short-term investments — 22 — 22 Total assets in the fair value hierarchy 512 1,269 1 1,782 Investments measured at Net Asset Value — — — 559 Investments at fair value $ 512 $ 1,269 $ 1 $ 2,341 Level 1 Level 2 Level 3 Total (in millions) December 31, 2017: Fixed Maturities: Corporate $ — $ 792 $ 2 $ 794 U.S. Treasury, government and agency — 471 — 471 States and political subdivisions — 26 — 26 Foreign governments — 5 — 5 Commercial mortgage-backed — — 1 1 Common and preferred equity 730 98 — 828 Mutual funds 99 — — 99 Commercial paper — 44 — 44 Private real estate investment trusts 2 — — 2 Cash and cash equivalents 12 — — 12 Short-term investments — 27 — 27 Total assets in the fair value hierarchy 843 1,463 3 2,309 Investments measured at Net Asset Value — — — 530 Investments at fair value $ 843 $ 1,463 $ 3 $ 2,839
Effects of Practical Expedient Application	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09 This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. Adoption did not change the amounts or timing of the Company’s revenue recognition for base investment management and advisory fees, distribution revenues, shareholder servicing revenues or broker-dealer revenues. Some performance-based fees and carried-interest distributions that were recognized prior to adoption when no risk of reversal remained, in certain instances may now be recognized earlier if it is probable that significant reversal will not occur. Description Effect on the Financial Statement or Other Significant Matters ASU 2016-01 This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in a reclassification adjustment of $7 million from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $46 million common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15 Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07 This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09 This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02 Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by increasing AOCI and decreasing retained earnings by $89 million. ASU 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018, the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17 Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13 This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12 This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. ASU 2018-07 Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2017-12 The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02 This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company will adopt ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $750 million to $850 million and operating lease liabilities ranging from $950 million to $1.1 billion, respectively, for operating leases. The adoption of this standard will not have a significant impact on opening retained earnings. The reclassification adjustments for the years ended December 31, 2017 and 2016 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and distribution plan payments, and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item. Years Ended December 31, 2017 2016 Individual Retirement Group Retirement Protection Solutions Consoli- dated Individual Retirement Group Retirement Protection Solutions Consoli- dated (in millions) Reductions to expense line items: Compensation and benefits $ 71 $ 30 $ 56 $ 157 $ 72 $ 28 $ 54 $ 154 Commissions and distribution plan payments 328 55 140 523 347 54 135 537 Other operating costs and expenses 2 1 4 7 2 — 4 6 Total reductions $ 401 $ 86 $ 200 $ 687 $ 421 $ 82 $ 193 $ 697 Increase to expense line item: Amortization of deferred policy acquisition costs $ 401 $ 86 $ 200 $ 687 $ 421 $ 82 $ 193 $ 697 The following table lists investments for which net asset value (“NAV”) is calculated; NAV is used as a practical expedient to determine the fair value of these investments at December 31, 2018 and 2017 . Practical Expedient Disclosure as of December 31, 2018 and 2017 Investment Fair Value Redemption Frequency (If currently eligible) Redemption Notice Period Unfunded Commitments (in millions) December 31, 2018: Private Equity Fund $ 64 N/A (1)(2) N/A $ 33 Private Real Estate Investment Trust 402 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 12 Total $ 559 December 31, 2017: Private Equity Fund $ 61 N/A (1)(2) N/A $ 29 Private Real Estate Investment Trust 376 Quarterly One Quarter — Hedge Fund 93 Calendar Quarters (3) Previous Quarter End $ 34 Total $ 530 ______________ (1) Cannot sell or transfer ownership interest without prior written consent to transfer, and by meeting several criteria (e.g., does not adversely affect other investors). (2) Cannot sell interest in the vehicle without prior written consent of the managing member. (3) March, June, September and December.
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets	The table below presents a reconciliation for all Level 3 fair values of qualified pension plan assets at December 31, 2018 , 2017 and 2016 , respectively: Level 3 Instruments Fair Value Measurements Private Real Estate Investment Trusts Other Equity Investments Fixed Maturities Total (in millions) Balance, January 1, 2018 $ — $ — $ 3 $ 3 Actual return on plan assets: Relating to assets still held at December 31, 2018 — — — — Relating to assets sold during 2018 — — — — Purchases/Issues — — — — Sales/Settlements — — (1 ) (1 ) Transfers into/out of Level 3 — — — — Balance, December 31, 2018 $ — $ — $ 2 $ 2 Balance, January 1, 2017 $ — $ — $ 5 $ 5 Actual return on plan assets: Relating to assets still held at December 31, 2017 — — — — Relating to assets sold during 2017 — — — — Purchases/Issues — — — — Sales/Settlements — — (2 ) (2 ) Transfers into/out of Level 3 — — — — Balance, December 31, 2017 $ — $ — $ 3 $ 3 Balance, January 1, 2016 $ — $ — $ 8 $ 8 Actual return on plan assets: Relating to assets still held at December 31, 2016 — — — — Relating to assets sold during 2016 — — — — Purchases/Issues — — — — Sales/Settlements — — (1 ) (1 ) Transfers into/out of Level 3 — — (2 ) (2 ) Balance, December 31, 2016 $ — $ — $ 5 $ 5
Schedule of Assumptions Used	The following table discloses assumptions used to measure the Company’s pension benefit obligations and net periodic pension cost at and for the years ended December 31, 2018 and 2017 . As of December 31, 2018 2017 Discount rates: AXA Equitable Life QP 4.07% 3.4% AXA Equitable Excess Retirement Plan 4.01% 3.32% MONY Life Retirement Income Security Plan for Employees 4.2% 3.5% AB Qualified Retirement Plan 3.9% 4.55% Other defined benefit plans 3.75%-4.10% 3.00%-3.43% Periodic cost 3.00%-3.50% 3.17%-3.98% Cash balance interest crediting rate for pre-April 1, 2012 accruals 4.00% 4.00% Cash balance interest crediting rate for post-April 1, 2012 accruals 2.50% 1.25% Rates of compensation increase: Benefit obligation 5.99% 5.99% Periodic cost 6.34% 6.38% Expected long-term rates of return on pension plan assets (periodic cost) 6.75% 6.75% The assumed discount rates for measuring the post-retirement benefit obligations at December 31, 2018 and 2017 were determined in substantially the same manner as described above for measuring the pension benefit obligations. The following table discloses the range of discrete single equivalent discount rates and related net periodic cost at and for the years ended December 31, 2018 and 2017 . December 31, 2018 2017 Discount rates: Benefit obligation 3.52%-3.89% 2.80%-3.52% Periodic cost 3.00%-3.50% 3.17%-3.98%
Schedule of Expected Benefit Payments	The following table provides an estimate of future benefits expected to be paid in each of the next five years, beginning January 1, 2019 , and in the aggregate fr the five years thereafter. These estimates are based on the same assumptions used to measure the respective benefit obligations at December 31, 2018 and include benefits attributable to estimated future employee service. Postretirement Benefits Health Pension Benefits Life Insurance Gross Estimate Payment Estimated Medicare Part D Subsidy Net Estimate Payment (in millions) 2019 $ 221 $ 26 $ 16 $ 3 $ 13 2020 223 26 15 3 12 2021 220 26 14 3 11 2022 216 25 13 3 10 2023 209 25 12 3 9 Years 2024-2028 2,926 541 100 9 91

SHARE-BASED AND OTHER COMPENSAT

SHARE-BASED AND OTHER COMPENSATION PROGRAMS (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of compensation costs	Compensation costs for 2018 , 2017 and 2016 for share-based payment arrangements as further described herein are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Performance Shares (1) $ 11 $ 45 $ 37 Stock Options 2 1 1 AXA Shareplan — 13 19 Restricted Stock Unit Awards (2) 215 185 154 Other Compensation Plans (3) — 3 2 Total Compensation Expenses $ 228 $ 247 $ 213 ________________ (1) Reflects change to performance share retirement rules. Specifically, individuals who retire at any time after the grant date will continue to vest in their 2017 performance shares while individuals who retire prior to March 1, 2019 will forfeit all 2018 performance shares. (2) Reflects a $24 million adjustment for awards in 2018 with graded vesting, service-only conditions from the graded to the straight-line attribution method. (3) Includes stock appreciation rights and employee stock purchase plans.
Summary of stock option activity	A summary of activity in the AXA and the Company option plans during 2018 follows: Options Outstanding EQH Shares AB Holding Units AXA Ordinary Shares AXA ADRs (2) Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Number Weighted Number Weighted Options Outstanding at January 1, 2018 — $ — 3,082 $ 52.37 5,402 € 17.36 35 $ 20.98 Options granted 1,035 $ 21.34 — $ — — € — — $ — Options exercised — $ — (889 ) $ 18.66 (565 ) € 11.80 — $ — Options forfeited, net (41 ) $ 21.34 — $ — — € — — $ — Options expired — $ — (1,522 ) $ 85.09 (1,225 ) € 17.45 (10 ) $ 35.25 Options Outstanding at December 31, 2018 994 $ 21.34 671 $ 22.83 3,612 € 18.20 25 $ 15.37 Aggregate Intrinsic Value (1) $ — $ 3 € 2,383 $ 151 Weighted Average Remaining Contractual Term (in years) 9.16 1.60 4.50 0.58 Options Exercisable at December 31, 2018 — $ — 635 $ 22.84 2,147 € 15.27 25 $ 15.37 Aggregate Intrinsic Value (1) $ — $ 3 € 7,698 $ 151 Weighted Average Remaining Contractual Term (in years) — 1.50 2.45 0.58 __________ (1) Aggregate intrinsic value, presented in thousands, is calculated as the excess of the closing market price on December 31, 2018 of the respective underlying shares over the strike prices of the option awards. For awards with strike prices higher then market prices, intrinsic value is shown as zero. (2) AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity.
Schedule of share-based payment award, valuation assumptions	EQH Shares AB Holding Units (1) AXA Ordinary Shares (2) 2018 2018 2017 2016 2018 2017 2016 Dividend yield 2.44 % NA NA 7.10 % NA 6.53 % 6.50 % Expected volatility 25.40 % NA NA 31.00 % NA 25.05 % 26.6 % Risk-free interest rates 2.83 % NA NA 1.30 % NA 0.59 % 0.33 % Expected life in years 9.7 NA NA 6.0 NA 8.8 8.1 Weighted average fair value per option at grant date $ 4.61 NA NA $ 2.75 NA $ 2.01 $ 2.06 _____________ (1) There were no options to buy AB Holding Units awarded during 2018 and 2017. As such, the input assumptions for 2018 and 2017 are not applicable. (2) There were no options to buy AXA Ordinary Shares awarded during 2018. As such, the input assumptions for 2018 are not applicable.
Schedule of share-based compensation, restricted stock units award activity	The following table summarizes restricted Holdings share and AXA ordinary share activity for 2018 . Shares of Holdings Restricted Stock Weighted Average Grant Date Fair Value Shares of AXA Restricted Stock Weighted Average Grant Date Fair Value Unvested as of January 1, 2018 — $ — 93,720 $ 21.07 Granted 2,877,011 $ 20.83 — $ — Cancelled 92,526 $ 21.21 208 $ 26.64 Vested 511,575 $ 21.09 39,528 $ 21.99 Unvested as of December 31, 2018 2,272,910 $ 21.00 53,984 $ 20.38

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Summary of income tax expense (benefit)	A summary of the income tax (expense) benefit in the consolidated statements of income (loss) follows: Years Ended December 31, 2018 2017 2016 (in millions) Income tax (expense) benefit: Current (expense) benefit $ 508 $ 119 $ (169 ) Deferred (expense) benefit (815 ) (168 ) (209 ) Total $ (307 ) $ (49 ) $ (378 )
Schedule of effective income tax rate reconciliation	The sources of the difference and their tax effects are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Expected income tax (expense) benefit $ (516 ) $ (457 ) $ (710 ) Noncontrolling interest 54 138 125 Non-taxable investment income (loss) 105 255 177 Tax audit interest (22 ) (14 ) (32 ) State income taxes (18 ) (16 ) (108 ) Tax settlements/uncertain tax position release — 228 181 Change in tax law 104 (32 ) — Intangibles (3 ) (138 ) (9 ) Other (11 ) (13 ) (2 ) Income tax (expense) benefit $ (307 ) $ (49 ) $ (378 )
Schedule of net deferred income taxes	The components of the net deferred income taxes are as follows: As of December 31, 2018 2017 Assets Liabilities Assets Liabilities (in millions) Compensation and related benefits $ 312 $ — $ 328 $ — Net operating loss 90 — 35 — Reserves and reinsurance 321 — 1,460 — DAC — 1,175 — 850 Unrealized investment gains (losses) 108 — — 373 Investments 124 — — 891 Tax credits 149 — 528 — Other — 208 170 — Total $ 1,104 $ 1,383 $ 2,521 $ 2,114
Unrecognized tax benefits reconciliation	A reconciliation of unrecognized tax benefits (excluding interest and penalties) follows: 2018 2017 2016 (in millions) Balance at January 1, $ 477 $ 729 $ 802 Additions for tax positions of prior years 91 28 99 Reductions for tax positions of prior years (29 ) (247 ) (172 ) Additions for tax positions of current year — — — Settlements with tax authorities — (33 ) — Balance at December 31, $ 539 $ 477 $ 729 Unrecognized tax benefits that, if recognized, would impact the effective rate $ 407 $ 317 $ 485

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances for the past three years follow: December 31, 2018 2017 2016 (in millions) Unrealized gains (losses) on investments (1) (3) $ (394 ) $ 830 $ 140 Defined benefit pension plans (2) (968 ) (955 ) (1,055 ) Foreign currency translation adjustments (72 ) (35 ) (77 ) Total accumulated other comprehensive income (loss) (1,434 ) (160 ) (992 ) Less: Accumulated other comprehensive (income) loss attributable to the noncontrolling interest 38 52 71 Accumulated other comprehensive income (loss) attributable to Holdings $ (1,396 ) $ (108 ) $ (921 ) ______________ (1) 2018 includes a $113 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (2) 2018 includes a $202 million increase to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (3) 2018 includes a $ 7 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2016-01.
Comprehensive Income (Loss)	The components of OCI for the past three years, net of tax, follow: Years Ended December 31, 2018 2017 2016 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the year $ (1,952 ) $ 910 $ (227 ) (Gains) losses reclassified into net income (loss) during the year (1) 60 10 (55 ) Net unrealized gains (losses) on investments (1,892 ) 920 (282 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other 563 (230 ) 8 Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(356), $262 and $(164)) (1,329 ) 690 (274 ) Change in defined benefit plans: Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost (2) 189 100 34 Change in defined benefit plans (net of deferred income tax expense (benefit) of $50, $51 and $19) 189 100 34 Foreign currency translation adjustments: Foreign currency translation gains (losses) arising during the year (37 ) $ 42 $ (18 ) (Gains) losses reclassified into net income (loss) during the year — — — Foreign currency translation adjustment (37 ) 42 (18 ) Total other comprehensive income (loss), net of income taxes (1,177 ) 832 (258 ) Less: Other comprehensive (income) loss attributable to noncontrolling interest (15 ) (19 ) 14 Other comprehensive income (loss) attributable to Holdings $ (1,192 ) $ 813 $ (244 ) ______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $13 million , $5 million and $29 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. (2) These AOCI components are included in the computation of net periodic costs (see “Employee Benefit Plans” in Note 13 ).

COMMITMENTS AND CONTINGENT LI_2

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Schedule of Maturities of Long-term Debt	The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2018: Calendar Year 2020 2021 2022 2023 2024 and thereafter Long-term debt $ — $ 300 $ — $ 800 $ 3,350
Activity of Funding Agreements with FHLBNY	Outstanding balance at end of period Maturity of Outstanding balance Issued during the period Repaid during the period (in millions) December 31, 2018: Short-term FHLBNY funding agreements $ 1,490 Less than one month $ 7,980 $ 6,990 Long-term FHLBNY funding agreements 1,621 Less than four years — — 98 Less than five years — — 781 Greater than five years — — Total long-term funding agreements 2,500 — — Total FHLBNY funding agreements at December 31, 2018 (1) $ 3,990 $ 7,980 $ 6,990 December 31, 2017: Short-term FHLBNY funding agreements $ 500 Less than one month $ 6,000 $ 6,000 Long-term FHLBNY funding agreements 1,244 Less than four years 324 — 377 Less than five years 303 — 879 Greater than five years 135 — Total long-term funding agreements 2,500 762 — Total FHLBNY funding agreements at December 31, 2017 (1) $ 3,000 $ 6,762 $ 6,000 ____________ (1) The $11 million and $14 million difference between the funding agreements carrying value shown in fair value table for 2018 and 2017 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.

BUSINESS SEGMENT INFORMATION (T

BUSINESS SEGMENT INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The table below presents operating earnings (loss) by segment and Corporate and Other and a reconciliation to Net income (loss) attributable to Holdings for the years ended December 31, 2018 , 2017 and 2016 , respectively: Years Ended December 31, 2018 2017 2016 (in millions) Net income (loss) attributable to Holdings $ 1,820 $ 834 $ 1,254 Adjustments related to: Variable annuity product features (70 ) 1,107 2,143 Investment (gains) losses 86 191 (1,983 ) Goodwill impairment — 369 — Net actuarial (gains) losses related to pension and other postretirement benefit obligations 215 135 140 Other adjustments (1) 299 119 (7 ) Income tax expense (benefit) related to above adjustments (111 ) (644 ) (93 ) Non-recurring tax items (73 ) (76 ) (63 ) Non-GAAP Operating Earnings $ 2,166 $ 2,035 $ 1,391 Operating earnings (loss) by segment: Individual Retirement $ 1,555 $ 1,252 $ 1,167 Group Retirement 389 283 167 Investment Management and Research 381 211 161 Protection Solutions 197 502 77 Corporate and Other (2) (356 ) (213 ) (181 ) _______________ (1) Other adjustments include separation costs of $213 million in 2018 and $93 million in 2017. (2) Includes interest expense of $223 million , $138 million and $161 million , in 2018 , 2017 and 2016 , respectively. Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to Total revenues by excluding the following items: • Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features; • Investment gains (losses), which include other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses, and valuation allowances; and • Other adjustments, which includes investment income (loss) from certain derivative instruments, excluding derivative instruments used to hedge risks associated with interest margins on interest sensitive life and annuity contracts and freestanding and embedded derivatives associated with products with GMxB features. The table below presents segment revenues for the years ended December 31, 2018 , 2017 and 2016 . Years Ended December 31, 2018 2017 2016 (in millions) Segment revenues: Individual Retirement (1) $ 4,054 $ 4,374 $ 3,703 Group Retirement (1) 1,019 942 801 Investment Management and Research (2) 3,411 3,216 2,933 Protection Solutions (1) 3,232 3,057 3,129 Corporate and Other (1) 1,148 1,212 1,256 Adjustments: Variable annuity product features (643 ) (214 ) (2,132 ) Investment gains (losses) (86 ) (191 ) 1,983 Other adjustments to segment revenues (57 ) 64 90 Total revenues $ 12,078 $ 12,460 $ 11,763 _____________ (1) Includes investment expenses charged by AB of approximately $67 million , $68 million and $60 million for 2018 , 2017 and 2016 , respectively, for services provided to the Company. (2) Inter-segment investment management and other fees of approximately $94 million , $96 million and $86 million for 2018 , 2017 and 2016 , respectively, are included in segment revenues of the Investment Management and Research segment. The table below presents total assets by segment as of December 31, 2018 and 2017 : December 31, 2018 2017 (in millions) Total assets by segment: Individual Retirement (1) $ 105,532 $ 121,824 Group Retirement (1) 38,874 38,419 Investment Management and Research 10,294 10,057 Protection Solutions (1) 44,633 43,205 Corporate and Other 21,464 22,110 Total assets $ 220,797 $ 235,615 ________ (1) Amounts for December 31, 2017 as previously reported were: Individual Retirement of $121,713 million , Group Retirement of $38,578 million and Protection Solutions of $43,157 million .

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents the reconciliation of the numerator for the basic and diluted net income per share calculations: Years Ended December 31, 2018 2017 2016 (in millions) Net income (loss) attributable to Holdings common shareholders: Net income (loss) attributable to Holdings common shareholders (basic): $ 1,820 $ 834 $ 1,254 Less: Incremental dilution from AB (1) — 1 — Net income (loss) attributable to Holdings common shareholders (diluted): $ 1,820 $ 833 $ 1,254 ______________ (1) The incremental dilution from AB represents the impact of AB’s dilutive units on the Company’s diluted earnings per share and is calculated based on the Company’s proportionate ownership interest in AB. The following table presents the weighted average shares used in calculating basic and diluted earnings per common share: Years Ended December 31, 2018 2017 2016 (in millions) Weighted Average Shares: Weighted average common stock outstanding for basic earnings per common share 556.4 561.0 561.0 Effect of dilutive securities: Employee stock awards 0.1 — — Weighted average common stock outstanding for diluted earnings per common share 556.5 561.0 561.0 The following table presents both basic and diluted income (loss) per share for each period presented: Years Ended December 31, 2018 2017 2016 (in U.S. dollars per share) Net income (loss) attributable to Holdings per common share: Basic $ 3.27 $ 1.49 $ 2.24 Diluted $ 3.27 $ 1.48 $ 2.24

REVISION OF PRIOR PERIOD FINA_2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	The following table presents line items for the consolidated statement of cash flows for the year ended December 31, 2017 that have been affected by the revisions. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Year Ended December 31, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Non-cash long term incentive compensation expense $ 185 $ 62 $ — $ 247 Amortization and depreciation (104 ) 503 — 399 Distributions from joint ventures and limited partnerships 140 (140 ) — — Equity (income) loss from limited partnerships — (155 ) — (155 ) Changes in: — Reinsurance recoverable — 124 124 Capitalization of deferred policy acquisition costs (184 ) (503 ) — (687 ) Future policy benefits 1,599 — (502 ) 1,097 Current and deferred income taxes 767 — (777 ) (10 ) Other, net 127 109 15 251 Net cash provided by (used in) operating activities $ 1,021 $ — $ (1,264 ) $ (243 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short term investments — 4,555 — 4,555 Payment for the purchase/origination of: Short-term investments — (4,897 ) — (4,897 ) Change in short-term investments (342 ) 342 — — Net cash provided by (used in) investing activities $ (9,689 ) $ — $ — $ (9,689 ) Cash flows from financing activities: Policyholders’ account balances: Deposits 10,591 — (675 ) 9,916 Withdrawals (6,140 ) — 2,130 (4,010 ) Transfers (to) from Separate Accounts 1,677 — (191 ) 1,486 Net cash provided by (used in) financing activities $ 7,806 $ — $ 1,264 $ 9,070 Change in cash and cash equivalents $ (840 ) $ — $ — $ (840 ) Cash and cash equivalents, end of year $ 4,814 $ — $ — $ 4,814 The table below presents the impacts of these revisions to the quarterly financial information presented above. As Previously Reported Impact of Revisions As Revised (in millions) Three Months Ended June 30, 2018 Total revenues $ 2,962 $ 4 $ 2,966 Total benefits and other deductions 2,648 (4 ) 2,644 Net income (loss) $ 255 $ 6 $ 261 Three Months Ended March 31, 2018 Total revenues $ 2,835 $ 39 $ 2,874 Total benefits and other deductions 2,465 (19 ) 2,446 Net income (loss) $ 291 $ 46 $ 337 Three Months Ended June 30, 2017 Total revenues $ 3,882 $ 6 $ 3,888 Total benefits and other deductions 3,268 (10 ) 3,258 Net income (loss) $ 698 $ 10 $ 708 Three Months Ended March 31, 2017 Total revenues $ 2,830 $ 14 $ 2,844 Total benefits and other deductions 2,997 (6 ) 2,991 Net income (loss) $ (197 ) $ 13 $ (184 ) The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2018 (in millions) Net income (loss) $ 291 $ — $ 46 $ 337 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances — Policy charges and fee income (972 ) — 6 (966 ) Net derivative (gains) losses 281 — (45 ) 236 Amortization of deferred sales commission 7 (7 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (20 ) 184 (5 ) 159 Distributions from joint ventures and limited partnerships 25 (25 ) — — Equity (income) loss from limited partnerships — (38 ) — (38 ) Changes in: Reinsurance recoverable 32 — (3 ) 29 Capitalization of deferred policy acquisition costs 15 (172 ) — (157 ) Future policy benefits (254 ) — 6 (248 ) Current and deferred income taxes 103 — 12 115 Other, net (255 ) 63 — (192 ) Net cash provided by (used in) operating activities $ (264 ) $ — $ 17 $ (247 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Real estate joint ventures $ — $ — $ 140 $ 140 Short-term investments 876 — 77 953 Cash settlements related to derivative instruments (54 ) — (620 ) (674 ) Other, net (371 ) — 60 (311 ) Net cash provided by (used in) investing activities $ 459 $ — $ (343 ) $ 116 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,532 $ — $ (491 ) $ 2,041 Withdrawals (1,384 ) — 284 (1,100 ) Transfers (to) from Separate Accounts (102 ) — 533 431 Net cash provided by (used in) financing activities $ 1,074 $ — $ 326 $ 1,400 Change in cash and cash equivalents $ 1,277 $ — $ — $ 1,277 Cash and Cash Equivalents, end of period $ 6,091 $ — $ — $ 6,091 The following table presents line items for the consolidated statement of cash flows for the six months ended June 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2018 (in millions) Net income (loss) $ 546 $ — $ 52 $ 598 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,959 ) $ — 29 $ (1,930 ) Net derivative (gains) losses 354 — (72 ) 282 Amortization of deferred sales commission 13 (13 ) — — Amortization of reinsurance cost 10 (10 ) — — Amortization and depreciation $ (32 ) $ 380 $ 11 $ 359 Distributions from joint ventures and limited partnerships 44 (44 ) — — Equity (income) loss from limited partnerships — (59 ) — (59 ) Changes in: Reinsurance recoverable 20 — 9 29 Capitalization of deferred policy acquisition costs 14 (357 ) — (343 ) Future policy benefits (171 ) — (15 ) (186 ) Current and deferred income taxes 224 — (42 ) 182 Other, net (180 ) 103 — (77 ) Net cash provided by (used in) operating activities $ (314 ) $ — $ (28 ) $ (342 ) Cash flows from investing activities: Real estate joint ventures — 139 — 139 Other 261 (139 ) — 122 Cash settlements related to derivative instruments $ (333 ) $ — $ (637 ) $ (970 ) Other, net 419 — 61 480 Net cash provided by (used in) investing activities $ 1,807 $ — $ (576 ) $ 1,231 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,567 $ — $ (1,141 ) $ 4,426 Withdrawals (2,750 ) — 572 (2,178 ) Transfers (to) from Separate Accounts (307 ) — 1,173 866 Net cash provided by (used in) financing activities $ 532 $ — $ 604 $ 1,136 Change in cash and cash equivalents 2,019 — — 2,019 Cash and Cash Equivalents, end of period $ 6,833 $ — — $ 6,833 The following table presents line items for the consolidated statement of cash flows for the nine months ended September 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2018 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission $ 18 $ (18 ) $ — $ — Amortization of reinsurance cost 17 (17 ) — — Amortization and depreciation (57 ) $ 210 $ — $ 153 Distribution from joint ventures and limited partnerships 63 (63 ) — — Equity (income) loss from limited partnerships — (82 ) — (82 ) Changes in: Reinsurance recoverable 92 — (2 ) 90 Capitalization of deferred policy acquisition costs (338 ) (175 ) — (513 ) Future policy benefits (620 ) — (44 ) (664 ) Current and deferred income taxes 249 — (56 ) 193 Other, net (139 ) 145 — 6 Net cash provided by (used in) operating activities $ (34 ) $ — $ (102 ) $ (136 ) Cash flows from investing activities: Real estate joint ventures $ — $ 139 $ — $ 139 Other 335 (139 ) — 196 Cash settlements related to derivative instruments $ (609 ) $ — $ (668 ) $ (1,277 ) Other, net 319 — (5 ) 314 Net cash provided by (used in) investing activities $ (1,057 ) $ — $ (673 ) $ (1,730 ) Cash flows from financing activities: Deposits $ 8,372 $ — $ (1,719 ) $ 6,653 Withdrawals (4,170 ) — 846 (3,324 ) Transfers (to) from Separate Accounts (335 ) — 1,648 1,313 Net cash provided by (used in) financing activities $ 1,063 $ — $ 775 $ 1,838 Change in cash and cash equivalents (37 ) — — (37 ) Cash and Cash Equivalents, end of period $ 4,777 $ — $ — $ 4,777 The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2017 (in millions) Net income (loss) $ (197 ) $ — $ 13 $ (184 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (956 ) — 17 (939 ) (Income) loss related to derivative instruments 235 — (31 ) 204 Amortization of deferred sales commission 9 (9 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (42 ) 128 (4 ) 82 Equity (income) loss from limited partnerships — (40 ) — (40 ) Distributions from joint ventures and limited partnersh 26 (26 ) — — Changes in: Net broker-dealer and customer related receivables/payables 297 — (10 ) 287 Reinsurance recoverable 27 — 3 30 Capitalization of deferred policy acquisition costs (55 ) (114 ) (169 ) Future policy benefits 296 — 52 348 Current and deferred income taxes 252 — (256 ) (4 ) Other, net (71 ) 66 — (5 ) Net cash provided by (used in) operating activities $ 72 $ — $ (216 ) $ (144 ) Cash flows from investing activities: Change in short-term investments 573 — (308 ) 265 Cash settlements related to derivative instruments (1,400 ) — 22 (1,378 ) Other, net (191 ) — 76 (115 ) Net cash provided by (used in) investing activities $ (2,899 ) $ — $ (210 ) $ (3,109 ) Cash flows from financing activities: Policyholders’ account balances: — Deposits 2,790 — (144 ) 2,646 Withdrawals (1,342 ) — 376 (966 ) Transfers (to) from Separate Accounts 186 — 194 380 Net cash provided by (used in) financing activities $ 2,630 $ — $ 426 $ 3,056 Change in cash and cash equivalents $ (189 ) $ — $ — $ (189 ) Cash and cash equivalents, end of period $ 5,465 $ — $ — $ 5,465 The following tables present line items for the consolidated statement of cash flows for the six months ended June 30, 2017 that has been affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2017 (in millions) Net income (loss) $ 501 $ — $ 23 $ 524 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,891 ) $ — $ 34 $ (1,857 ) Net derivative (gains) losses (494 ) — (54 ) (548 ) Amortization of reinsurance cost 7 (7 ) — — Amortization of deferred sales commission 17 (17 ) — — Amortization and depreciation (60 ) 203 (5 ) 138 Equity (income) loss from limited partnerships — (66 ) — (66 ) Distribution from joint ventures and limited partnerships 53 (53 ) — — Changes in: — Reinsurance recoverable 40 — 9 49 Capitalization of deferred policy acquisition costs (168 ) (179 ) — (347 ) Future policy benefits 1,516 — (169 ) 1,347 Current and deferred income taxes 123 — (210 ) (87 ) Other, net 333 119 — 452 Net cash provided by (used in) operating activities $ 666 $ — $ (372 ) $ 294 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,537 ) $ — $ 34 $ (1,503 ) Other, net 179 — (173 ) 6 Net cash provided by (used in) investing activities $ (5,067 ) $ — $ (139 ) $ (5,206 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 4,401 — $ 766 $ 5,167 Withdrawals (1,724 ) — (158 ) (1,882 ) Transfers (to) from Separate Accounts 826 — (97 ) 729 Net cash provided by (used in) financing activities $ 4,923 $ — $ 511 $ 5,434 Change in cash and cash equivalents 533 — — 533 Cash and Cash Equivalents, end of period $ 6,187 $ — $ — $ 6,187 The following tables present line items for the consolidated statement of cash flows for the nine months ended September 30, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission 25 (25 ) — — Amortization of reinsurance cost 11 (11 ) — — Amortization and depreciation $ (121 ) $ 399 $ — $ 278 Equity (income) loss from limited partnerships — (103 ) — (103 ) Distribution from joint ventures and limited partnerships 94 (94 ) — — Changes in: — Reinsurance recoverable 115 — 10 125 Capitalization of deferred policy acquisition costs (150 ) (363 ) — (513 ) Future policy benefits 1,587 — (10 ) 1,577 Current and deferred income taxes 498 — (546 ) (48 ) Other, net 253 197 15 465 Net cash provided by (used in) operating activities $ 1,044 $ — $ (531 ) $ 513 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,722 ) $ — $ 50 $ (1,672 ) Other, net (133 ) — (230 ) (363 ) Net cash provided by (used in) investing activities $ (6,568 ) $ — $ (180 ) $ (6,748 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 6,135 $ — $ 1,283 $ 7,418 Withdrawals (2,765 ) — (114 ) (2,879 ) Transfers (to) from Separate Accounts 1,617 — (458 ) 1,159 Net cash provided by (used in) financing activities $ 6,299 $ — $ 711 $ 7,010 Change in cash and cash equivalents 792 — — 792 Cash and Cash Equivalents, end of period $ 6,446 $ — $ — $ 6,446

QUARTERLY FINANCIAL INFORMATI_2

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Schedule of Quarterly Financial Information	The unaudited quarterly financial information for the years ended December 31, 2018 and 2017 are summarized in the table below: Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2018 Total revenues $ 2,874 $ 2,966 $ 1,083 $ 5,155 Total benefits and other deductions 2,446 2,644 1,701 2,826 Income (loss) before income taxes 428 322 (618 ) 2,329 Income tax (expense) benefit (91 ) (61 ) 175 (330 ) Net income (loss) 337 261 (443 ) 1,999 Less: Net (income) loss attributable to the noncontrolling interest (123 ) (97 ) (53 ) (61 ) Net Income (Loss) Attributable to Holdings $ 168 $ 164 $ (496 ) $ 1,938 Earnings per share - common stock: Basic $ 0.30 $ 0.29 $ (0.89 ) $ 3.57 Diluted $ 0.30 $ 0.29 $ (0.89 ) $ 3.57 Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2017 Total revenues $ 2,844 $ 3,888 $ 2,806 $ 2,922 Total benefits and other deductions 2,991 3,258 2,759 2,146 Income (loss) before income taxes (147 ) 630 47 776 Income tax (expense) benefit (37 ) 78 59 (149 ) Net income (loss) (184 ) 708 106 627 Less: Net (income) loss attributable to the noncontrolling interest (93 ) (90 ) (96 ) (144 ) Net Income (Loss) Attributable to Holdings $ (277 ) $ 618 $ 10 $ 483 Earnings per share - common stock: Basic $ (0.49 ) $ 1.10 $ 0.02 $ 0.86 Diluted $ (0.50 ) $ 1.10 $ 0.02 $ 0.86
Schedule of Error Corrections and Prior Period Adjustments	The following table presents line items for the consolidated statement of cash flows for the year ended December 31, 2017 that have been affected by the revisions. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Year Ended December 31, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Non-cash long term incentive compensation expense $ 185 $ 62 $ — $ 247 Amortization and depreciation (104 ) 503 — 399 Distributions from joint ventures and limited partnerships 140 (140 ) — — Equity (income) loss from limited partnerships — (155 ) — (155 ) Changes in: — Reinsurance recoverable — 124 124 Capitalization of deferred policy acquisition costs (184 ) (503 ) — (687 ) Future policy benefits 1,599 — (502 ) 1,097 Current and deferred income taxes 767 — (777 ) (10 ) Other, net 127 109 15 251 Net cash provided by (used in) operating activities $ 1,021 $ — $ (1,264 ) $ (243 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short term investments — 4,555 — 4,555 Payment for the purchase/origination of: Short-term investments — (4,897 ) — (4,897 ) Change in short-term investments (342 ) 342 — — Net cash provided by (used in) investing activities $ (9,689 ) $ — $ — $ (9,689 ) Cash flows from financing activities: Policyholders’ account balances: Deposits 10,591 — (675 ) 9,916 Withdrawals (6,140 ) — 2,130 (4,010 ) Transfers (to) from Separate Accounts 1,677 — (191 ) 1,486 Net cash provided by (used in) financing activities $ 7,806 $ — $ 1,264 $ 9,070 Change in cash and cash equivalents $ (840 ) $ — $ — $ (840 ) Cash and cash equivalents, end of year $ 4,814 $ — $ — $ 4,814 The table below presents the impacts of these revisions to the quarterly financial information presented above. As Previously Reported Impact of Revisions As Revised (in millions) Three Months Ended June 30, 2018 Total revenues $ 2,962 $ 4 $ 2,966 Total benefits and other deductions 2,648 (4 ) 2,644 Net income (loss) $ 255 $ 6 $ 261 Three Months Ended March 31, 2018 Total revenues $ 2,835 $ 39 $ 2,874 Total benefits and other deductions 2,465 (19 ) 2,446 Net income (loss) $ 291 $ 46 $ 337 Three Months Ended June 30, 2017 Total revenues $ 3,882 $ 6 $ 3,888 Total benefits and other deductions 3,268 (10 ) 3,258 Net income (loss) $ 698 $ 10 $ 708 Three Months Ended March 31, 2017 Total revenues $ 2,830 $ 14 $ 2,844 Total benefits and other deductions 2,997 (6 ) 2,991 Net income (loss) $ (197 ) $ 13 $ (184 ) The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2018 (in millions) Net income (loss) $ 291 $ — $ 46 $ 337 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances — Policy charges and fee income (972 ) — 6 (966 ) Net derivative (gains) losses 281 — (45 ) 236 Amortization of deferred sales commission 7 (7 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (20 ) 184 (5 ) 159 Distributions from joint ventures and limited partnerships 25 (25 ) — — Equity (income) loss from limited partnerships — (38 ) — (38 ) Changes in: Reinsurance recoverable 32 — (3 ) 29 Capitalization of deferred policy acquisition costs 15 (172 ) — (157 ) Future policy benefits (254 ) — 6 (248 ) Current and deferred income taxes 103 — 12 115 Other, net (255 ) 63 — (192 ) Net cash provided by (used in) operating activities $ (264 ) $ — $ 17 $ (247 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Real estate joint ventures $ — $ — $ 140 $ 140 Short-term investments 876 — 77 953 Cash settlements related to derivative instruments (54 ) — (620 ) (674 ) Other, net (371 ) — 60 (311 ) Net cash provided by (used in) investing activities $ 459 $ — $ (343 ) $ 116 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,532 $ — $ (491 ) $ 2,041 Withdrawals (1,384 ) — 284 (1,100 ) Transfers (to) from Separate Accounts (102 ) — 533 431 Net cash provided by (used in) financing activities $ 1,074 $ — $ 326 $ 1,400 Change in cash and cash equivalents $ 1,277 $ — $ — $ 1,277 Cash and Cash Equivalents, end of period $ 6,091 $ — $ — $ 6,091 The following table presents line items for the consolidated statement of cash flows for the six months ended June 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2018 (in millions) Net income (loss) $ 546 $ — $ 52 $ 598 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,959 ) $ — 29 $ (1,930 ) Net derivative (gains) losses 354 — (72 ) 282 Amortization of deferred sales commission 13 (13 ) — — Amortization of reinsurance cost 10 (10 ) — — Amortization and depreciation $ (32 ) $ 380 $ 11 $ 359 Distributions from joint ventures and limited partnerships 44 (44 ) — — Equity (income) loss from limited partnerships — (59 ) — (59 ) Changes in: Reinsurance recoverable 20 — 9 29 Capitalization of deferred policy acquisition costs 14 (357 ) — (343 ) Future policy benefits (171 ) — (15 ) (186 ) Current and deferred income taxes 224 — (42 ) 182 Other, net (180 ) 103 — (77 ) Net cash provided by (used in) operating activities $ (314 ) $ — $ (28 ) $ (342 ) Cash flows from investing activities: Real estate joint ventures — 139 — 139 Other 261 (139 ) — 122 Cash settlements related to derivative instruments $ (333 ) $ — $ (637 ) $ (970 ) Other, net 419 — 61 480 Net cash provided by (used in) investing activities $ 1,807 $ — $ (576 ) $ 1,231 Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,567 $ — $ (1,141 ) $ 4,426 Withdrawals (2,750 ) — 572 (2,178 ) Transfers (to) from Separate Accounts (307 ) — 1,173 866 Net cash provided by (used in) financing activities $ 532 $ — $ 604 $ 1,136 Change in cash and cash equivalents 2,019 — — 2,019 Cash and Cash Equivalents, end of period $ 6,833 $ — — $ 6,833 The following table presents line items for the consolidated statement of cash flows for the nine months ended September 30, 2018 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2018 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission $ 18 $ (18 ) $ — $ — Amortization of reinsurance cost 17 (17 ) — — Amortization and depreciation (57 ) $ 210 $ — $ 153 Distribution from joint ventures and limited partnerships 63 (63 ) — — Equity (income) loss from limited partnerships — (82 ) — (82 ) Changes in: Reinsurance recoverable 92 — (2 ) 90 Capitalization of deferred policy acquisition costs (338 ) (175 ) — (513 ) Future policy benefits (620 ) — (44 ) (664 ) Current and deferred income taxes 249 — (56 ) 193 Other, net (139 ) 145 — 6 Net cash provided by (used in) operating activities $ (34 ) $ — $ (102 ) $ (136 ) Cash flows from investing activities: Real estate joint ventures $ — $ 139 $ — $ 139 Other 335 (139 ) — 196 Cash settlements related to derivative instruments $ (609 ) $ — $ (668 ) $ (1,277 ) Other, net 319 — (5 ) 314 Net cash provided by (used in) investing activities $ (1,057 ) $ — $ (673 ) $ (1,730 ) Cash flows from financing activities: Deposits $ 8,372 $ — $ (1,719 ) $ 6,653 Withdrawals (4,170 ) — 846 (3,324 ) Transfers (to) from Separate Accounts (335 ) — 1,648 1,313 Net cash provided by (used in) financing activities $ 1,063 $ — $ 775 $ 1,838 Change in cash and cash equivalents (37 ) — — (37 ) Cash and Cash Equivalents, end of period $ 4,777 $ — $ — $ 4,777 The following tables present line items for the consolidated statement of cash flows for the three months ended March 31, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q1 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Three Months Ended March 31, 2017 (in millions) Net income (loss) $ (197 ) $ — $ 13 $ (184 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (956 ) — 17 (939 ) (Income) loss related to derivative instruments 235 — (31 ) 204 Amortization of deferred sales commission 9 (9 ) — — Amortization of reinsurance cost 5 (5 ) — — Amortization and depreciation (42 ) 128 (4 ) 82 Equity (income) loss from limited partnerships — (40 ) — (40 ) Distributions from joint ventures and limited partnersh 26 (26 ) — — Changes in: Net broker-dealer and customer related receivables/payables 297 — (10 ) 287 Reinsurance recoverable 27 — 3 30 Capitalization of deferred policy acquisition costs (55 ) (114 ) (169 ) Future policy benefits 296 — 52 348 Current and deferred income taxes 252 — (256 ) (4 ) Other, net (71 ) 66 — (5 ) Net cash provided by (used in) operating activities $ 72 $ — $ (216 ) $ (144 ) Cash flows from investing activities: Change in short-term investments 573 — (308 ) 265 Cash settlements related to derivative instruments (1,400 ) — 22 (1,378 ) Other, net (191 ) — 76 (115 ) Net cash provided by (used in) investing activities $ (2,899 ) $ — $ (210 ) $ (3,109 ) Cash flows from financing activities: Policyholders’ account balances: — Deposits 2,790 — (144 ) 2,646 Withdrawals (1,342 ) — 376 (966 ) Transfers (to) from Separate Accounts 186 — 194 380 Net cash provided by (used in) financing activities $ 2,630 $ — $ 426 $ 3,056 Change in cash and cash equivalents $ (189 ) $ — $ — $ (189 ) Cash and cash equivalents, end of period $ 5,465 $ — $ — $ 5,465 The following tables present line items for the consolidated statement of cash flows for the six months ended June 30, 2017 that has been affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q2 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Six Months Ended June 30, 2017 (in millions) Net income (loss) $ 501 $ — $ 23 $ 524 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income $ (1,891 ) $ — $ 34 $ (1,857 ) Net derivative (gains) losses (494 ) — (54 ) (548 ) Amortization of reinsurance cost 7 (7 ) — — Amortization of deferred sales commission 17 (17 ) — — Amortization and depreciation (60 ) 203 (5 ) 138 Equity (income) loss from limited partnerships — (66 ) — (66 ) Distribution from joint ventures and limited partnerships 53 (53 ) — — Changes in: — Reinsurance recoverable 40 — 9 49 Capitalization of deferred policy acquisition costs (168 ) (179 ) — (347 ) Future policy benefits 1,516 — (169 ) 1,347 Current and deferred income taxes 123 — (210 ) (87 ) Other, net 333 119 — 452 Net cash provided by (used in) operating activities $ 666 $ — $ (372 ) $ 294 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,537 ) $ — $ 34 $ (1,503 ) Other, net 179 — (173 ) 6 Net cash provided by (used in) investing activities $ (5,067 ) $ — $ (139 ) $ (5,206 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 4,401 — $ 766 $ 5,167 Withdrawals (1,724 ) — (158 ) (1,882 ) Transfers (to) from Separate Accounts 826 — (97 ) 729 Net cash provided by (used in) financing activities $ 4,923 $ — $ 511 $ 5,434 Change in cash and cash equivalents 533 — — 533 Cash and Cash Equivalents, end of period $ 6,187 $ — $ — $ 6,187 The following tables present line items for the consolidated statement of cash flows for the nine months ended September 30, 2017 affected by the revisions. This information has been corrected from the information previously presented in the Company’s Q3 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, revisions and the amounts as currently revised. As Reported Presentation Reclassifications Revisions As Revised Nine Months Ended September 30, 2017 (in millions) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization of deferred sales commission 25 (25 ) — — Amortization of reinsurance cost 11 (11 ) — — Amortization and depreciation $ (121 ) $ 399 $ — $ 278 Equity (income) loss from limited partnerships — (103 ) — (103 ) Distribution from joint ventures and limited partnerships 94 (94 ) — — Changes in: — Reinsurance recoverable 115 — 10 125 Capitalization of deferred policy acquisition costs (150 ) (363 ) — (513 ) Future policy benefits 1,587 — (10 ) 1,577 Current and deferred income taxes 498 — (546 ) (48 ) Other, net 253 197 15 465 Net cash provided by (used in) operating activities $ 1,044 $ — $ (531 ) $ 513 Cash flows from investing activities: Cash settlements related to derivative instruments $ (1,722 ) $ — $ 50 $ (1,672 ) Other, net (133 ) — (230 ) (363 ) Net cash provided by (used in) investing activities $ (6,568 ) $ — $ (180 ) $ (6,748 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 6,135 $ — $ 1,283 $ 7,418 Withdrawals (2,765 ) — (114 ) (2,879 ) Transfers (to) from Separate Accounts 1,617 — (458 ) 1,159 Net cash provided by (used in) financing activities $ 6,299 $ — $ 711 $ 7,010 Change in cash and cash equivalents 792 — — 792 Cash and Cash Equivalents, end of period $ 6,446 $ — $ — $ 6,446

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details) $ in Millions	Nov. 20, 2018shares	May 14, 2018shares	Apr. 23, 2018shares	Mar. 31, 2018	Feb. 28, 2018	Dec. 31, 2018USD ($)segmentshares	Dec. 31, 2017USD ($)shares
Organization Basis Of Presentation [Line Items]
Units purchased during the period (in shares)	30,000,000					32,500,000
Number of reportable segments | segment						4
Long-term debt | $						$ 4,409	$ 551
AXA
Organization Basis Of Presentation [Line Items]
Ownership percentage after transaction						59.00%
Alliance Bernstein
Organization Basis Of Presentation [Line Items]
Units purchased during the period (in shares)							9,300,000
Purchase of interest by Parent (in shares)			8,160,000
Economic interest			65.00%			65.00%	47.00%
Alliance Bernstein | Parent
Organization Basis Of Presentation [Line Items]
Purchase of interest by Parent (in shares)			8,160,000
Economic interest			65.00%
AXA-IM Holding U.S., Inc.
Organization Basis Of Presentation [Line Items]
Ownership percentage after transaction			100.00%
Purchase of interest by Parent (in shares)			41,934,582
AXA-IM Holding U.S., Inc. | Parent
Organization Basis Of Presentation [Line Items]
Ownership percentage after transaction			100.00%
Purchase of interest by Parent (in shares)			41,934,582
AXA Financial
Organization Basis Of Presentation [Line Items]
Economic interest				100.00%	99.50%
Ownership percentage by noncontrolling interest				0.50%
AXA Financial | Parent
Organization Basis Of Presentation [Line Items]
Ownership percentage by noncontrolling interest				0.50%
Public Offering
Organization Basis Of Presentation [Line Items]
Shares issued (in shares)		157,837,500
Secondary Offering
Organization Basis Of Presentation [Line Items]
Shares issued (in shares)	60,000,000
AXA Financial
Organization Basis Of Presentation [Line Items]
Ownership percentage by noncontrolling interest				0.50%
Commercial paper | AXA Financial Commercial Paper
Organization Basis Of Presentation [Line Items]
Maximum amount of short-term unsecured debt allowed under agreement | $						$ 2,000	$ 1,300
Senior Debentures
Organization Basis Of Presentation [Line Items]
Long-term debt | $						$ 349	$ 349
Debt instrument, stated percentage						7.00%	7.00%

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - Basis of Presentation and Principles of Consolidation (Details)	Apr. 24, 2018$ / sharesshares	Dec. 31, 2018$ / sharesshares	Dec. 31, 2017$ / sharesshares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock authorized (in shares)	2,000,000,000	2,000,000,000	2,000,000,000
Common stock par value (in dollars per share) | $ / shares	$ 0.01	$ 0.01	$ 0.01
Stock split ratio	459.4752645
Shares issued (in shares)	561,000,000
AXA SA
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Shares issued (in shares)	561,000,000

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - New ASU Adjustments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Jan. 01, 2019	Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings	$ 13,989		$ 12,225
Noncontrolling interest	1,566		$ 3,097
ASU 2016-01
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity securities, fair value	46
ASU 2018-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reclassification from AOCI	89
Difference between Revenue Guidance in Effect before and after Topic 606 | ASU 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings	13
Noncontrolling interest	19
Noncontrolling interest, cumulative contributions received	78
Noncontrolling interest, cumulative contributions paid	$ 43
Scenario, Forecast | Minimum | ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right of use asset		$ 750
Operating lease, liability		950
Scenario, Forecast | Maximum | ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right of use asset		850
Operating lease, liability		$ 1,100

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Life Insurance, Corporate or Bank Owned, Amount	$ 872	$ 918	$ 889
Equity real estate | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	40 years
Equity real estate | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	50 years

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Deferred Policy Acquisition Costs (Details)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Average annual rate of return, gross	7.00%
Average annual rate of return, net	4.70%
Future annual rate of return, gross, maximum	15.00%
Future annual rate of return, net, maximum	12.70%
Future annual rate of return, gross, minimum	0.00%
Future annual rate of return, net, minimum	(2.30%)
Future annual rate of return assumption duration maximum	5 years
Assumed average investment yield excluding policy loans, high end	4.70%
Assumed average investment yield excluding policy loans, low end	4.30%
Period used In assumed average investment yield excluding policy loans	6 years

SIGNIFICANT ACCOUNTING POLICI_8

SIGNIFICANT ACCOUNTING POLICIES - Policyholders' Account Balances and Future Policy Benefits (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Liability For Future Policy Benefits Assumptions [Line Items]
Percentage of life insurance liabilities calculate within traditional life interest rate range	99.10%
Unincorporated business tax (UBT) rate, percent			4.00%
Separate Accounts Disclosure [Abstract]
Gain (loss) recognized on assets transferred to separate account	$ (7.3)	$ 17	$ 8.3
State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]
Unincorporated business tax (UBT) rate, percent			4.00%
Minimum | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	5.00%
Minimum | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	1.60%
Maximum | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	6.30%
Maximum | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	5.50%
Weighted Average | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	5.10%
Weighted Average | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	4.80%

SIGNIFICANT ACCOUNTING POLICI_9

SIGNIFICANT ACCOUNTING POLICIES - Separate Accounts (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Gain (loss) recognized on assets transferred to separate account	$ (7.3)	$ 17	$ 8.3

SIGNIFICANT ACCOUNTING POLIC_10

SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2018
Computer Software, Intangible Asset | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	3 years
Computer Software, Intangible Asset | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	5 years
Alliance Bernstein | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	6 years
Alliance Bernstein | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life	20 years

SIGNIFICANT ACCOUNTING POLIC_11

SIGNIFICANT ACCOUNTING POLICIES - Income Taxes (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2016
Income Tax Contingency [Line Items]
Unincorporated business tax (UBT) rate, percent		4.00%
AB Holding
Income Tax Contingency [Line Items]
Tax rate	3.50%

- Accounting and Consolidation

- Accounting and Consolidation of VIEs (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017
Variable Interest Entity [Line Items]
Redeemable noncontrolling interest	[1]	$ 187	$ 626
AB-Sponsored Investment Funds
Variable Interest Entity [Line Items]
Nonconsolidated VIE, carrying amount, assets		44,300
Maximum loss exposure, amount		6
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Consolidated VIE, carrying amount, assets		1,200	1,100
Nonconsolidated VIE, carrying amount, assets		166,100	160,200
Maximum loss exposure, amount		1,200	1,100
Unfunded commitments		940	769
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Consolidated VIE, carrying amount, assets		36	393
Consolidated presentation, amount		36	372
Real estate held for production income		16	$ 18
Ownership percentage			95.00%
Consolidated VIE, carrying amount, liabilities			$ 229
Consolidated VIE, carrying amount, long-term debt			203
Variable Interest Entity, Primary Beneficiary | AB-Sponsored Investment Funds
Variable Interest Entity [Line Items]
Consolidated VIE, carrying amount, assets		236	1,500
Consolidated VIE, carrying amount, liabilities		5	696
Redeemable noncontrolling interest		118	$ 596
Variable Interest Entity, Primary Beneficiary | Venture Partner
Variable Interest Entity [Line Items]
Ownership percentage by noncontrolling interest			5.00%
VOE Consolidation Model | AB-Sponsored Investment Funds
Variable Interest Entity [Line Items]
Consolidated VIE, carrying amount, assets		152	$ 58
Consolidated VIE, carrying amount, liabilities		17	2
Redeemable noncontrolling interest		$ 28	$ 0
[1]	See Note 2 for details of balances with variable interest entities.

SIGNIFICANT ACCOUNTING POLIC_12

SIGNIFICANT ACCOUNTING POLICIES - Assumption Updates and Model Changes (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Change in Accounting Estimate [Line Items]
Policy charges and fee income									$ 3,824	$ 3,693	$ 3,729
Policyholders’ benefits									2,915	4,366	3,342
Net derivative gains (losses)									(231)	214	(1,848)
Amortization of deferred policy acquisition costs, net									333	503	779
Earnings (loss) from operations, before income taxes	$ 2,329	$ (618)	$ 322	$ 428	$ 776	$ 47	$ 630	$ (147)	2,461	1,306	2,027
Net income (loss)	$ 1,999	(443)	$ 261	$ 337	$ 627	$ 106	$ 708	$ (184)	2,154	1,257	1,649
Increase (decrease) in the fair value of the reinsurance contract asset									$ 162	159	(93)
Long-term Lapses, Partial Withdrawal Rates and Election Assumptions Updates
Change in Accounting Estimate [Line Items]
Policy charges and fee income		(24)								(85)	54
Policyholders’ benefits		(673)								277	(117)
Net derivative gains (losses)		(1,100)
Amortization of deferred policy acquisition costs, net		(286)								(112)	201
Earnings (loss) from operations, before income taxes		160								711	(30)
Net income (loss)		$ (131)								462	$ (20)
Long-term Lapses, Partial Withdrawal Rates and Election Assumptions Updates | GMIB
Change in Accounting Estimate [Line Items]
Increase (decrease) in the fair value of the reinsurance contract asset										504
Increase (decrease) in fair value of policy liability										$ 457

SIGNIFICANT ACCOUNTING POLIC_13

SIGNIFICANT ACCOUNTING POLICIES - Reclassification of DAC Capitalized Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amortization of deferred policy acquisition costs, net	$ 333	$ 503	$ 779
Reclassification Of DAC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		687	697
Amortization of deferred policy acquisition costs, net		687	697
Reclassification Of DAC | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		157	154
Reclassification Of DAC | Commissions and distribution plan payments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		523	537
Reclassification Of DAC | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		7	6
Individual Retirement | Reclassification Of DAC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		401	421
Amortization of deferred policy acquisition costs, net		401	421
Individual Retirement | Reclassification Of DAC | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		71	72
Individual Retirement | Reclassification Of DAC | Commissions and distribution plan payments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		328	347
Individual Retirement | Reclassification Of DAC | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		2	2
Group Retirement | Reclassification Of DAC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		86	82
Amortization of deferred policy acquisition costs, net		86	82
Group Retirement | Reclassification Of DAC | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		30	28
Group Retirement | Reclassification Of DAC | Commissions and distribution plan payments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		55	54
Group Retirement | Reclassification Of DAC | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		1	0
Protection Solutions | Reclassification Of DAC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		200	193
Amortization of deferred policy acquisition costs, net		200	193
Protection Solutions | Reclassification Of DAC | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		56	54
Protection Solutions | Reclassification Of DAC | Commissions and distribution plan payments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		140	135
Protection Solutions | Reclassification Of DAC | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total reductions		$ 4	$ 4

INVESTMENTS - Available-for-sal

INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		$ 45,256
Gross Unrealized Gains		2,199
Gross Unrealized Losses		324
Fair Value		47,131
OTTI in AOCI		2
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Due in one year or less, Amortized Cost	$ 2,598
Due in years two through five, Amortized Cost	9,396
Due in years six through ten, Amortized Cost	16,501
Due after ten years, Amortized Cost	17,020
Subtotal, Amortized Cost Basis	46,801
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Due in one year or less, Fair Value	2,603
Due in years two through five, Fair Value	9,444
Due in years six through ten, Fair Value	16,327
Due after ten years, Fair Value	16,624
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract]
Proceeds from sales	8,523	8,213	$ 5,036
Gross gains on sales	180	107	212
Gross losses on sales	(215)	(259)	(60)
Non-credit losses recognized in OCI	0	0	0
Net impairment losses recognized	(42)	(15)	(68)
Fixed Maturities - Credit Loss Impairments
Balance beginning of period	(18)	(239)
Previously recognized impairments on securities that matured, paid, prepaid or sold	2	236
Recognized impairments on securities impaired to fair value this period	0	0
Impairments recognized this period on securities not previously impaired	(42)	(14)
Additional impairments this period on securities previously impaired	0	(1)
Increases due to passage of time on previously recorded credit losses	0	0
Accretion of previously recognized impairments due to increases in expected cash flows	0	0
Balances at December 31,	(58)	(18)	(239)
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost	45,515
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value	44,998
Available For Sale Securities Debt Maturities Fair Value 1	46,279
Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings	(42)	(15)	$ (68)
Public corporate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	30,572	24,480
Gross Unrealized Gains	406	1,031
Gross Unrealized Losses	800	65
Fair Value	30,178	25,446
OTTI in AOCI	0	0
U.S. Treasury, government and agency
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	14,004	17,759
Gross Unrealized Gains	295	1,000
Gross Unrealized Losses	470	251
Fair Value	13,829	18,508
OTTI in AOCI	0	0
States and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	415	422
Gross Unrealized Gains	47	67
Gross Unrealized Losses	1	0
Fair Value	461	489
OTTI in AOCI	0	0
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	524	395
Gross Unrealized Gains	19	29
Gross Unrealized Losses	13	5
Fair Value	530	419
OTTI in AOCI	0	0
Commercial mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	225	797
Gross Unrealized Gains	10	22
Gross Unrealized Losses	1	1
Fair Value	234	818
OTTI in AOCI	0	0
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	612	745
Gross Unrealized Gains	1	5
Gross Unrealized Losses	12	1
Fair Value	601	749
OTTI in AOCI	2	2
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	225
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	234
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	449	470
Gross Unrealized Gains	15	43
Gross Unrealized Losses	18	1
Fair Value	446	512
OTTI in AOCI	0	0
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	612
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	601
Redeemable preferred stock
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	46,801	45,068
Gross Unrealized Gains	793	2,197
Gross Unrealized Losses	1,315	324
Fair Value	46,279	46,941
OTTI in AOCI	2	2
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	449
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	446
Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 46,801	45,068
Equity securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		188
Gross Unrealized Gains		2
Gross Unrealized Losses		0
Fair Value		190
OTTI in AOCI		$ 0

INVESTMENTS - Net Unrealized In

INVESTMENTS - Net Unrealized Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2014
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	$ (394)	$ 830		$ 140
Net unrealized gains (losses) arising during the year	(1,952)	910	$ (227)
DAC	(458)	314	(84)
Deferred income taxes	356	(262)	164
Balance, end of the period	(31)
Net Unrealized Gains (Losses) On Investments [Member]
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	(522)	1,875
Unrealized Investment Gains Losses With Otti Losses | Net Unrealized Gains (Losses) On Investments [Member]
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	2	19
Excluded from Net earnings (loss)	0	0
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax	(1)	(18)
Unrealized Investment Gains Losses With Otti Losses | Net Unrealized Gains (Losses) On Investments [Member] | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	2
Other Comprehensive Income Reclassification Adjustment For Sale Of Securities And For Write Down Of Securities Included In, Before Tax	(1)	1
Unrealized Investment Gains Losses With Otti Losses | DAC
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	0	1
DAC	0	(1)
Unrealized Investment Gains Losses With Otti Losses | Policyholders Liabilities
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	(1)	(10)
Policyholders liabilities	1	9
Unrealized Investment Gains Losses With Otti Losses | Deferred Income Tax Asset Liability
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	0	(4)
Deferred income taxes	0	4
Unrealized Investment Gains Losses With Otti Losses | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	1	6
Excluded from Net earnings (loss)	0	0
DAC	0	(1)
Deferred income taxes	0	4
Policyholders liabilities	1	9
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax	(1)	(18)
Unrealized Investment Gains Losses With Otti Losses | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Other Comprehensive Income Reclassification Adjustment For Sale Of Securities And For Write Down Of Securities Included In, Before Tax	(1)	1
Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) On Investments [Member] | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	(522)	1,871
Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) On Investments [Member] | Equity securities
Debt Securities, Available-for-sale [Line Items]
Accumulated Other Comprehensive Income (Loss), Debt Securities, Available-for-sale, Adjustment, after Tax	0	2
Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) On Investments | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1,871	528
Net unrealized gains (losses) arising during the year	(2,470)	1,329
Included in Net earnings (loss)	77	14
Excluded from Net earnings (loss)	0	0
Balance, end of the period	(522)	1,871	528
Unrealized Investment Gains Losses All Other | DAC | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(358)	(45)
DAC	458	(313)
Balance, end of the period	100	(358)	(45)
Unrealized Investment Gains Losses All Other | Policyholders Liabilities | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(238)	(192)
Policyholders liabilities	165	(46)
Balance, end of the period	(73)	(238)	(192)
Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset Liability | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(397)	(102)
Deferred income taxes	501	(295)
Balance, end of the period	104	(397)	(102)
Unrealized Investment Gains Losses All Other | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	878	189
Net unrealized gains (losses) arising during the year	(2,470)	1,329
Included in Net earnings (loss)	77	14
Excluded from Net earnings (loss)		0
DAC	458	(313)
Deferred income taxes	501	(295)
Policyholders liabilities	165	(46)
Balance, end of the period	(391)	$ 878	$ 189
Unrealized gains (losses) on investments
Debt Securities, Available-for-sale [Line Items]
Reclassification from AOCI	$ 113

INVESTMENTS - Fixed Maturities

INVESTMENTS - Fixed Maturities Available-for-sale (Details) $ in Millions	Dec. 31, 2018USD ($)security	Dec. 31, 2017USD ($)security
Investments, Debt and Equity Securities [Abstract]
Number of positions in unrealized loss position | security	1,700	752
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	$ 10,878	$ 5,739
Less than 12 Months, Gross unrealized Losses	393	30
12 Months or Longer, Fair Value	12,720	6,011
12 Months or Longer, Gross unrealized Losses	922	294
Total Fair Value	23,598	11,750
Total Gross unrealized losses	$ 1,315	324
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Debt securities exposure in single issuer greater than stated percentage of total investments	0.70%
Amortized Cost		45,256
Unrealized loss on available for sale securities	$ (31)
Trading securities, at fair value	16,017	14,170
Separate Account Equity Investment Carrying Value	49	50
Public corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	8,964	2,903
Less than 12 Months, Gross unrealized Losses	313	23
12 Months or Longer, Fair Value	8,244	1,331
12 Months or Longer, Gross unrealized Losses	487	42
Total Fair Value	17,208	4,234
Total Gross unrealized losses	800	65
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Exposure in single issuer of total investments	226	207
Amortized Cost	30,572	24,480
U.S. Treasury, government and agency
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	1,077	2,718
Less than 12 Months, Gross unrealized Losses	53	6
12 Months or Longer, Fair Value	4,306	4,506
12 Months or Longer, Gross unrealized Losses	417	245
Total Fair Value	5,383	7,224
Total Gross unrealized losses	470	251
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	14,004	17,759
States and political subdivisions
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	0	20
Less than 12 Months, Gross unrealized Losses	0	0
12 Months or Longer, Fair Value	19	0
12 Months or Longer, Gross unrealized Losses	1	0
Total Fair Value	19	20
Total Gross unrealized losses	1	0
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	415	422
Foreign governments
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	109	11
Less than 12 Months, Gross unrealized Losses	3	0
12 Months or Longer, Fair Value	76	73
12 Months or Longer, Gross unrealized Losses	10	5
Total Fair Value	185	84
Total Gross unrealized losses	13	5
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	524	395
Commercial mortgage-backed
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	225	797
Residential mortgage-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	0	62
Less than 12 Months, Gross unrealized Losses	0	0
12 Months or Longer, Fair Value	29	76
12 Months or Longer, Gross unrealized Losses	1	1
Total Fair Value	29	138
Total Gross unrealized losses	1	1
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	612	745
Asset-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	563	15
Less than 12 Months, Gross unrealized Losses	11	1
12 Months or Longer, Fair Value	13	12
12 Months or Longer, Gross unrealized Losses	1	0
Total Fair Value	576	27
Total Gross unrealized losses	12	1
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	449	470
Redeemable preferred stock
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	165	10
Less than 12 Months, Gross unrealized Losses	13	0
12 Months or Longer, Fair Value	33	13
12 Months or Longer, Gross unrealized Losses	5	1
Total Fair Value	198	23
Total Gross unrealized losses	18	1
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	46,801	45,068
Fixed maturities
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	46,801	45,068
Carrying value of fixed maturities non-income producing	2
Fixed maturities | Other Than Investment Grade | External Credit Rating, Non Investment Grade
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Available-for-sale securities, amortized cost basis other than investment grade	$ 1,268	$ 1,372
Percentage of available for sale securities	2.70%	3.00%
Unrealized loss on available for sale securities		$ 5

INVESTMENTS - Mortgage Loans (D

INVESTMENTS - Mortgage Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually Evaluated for Impairment	$ 7	$ 8
Commercial Real Estate Portfolio Segment
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning balance	8	8	$ 6
Charge-offs	0	0	0
Recoveries	(1)	0	(2)
Provisions	0	0	4
Ending balance	7	8	8
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually Evaluated for Impairment	$ 7	$ 8	$ 8

INVESTMENTS - Loans (Details)

INVESTMENTS - Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Commercial Real Estate Portfolio Segment
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	$ 9,147	$ 8,386
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	27	27
Current	9,120	8,359
Total financing receivables	9,147	8,386
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	0	0
Commercial Real Estate Portfolio Segment | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	0
Unpaid Principal Balance	0	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Commercial Real Estate Portfolio Segment | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	27	27
Unpaid Principal Balance	31	31
Related Allowance	(7)	(8)
Average Recorded Investment	27	27
Interest Income Recognized	0	2
Commercial Real Estate Portfolio Segment | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	27
Commercial Real Estate Portfolio Segment | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Commercial Real Estate Portfolio Segment | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	27	0
Commercial Real Estate Portfolio Segment | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	5,965	5,016
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	5,965	5,016
Commercial Real Estate Portfolio Segment | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	677	792
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	677	792
Commercial Real Estate Portfolio Segment | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,510	1,609
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,510	1,609
Commercial Real Estate Portfolio Segment | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	746	774
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	746	774
Commercial Real Estate Portfolio Segment | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	249	195
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	249	195
Commercial Real Estate Portfolio Segment | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,089	1,153
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,089	1,153
Commercial Real Estate Portfolio Segment | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	797	759
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	797	759
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	21	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	21	0
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	247	320
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	247	320
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	24	74
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	24	74
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	7,186	6,409
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	7,186	6,409
Commercial Real Estate Portfolio Segment | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	4,908	4,088
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	4,908	4,088
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	656	682
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	656	682
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,146	1,066
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,146	1,066
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	325	428
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	325	428
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	151	145
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	151	145
Commercial Real Estate Portfolio Segment | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	845	797
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	845	797
Commercial Real Estate Portfolio Segment | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	260	169
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	260	169
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	110
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	110
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	117	196
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	117	196
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	370	272
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	370	272
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	98	50
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	98	50
Commercial Real Estate Portfolio Segment | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	27
Commercial Real Estate Portfolio Segment | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	27
Commercial Real Estate Portfolio Segment | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,695	2,574
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	68	74
Current	2,627	2,500
Total financing receivables	2,695	2,574
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	40	22
Agricultural Real Estate Portfolio Segment | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	2	0
Unpaid Principal Balance	2	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Agricultural Real Estate Portfolio Segment | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	0
Unpaid Principal Balance	0	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Agricultural Real Estate Portfolio Segment | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	18	49
Agricultural Real Estate Portfolio Segment | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	8	3
Agricultural Real Estate Portfolio Segment | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	42	22
Agricultural Real Estate Portfolio Segment | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	394	383
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	394	383
Agricultural Real Estate Portfolio Segment | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	193	195
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	193	195
Agricultural Real Estate Portfolio Segment | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	513	502
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	513	502
Agricultural Real Estate Portfolio Segment | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	941	878
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	941	878
Agricultural Real Estate Portfolio Segment | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	572	537
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	572	537
Agricultural Real Estate Portfolio Segment | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	82	79
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	82	79
Agricultural Real Estate Portfolio Segment | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,611	1,557
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,611	1,557
Agricultural Real Estate Portfolio Segment | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	282	272
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	282	272
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	147	149
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	147	149
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	267	275
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	267	275
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	543	515
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	543	515
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	321	316
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	321	316
Agricultural Real Estate Portfolio Segment | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	51	30
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	51	30
Agricultural Real Estate Portfolio Segment | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,038	1,013
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,038	1,013
Agricultural Real Estate Portfolio Segment | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	112	111
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	112	111
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	46	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	46	46
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	246	227
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	246	227
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	379	359
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	379	359
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	224	221
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	224	221
Agricultural Real Estate Portfolio Segment | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	31	49
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	31	49
Agricultural Real Estate Portfolio Segment | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	46	4
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	46	4
Agricultural Real Estate Portfolio Segment | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	19	4
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	19	4
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	11,842	10,960
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	95	101
Current	11,747	10,859
Total financing receivables	11,842	10,960
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	40	22
Total Mortgages Loan | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	2	0
Unpaid Principal Balance	2	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Total Mortgages Loan | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	27	27
Unpaid Principal Balance	31	31
Related Allowance	(7)	(8)
Average Recorded Investment	27	27
Interest Income Recognized	0	2
Total Mortgages Loan | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	18	76
Total Mortgages Loan | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	8	3
Total Mortgages Loan | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	69	22
Total Mortgages Loan | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	6,359	5,399
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	6,359	5,399
Total Mortgages Loan | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	870	987
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	870	987
Total Mortgages Loan | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,023	2,111
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	2,023	2,111
Total Mortgages Loan | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,687	1,652
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,687	1,652
Total Mortgages Loan | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	821	732
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	821	732
Total Mortgages Loan | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	82	79
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	82	79
Total Mortgages Loan | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,700	2,710
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	2,700	2,710
Total Mortgages Loan | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,079	1,031
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,079	1,031
Total Mortgages Loan | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	168	149
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	168	149
Total Mortgages Loan | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	514	595
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	514	595
Total Mortgages Loan | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	567	589
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	567	589
Total Mortgages Loan | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	321	316
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	321	316
Total Mortgages Loan | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	51	30
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	51	30
Total Mortgages Loan | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	8,224	7,422
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	8,224	7,422
Total Mortgages Loan | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	5,020	4,199
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	5,020	4,199
Total Mortgages Loan | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	702	728
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	702	728
Total Mortgages Loan | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,392	1,293
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,392	1,293
Total Mortgages Loan | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	704	787
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	704	787
Total Mortgages Loan | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	375	366
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	375	366
Total Mortgages Loan | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	31	49
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	31	49
Total Mortgages Loan | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	891	801
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	891	801
Total Mortgages Loan | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	260	169
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	260	169
Total Mortgages Loan | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	110
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	110
Total Mortgages Loan | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	117	196
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	117	196
Total Mortgages Loan | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	389	276
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	389	276
Total Mortgages Loan | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	125	50
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	125	50
Total Mortgages Loan | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	27
Total Mortgages Loan | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	27
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	27
Total Mortgages Loan | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	0
Total Mortgages Loan | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	$ 0	$ 0

INVESTMENTS - Derivatives (Deta

INVESTMENTS - Derivatives (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Derivatives, Fair Value [Line Items]
Notional Amount	$ 83,228	$ 87,914
Asset Derivatives	4,725	6,046
Liability Derivatives	9,471	10,230
Gains (Losses) Reported In Earnings (Loss)	(222)	254
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	11,143	6,716
Asset Derivatives	2	1
Liability Derivatives	3	2
Gains (Losses) Reported In Earnings (Loss)	541	(1,297)
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	7,796	7,623
Asset Derivatives	143	4
Liability Derivatives	168	201
Gains (Losses) Reported In Earnings (Loss)	715	(1,413)
Options
Derivatives, Fair Value [Line Items]
Notional Amount	21,821	22,223
Asset Derivatives	2,133	3,456
Liability Derivatives	1,164	1,457
Gains (Losses) Reported In Earnings (Loss)	(899)	1,265
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	27,116	26,769
Asset Derivatives	634	604
Liability Derivatives	196	193
Gains (Losses) Reported In Earnings (Loss)	(656)	863
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	11,792	20,675
Asset Derivatives	0	0
Liability Derivatives	0	0
Gains (Losses) Reported In Earnings (Loss)	112	293
Credit default swaps
Derivatives, Fair Value [Line Items]
Notional Amount	1,376	2,131
Asset Derivatives	20	35
Liability Derivatives	3	3
Gains (Losses) Reported In Earnings (Loss)	(2)	19
Foreign currency contracts
Derivatives, Fair Value [Line Items]
Notional Amount	2,184	1,423
Asset Derivatives	35	19
Liability Derivatives	22	10
Gains (Losses) Reported In Earnings (Loss)	6	(39)
Margin
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	18	24
Liability Derivatives	5	4
Gains (Losses) Reported In Earnings (Loss)	0	0
Collateral Contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	8	4
Liability Derivatives	1,581	2,123
Gains (Losses) Reported In Earnings (Loss)	0	0
GMIB reinsurance contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	1,732	1,894
Liability Derivatives	0	0
Gains (Losses) Reported In Earnings (Loss)	(162)	174
GIB and GWBL and Other Features
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	0	0
Liability Derivatives	5,614	4,451
Gains (Losses) Reported In Earnings (Loss)	(775)	1,652
SCS, SIO, MSO and IUL indexed features liability
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	0	0
Liability Derivatives	715	1,786
Gains (Losses) Reported In Earnings (Loss)	889	(1,303)
Embedded Derivative Financial Instruments
Derivatives, Fair Value [Line Items]
Gains (Losses) Reported In Earnings (Loss)	(231)	214
Currency Swap
Derivatives, Fair Value [Line Items]
Notional Amount	0	354
Asset Derivatives	0	5
Liability Derivatives	0	0
Gains (Losses) Reported In Earnings (Loss)	$ 9	$ 40

INVESTMENTS - Derivatives 1 (De

INVESTMENTS - Derivatives 1 (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Investments, Debt and Equity Securities [Abstract]
Cash and securities collateral for derivative contract	$ 1,581	$ 2,123
Cash and securities collateral	8	$ 4
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Exchange Traded Future Contract [Line Items]
Initial margin requirement	279
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Exchange Traded Future Contract [Line Items]
Initial margin requirement	71
Euro Stoxx, FTSE100, EAFE And Topix Indices
Exchange Traded Future Contract [Line Items]
Initial margin requirement	$ 25

INVESTMENTS - Offsetting (Detai

INVESTMENTS - Offsetting (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Offsetting Assets [Line Items]
Securities sold under agreements to repurchase	$ 573	$ 1,887
ASSETS
Gross Amount Recognized	2,993
Gross Amount Offset in the Balance Sheets	2,945
Net Amount Presented in the Balance Sheets	48
LIABILITIES
Gross Amount Recognized	3,142
Gross Amount Offset in the Balance Sheets	2,945
Net Amount Presented in the Balance Sheets	197
Asset Derivatives	4,725	6,046
Liability Derivatives	9,471	10,230
Currency Swap
LIABILITIES
Asset Derivatives	0	5
Liability Derivatives	0	0
Credit default swaps
LIABILITIES
Asset Derivatives	20	35
Liability Derivatives	3	3
Margin
LIABILITIES
Asset Derivatives	18	24
Liability Derivatives	5	4
Collateral Contracts
LIABILITIES
Asset Derivatives	8	4
Liability Derivatives	1,581	2,123
Derivatives not subject to an ISDA Master Agreements
ASSETS
Gross Amount Recognized		5
Gross Amount Offset in the Balance Sheets		0
Net Amount Presented in the Balance Sheets		5
Derivative investments
Offsetting Assets [Line Items]
Securities purchased under agreements to resell	197
ASSETS
Gross Amount Recognized		4,147
Gross Amount Offset in the Balance Sheets		3,993
Net Amount Presented in the Balance Sheets		154
LIABILITIES
Gross Amount Recognized		3,993
Gross Amount Offset in the Balance Sheets		3,993
Net Amount Presented in the Balance Sheets		0
Other Financial Instruments
ASSETS
Gross Amount Recognized	1,989	3,964
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,989	3,964
Other Invested Assets
ASSETS
Gross Amount Recognized	4,982	8,111
Gross Amount Offset in the Balance Sheets	2,945	3,993
Net Amount Presented in the Balance Sheets	2,037	4,118
Other financial liabilities
Offsetting Assets [Line Items]
Securities purchased under agreements to resell	3,163
LIABILITIES
Gross Amount Recognized	3,163	4,053
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	3,163	4,053
Other liabilities
LIABILITIES
Gross Amount Recognized	6,305	8,046
Gross Amount Offset in the Balance Sheets	2,945	3,993
Net Amount Presented in the Balance Sheets	3,360	4,053
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Securities sold under agreements to repurchase	571
LIABILITIES
Gross Amount Recognized	571	1,882
Gross Amount Offset in the Balance Sheets	0	2,009
Net Amount Presented in the Balance Sheets	$ 571	$ (127)

INVESTMENTS - Offsetting 1 (Det

INVESTMENTS - Offsetting 1 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	$ 48
Repurchase agreements, net amount presented on the balance sheet	573	$ 1,887
Asset Derivatives	4,725	6,046
Securities sold under agreements to repurchase	2	5
Derivative investments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets		154
Reverse repurchase agreements, net amount presented on the balance sheet	197
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	197
Other financial liabilities
Offsetting Assets [Line Items]
Reverse repurchase agreements, net amount presented on the balance sheet	3,163
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	3,163
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Repurchase agreements, net amount presented on the balance sheet	571
Collateral (Received)/Held, Financial Instruments	(588)
Collateral (Received)/Held, Cash	0
Net amounts	(17)
Securities purchased under agreements to resell
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets		4,053
Colleteral (Received)/Held, Financial Instruments		0
Collateral (Received)/Held, Cash		0
Net Amount		4,053
Securities purchased under agreements to resell | Other financial liabilities
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets		4,053
Colleteral (Received)/Held, Financial Instruments		0
Collateral (Received)/Held, Cash		0
Net Amount		4,053
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Repurchase agreements, net amount presented on the balance sheet		1,882
Collateral (Received)/Held, Financial Instruments		(1,988)
Collateral (Received)/Held, Cash		(21)
Net amounts		(127)
Other Investments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	3,400	6,217
Colleteral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	(1,363)	(2,099)
Net Amount	2,037	4,118
Other Financial Instruments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	1,989	3,964
Colleteral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	0	0
Net Amount	1,989	3,964
Derivative investments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	1,411	2,253
Colleteral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	(1,363)	(2,099)
Net Amount	48	$ 154
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Reverse repurchase agreements, net amount presented on the balance sheet	3,360
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	$ 3,360

INVESTMENTS - Repurchase to Mat

INVESTMENTS - Repurchase to Maturity Transactions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Derivative [Line Items]
Securities sold under agreement to repurchase	$ 571	$ 1,882
Securities sold under agreements to repurchase	2	5
U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity Overnight and on Demand
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Overnight and on Demand | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Less than 30 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity Less than 30 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity 30 to 90 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity 30 to 90 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Greater than 90 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Greater than 90 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	$ 0	$ 0

INVESTMENTS - Net Investment In

INVESTMENTS - Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net Investment Income [Line Items]
Investment income	$ 2,765	$ 3,154	$ 2,744
Investment expenses	(72)	(72)	(79)
Total net investment income (loss)	2,693	3,082	2,665
Net investment income (loss) from derivatives	(86)	(191)	1,983
Schedule Of Gain Loss On Investments Including Marketable Securities And Investments Held At Cost Income Statement Reported Amounts Summary [Abstract]
Interest Credited To Policyholders Account Balances Participating Group Annuity Contracts	3	3	4
Fixed maturities
Net Investment Income [Line Items]
Investment income	1,725	1,629	1,723
Net investment income (loss) from derivatives	(75)	(194)	83
Mortgage loans on real estate
Net Investment Income [Line Items]
Investment income	494	454	397
Net investment income (loss) from derivatives	0	2	(2)
Real estate held for the production of income
Net Investment Income [Line Items]
Investment income	(6)	2	19
Net investment income (loss) from derivatives	0	0	1,880
Other equity investments
Net Investment Income [Line Items]
Investment income	147	186	168
Net investment income (loss) from derivatives	0	2	(2)
Repurchase agreement
Net Investment Income [Line Items]
Investment income	0	0	1
Policy loans
Net Investment Income [Line Items]
Investment income	215	221	225
Trading securities
Net Investment Income [Line Items]
Investment income	105	553	144
Other Investments
Net Investment Income [Line Items]
Investment income	85	109	67
Net investment income (loss) from derivatives	$ (11)	$ (1)	$ 24

INVESTMENTS - Trading Securitie

INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Net investment gains (losses) recognized during the period on securities held at the end of the period	$ (223)	$ 247	$ (51)
Net investment gains (losses) recognized on securities sold during the period	(14)	19	(12)
Unrealized and realized gains (losses) on trading securities	(237)	266	(63)
Interest and dividend income from trading securities	342	287	207
Net investment income (loss) from trading securities	$ 105	$ 553	$ 144

INVESTMENTS - Investment Gains

INVESTMENTS - Investment Gains (Losses), Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Investment [Line Items]
Trading securities, at fair value	$ 16,017	$ 14,170
Net investment income (loss) from derivatives	(86)	(191)	$ 1,983
Interest Credited To Policyholders Account Balances Participating Group Annuity Contracts	3	3	4
Separate Account Equity Investment Carrying Value	49	50
Fixed maturities
Investment [Line Items]
Net investment income (loss) from derivatives	(75)	(194)	83
Real estate held for the production of income
Investment [Line Items]
Net investment income (loss) from derivatives	0	0	1,880
Mortgage loans on real estate
Investment [Line Items]
Net investment income (loss) from derivatives	0	2	(2)
Other equity investments
Investment [Line Items]
Net investment income (loss) from derivatives	0	2	(2)
Other Investments
Investment [Line Items]
Net investment income (loss) from derivatives	$ (11)	$ (1)	$ 24

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)security	Dec. 31, 2017USD ($)security
Investment [Line Items]
Trading securities, at fair value	$ 16,017	$ 14,170
Separate Account Equity Investment Carrying Value	$ 49	$ 50
Number of positions in unrealized loss position | security	1,700	752
Debt securities exposure in single issuer greater than stated percentage of total investments	0.70%
Amortized Cost		$ 45,256
Unrealized loss on available for sale securities	$ (31)
12 Months or Longer, Gross unrealized Losses	922	294
Cash and securities collateral for derivative contract	1,581	2,123
Cash and securities collateral	8	4
Securities sold under agreements to repurchase	573	1,887
Proceeds from sale of treasury stock	3,905
Corporate
Investment [Line Items]
Exposure in single issuer of total investments	226	207
Amortized Cost	30,572	24,480
Fixed maturities
Investment [Line Items]
Amortized Cost	46,801	45,068
Carrying value of fixed maturities non-income producing	2
US Treasury Securities
Investment [Line Items]
Aggregate fair value	3,690
Other Than Investment Grade | External Credit Rating, Non Investment Grade | Fixed maturities
Investment [Line Items]
Available-for-sale securities, amortized cost basis other than investment grade	$ 1,268	$ 1,372
Percentage of available for sale securities	2.70%	3.00%
Unrealized loss on available for sale securities		$ 5
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Investment [Line Items]
Initial margin requirement	$ 279
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Investment [Line Items]
Initial margin requirement	71
Euro Stoxx, FTSE100, EAFE And Topix Indices
Investment [Line Items]
Initial margin requirement	25
Total Return Swap
Investment [Line Items]
Aggregate fair value	24
Commercial Real Estate Portfolio Segment
Investment [Line Items]
Recorded Investment, Nonaccrual Status	$ 19	$ 19

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions		Jun. 20, 2014	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Goodwill [Line Items]
Goodwill impairment loss				$ 0	$ 369	$ 0
Carrying value of goodwill				4,570	4,570	4,939	$ 4,917
Redeemable noncontrolling interest	[1]			187	626
Capitalized software, net				181	162
Amortization of capitalized software				49	51	56
Financial Advisory/Insurance
Goodwill [Line Items]
Goodwill impairment loss			$ 369
Investment Management
Goodwill [Line Items]
Carrying value of goodwill					4,570
Alliance Bernstein
Goodwill [Line Items]
Amortization of Intangible Assets				43	44	$ 42
Gross carrying amount of AllianceBernstein related intangible assets				909	909
Accumulated amortization of these intangible assets				702	659
Amortization expense, 2019				43
Amortization expense, 2020				36
Amortization expense, 2021				20
Amortization expense, 2022				19
Amortization expense, 2023				16
Alliance Bernstein | Investment Management
Goodwill [Line Items]
Amortization of Intangible Assets				$ 4,570
CPH Capital | Alliance Bernstein
Goodwill [Line Items]
Ownership percentage acquired		81.70%		96.80%
Assets under management, carrying amount		$ 3,000
Cash payment		64
Contingent consideration payable		9
Carrying value of goodwill		58
Finite-lived intangible assets acquired		24
Indefinite-lived intangible assets acquired		4
Redeemable noncontrolling interest		$ 17
Deferred Sales Commissions | Alliance Bernstein
Goodwill [Line Items]
Gross carrying amount of AllianceBernstein related intangible assets				$ 17	$ 30
Amortization expense, 2019				10
Amortization expense, 2020				5
Amortization expense, 2021				3
Amortization expense, 2022				0
Amortization expense, 2023				$ 0
[1]	See Note 2 for details of balances with variable interest entities.

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Roll Forward]
Goodwill, beginning of year	$ 4,570	$ 4,939	$ 4,917
Goodwill acquired during year	0	0	22
Impairment losses recognized during the year	0	(369)	0
Goodwill, end of year, net	4,570	4,570	4,939
Investment Management And Research
Goodwill [Roll Forward]
Goodwill, beginning of year	4,570	4,570	4,548
Goodwill acquired during year	0	0	22
Impairment losses recognized during the year	0	0	0
Goodwill, end of year, net	4,570	4,570	4,570
Operating Segments
Goodwill [Roll Forward]
Goodwill, beginning of year	0	369	369
Goodwill acquired during year	0	0	0
Impairment losses recognized during the year	0	(369)	0
Goodwill, end of year, net	0	0	369
Operating Segments | Individual Retirement
Goodwill [Roll Forward]
Goodwill, beginning of year	0	53	53
Goodwill acquired during year	0	0	0
Impairment losses recognized during the year	0	(53)	0
Goodwill, end of year, net	0	0	53
Operating Segments | Group Retirement
Goodwill [Roll Forward]
Goodwill, beginning of year	0	122	122
Goodwill acquired during year	0	0	0
Impairment losses recognized during the year	0	(122)	0
Goodwill, end of year, net	0	0	122
Operating Segments | Protection Solutions
Goodwill [Roll Forward]
Goodwill, beginning of year	0	139	139
Goodwill acquired during year	0	0	0
Impairment losses recognized during the year	0	(139)	0
Goodwill, end of year, net	0	0	139
Operating Segments | Corporate and Other
Goodwill [Roll Forward]
Goodwill, beginning of year	0	55	55
Goodwill acquired during year	0	0	0
Impairment losses recognized during the year	0	(55)	0
Goodwill, end of year, net	$ 0	$ 0	$ 55

CLOSED BLOCK - Closed Block Sum

CLOSED BLOCK - Closed Block Summarized Financial Information (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other	$ 6,709	$ 6,958
Policyholders’ dividend obligation	0	(19)	$ (52)
Other liabilities	47	271
Total Closed Block liabilities	6,756	7,248
Assets Designated To The Closed Block:
Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923)	3,672	4,070
Mortgage loans on real estate, net of valuation allowance of $- and $-	1,824	1,720
Policy loans	736	781
Cash and other invested assets	76	351
Other assets	179	182
Total assets designated to the Closed Block	6,487	7,104
Excess of Closed Block liabilities over assets designated to the Closed Block	269	144
Amounts included in Accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholders' dividend obligation of $- and $19	8	138
Maximum future income to be recognized from closed block assets and liabilities	$ 277	282
Closed block investments fixed maturity available for sale amortized cost		3,680		$ 3,923
Closed block operations, income taxes		$ 0		$ 19

CLOSED BLOCK - Closed Block Rev

CLOSED BLOCK - Closed Block Revenues and Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Premiums and other income	$ 194	$ 224	$ 212
Net investment income (loss)	291	314	349
Investment gains (losses), net	(3)	(20)	(1)
Total revenues	482	518	560
Benefits and Other Deductions:
Policyholders’ benefits and dividends	471	537	522
Other operating costs and expenses	3	2	4
Total benefits and other deductions	474	539	526
Net income, before income taxes	8	(21)	34
Income tax (expense) benefit	(3)	(36)	(12)
Net income (losses)	$ 5	$ (57)	$ 22

CLOSED BLOCK - Reconciliation o

CLOSED BLOCK - Reconciliation of Policyholder Dividend Obligation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Movement in Closed Block Dividend Obligation [Roll Forward]
Balances, beginning of year	$ (19)	$ (52)
Unrealized investment gains (losses)	(19)	(33)
Balances, End of year	$ 0	$ (19)

DAC AND POLICYHOLDER BONUS IN_3

DAC AND POLICYHOLDER BONUS INTEREST CREDITS - Changes in Deferred Acquisition Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of year	$ 5,919	$ 6,049	$ 6,047
Capitalization of commissions, sales and issue expenses	701	687	697
Amortization:
Impact of assumptions updates and model changes	286	112	(201)
All other	(619)	(615)	(578)
Total amortization	(333)	(503)	(779)
Change in unrealized investment gains and losses	458	(314)	84
Balance, end of year	$ 6,745	$ 5,919	$ 6,049

DAC AND POLICYHOLDER BONUS IN_4

DAC AND POLICYHOLDER BONUS INTEREST CREDITS - Changes in Deferred Asset for Policyholder Bonus Interest Credits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Changes in the deferred asset for contractholder bonus interest credits
Balance, beginning of year	$ 473	$ 504	$ 534
Contractholder bonus interest credits deferred	4	7	13
Amortization charged to income	51	38	43
Balance, End of Year	$ 426	$ 473	$ 504

FAIR VALUE DISCLOSURES - Assets

FAIR VALUE DISCLOSURES - Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:		$ 47,131
Trading securities, at fair value	$ 16,017	14,170
Fair Value, Measurements, Recurring
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	46,279	46,941
Other equity investments	85	47
Trading securities, at fair value	16,017	14,170
Other invested assets	2,303	5,289
Cash equivalents	3,482	3,608
Segregated securities	1,170	825
GMIB reinsurance contracts asset	1,732	1,894
Separate Accounts assets	110,115	124,346
Total Assets	181,183	197,120
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	6,343	6,944
Fair Value, Measurements, Recurring | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	30,178	25,446
Fair Value, Measurements, Recurring | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	13,829	18,508
Fair Value, Measurements, Recurring | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	461	489
Fair Value, Measurements, Recurring | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	530	419
Fair Value, Measurements, Recurring | Residential mortgage-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	234	818
Fair Value, Measurements, Recurring | Asset-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	601	749
Fair Value, Measurements, Recurring | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	446	512
Fair Value, Measurements, Recurring | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	515	1,730
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	378	1,302
Fair Value, Measurements, Recurring | Swap
Investment Fair Value Disclosure [Abstract]
Other invested assets	426	222
Fair Value, Measurements, Recurring | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	17	33
Fair Value, Measurements, Recurring | Future
Investment Fair Value Disclosure [Abstract]
Other invested assets	(1)	(2)
Fair Value, Measurements, Recurring | Options Held
Investment Fair Value Disclosure [Abstract]
Other invested assets	968	1,999
Fair Value, Measurements, Recurring | Foreign currency contracts
Investment Fair Value Disclosure [Abstract]
Other invested assets		5
Fair Value, Measurements, Recurring | Guaranteed Minimum Withdrawal Benefit
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	5,614	4,451
Fair Value, Measurements, Recurring | SCS, SIO, MSO and IUL indexed features liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	715	1,786
Fair Value, Measurements, Recurring | Liabilities of consolidated VIEs and VOEs
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	7	692
Fair Value, Measurements, Recurring | Contingent Payment Arrangements
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	7	15
Fair Value, Measurements, Recurring | Level 1
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	167	184
Other equity investments	11	13
Trading securities, at fair value	446	485
Other invested assets	91	1,058
Cash equivalents	3,482	3,608
Segregated securities	0	0
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	106,994	121,000
Total Assets	111,191	126,348
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	0	670
Fair Value, Measurements, Recurring | Level 1 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | Asset-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 1 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	167	184
Fair Value, Measurements, Recurring | Level 1 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	92	1,060
Fair Value, Measurements, Recurring | Level 1 | Swap
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Future
Investment Fair Value Disclosure [Abstract]
Other invested assets	(1)	(2)
Fair Value, Measurements, Recurring | Level 1 | Options Held
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Foreign currency contracts
Investment Fair Value Disclosure [Abstract]
Other invested assets		0
Fair Value, Measurements, Recurring | Level 1 | Guaranteed Minimum Withdrawal Benefit
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 1 | SCS, SIO, MSO and IUL indexed features liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 1 | Liabilities of consolidated VIEs and VOEs
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	670
Fair Value, Measurements, Recurring | Level 1 | Contingent Payment Arrangements
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 2
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	44,368	45,025
Other equity investments	0	0
Trading securities, at fair value	15,507	13,647
Other invested assets	2,185	4,204
Cash equivalents	0	0
Segregated securities	1,170	825
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	2,747	2,997
Total Assets	65,977	66,698
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	722	1,808
Fair Value, Measurements, Recurring | Level 2 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	28,992	24,296
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	13,829	18,508
Fair Value, Measurements, Recurring | Level 2 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	422	449
Fair Value, Measurements, Recurring | Level 2 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	530	419
Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	234	818
Fair Value, Measurements, Recurring | Level 2 | Asset-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	82	208
Fair Value, Measurements, Recurring | Level 2 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	279	327
Fair Value, Measurements, Recurring | Level 2 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	515	1,730
Fair Value, Measurements, Recurring | Level 2 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	259	215
Fair Value, Measurements, Recurring | Level 2 | Swap
Investment Fair Value Disclosure [Abstract]
Other invested assets	426	222
Fair Value, Measurements, Recurring | Level 2 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	17	33
Fair Value, Measurements, Recurring | Level 2 | Future
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 2 | Options Held
Investment Fair Value Disclosure [Abstract]
Other invested assets	968	1,999
Fair Value, Measurements, Recurring | Level 2 | Foreign currency contracts
Investment Fair Value Disclosure [Abstract]
Other invested assets		5
Fair Value, Measurements, Recurring | Level 2 | Guaranteed Minimum Withdrawal Benefit
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 2 | SCS, SIO, MSO and IUL indexed features liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	715	1,786
Fair Value, Measurements, Recurring | Level 2 | Liabilities of consolidated VIEs and VOEs
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	7	22
Fair Value, Measurements, Recurring | Level 2 | Contingent Payment Arrangements
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 3
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	1,744	1,732
Other equity investments	74	34
Trading securities, at fair value	64	38
Other invested assets	27	27
Cash equivalents	0	0
Segregated securities	0	0
GMIB reinsurance contracts asset	1,732	1,894
Separate Accounts assets	374	349
Total Assets	4,015	4,074
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	5,621	4,466
Fair Value, Measurements, Recurring | Level 3 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	1,186	1,150
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 3 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	39	40
Fair Value, Measurements, Recurring | Level 3 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	0
Fair Value, Measurements, Recurring | Level 3 | Asset-backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	519	541
Fair Value, Measurements, Recurring | Level 3 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale:	0	1
Fair Value, Measurements, Recurring | Level 3 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	27	27
Fair Value, Measurements, Recurring | Level 3 | Swap
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Future
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Options Held
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Foreign currency contracts
Investment Fair Value Disclosure [Abstract]
Other invested assets		0
Fair Value, Measurements, Recurring | Level 3 | Guaranteed Minimum Withdrawal Benefit
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	5,614	4,451
Fair Value, Measurements, Recurring | Level 3 | SCS, SIO, MSO and IUL indexed features liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 3 | Liabilities of consolidated VIEs and VOEs
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	0	0
Fair Value, Measurements, Recurring | Level 3 | Contingent Payment Arrangements
Liabilities, Fair Value Disclosure [Abstract]
Guarantees	$ 7	$ 15

FAIR VALUE DISCLOSURES - Fair V

FAIR VALUE DISCLOSURES - Fair Value Measurement Reconciliation for All Levels (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	$ (86)	$ (191)	$ 1,983
Transfers into level 3	89	7
Transfers into level 3	(28)	(5)
Public corporate | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(1,150)	(857)	(430)
Net investment income (loss)	8	4
Investment gains (losses), net	(9)	1	2
Subtotal	(1)	5
Other comprehensive income (loss)	(21)	4	8
Purchases	334	615	574
Sales	337	333	144
Transfers into level 3	89	7	25
Transfers into level 3	28	5	38
Closing Balance	(1,186)	(1,150)	(857)
Redeemable preferred stock | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(1)	(1)	0
Investment gains (losses), net	0	0	0
Increase (decrease) in the fair value of the reinsurance contracts	0	0	0
Nonperformance risk	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)	0	0	0
Purchases	0	0	1
Sales	(1)	0	0
Settlements	0	0
Change in estimate	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers into level 3	0	0	0
Closing Balance	0	(1)	(1)
Contingent Payment Arrangements | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	15	25	31
Investment gains (losses), net	0	0	0
Increase (decrease) in the fair value of the reinsurance contracts	0	0	0
Nonperformance risk	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)	0	0	0
Purchases	0	0	(18)
Sales	0	0	0
Settlements	6	10
Change in estimate	2
Activity related to consolidated VIEs/VOEs	0	0	24
Transfers into level 3	0	0	0
Transfers into level 3	0	0	0
Closing Balance	7	15	25
Other equity investments | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(99)	(88)	(81)
Investment gains (losses), net	(3)	0	0
Increase (decrease) in the fair value of the reinsurance contracts	0	0	0
Nonperformance risk	0	0	0
Subtotal	(3)	0	0
Other comprehensive income (loss)	15	14	(1)
Purchases	62	22	4
Sales	(3)	(3)	0
Settlements	0	0
Change in estimate	0
Activity related to consolidated VIEs/VOEs	(6)	(22)	60
Transfers into level 3	6	0	0
Transfers into level 3	(5)	0	(56)
Closing Balance	(165)	(99)	(88)
Gmib Reinsurance | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(1,894)	(1,735)	(1,829)
Investment gains (losses), net	0	0	0
Increase (decrease) in the fair value of the reinsurance contracts	(131)	171	(75)
Nonperformance risk	(33)	3	(2)
Subtotal	(164)	174	(77)
Other comprehensive income (loss)	0	0	0
Purchases	46	48	48
Sales	(44)	(63)	(65)
Settlements	0	0
Change in estimate	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers into level 3	0	0	0
Closing Balance	(1,732)	(1,894)	(1,735)
Separate Accounts | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(349)	(313)	(313)
Investment gains (losses), net	26	29	19
Increase (decrease) in the fair value of the reinsurance contracts	0	0	0
Nonperformance risk	0	0	0
Subtotal	26	29	19
Other comprehensive income (loss)	0	0	0
Purchases	5	13	10
Sales	(1)	(2)	0
Settlements	(5)	(4)
Change in estimate	0
Activity related to consolidated VIEs/VOEs	0	0	(7)
Transfers into level 3	0	0	1
Transfers into level 3	0	0	(23)
Closing Balance	(374)	(349)	(313)
GIB and GWBL and Other Features | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	4,451	5,731	5,534
Investment gains (losses), net	0	0	0
Increase (decrease) in the fair value of the reinsurance contracts	(1,272)	1,809	417
Nonperformance risk	497	(157)	(281)
Subtotal	(775)	1,652	136
Other comprehensive income (loss)	0	0	0
Purchases	(412)	(393)	(356)
Sales	24	21	23
Settlements	0	0
Change in estimate	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers into level 3	0	0	0
Closing Balance	5,614	4,451	5,731
States and political subdivisions | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(40)	(42)	(45)
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Subtotal	0	0
Other comprehensive income (loss)	(1)	(1)	(2)
Purchases	0	0	0
Sales	1	1	1
Transfers into level 3	1	0	0
Transfers into level 3	0	0	0
Closing Balance	(39)	(40)	(42)
Foreign governments | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	0	0	(1)
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Subtotal	0	0
Other comprehensive income (loss)	0	0	0
Purchases	0	0	0
Sales	0	0	0
Transfers into level 3	0	0	0
Transfers into level 3	0	0	1
Closing Balance	0	0	0
Commercial mortgage-backed | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	0	(373)	(535)
Net investment income (loss)	0	(2)
Investment gains (losses), net	0	(95)	(71)
Subtotal	0	(97)
Other comprehensive income (loss)	0	78	14
Purchases	0	0	0
Sales	0	354	91
Transfers into level 3	0	0	0
Transfers into level 3	0	0	14
Closing Balance	0	0	(373)
Asset-backed | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(541)	(120)	(41)
Net investment income (loss)	0	0
Investment gains (losses), net	0	15	0
Subtotal	0	15
Other comprehensive income (loss)	(9)	(7)	1
Purchases	17	434	96
Sales	30	21	9
Transfers into level 3	0	0	0
Transfers into level 3	0	0	9
Closing Balance	$ (519)	$ (541)	$ (120)

FAIR VALUE DISCLOSURES - Quanti

FAIR VALUE DISCLOSURES - Quantitative Information about Level 3 (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment gains (losses), net	$ (86)	$ (191)	$ 1,983
AFS fixed maturities transferred from Level 3 to Level 2	89	7
AFS fixed maturities transferred from Level 3 to Level 2	28	5
Asset Derivatives	4,725	6,046
Level 3 | Public corporate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	1,186	1,150	857	$ 430
Net investment income (loss)	8	4
Investment gains (losses), net	(9)	1	2
Gain (loss) included in earnings	(1)	5
Other comprehensive income (loss)	(21)	4	8
Purchases	334	615	574
Sales	(337)	(333)	(144)
AFS fixed maturities transferred from Level 3 to Level 2	89	7	25
AFS fixed maturities transferred from Level 3 to Level 2	(28)	(5)	(38)
Level 3 | Asset-backed
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	519	541	120	41
Net investment income (loss)	0	0
Investment gains (losses), net	0	15	0
Gain (loss) included in earnings	0	15
Other comprehensive income (loss)	(9)	(7)	1
Purchases	17	434	96
Sales	(30)	(21)	(9)
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	(9)
Level 3 | Separate Accounts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	374	349	313	313
Investment gains (losses), net	26	29	19
Gain (loss) included in earnings	26	29	19
Other comprehensive income (loss)	0	0	0
Purchases	5	13	10
Sales	1	2	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	1
AFS fixed maturities transferred from Level 3 to Level 2	0	0	23
Level 3 | GMIB reinsurance contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	1,732	1,894	1,735	1,829
Investment gains (losses), net	0	0	0
Gain (loss) included in earnings	(164)	174	(77)
Other comprehensive income (loss)	0	0	0
Purchases	46	48	48
Sales	44	63	65
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
Level 3 | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	39	40	42	45
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Gain (loss) included in earnings	0	0
Other comprehensive income (loss)	(1)	(1)	(2)
Purchases	0	0	0
Sales	(1)	(1)	(1)
AFS fixed maturities transferred from Level 3 to Level 2	1	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
Level 3 | Foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	0	0	0	1
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Gain (loss) included in earnings	0	0
Other comprehensive income (loss)	0	0	0
Purchases	0	0	0
Sales	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	(1)
Level 3 | Commercial mortgage-backed
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	0	0	373	$ 535
Net investment income (loss)	0	(2)
Investment gains (losses), net	0	(95)	(71)
Gain (loss) included in earnings	0	(97)
Other comprehensive income (loss)	0	78	14
Purchases	0	0	0
Sales	0	(354)	(91)
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	0	0	$ (14)
Other equity investments | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	$ 35	$ 38
Fair Value Inputs, Discount Period	12 years	12 years
Other equity investments | Discount Rate | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.100	0.100
Other equity investments | Revenue Multiple | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	9.4	10.8
Other equity investments | Revenue Multiple | Level 3 | Discounted Cash Flow Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	9.4
Public corporate | Level 3 | Matrix Pricing Model Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	$ 99	$ 53
Public corporate | Level 3 | Matrix Pricing Model Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread Over Industry Yield Curve BPS	0.015	0
Public corporate | Level 3 | Matrix Pricing Model Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread Over Industry Yield Curve BPS	0.0580	0.0565
Public corporate | Level 3 | Matrix Pricing Model Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread Over Industry Yield Curve BPS	0.0109	0.0125
Public corporate | Level 3 | Market Comparable Companies Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	$ 881	$ 789
Public corporate | EBITDA Multiple | Level 3 | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	4.1	5.3
Public corporate | EBITDA Multiple | Level 3 | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	37.8	27.9
Public corporate | EBITDA Multiple | Level 3 | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	12.1	12.9
Public corporate | Discount Rate | Level 3 | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.064	0.072
Public corporate | Discount Rate | Level 3 | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.165	0.170
Public corporate | Discount Rate | Level 3 | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	0.110	0.111
Public corporate | Cash Flow Multiples | Level 3 | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	1.8	9
Public corporate | Cash Flow Multiples | Level 3 | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	18	17.7
Public corporate | Cash Flow Multiples | Level 3 | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, measurement input	11.4	13.1
Guaranteed Insurance Benefits | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability, fair value	$ (48)	$ (27)
Guaranteed Insurance Benefits | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.005	0.009
Guaranteed Insurance Benefits | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.057	0.057
Guaranteed Insurance Benefits | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Insurance Benefits | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.080	0.070
Guaranteed Insurance Benefits | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Insurance Benefits | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.160	0.160
Guaranteed Insurance Benefits | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
Guaranteed Insurance Benefits | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
Assumed GMIB Reinsurance Contracts | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability, fair value	$ 183	$ 194
Assumed GMIB Reinsurance Contracts | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.011	0.011
Assumed GMIB Reinsurance Contracts | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.112	0.133
Assumed GMIB Reinsurance Contracts | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.007	0.007
Assumed GMIB Reinsurance Contracts | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.222	0.222
Assumed GMIB Reinsurance Contracts | Withdrawal Rate 2 | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.013	0.013
Assumed GMIB Reinsurance Contracts | Withdrawal Rate 2 | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
Assumed GMIB Reinsurance Contracts | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Assumed GMIB Reinsurance Contracts | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.300	0.300
Assumed GMIB Reinsurance Contracts | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.013
Assumed GMIB Reinsurance Contracts | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.011
Assumed GMIB Reinsurance Contracts | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.024
Assumed GMIB Reinsurance Contracts | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
Assumed GMIB Reinsurance Contracts | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
GMIB and GWBL | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability, fair value	$ 130	$ 130
GMIB and GWBL | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.005	0.009
GMIB and GWBL | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.057	0.057
GMIB and GWBL | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GMIB and GWBL | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.070	0.070
GMIB and GWBL | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
GMIB and GWBL | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
GMIB and GWBL | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
Guaranteed Minimum Annuity Benefits | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability, fair value	$ 7	$ 5
Guaranteed Minimum Annuity Benefits | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.005	0.005
Guaranteed Minimum Annuity Benefits | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.110	0.110
Guaranteed Minimum Annuity Benefits | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
Guaranteed Minimum Annuity Benefits | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
GMIB reinsurance contracts | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset Derivatives	$ 1,732	$ 1,894
GMIB reinsurance contracts | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.01	0.010
GMIB reinsurance contracts | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0627	0.063
GMIB reinsurance contracts | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.08	0.080
GMIB reinsurance contracts | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.16	0.160
GMIB reinsurance contracts | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0074	0.0005
GMIB reinsurance contracts | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0159	0.0010
GMIB reinsurance contracts | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.10	0.099
GMIB reinsurance contracts | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.34	0.309
Separate Accounts | Level 3 | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Unabsorvable Inputs	$ 352	$ 326
Separate Accounts | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Spread Over Industry Yield Curve BPS	0.0248	243
Fair Value Unabsorvable Inputs	$ 1	$ 1
Separate Accounts | Discount Rate | Level 3 | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.065	0.066
Separate Accounts | Discount Rate | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.051	0.04409
Separate Accounts | Cap Rate | Level 3 | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.044	0.046
Separate Accounts | Exit Capitalization Rate | Level 3 | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.056	0.056
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability, fair value	$ 5,341	$ 4,149
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.008	0.008
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Lapse Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.262	0.262
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Withdrawal Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.121	0.124
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Utilization Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	0.160
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Non Performance | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0189	0.010
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Forfeiture Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.0055
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Forfeiture Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.021
Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Equity Volatility | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.200
Ages 0 - 40 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0001	0.0001
Ages 0 - 40 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0018	0.0018
Ages 0 - 40 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0001	0.0001
Ages 0 - 40 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0019	0.0019
Ages 41 - 60 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0007	0.0007
Ages 41 - 60 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0054	0.0054
Ages 41 - 60 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0006	0.0006
Ages 41 - 60 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0053	0.0053
Ages 60 - 115 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0042	0.0042
Ages 60 - 115 | GMIB reinsurance contracts | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.420	0.4200
Ages 60 - 115 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0041	0.0041
Ages 60 - 115 | Guaranteed Minimum Insurance Benefits no Lapse Guarantee | Mortality Rate | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.412	0.412

FAIR VALUE DISCLOSURES - Narrat

FAIR VALUE DISCLOSURES - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value adjustments on GMIB asset	$ 112	$ 8
Fair value adjustments on GMIB liability	41	24
AFS fixed maturities transferred from Level 3 to Level 2	28	5
AFS fixed maturities transferred from Level 3 to Level 2	$ 89	$ 7
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Percentage	0.80%	0.10%
MONY Life | Discount for Lack of Marketability
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Business Combination, Contingent Consideration, Liability, Measurement Input	0.086
Level 3 | Public corporate | Matrix Pricing Model Valuation Technique
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Unabsorvable Inputs	$ 99	$ 53
Level 3 | Public corporate | Market Comparable Companies Valuation Technique
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Unabsorvable Inputs	881	789
Level 3 | Other equity investments | Discounted Cash Flow Valuation Technique
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Unabsorvable Inputs	35	38
Level 3 | Separate Accounts | Discounted Cash Flow Valuation Technique
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Unabsorvable Inputs	1	1
Level 3 | Separate Accounts | Third Party Appraisal Valuation Technique
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Unabsorvable Inputs	$ 352	326
Level 3 | Discount Rate
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Contingent Payment Arrangement, Measurement Input	8.60%
Nonrecurring | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Investments, fair value disclosure	$ 915
AB 2016 Acquisition | Level 3 | Alliance Bernstein
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Business combination, contingent consideration, liability	$ 7	$ 11
AB 2016 Acquisition | Level 3 | Alliance Bernstein | Discount Rate | Minimum
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Contingent Payment Arrangement, Measurement Input	3.20%	1.40%
AB 2016 Acquisition | Level 3 | Alliance Bernstein | Discount Rate | Maximum
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Contingent Payment Arrangement, Measurement Input	3.70%	2.30%
AB 2016 Acquisition | Level 3 | Alliance Bernstein | Long-term Revenue Growth Rate
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Contingent Payment Arrangement, Measurement Input	17.60%	31.00%
Contingent Payment Arrangements | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Change in estimate	$ 2
Fair Value Unabsorvable Inputs	(7)	$ (15)	$ (25)	$ (31)
AFS fixed maturities transferred from Level 3 to Level 2	0	0	0
AFS fixed maturities transferred from Level 3 to Level 2	$ 0	$ 0	$ 0

FAIR VALUE DISCLOSURES - Carryi

FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Consolidated Amounts [Abstract]
Mortgage loans on real estate	$ 11,835	$ 10,952
Loans to affiliates	0	1,230
Policyholders liabilities: Investment contracts	49,923	47,171
Policy loans	3,779	3,819
Short-term debt	546	1,857
Loans from affiliates	0	3,622
Separate Accounts liabilities	110,337	124,552
Carrying Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,835	10,952
Loans to affiliates		1,230
Policyholders liabilities: Investment contracts	2,127	2,224
Funding Agreements	4,002	3,014
Policy loans	3,779	3,819
Short-term debt	4,955	2,408
Loans from affiliates		3,622
Separate Accounts liabilities	7,406	7,537
Measured at Fair Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,494	10,912
Loans to affiliates		1,230
Policyholders liabilities: Investment contracts	2,174	2,329
Funding Agreements	3,956	3,020
Policy loans	4,183	4,754
Short-term debt	4,749	2,500
Loans from affiliates		3,622
Separate Accounts liabilities	7,406	7,537
Measured at Fair Value | Level 1
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Loans to affiliates		0
Policyholders liabilities: Investment contracts	0	0
Funding Agreements	0	0
Policy loans	0	0
Short-term debt	0	0
Loans from affiliates		0
Separate Accounts liabilities	0	0
Measured at Fair Value | Level 2
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Loans to affiliates		1,230
Policyholders liabilities: Investment contracts	0	0
Funding Agreements	3,956	3,020
Policy loans	0	0
Short-term debt	4,749	2,500
Loans from affiliates		3,622
Separate Accounts liabilities	0	0
Measured at Fair Value | Level 3
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,494	10,912
Loans to affiliates		0
Policyholders liabilities: Investment contracts	2,174	2,329
Funding Agreements	0	0
Policy loans	4,183	4,754
Short-term debt	0	0
Loans from affiliates		0
Separate Accounts liabilities	$ 7,406	$ 7,537

FAIR VALUE DISCLOSURES - Unreal

FAIR VALUE DISCLOSURES - Unrealized Gains (Losses) for Level 3 Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	$ (86)	$ (191)	$ 1,983
Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	26	29	20
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	(939)	1,826	59
Other comprehensive income (loss)	(26)	5	20
Corporate | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0
Other comprehensive income (loss)	(19)	5	11
States and political subdivisions | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0
Other comprehensive income (loss)	(1)	(1)	(2)
Commercial mortgage-backed | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0
Other comprehensive income (loss)	0	0	10
Asset-backed | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0
Other comprehensive income (loss)	(6)	1	1
Gmib Reinsurance | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	(164)	174	(77)
Other comprehensive income (loss)	0	0	0
Separate Accounts | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	26	29	20
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0
Other comprehensive income (loss)	0	0	0
GMxB derivative features' liability | Level 3 Assets And Liabilities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment gains (losses), net	0	0	0
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	(775)	1,652	136
Other comprehensive income (loss)	$ 0	$ 0	$ 0

INSURANCE LIABILITIES - Rollfor

INSURANCE LIABILITIES - Rollforward of Liability and Reinsurance Ceded (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
GMDB Direct
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	$ 4,059	$ 3,164	$ 2,969
Paid guarantee benefits	(393)	(354)	(357)
Other changes in reserves	993	1,249	552
Closing Balance	4,659	4,059	3,164
GMDB Assumed
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	95	121	135
Paid guarantee benefits	(24)	(21)	(33)
Other changes in reserves	11	(5)	19
Closing Balance	82	95	121
GMDB
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward]
Opening Balance	(108)	(90)	(98)
Paid guarantee benefits	(16)	(14)	(15)
Other changes in reserve	(21)	(32)	(7)
Ending Balance	(113)	(108)	(90)
GMIB Direct
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	4,752	3,802	3,842
Paid guarantee benefits	(153)	(151)	(281)
Other changes in reserves	(856)	1,101	241
Closing Balance	3,743	4,752	3,802
GMIB Assumed
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	195	258	268
Paid guarantee benefits	(12)	(59)	(20)
Other changes in reserves	1	(4)	10
Closing Balance	184	195	258
GMIB Ceded
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward]
Opening Balance	(1,894)	(1,737)	(1,829)
Paid guarantee benefits	(44)	(63)	(65)
Other changes in reserve	118	(220)	27
Ending Balance	$ (1,732)	$ (1,894)	$ (1,737)

INSURANCE LIABILITIES - Variabl

INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features and Buybacks (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 14,382
Separate Accounts	83,154	$ 94,672
Net Amount At Risk By Product And Guarantee, Account Value	97,536
Net Amount at Risk, gross	24,087
Net Amount at Risk, net of amounts reinsured	$ 23,392
Average attained age of contractholders (in years)	55 years 3 months 19 days
Percentage of policyholders over age 70	18.80%
GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 270
Separate Accounts	52,835	$ 61,498
Net Amount At Risk By Product And Guarantee, Account Value	53,105
Net Amount at Risk, gross	10,150
Net Amount at Risk, net of amounts reinsured	$ 8,577
Average attained age of contractholders (in years)	68 years 9 months 18 days
Weighted average years remaining until annuitization (in years)	7 months 6 days
GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
Return of Premium | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 14,035
Separate Accounts	41,463
Net Amount At Risk By Product And Guarantee, Account Value	55,498
Net Amount at Risk, gross	418
Net Amount at Risk, net of amounts reinsured	$ 418
Average attained age of contractholders (in years)	51 years 4 months 24 days
Percentage of policyholders over age 70	10.00%
Return of Premium | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 0
Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Ratchet | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	102
Separate Accounts	8,382
Net Amount At Risk By Product And Guarantee, Account Value	8,484
Net Amount at Risk, gross	791
Net Amount at Risk, net of amounts reinsured	$ 772
Average attained age of contractholders (in years)	67 years
Percentage of policyholders over age 70	43.00%
Ratchet | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 0
Separate Accounts	0
Net Amount At Risk By Product And Guarantee, Account Value	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Roll-Up | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	61
Separate Accounts	2,903
Net Amount At Risk By Product And Guarantee, Account Value	2,964
Net Amount at Risk, gross	2,291
Net Amount at Risk, net of amounts reinsured	$ 1,615
Average attained age of contractholders (in years)	73 years 7 months 6 days
Percentage of policyholders over age 70	65.50%
Roll-Up | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Roll-Up | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.00%
Roll-Up | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 19
Separate Accounts	19,407
Net Amount At Risk By Product And Guarantee, Account Value	19,426
Net Amount at Risk, gross	994
Net Amount at Risk, net of amounts reinsured	$ 309
Average attained age of contractholders (in years)	68 years 10 months 25 days
Weighted average years remaining until annuitization (in years)	1 year 8 months 12 days
Roll-Up | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Roll-Up | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.00%
Combo | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 184
Separate Accounts	30,406
Net Amount At Risk By Product And Guarantee, Account Value	30,590
Net Amount at Risk, gross	20,587
Net Amount at Risk, net of amounts reinsured	$ 20,587
Average attained age of contractholders (in years)	69 years
Percentage of policyholders over age 70	49.90%
Combo | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Combo | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
Combo | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 251
Separate Accounts	33,428
Net Amount At Risk By Product And Guarantee, Account Value	33,679
Net Amount at Risk, gross	9,156
Net Amount at Risk, net of amounts reinsured	$ 8,268
Average attained age of contractholders (in years)	68 years 9 months 18 days
Weighted average years remaining until annuitization (in years)	6 months
Combo | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Combo | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
Deferred Variable Annuity | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 7,734
Net Amount at Risk, gross	$ 1,041
Average attained age of contractholders (in years)	73 years
Percentage of policyholders over age 70	63.60%
Deferred Variable Annuity | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Deferred Variable Annuity | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	10.00%
Deferred Variable Annuity | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 2,242
Net Amount at Risk, gross	$ 362
Average attained age of contractholders (in years)	70 years
Percentage of policyholders over age 70	56.40%
Deferred Variable Annuity | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.30%
Deferred Variable Annuity | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
Deferred Variable Annuity | Return of Premium | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 873
Net Amount at Risk, gross	$ 10
Average attained age of contractholders (in years)	67 years
Percentage of policyholders over age 70	43.50%
Deferred Variable Annuity | Return of Premium | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 846
Net Amount at Risk, gross	$ 2
Average attained age of contractholders (in years)	72 years
Percentage of policyholders over age 70	63.20%
Deferred Variable Annuity | Ratchet | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 5,004
Net Amount at Risk, gross	$ 608
Average attained age of contractholders (in years)	72 years
Percentage of policyholders over age 70	62.50%
Deferred Variable Annuity | Ratchet | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 43
Net Amount at Risk, gross	$ 1
Average attained age of contractholders (in years)	74 years
Percentage of policyholders over age 70	64.50%
Deferred Variable Annuity | Roll-Up | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 257
Net Amount at Risk, gross	$ 26
Average attained age of contractholders (in years)	77 years
Percentage of policyholders over age 70	78.60%
Deferred Variable Annuity | Roll-Up | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.00%
Deferred Variable Annuity | Roll-Up | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	10.00%
Deferred Variable Annuity | Roll-Up | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 229
Net Amount at Risk, gross	$ 46
Average attained age of contractholders (in years)	72 years
Percentage of policyholders over age 70	58.80%
Deferred Variable Annuity | Roll-Up | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	3.30%
Deferred Variable Annuity | Roll-Up | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.50%
Deferred Variable Annuity | Combo | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 1,600
Net Amount at Risk, gross	$ 397
Average attained age of contractholders (in years)	75 years
Percentage of policyholders over age 70	75.50%
Deferred Variable Annuity | Combo | GMDB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	5.00%
Deferred Variable Annuity | Combo | GMDB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	10.00%
Deferred Variable Annuity | Combo | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 1,124
Net Amount at Risk, gross	$ 313
Average attained age of contractholders (in years)	69 years
Percentage of policyholders over age 70	50.40%
Deferred Variable Annuity | Combo | GMIB | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.00%
Deferred Variable Annuity | Combo | GMIB | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)	6.00%

INSURANCE LIABILITIES - Separat

INSURANCE LIABILITIES - Separate Account Investments, Hedging Programs and Variable and Interest-Sensitive Live Insurance Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
GMDB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	$ 83,154	$ 94,672
Direct Liabilities For Guarantees
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	709	1,311	$ 1,247
Other changes in reserves	126	(578)	64
Paid guarantee benefits		(24)	(23)
Closing Balance	812	709	$ 1,311
GMIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	52,835	61,498
Equity | GMDB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	35,541	41,658
Equity | GMIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	15,759	19,676
Fixed income | GMDB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	5,173	5,469
Fixed income | GMIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	2,812	3,110
Balanced | GMDB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	41,588	46,577
Balanced | GMIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	33,974	38,398
Other | GMDB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	852	968
Other | GMIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Separate Accounts	$ 290	$ 314

INSURANCE LIABILITIES - Fair Va

INSURANCE LIABILITIES - Fair Value of GMxB and Other Derivative Liability (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
GMIB reinsurance contract asset, at fair value	$ 1,732	$ 1,894

REINSURANCE AGREEMENTS - Narrat

REINSURANCE AGREEMENTS - Narrative (Details) - USD ($) $ in Millions	Feb. 01, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, percentage of excess reinsured		100.00%
GMIB reinsurance contract asset, at fair value		$ 1,732	$ 1,894
Increase (decrease) in the fair value of the reinsurance contract asset		162	159	$ (93)
Amounts due to reinsurers		1,438	1,436
AXA Equitable Life
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance Retention Policy, Reinsured Risk, Percentage	90.00%
Reinsurance retention policy, amount retained	$ 635
Deposit Contracts, Assets	635
Reinsurance Retention Policy, Amount Retained, Excluding Cash	604
Reinsurance Retention Policy, Amount Retained, Cash	$ 31
Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance recoverables related to insurance contracts		4,895	5,023
Amounts due to reinsurers		1,438	1,436
Non Affiliated Entity | Credit Concentration Risk
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance recoverables related to insurance contracts		2,796	2,962
Variable Universal Term Life Insurance Single Life
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, amount retained		25
Variable Universal Term Life Insurance Second To Die Life
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, amount retained		30
Group Life And Health Insurance | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Insurance liabilities ceded		62	71
Reinsurance assumed reserves		$ 1,095	$ 1,111
GMIB | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Exposure reinsured percentage		15.50%	16.80%
GMIB | Group Life And Health Insurance | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance assumed reserves		$ 183	$ 194
GMDB | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Exposure reinsured percentage		2.90%	3.50%
RGA Reinsurance Company | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Amounts due to reinsurers		$ 1,211	$ 1,212
Protective Life | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Amounts due to reinsurers		$ 125	$ 128

REVENUE RECOGNITION - Disaggreg

REVENUE RECOGNITION - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Total investment management and service fees
Disaggregation of Revenue [Line Items]
Revenues	$ 4,252	$ 4,069	$ 3,746
Investment management, advisory and service fees: Base fees
Disaggregation of Revenue [Line Items]
Revenues	2,877	2,730	2,487
Investment management, advisory and service fees: Performance-based fees
Disaggregation of Revenue [Line Items]
Revenues	118	95	33
Research services
Disaggregation of Revenue [Line Items]
Revenues	439	450	480
Distribution services
Disaggregation of Revenue [Line Items]
Revenues	723	701	651
Other revenues: Shareholder services
Disaggregation of Revenue [Line Items]
Revenues	76	75	78
Other revenues: Other
Disaggregation of Revenue [Line Items]
Revenues	19	18	17
Other income
Disaggregation of Revenue [Line Items]
Revenues	$ 479	$ 423	$ 385

REINSURANCE AGREEMENTS - Effect

REINSURANCE AGREEMENTS - Effects of Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Premiums
Direct premiums	$ 1,012	$ 1,038	$ 998
Reinsurance assumed	214	225	231
Reinsurance ceded	(132)	(139)	(146)
Premiums	1,094	1,124	1,083
Universal Life and Investment-type Product Policy Fee Income Ceded	418	381	393
Policyholders’ Benefits Ceded	580	657	871
Interest Credited To Policyholders Account Balances, Ceded	$ 50	$ 46	$ 51

SHORT-TERM AND LONG-TERM DEBT -

SHORT-TERM AND LONG-TERM DEBT - Summary of Short and Long-term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Apr. 20, 2018
Short-term Debt [Line Items]
Total short-term debt	$ 546	$ 1,857
Debt Instrument [Line Items]
Total long-term debt	4,409	551
Total short-term and long-term debt	4,955	2,408
Term loan
Debt Instrument [Line Items]
Total long-term debt	$ 300	$ 0
Senior Debentures
Debt Instrument [Line Items]
Debt instrument, stated percentage	7.00%	7.00%
Total long-term debt	$ 349	$ 349
Senior Notes (5.00%, due 2048) | Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated percentage	5.00%		5.00%
Total long-term debt	$ 1,480	0
Senior Notes (4.35%, due 2028) | Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated percentage	4.30%		4.35%
Total long-term debt	$ 1,486	0
Senior Notes (3.90%, due 2023) | Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated percentage	3.90%		3.90%
Total long-term debt	$ 794	$ 0
AXA Equitable non-recourse mortgage debt (with interest rates of 4.1%) | Mortgage
Debt Instrument [Line Items]
Debt instrument, stated percentage		4.10%
Total long-term debt	0	$ 82
AXA Equitable non-recourse mortgage debt (with interest rates of 3.9%) | Mortgage
Debt Instrument [Line Items]
Debt instrument, stated percentage		3.90%
Total long-term debt	$ 0	$ 120
3-Month LIBOR | Term loan
Debt Instrument [Line Items]
Debt instrument, stated percentage	1.125%
Commercial paper | AB commercial paper (with interest rates of 2.2% and 1.6%)
Short-term Debt [Line Items]
Commercial paper, interest rate	2.70%	1.60%
Total short-term debt	$ 521	$ 491
Commercial paper | AXA Financial commercial paper (with interest rates of 0% and 1.6%)
Short-term Debt [Line Items]
Commercial paper, interest rate		1.60%
Total short-term debt	$ 0	$ 1,291
Revolving credit facility
Short-term Debt [Line Items]
Interest rate	2.40%	2.40%
Total short-term debt	$ 25	$ 75

SHORT-TERM AND LONG-TERM DEBT_2

SHORT-TERM AND LONG-TERM DEBT - Short-term Debt Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Sep. 27, 2018	Dec. 01, 2016
Short-term Debt [Line Items]
Short-term debt	$ 546	$ 1,857
Commercial paper | AB commercial paper (with interest rates of 2.2% and 1.6%)
Short-term Debt [Line Items]
Short-term debt	$ 521	$ 491
Commercial paper, interest rate	2.70%	1.60%
Average outstanding balance	$ 350	$ 482
Weighted average interest rate over period	2.00%	1.20%
Commercial paper | AXA Financial commercial paper (with interest rates of 0% and 1.6%)
Short-term Debt [Line Items]
Short-term debt	$ 0	$ 1,291
Commercial paper, interest rate		1.60%
Maximum amount of short-term unsecured debt allowed under agreement	2,000	$ 1,300
Revolving credit facility
Short-term Debt [Line Items]
Short-term debt	$ 25	$ 75
Interest rate	2.40%	2.40%
Revolving credit facility | AB Committed Unsecured Senior Revolving Credit Facility
Short-term Debt [Line Items]
Line of credit facility, maximum borrowing capacity	$ 800		$ 1,000	$ 200
Revolving credit facility | AB Revolving Credit Facility
Short-term Debt [Line Items]
Interest rate	2.80%	2.00%
Borrowing	$ 25	$ 75
Interest rate at period end	3.40%	2.40%
Average outstanding amount	$ 19	$ 21

SHORT-TERM AND LONG-TERM DEBT_3

SHORT-TERM AND LONG-TERM DEBT - Long-term Debt Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2018	May 04, 2018	Apr. 20, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Long-term debt	$ 4,409				$ 551
Senior Notes | Senior Notes (3.90%, due 2023)
Debt Instrument [Line Items]
2,023				$ 800
Long-term debt	$ 794				0
Debt instrument, stated percentage	3.90%			3.90%
Senior Notes | Senior Notes (4.35%, due 2028)
Debt Instrument [Line Items]
Debt instrument, face amount				$ 1,500
Long-term debt	$ 1,486				0
Debt instrument, stated percentage	4.30%			4.35%
Senior Notes | Senior Notes (5.00%, due 2048)
Debt Instrument [Line Items]
Debt instrument, face amount				$ 1,500
Long-term debt	$ 1,480				0
Debt instrument, stated percentage	5.00%			5.00%
Senior Debentures
Debt Instrument [Line Items]
Long-term debt	$ 349				$ 349
Debt instrument, stated percentage	7.00%				7.00%
Senior Debentures | Three Year Term Loan
Debt Instrument [Line Items]
Undrawn balance			$ 200
2,021	$ 300
Term loan facility | Three Year Term Loan
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 500

SHORT-TERM AND LONG-TERM DEBT_4

SHORT-TERM AND LONG-TERM DEBT - Credit Facility Narrative (Details) $ in Millions, € in Billions	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 27, 2018USD ($)	Jun. 30, 2018USD ($)	May 14, 2018USD ($)	May 14, 2018EUR (€)	Apr. 30, 2018USD ($)	Apr. 25, 2018USD ($)	Feb. 28, 2018USD ($)	Dec. 01, 2016USD ($)
Revolving credit facility | JP Morgan
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity					$ 250
Revolving credit facility | Major European Lending Institutions
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity						€ 1.6		$ 1,500
Credit Facility | Citi
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity					300
Credit Facility | Bank of America Merrill Lynch
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity					300
Credit Facility | Various Lending Institutions
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity					$ 1,300
AB Revolving Credit Facility | Revolving credit facility
Line of Credit Facility [Line Items]
Borrowing	$ 25	$ 75
Interest rate at period end	3.40%	2.40%
Average outstanding amount	$ 19	$ 21
Interest rate	2.80%	2.00%
AB Committed Unsecured Senior Revolving Credit Facility | Revolving credit facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 800		$ 1,000							$ 200
Incremental borrowing base	200
Holdings Three-Year Delayed Draw Term Loan
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									$ 3,900
Holdings Revolving Credit Facility | Letter of Credit
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									1,500
Holdings Revolving Credit Facility | Revolving credit facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									2,500
Bilateral Letter Of Credit Facilities | Letter of Credit
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									1,900
Bilateral Letter Of Credit Facilities | Letter of Credit | JP Morgan
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									150
Bilateral Letter Of Credit Facilities | Letter of Credit | Citi
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									175
Bilateral Letter Of Credit Facilities | Letter of Credit | Barclays
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									150
Bilateral Letter Of Credit Facilities | Letter of Credit | HSBC
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									150
Bilateral Letter Of Credit Facilities | Letter of Credit | CACIB
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									400
Bilateral Letter Of Credit Facilities | Letter of Credit | Helaba
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									300
Bilateral Letter Of Credit Facilities | Letter of Credit | Commerzbank
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									325
Bilateral Letter Of Credit Facilities | Letter of Credit | Natixis
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity									$ 250
SCB Line of Credit | Revolving credit facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 175
Interest rate	1.60%	1.40%
ACS Life | Holdings Revolving Credit Facility | Letter of Credit
Line of Credit Facility [Line Items]
Remaining capacity at termination							$ 125
AXA Equitable Life | Holdings Revolving Credit Facility | Letter of Credit
Line of Credit Facility [Line Items]
Remaining capacity at termination							$ 600
AXA Arizona | Letter of Credit | Helaba
Line of Credit Facility [Line Items]
Remaining capacity at termination				$ 250
AXA Arizona | Letter of Credit | Commerzbank
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity				700
AXA Arizona | Letter of Credit | Citibank Europe Plc
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity				2,500
AXA Arizona | Letter of Credit | JP Morgan Europe Limits
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity				$ 200

RELATED PARTY TRANSACTIONS - Na

RELATED PARTY TRANSACTIONS - Narrative (Details) € in Millions, $ in Millions	Nov. 20, 2018USD ($)shares	May 07, 2018USD ($)	Apr. 23, 2018USD ($)shares	Mar. 31, 2018USD ($)	Feb. 28, 2018	Jan. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017EUR (€)	Dec. 31, 2015USD ($)	Jun. 30, 2015USD ($)	Dec. 31, 2014USD ($)	Oct. 31, 2012USD ($)	Mar. 31, 2010USD ($)	Sep. 30, 2007USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2018USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2018EUR (€)	Nov. 09, 2018USD ($)	Aug. 10, 2018USD ($)	Apr. 25, 2018USD ($)	Mar. 30, 2018	Dec. 31, 2017EUR (€)	Oct. 31, 2017	Oct. 31, 2012EUR (€)
Related Party Transaction [Line Items]
Investments							$ 81,782								$ 81,782	$ 81,333	$ 81,782
Assumed Premiums Earned Affiliated																8	8	$ 9
Share repurchase plan, authorized amount																							$ 800	$ 500
Loans to affiliates							1,230								1,230	0	1,230
Due to Related Parties [Abstract]
Note issued							$ 3,622								3,622	0	3,622
Proceeds from Sales of Business, Affiliate and Productive Assets				$ 143
Related Party Transactions Other [Abstract]
Ceded premiums																4	4	4
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Repayment of loans from affiliates																3,000	56	1,752
Interest expense																231	160	174
Proceeds from loans from affiliates																0	731	0
Reinsurance Effect On Claims And Benefits Incurred Amount Assumed Affiliates																3	2	2
Payments To Acquire Noncontrolling Interests																$ 1,340	0	0
Tax Sharing Agreement, Percent Of Seller's Responsibility																90.00%
Tax Sharing Agreement, Percent Of Buyer's Responsibility																10.00%
Tax Sharing Agreement, Percent Of Responsible Party																100.00%
Capital contribution from parent company															$ 8	$ 8	318	0
Change in cash and cash equivalents																$ (345)	$ (840)	(903)
Adjustments to APIC, other			$ 17
Increase (decrease) in accrued taxes payable			$ 174
Shares repurchased (in shares) | shares	30,000,000															32,500,000
Senior Debentures
Related Party Transaction [Line Items]
Debt instrument, stated percentage							7.00%								7.00%	7.00%	7.00%					7.00%					7.00%
Affiliated Entity
Related Party Transactions Other [Abstract]
Expenses paid or accrued for:																$ 151	$ 157	147
Amount charged to subsidiaries for their share of operating expenses																733	747	703
XL Catlin
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross																$ 93
AXA-IM Holding U.S., Inc.
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Ownership percentage after transaction			100.00%
Purchase of interest by Parent (in shares) | shares			41,934,582
Changes in ownership interest			$ 1,113
AXA-IM Holding U.S., Inc. | Senior Debentures
Related Party Transaction [Line Items]
Loans to affiliates									$ 185										$ 185
AXA
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Ownership percentage after transaction																59.00%
AXA Financial
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Ownership percentage by noncontrolling interest				0.50%
Payments of capital distribution				$ 66
Economic interest				100.00%	99.50%
Colisee | Senior Debentures
Related Party Transaction [Line Items]
Loans to affiliates																					$ 145
Debt instrument, stated percentage																					4.75%
AXA Holdings | Note Maturity September 2012
Related Party Transaction [Line Items]
Debt instrument, stated percentage														5.40%
Due to Related Parties [Abstract]
Note issued														$ 500
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Repayment of notes payable						$ 150														$ 300
AXA Holdings | Note Maturity June 2018
Due to Related Parties [Abstract]
Note issued				$ 630			$ 622								$ 622		622
Alliance Bernstein
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Other revenues - shareholder servicing fees																$ 74	73	76
Other revenues - other																$ 7	$ 7	6
Purchase of interest by Parent (in shares) | shares			8,160,000
Changes in ownership interest			$ 217
Economic interest			65.00%													65.00%	47.00%
Shares repurchased (in shares) | shares																	9,300,000
AXA Venture Partners SAS
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Economic interest		30.30%
Payments to Acquire Additional Interest in Subsidiaries		$ 3
2007 Senior Unsecured Note, 5.7%, due 2020
Related Party Transaction [Line Items]
Loans to affiliates							700							$ 700	$ 700	$ 0	$ 700
Related party transaction, rate (as a percent)														5.70%			5.70%
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Proceeds from loans from affiliates						$ 50
3-Month LIBOR | AXA-IM Holding U.S., Inc. | Senior Debentures
Related Party Transaction [Line Items]
Basis spread on variable rate									1.50%
LIBOR | AXA Holdings | Note Maturity June 2018
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)															0.439%
Coliseum Reinsurance Company, 4.75%, due 2028
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)																	4.75%				4.75%
Due to Related Parties [Abstract]
Note issued							387								$ 387	0	$ 387
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Interest expense																6	18	18
Coliseum Re loan 4.75% tranche two
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Proceeds from loans from affiliates																					$ 145
Coliseum Re loan 4.75% tranche one
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Proceeds from loans from affiliates																					$ 242
AXA Japan Subordinated Notes, floating rate of LIBOR 1.20%, due 2020
Due to Related Parties [Abstract]
Note issued							770						$ 770		770	0	770
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Interest expense																12	$ 19	16
AXA Japan Subordinated Notes, floating rate of LIBOR 1.20%, due 2020 | LIBOR
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)													1.20%				1.20%
AXA Belgium €300 million EURIBOR 0.06%, due 2018
Due to Related Parties [Abstract]
Note issued							391								391	0	$ 391
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Interest expense																2	$ 12	9
Debt instrument, face amount												$ 391															€ 300		€ 300
AXA Belgium €300 million EURIBOR 0.06%, due 2018 | EURIBOR
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)												1.15%					0.06%
AXA Belgium €300 million EURIBOR 0.06%, due 2018 | Swaps | EURIBOR
Related Party Transaction [Line Items]
Derivative, Swaption Interest Rate																												1.475%
AXA S.A. term loan, three- month LIBOR 1.06%, due 2024
Due to Related Parties [Abstract]
Note issued							1,007				$ 2,727				1,007	0	$ 1,007			$ 2,727
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Repayment of loans from affiliates										$ 520								1,200
Interest expense																10	$ 23	23
AXA S.A. term loan, three- month LIBOR 1.06%, due 2024 | 3-Month LIBOR
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)											1.06%						1.06%
AXA S.A. loan, LIBOR 1.44%, due 2022
Due to Related Parties [Abstract]
Note issued							366		$ 366						366	0	$ 366		$ 366
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Interest expense																$ 6	$ 9	8
AXA S.A. loan, LIBOR 1.44%, due 2022 | LIBOR
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)																	1.44%		1.44%
AXA America Corporate Solutions, Inc., 1.85%, due 2018
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)																1.85%	1.39%
Due to Related Parties [Abstract]
Note issued							110								110	$ 0	$ 110
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Repayment of loans from affiliates																	56
Interest expense																2	2	1
ASV Capital B FPCI | Affiliated Entity
Related Party Transaction [Line Items]
Investments							7								7	23	7
ASV Diversified | Affiliated Entity
Related Party Transaction [Line Items]
Related Party Transaction, Commitment Amount | €								€ 30
Related Party Transaction, Commitment Amount Called | €																						€ 0.8					€ 0.5
AXA Tech | AXA US Holdings Inc
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Business Combination, Consideration Transferred							18
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net							$ 18								$ 18		18
AXA CS | AXA Holdings
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Economic interest																										78.99%
AXA
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Shares repurchased (in shares) | shares	30,000,000
Shares repurchased	$ 592
Corporate Segment | AXA
Related Party Transactions Other [Abstract]
Expenses paid or accrued for:																34	35	26
AXA CS
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Increase (decrease) in loans from affiliates				(622)
Change in cash and cash equivalents				8
Adjustments to APIC, other				$ 630
Noncontrolling Interest
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Decrease in noncontrolling interest			$ 29													$ 95	$ 121	$ 128
Revolving credit facility | Line of Credit
Schedule Of Commission Fees And Other Income Revenues For Services Related To Mutual Funds Managed By Subsidiary [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity																									$ 1,500

RELATED PARTY TRANSACTIONS - Lo

RELATED PARTY TRANSACTIONS - Loans to and from Affiliates (Details) € in Millions, $ in Millions	1 Months Ended				12 Months Ended
	Dec. 31, 2014USD ($)	Oct. 31, 2012USD ($)	Mar. 31, 2010USD ($)	Sep. 30, 2007USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2017EUR (€)	Oct. 31, 2012EUR (€)
Related Party Transaction [Line Items]
Loans to affiliates					$ 0	$ 1,230
Note issued					0	3,622
2007 Senior Unsecured Note, 5.7%, due 2020
Related Party Transaction [Line Items]
Loans to affiliates				$ 700	0	$ 700
Related party transaction, rate (as a percent)				5.70%		5.70%
2008 Senior Unsecured Note, 5.4%, due 2020
Related Party Transaction [Line Items]
Loans to affiliates					0	$ 200
Related party transaction, rate (as a percent)						5.40%
Unsecured Loan to AXA IM Holding US, three-month LIBOR 1.5%, due 2025
Related Party Transaction [Line Items]
Loans to affiliates					0	$ 185
Unsecured Loan to Colisée Re. 4.75%, due 2028
Related Party Transaction [Line Items]
Loans to affiliates					0	$ 145
Related party transaction, rate (as a percent)						4.75%
Senior Debentures | AXA-IM Holding U.S., Inc.
Related Party Transaction [Line Items]
Loans to affiliates							$ 185
Senior Debentures | Colisee
Related Party Transaction [Line Items]
Loans to affiliates								$ 145
AXA S.A. term loan, three- month LIBOR 1.06%, due 2024
Related Party Transaction [Line Items]
Note issued	$ 2,727				0	$ 1,007
AXA Japan Subordinated Notes, floating rate of LIBOR 1.20%, due 2020
Related Party Transaction [Line Items]
Note issued			$ 770		0	770
AXA Belgium €300 million EURIBOR 0.06%, due 2018
Related Party Transaction [Line Items]
Note issued					0	391
Debt instrument, face amount		$ 391							€ 300	€ 300
AXA S.A. loan, LIBOR 1.44%, due 2022
Related Party Transaction [Line Items]
Note issued					0	366	$ 366
Coliseum Reinsurance Company, 4.75%, due 2028
Related Party Transaction [Line Items]
Note issued					0	$ 387
Related party transaction, rate (as a percent)						4.75%		4.75%
AXA America Corporate Solutions, Inc., 1.85%, due 2018
Related Party Transaction [Line Items]
Note issued					$ 0	$ 110
Related party transaction, rate (as a percent)					1.85%	1.39%
Foreign Exchange impact of AXA Belgium loan
Related Party Transaction [Line Items]
Foreign Exchange impact of AXA Belgium loan					$ 0	$ (31)
AXA S.A. loan, LIBOR 0.439%, due 2018
Related Party Transaction [Line Items]
Note issued					$ 0	$ 622
3-Month LIBOR | Unsecured Loan to AXA IM Holding US, three-month LIBOR 1.5%, due 2025
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)						1.50%
3-Month LIBOR | AXA S.A. term loan, three- month LIBOR 1.06%, due 2024
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)	1.06%					1.06%
LIBOR | AXA Japan Subordinated Notes, floating rate of LIBOR 1.20%, due 2020
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)			1.20%			1.20%
LIBOR | AXA S.A. loan, LIBOR 1.44%, due 2022
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)						1.44%	1.44%
LIBOR | AXA S.A. loan, LIBOR 0.439%, due 2018
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)						0.439%
EURIBOR | AXA Belgium €300 million EURIBOR 0.06%, due 2018
Related Party Transaction [Line Items]
Related party transaction, rate (as a percent)		1.15%				0.06%

RELATED PARTY TRANSACTIONS - In

RELATED PARTY TRANSACTIONS - Investment Management and Service Fees Related to AB (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Investment management and service fees	$ 4,268	$ 4,093	$ 3,749
Alliance Bernstein
Related Party Transaction [Line Items]
Investment management and service fees	1,207	1,148	999
Distribution revenues	404	398	372
Other revenues - shareholder servicing fees	74	73	76
Other revenues - other	7	7	6
Total	$ 1,692	$ 1,626	$ 1,453

RELATED PARTY TRANSACTIONS - Sc

RELATED PARTY TRANSACTIONS - Schedule of Related Party Transactions (Details) - Affiliated Entity - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Expenses paid or accrued for:	$ 151	$ 157	$ 147
Revenue received or accrued for:	733	747	703
General services provided by AXA affiliates
Related Party Transaction [Line Items]
Expenses paid or accrued for:	146	141	118
Investment management services provided by AXA IM, AXA REIM, and AXA Rosenberg
Related Party Transaction [Line Items]
Expenses paid or accrued for:	2	5	15
Investment management services provided by AXA Strategic Ventures Corporation (“ASV Corp”)
Related Party Transaction [Line Items]
Expenses paid or accrued for:	2	2	2
Guarantees and credit facility
Related Party Transaction [Line Items]
Expenses paid or accrued for:	1	9	12
Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts
Related Party Transaction [Line Items]
Revenue received or accrued for:	727	720	674
General services provided to AXA affiliates
Related Party Transaction [Line Items]
Revenue received or accrued for:	$ 6	$ 27	$ 29

EMPLOYEE BENEFIT PLANS - Narrat

EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($) $ in Millions	Mar. 13, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
PBO in excess of plan assets		$ 533	$ 616
Market value of plan		2,341	2,839
Liability of plan		2,874	3,455
Interest cost credit				$ 76
Benefits paid		36
Remeasurement gain (loss) on plan assets		(109)
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Market value of plan		2,341	2,839	2,679
Unrecognized prior service cost (credit)		1	1
PBO		2,874	3,455
Unrecognized net actuarial gain (loss)		$ (1,123)	$ (1,315)
Defined benefit plan, actual plan asset allocations (as a percent)		100.00%	100.00%
Actual return on plan assets		$ (53)	$ 357
Contributions		5	4
Pension Benefits | Alliance Bernstein
Defined Benefit Plan Disclosure [Line Items]
Estimated future employer contributions in next fiscal year		5
Contributions		4
Post-retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Benefits paid		46	38
Liability of plan		491	537	539
Actuarial gains (losses)		18	(18)
Unrecognized prior service cost (credit)		0		0
Unrecognized net actuarial gain (loss)		(116)		(143)
Post-employment Benefits
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, liability		10	11
AXA Equitable 401(k) Plan
Defined Benefit Plan Disclosure [Line Items]
Cost recognized		36	28	28
Qualified Plan | Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Benefits paid		190	236
Market value of plan		2,341	2,839
Liability of plan		2,874	3,455	$ 3,442
Actuarial gains (losses)		204	(144)
Plan amendments and curtailments		0	0
Qualified Plan | Pension Benefits | Level 1
Defined Benefit Plan Disclosure [Line Items]
Market value of plan		$ 512	$ 843
Defined benefit plan, actual plan asset allocations (as a percent)		21.90%	29.70%
Qualified Plan | Pension Benefits | Level 2
Defined Benefit Plan Disclosure [Line Items]
Market value of plan		$ 1,269	$ 1,463
Defined benefit plan, actual plan asset allocations (as a percent)		54.20%	51.50%
Qualified Plan | Pension Benefits | Level 3
Defined Benefit Plan Disclosure [Line Items]
Market value of plan		$ 1	$ 3
Defined benefit plan, actual plan asset allocations (as a percent)		0.00%	0.10%
Qualified Plan | AXA Equitable Life QP - Pre-1987
Defined Benefit Plan Disclosure [Line Items]
Benefits paid		$ 6	$ 6
Qualified Plan | MONY Life Retirement Income Security Plan And The AXA Equitable QP | Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Plan amendments and curtailments	$ (254)
Benefit obligation transferred out, percent	10.00%
Executive Survivor Benefits Plan | Post-retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Benefit cap		$ 25

EMPLOYEE BENEFIT PLANS - Net Pe

EMPLOYEE BENEFIT PLANS - Net Periodic Benefit Cost (Credit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 8	$ 10	$ 11
Interest cost	103	105	108
Expected return on assets	(163)	(173)	(177)
Actuarial (gain) loss	(1)	(1)	(1)
Net amortization	98	126	133
Impact of settlement	109	0	0
Net periodic pension expense	156	69	76
Post-retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	2	2	2
Interest cost	16	16	16
Net amortization	9	6	7
Net periodic pension expense	27	24	25
Post-employment Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	2	2	2
Interest cost	0	0	0
Net amortization	(1)	(2)	0
Net periodic pension expense	$ 1	$ 0	$ 2

EMPLOYEE BENEFIT PLANS - Change

EMPLOYEE BENEFIT PLANS - Change in Benefit Obligation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Projected benefit obligation, beginning of year	$ 3,455
Projected Benefit Obligation, End of Year	2,874	$ 3,455
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Pension plan assets at fair value, beginning of year	2,839
Pension plan assets at fair value, end of year	2,341	2,839
Post-retirement Plans
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Projected benefit obligation, beginning of year	537	539
Service cost	2	2	$ 2
Interest cost	16	16	16
Actuarial (gains)/losses	(18)	18
Benefits paid	(46)	(38)
Contributions and benefits paid	(46)	(38)
Projected Benefit Obligation, End of Year	491	537	539
Pension Benefits
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Service cost	8	10	11
Interest cost	103	105	108
Projected benefit obligation, end of year	2,874	3,455
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Pension plan assets at fair value, beginning of year	2,839	2,679
Actual return on plan assets	(53)	357
Contributions	5	4
Benefits paid	(184)	(201)
Pension plan assets at fair value, end of year	2,341	2,839	2,679
PBO	2,874	3,455
Excess of PBO over pension plan assets, end of year	(533)	(616)
Defined Benefit Plans Annuity Purchases	(266)	0
Qualified Plan | Pension Benefits
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Projected benefit obligation, beginning of year	3,455	3,442
Service cost	0	0
Interest cost	103	105
Actuarial (gains)/losses	(204)	144
Benefits paid	(190)	(236)
Plan amendments and curtailments	0	0
Settlements	(290)	0
Projected Benefit Obligation, End of Year	2,874	3,455	$ 3,442
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Pension plan assets at fair value, beginning of year	2,839
Pension plan assets at fair value, end of year	$ 2,341	$ 2,839

EMPLOYEE BENEFIT PLANS - Unreco

EMPLOYEE BENEFIT PLANS - Unrecognized Net Actuarial (Gain) Loss (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Unrecognized net actuarial (gain) loss	$ 1,123	$ 1,315
Unrecognized prior service cost (credit)	1	1
Total	1,124	$ 1,316
Post-retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Unrecognized net actuarial (gain) loss	116		$ 143
Unrecognized prior service cost (credit)	0		0
Total	$ 116		$ 143

EMPLOYEE BENEFIT PLANS - Asset

EMPLOYEE BENEFIT PLANS - Asset Allocations (Details) - Pension Benefits	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	100.00%	100.00%
Fixed maturities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	50.30%	46.20%
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	22.90%	33.90%
Equity real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	17.70%	13.90%
Cash and short-term investments
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	3.40%	1.40%
Other
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, actual plan asset allocations (as a percent)	5.70%	4.60%

EMPLOYEE BENEFIT PLANS - Fair V

EMPLOYEE BENEFIT PLANS - Fair Value of Plan Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 2,341,000,000	$ 2,839,000,000
NAV
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	559,000,000	530,000,000
Pension Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 2,341,000,000	$ 2,839,000,000	$ 2,679,000,000
Actual return on plan assets:
Defined benefit plan, actual plan asset allocations (as a percent)	100.00%	100.00%
Pension Benefits | Other
Actual return on plan assets:
Defined benefit plan, actual plan asset allocations (as a percent)	5.70%	4.60%
Pension Benefits | Common and preferred equity
Actual return on plan assets:
Defined benefit plan, actual plan asset allocations (as a percent)	22.90%	33.90%
Qualified Plan | Public corporate
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 677,000,000	$ 794,000,000
Qualified Plan | Public corporate | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	677,000,000	792,000,000
Qualified Plan | Public corporate | Level 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		2,000,000
Qualified Plan | U.S. Treasury, government and agency
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	467,000,000	471,000,000
Qualified Plan | U.S. Treasury, government and agency | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	467,000,000	471,000,000
Qualified Plan | States and political subdivisions
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	23,000,000	26,000,000
Qualified Plan | States and political subdivisions | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	23,000,000	26,000,000
Qualified Plan | Foreign governments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	2,000,000	5,000,000
Qualified Plan | Foreign governments | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	2,000,000	5,000,000
Qualified Plan | Asset-backed
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	1,000,000
Qualified Plan | Asset-backed | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	1,000,000
Qualified Plan | Commercial mortgage-backed
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		1,000,000
Qualified Plan | Commercial mortgage-backed | Level 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		1,000,000
Qualified Plan | Private real estate investment funds | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		44,000,000
Qualified Plan | Private real estate investment funds | Level 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		0
Qualified Plan | Cash and Cash Equivalents | Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	34,000,000	12,000,000
Qualified Plan | Short-term investments | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	22,000,000	27,000,000
Qualified Plan | Pension Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	2,341,000,000	2,839,000,000
Qualified Plan | Pension Benefits | Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 512,000,000	$ 843,000,000
Actual return on plan assets:
Defined benefit plan, actual plan asset allocations (as a percent)	21.90%	29.70%
Qualified Plan | Pension Benefits | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 1,269,000,000	$ 1,463,000,000
Actual return on plan assets:
Defined benefit plan, actual plan asset allocations (as a percent)	54.20%	51.50%
Qualified Plan | Pension Benefits | Level 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 1,000,000	$ 3,000,000
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	3,000,000	5,000,000	8,000,000
Actual return on plan assets:
Relating to assets still held	0	0	0
Relating to assets sold	0	0	0
Purchases	0	0	0
Sales	(1,000,000)	(2,000,000)	(1,000,000)
Transfers into/out of Level 3	0	0	(2,000,000)
Ending Balance	$ 2,000,000	$ 3,000,000	5,000,000
Defined benefit plan, actual plan asset allocations (as a percent)	0.00%	0.10%
Qualified Plan | Pension Benefits | Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 1,782,000,000	$ 2,309,000,000
Qualified Plan | Pension Benefits | NAV
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	559,000,000	530,000,000
Qualified Plan | Pension Benefits | Common and preferred equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	502,000,000	828,000,000
Qualified Plan | Pension Benefits | Common and preferred equity | Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	424,000,000	730,000,000
Qualified Plan | Pension Benefits | Common and preferred equity | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	78,000,000	98,000,000
Qualified Plan | Pension Benefits | Mutual funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	53,000,000	99,000,000
Qualified Plan | Pension Benefits | Mutual funds | Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	53,000,000	99,000,000
Qualified Plan | Pension Benefits | Private real estate investment funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets		44,000,000
Qualified Plan | Pension Benefits | Private real estate investment funds | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	0	0	0
Actual return on plan assets:
Relating to assets still held	0	0	0
Relating to assets sold	0	0	0
Purchases	0	0	0
Sales	0	0	0
Transfers into/out of Level 3	0	0	0
Ending Balance	0	0	0
Qualified Plan | Pension Benefits | Other Equity Investments | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	0	0	0
Actual return on plan assets:
Relating to assets still held	0	0	0
Relating to assets sold	0	0	0
Purchases	0	0	0
Sales	0	0	0
Transfers into/out of Level 3	0	0	0
Ending Balance	0	0	0
Qualified Plan | Pension Benefits | Fixed maturities | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	3,000,000	5,000,000	8,000,000
Actual return on plan assets:
Relating to assets still held	0	0	0
Relating to assets sold	0	0	0
Purchases	0	0	0
Sales	(1,000,000)	(2,000,000)	(1,000,000)
Transfers into/out of Level 3	0	0	(2,000,000)
Ending Balance	2,000,000	3,000,000	$ 5,000,000
Qualified Plan | Pension Benefits | Private Investment Trust
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	1,000,000	2,000,000
Qualified Plan | Pension Benefits | Private Investment Trust | Level 1
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	1,000,000	2,000,000
Qualified Plan | Pension Benefits | Private Investment Trust | Level 2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	0
Qualified Plan | Pension Benefits | Cash and Cash Equivalents
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	34,000,000	12,000,000
Qualified Plan | Pension Benefits | Short-term investments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan, fair value of plan assets	$ 22,000,000	$ 27,000,000

EMPLOYEE BENEFIT PLANS - Practi

EMPLOYEE BENEFIT PLANS - Practical Expedient Disclosures (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, fair value of plan assets	$ 2,341	$ 2,839
NAV
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, fair value of plan assets	559	530
Private Equity Funds | NAV
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, fair value of plan assets	64	61
Unfunded Commitments	33	29
Private Real Estate Fund | NAV
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, fair value of plan assets	402	376
Unfunded Commitments	0	0
Hedge Funds | NAV
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, fair value of plan assets	93	93
Unfunded Commitments	$ 12	$ 34

EMPLOYEE BENEFIT PLANS - Assump

EMPLOYEE BENEFIT PLANS - Assumptions (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Rates of compensation increase: Benefit obligation (as a percent)	5.99%	5.99%
Rates of compensation increase: Periodic cost (as a percent)	6.34%	6.38%
Expected long-term rates of return on pension plan assets (periodic cost) (as a percent)	6.75%	6.75%
Following year	10.20%	6.90%
Ultimate rate to which cost increase is assumed to decline	4.30%	4.20%
AXA Equitable Life QP
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Benefits obligations (aggregate methodology for 2014) (as a percent)	4.07%	3.40%
AXA Equitable Excess Retirement Plan
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Benefits obligations (aggregate methodology for 2014) (as a percent)	4.01%	3.32%
MONY Life Retirement Income Security Plan for Employees
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Benefits obligations (aggregate methodology for 2014) (as a percent)	4.20%	3.50%
AB Qualified Retirement Plan
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	3.90%	4.55%
Cash balance interest crediting rate for pre-April 1, 2012 accruals
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	4.00%	4.00%
Cash balance interest crediting rate for post-April 1, 2012 accruals
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	2.50%	1.25%
Minimum
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	3.00%	3.17%
Minimum | Other defined benefit plans
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	3.75%	3.00%
Maximum
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	3.50%	3.98%
Maximum | Other defined benefit plans
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Periodic cost (as a percent)	4.10%	3.43%
Post-retirement Plans | Minimum
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Benefits obligations (aggregate methodology for 2014) (as a percent)	3.52%	2.80%
Periodic cost (as a percent)	3.00%	3.17%
Post-retirement Plans | Maximum
Weighted Average Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Benefits obligations (aggregate methodology for 2014) (as a percent)	3.89%	3.52%
Periodic cost (as a percent)	3.50%	3.98%

EMPLOYEE BENEFIT PLANS - Future

EMPLOYEE BENEFIT PLANS - Future Obligations (Details) $ in Millions	Dec. 31, 2018USD ($)
Net Estimate Payment
2,019	$ 13
2,020	12
2,021	11
2,022	10
2,023	9
Years 2024-2028	91
Pension Benefits
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2,019	221
2,020	223
2,021	220
2,022	216
2,023	209
Years 2024-2028	2,926
Life Insurance
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2,019	26
2,020	26
2,021	26
2,022	25
2,023	25
Years 2024-2028	541
Health
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
2,019	16
2,020	15
2,021	14
2,022	13
2,023	12
Years 2024-2028	100
Estimated Medicare Part D Subsidy
2,019	3
2,020	3
2,021	3
2,022	3
2,023	3
Years 2024-2028	$ 9

SHARE-BASED COMPENSATION PROG_2

SHARE-BASED COMPENSATION PROGRAMS - Compensation Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	$ 228	$ 247	$ 213
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	11	45	37
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	2	1	1
AXA Shareplan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	0	13	19
Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	215	185	154
Other Compensation plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	0	$ 3	$ 2
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Adjustment to expense	$ 24

SHARE-BASED COMPENSATION PROG_3

SHARE-BASED COMPENSATION PROGRAMS - Stock Option Activity (Details) - 12 months ended Dec. 31, 2018 - Parent $ / shares in Units, shares in Thousands, $ in Thousands	USD ($)$ / sharesshares	USD ($)$ / shares€ / sharesshares	€ / shares
EQH Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	0	0
Options granted (in shares)	1,035	1,035
Options exercised (in shares)	0	0
Options forfeited, net (in shares)	(41)	(41)
Options expired/reinstated (in shares)	0	0
Options, Number Outstanding, Ending Balance (in shares)	994	994
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | $ / shares	$ 0
Options granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	21.34
Options exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | $ / shares	21.34
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | $ / shares	$ 21.34
Options Outstanding, Aggregate Intrinsic Value | $	$ 0	$ 0
Weighted Average Remaining Contractual Term (in years)	9 years 1 month 27 days	9 years 1 month 27 days
Options Excercisable (in shares)	0	0
Options Excercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 0	$ 0
Options Excercisable, Aggregate Intrinsic Value | $	$ 0	$ 0
Weighted Average Remaining Contractual Term (in years)	0 years	0 years
AXA Ordinary Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	5,402	5,402
Options granted (in shares)	0	0
Options exercised (in shares)	(565)	(565)
Options forfeited, net (in shares)	0	0
Options expired/reinstated (in shares)	(1,225)	(1,225)
Options, Number Outstanding, Ending Balance (in shares)	3,612	3,612
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | € / shares		$ 17.36
Options granted, Weighted Average Exercise Price (in dollars per share) | € / shares		0
Options exercised, Weighted Average Exercise Price (in dollars per share) | € / shares		11.80
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | € / shares		0
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | € / shares		17.45
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | € / shares		$ 18.20
Options Outstanding, Aggregate Intrinsic Value | $	$ 2,383	$ 2,383
Weighted Average Remaining Contractual Term (in years)	4 years 6 months	4 years 6 months
Options Excercisable (in shares)	2,147	2,147
Options Excercisable, Weighted Average Exercise Price (in dollars per share) | € / shares			€ 15.27
Options Excercisable, Aggregate Intrinsic Value | $	$ 7,698	$ 7,698
Weighted Average Remaining Contractual Term (in years)	2 years 5 months 12 days	2 years 5 months 12 days
AB Holding Units
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	3,082	3,082
Options granted (in shares)	0	0
Options exercised (in shares)	(889)	(889)
Options forfeited, net (in shares)	0	0
Options expired/reinstated (in shares)	(1,522)	(1,522)
Options, Number Outstanding, Ending Balance (in shares)	671	671
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | $ / shares	$ 52.37
Options granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	18.66
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | $ / shares	85.09
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | $ / shares	$ 22.83
Options Outstanding, Aggregate Intrinsic Value | $	$ 0	$ 0
Weighted Average Remaining Contractual Term (in years)	1 year 7 months 6 days	1 year 7 months 6 days
Options Excercisable (in shares)	635	635
Options Excercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 22.84	$ 22.84
Options Excercisable, Aggregate Intrinsic Value | $	$ 3	$ 3
Weighted Average Remaining Contractual Term (in years)	1 year 6 months	1 year 6 months
AXA ADRs
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	35	35
Options granted (in shares)	0	0
Options exercised (in shares)	0	0
Options forfeited, net (in shares)	0	0
Options expired/reinstated (in shares)	(10)	(10)
Options, Number Outstanding, Ending Balance (in shares)	25	25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | $ / shares	$ 20.98
Options granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | $ / shares	35.25
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | $ / shares	$ 15.37
Options Outstanding, Aggregate Intrinsic Value | $	$ 151	$ 151
Weighted Average Remaining Contractual Term (in years)	6 months 29 days	6 months 29 days
Options Excercisable (in shares)	25	25
Options Excercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 15.37	$ 15.37
Options Excercisable, Aggregate Intrinsic Value | $	$ 151	$ 151
Weighted Average Remaining Contractual Term (in years)	6 months 29 days	6 months 29 days

SHARE-BASED COMPENSATION PROG_4

SHARE-BASED COMPENSATION PROGRAMS - Fair Value Stock Option Assumptions (Details) - $ / shares	Jun. 11, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
EQH Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield		2.44%
Expected volatility		25.40%
Risk-free interest rates		2.83%
Expected life in years		5 years 8 months 12 days
Weighted average fair value per option at grant date (in dollars per share)	$ 21.34
Parent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield		2.44%
Expected volatility		25.40%
Risk-free interest rates		2.83%
Expected life in years		9 years 8 months 12 days
Weighted average fair value per option at grant date (in dollars per share)		$ 4.61
Parent | AXA Ordinary Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield			6.53%	6.50%
Expected volatility			25.05%	26.60%
Risk-free interest rates			0.59%	0.33%
Expected life in years			8 years 9 months 18 days	8 years 1 month 6 days
Weighted average fair value per option at grant date (in dollars per share)			$ 2.01	$ 2.06
Parent | AB Holding Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield				7.10%
Expected volatility				31.00%
Risk-free interest rates				1.30%
Expected life in years				6 years
Weighted average fair value per option at grant date (in dollars per share)				$ 2.75

SHARE-BASED COMPENSATION PROG_5

SHARE-BASED COMPENSATION PROGRAMS - Restricted Stock Activity (Details) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2018$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, Beginning Balance (in shares) | shares	0
Granted (in shares) | shares	2,877,011
Canceled (in shares) | shares	92,526
Vested (in shares) | shares	511,575
Unvested, Ending Balance (in shares) | shares	2,272,910
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 0
Granted (in usd per share) | $ / shares	20.83
Canceled (in usd per share) | $ / shares	21.21
Vested (in usd per share) | $ / shares	21.09
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 21
Parent
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, Beginning Balance (in shares) | shares	93,720
Granted (in shares) | shares	0
Canceled (in shares) | shares	208
Vested (in shares) | shares	39,528
Unvested, Ending Balance (in shares) | shares	53,984
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 21.07
Granted (in usd per share) | $ / shares	0
Canceled (in usd per share) | $ / shares	26.64
Vested (in usd per share) | $ / shares	21.99
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	$ 20.38

SHARE-BASED COMPENSATION PROG_6

SHARE-BASED COMPENSATION PROGRAMS - Narrative (Details) $ / shares in Units, $ in Millions

Nov. 20, 2018shares

Jun. 11, 2018$ / sharesshares

May 17, 2018$ / sharesshares

May 09, 2018$ / sharesshares

Jun. 21, 2017USD ($)shares

Jun. 21, 2017€ / shares

Apr. 07, 2017USD ($)shares

Mar. 24, 2017USD ($)shares

Jun. 06, 2016USD ($)shares

Jun. 06, 2016€ / shares

Jun. 30, 2018USD ($)shares

Apr. 30, 2018USD ($)shares

Sep. 30, 2018USD ($)

Jun. 30, 2018shares

Dec. 31, 2018USD ($)$ / sharesshares

Dec. 31, 2018USD ($)€ / sharesshares

Dec. 31, 2017USD ($)$ / sharesshares

Dec. 31, 2017USD ($)€ / shares

Dec. 31, 2016USD ($)$ / sharesshares

Sep. 30, 2017shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 228

$ 247

$ 213

Shares to be repurchased next year (in shares)

30,000

Grant of holding units (in shares)

1,000,000

Shares repurchased (in shares)

30,000,000

32,500,000

Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

400,000

Performance Shares | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Potential shares earned (in shares)

0.00%

Performance Shares | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Potential shares earned (in shares)

200.00%

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

2,877,011

Granted (in usd per share) | $ / shares

$ 20.83

EQH Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Compensation costs not yet recognized | $

$ 5

$ 5

Weighted average grant date fair value (in dollars and euros per share) | $ / shares

$ 21.34

Exercise price (in usd per share) | $ / shares

$ 4.61

Expected volatility

25.40%

Expected life in years

5 years 8 months 12 days

Dividend yield

2.44%

Risk-free interest rates

2.83%

EQH Shares | Vesting trach one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

EQH Shares | Vesting tranche two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

EQH Shares | Vesting tranche three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

Performance Unit Plan 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 6

14

Stock options granted (in shares)

1,700,000

Performance Unit Plan 2017 | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

0.00%

Performance Unit Plan 2017 | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

130.00%

Performance Unit Plan 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share based compensation arrangement by share based payment award equity instruments other than options equity settlement of vested units with ordinary shares value | $

$ 21

$ 22

Equity settlement of vested units with ordinary shares number (in shares)

2,300,000

800,000

Cash settlement | $

$ 6

$ 7

Settlement Of Units

200,000

200,000

Performance Unit Plan 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

5

6

15

Stock options granted (in shares)

1,900,000

Performance Unit Plan 2016 | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

0.00%

Performance Unit Plan 2016 | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

130.00%

Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

11

45

37

Deferred compensation liability | $

$ 32

$ 32

45

$ 45

Unvested restricted shares and holding units

2,000,000

2,000,000

Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost not yet recognized | $

$ 3

$ 3

Compensation cost, recognition period

9 months 18 days

Total Compensation Expenses | $

$ 2

1

1

AXA Shareplan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

5 years

Total Compensation Expenses | $

$ 0

13

19

Omnibus Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Holding unit-based awards authorized for grant (in shares)

5,500,000

5,500,000

TSR Performance Share Plan | Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation costs not yet recognized | $

$ 5

$ 5

Total Compensation Expenses | $

2

TSR Performance Share Plan | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share Price | $ / shares

$ 23.17

Transaction Incentive Grant Awards | Vesting tranche two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Intrinsic value, outstanding | $

7

7

Transaction Incentive Grant Awards | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

700,000

Compensation costs not yet recognized | $

$ 3

3

Vesting percentage

50.00%

Award requisite service period

5 years

Transaction Incentive Grant Awards | Restricted Stock Units (RSUs) | Vesting tranche three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 6

Transaction Incentive Grant Awards | Restricted Stock Units (RSUs) | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Growth rate

130.00%

Transaction Incentive Grant Awards | Restricted Stock Units (RSUs) | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Growth rate

150.00%

Transaction Incentive Grant Awards | RSU Service Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

2 years

Vesting percentage

50.00%

Transaction Incentive Grant Awards | RSU Service Units | Vesting tranche two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

400,000

Transaction Incentive Grant Awards | RSU Performance Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

50.00%

Transaction Incentive Grant Awards | RSU Performance Units | Vesting tranche three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

200,000

Compensation costs not yet recognized | $

$ 4

4

Granted (in usd per share) | $ / shares

$ 16.47

Transaction Incentive Grant Awards | RSU Performance Units | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

2 years

Transaction Incentive Grant Awards | RSU Performance Units | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

5 years

All-Employee Award | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost, recognition period

6 months

Granted (in shares)

400,000

Grants on an individual basis (in shares)

50

Compensation costs not yet recognized | $

$ 7

7

Annual Awards 2018 | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Granted (in shares)

1,300,000

Compensation costs not yet recognized | $

$ 27

$ 27

Total Compensation Expenses | $

$ 4

Annual Awards 2018 | Restricted Stock Units (RSUs) | Vesting trach one

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

Annual Awards 2018 | Restricted Stock Units (RSUs) | Vesting tranche two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

Annual Awards 2018 | Restricted Stock Units (RSUs) | Vesting tranche three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

33.33%

Annual Awards 2018 | Cash-settled RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

500,000

June 2018 Grant | EQH Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 2

Performance Unit Grants 2016 and 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

600,000

700,000

Total Compensation Expenses | $

$ (4)

15

10

2017 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Holding unit-based awards authorized for grant (in shares)

60,000,000

2017 Plan | Newly Issued AB Holding Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Holding unit-based awards authorized for grant (in shares)

30,000,000

Shares available for grant (in shares)

45,600,000

45,600,000

Plan 2017 Subject to Other Holding Unit Awards | Newly Issued AB Holding Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares available for grant (in shares)

14,400,000

14,400,000

Public Offering

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share Price | $ / shares

$ 20

Non-officer Directors

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 0.6

Shares issued (in shares)

30,000

Exercise price (in usd per share) | $ / shares

$ 21.68

Parent

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted average grant date fair value (in dollars and euros per share) | $ / shares

$ 4.61

Expected volatility

25.40%

Expected life in years

9 years 8 months 12 days

Dividend yield

2.44%

Risk-free interest rates

2.83%

Parent | Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost, recognition period

1 year 2 months 16 days

Granted (in shares)

0

Granted (in usd per share) | $ / shares

$ 0

Total Compensation Expenses | $

$ 215

185

154

Unvested restricted shares and holding units

2,300,000

2,300,000

Compensation cost not yet recognized | $

$ 30

$ 30

Parent | AB Holding

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost, recognition period

3 years 7 months 6 days

Unvested restricted shares and holding units

20,200,000

20,200,000

Compensation cost not yet recognized | $

$ 87

$ 87

Parent | EQH Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options granted (in shares)

1,035,000

Stock options granted, exercise price (in dollars and euros per share) | $ / shares

$ 21.34

Parent | Stock Option Plan 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 0.1

0.6

Stock options granted (in shares)

500,000

Stock options granted, exercise price (in dollars and euros per share) | € / shares

€ 23.92

Weighted average grant date fair value (in dollars and euros per share) | € / shares

€ 1.78

Expected volatility

25.05%

Expected life in years

8 years 9 months 18 days

Dividend yield

6.53%

Risk-free interest rates

0.59%

Fair value of options (net of expected forfeitures) | $

$ 1

Parent | Stock Option Plan 2017 | Conditional Vesting Term

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options granted (in shares)

300,000

Parent | Stock Option Plan 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total Compensation Expenses | $

$ 0.1

$ 0.1

$ 0.6

Stock options granted (in shares)

600,000

Expiration period

10 years

Stock options granted, exercise price (in dollars and euros per share) | € / shares

€ 21.52

Weighted average grant date fair value (in dollars and euros per share) | € / shares

€ 1.85

Expected volatility

26.60%

Expected life in years

8 years 1 month 6 days

Dividend yield

6.50%

Risk-free interest rates

0.33%

Fair value of options (net of expected forfeitures) | $

$ 1

Parent | Stock Option Plan 2016 | Conditional Vesting Term

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options granted (in shares)

300,000

Parent | AXA Ordinary Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options granted (in shares)

0

Stock options granted, exercise price (in dollars and euros per share) | € / shares

$ 0

Weighted average grant date fair value (in dollars and euros per share) | $ / shares

$ 2.01

$ 2.06

Expected volatility

25.05%

26.60%

Expected life in years

8 years 9 months 18 days

8 years 1 month 6 days

Dividend yield

6.53%

6.50%

Risk-free interest rates

0.59%

0.33%

Parent | Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost not yet recognized | $

$ 1

$ 1

Compensation cost, recognition period

2 years 2 months 19 days

AXA Shareplan Option Current Year | Parent

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Discount from market price, purchase date

20.00%

Weighted average purchase price of shares purchased | € / shares

$ 20.19

AXA Shareplan Option B 2015 | Parent

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Discount from market price, purchase date

8.98%

Weighted average purchase price of shares purchased | € / shares

$ 22.96

Shares issued during period under employee stock ownership plan

4,000,000

6,000,000

Alliance Bernstein

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares repurchased (in shares)

9,300,000

Payments for repurchase of other equity | $

$ 268

$ 220

Open market purchases (in shares)

6,500,000

5,200,000

Open-market purchases, value | $

$ 183

$ 117

Shares issued in period (in shares)

900,000

1,200,000

Proceeds from options exercised | $

$ 17

$ 20

Alliance Bernstein | Employees and Directors

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares issued in period (in shares)

8,700,000

8,600,000

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended									12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Contingency [Line Items]
Federal operating loss credit carryforward	$ 429				$ 167					$ 429	$ 167
Income tax penalties and interest accrued	75				83					75	83
AMT tax credits	140				528					140	528
TCJA of 2017, existing income tax expense (benefit)										(69)
TCJA, audit interest income tax expense (benefit)										17
TCJA of 2017 sequestration fee of AMT income tax expense (benefit)										35
Tax benefit	17
Tax settlement benefit							$ 228		$ 21
Sale of business benefit												$ 160
Nondeductible goodwill								$ 129
Domestic operating income (loss)										2,305	1,163	1,908
Foreign operating income (loss)										156	143	119
Income tax expense (benefit)	330	$ (175)	$ 61	$ 91	$ 149	$ (59)	$ (78)	$ 37		307	49	378
Unrecognized tax benefits, tax penalties and interest expense										(8)	(43)	25
Undistributed earnings of foreign subsidiaries	29									29
Additional taxes if undistributed earnings were remitted	$ 8									8
Foreign Tax Authority
Income Tax Contingency [Line Items]
Income tax expense (benefit)										$ (37)	$ (30)	$ (30)

INCOME TAXES - Components of In

INCOME TAXES - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Current (expense) benefit									$ 508	$ 119	$ (169)
Deferred (expense) benefit									(815)	(168)	(209)
Income tax (expense) benefit	$ (330)	$ 175	$ (61)	$ (91)	$ (149)	$ 59	$ 78	$ (37)	$ (307)	$ (49)	$ (378)

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of Tax Rate Amounts (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Expected income tax (expense) benefit									$ (516)	$ (457)	$ (710)
Noncontrolling interest									54	138	125
Non-taxable investment income (loss)									105	255	177
Tax audit interest									(22)	(14)	(32)
State income taxes									(18)	(16)	(108)
Tax settlements/uncertain tax position release									0	228	181
Change in tax law									104	(32)	0
Intangibles									(3)	(138)	(9)
Other									(11)	(13)	(2)
Income tax (expense) benefit	$ (330)	$ 175	$ (61)	$ (91)	$ (149)	$ 59	$ 78	$ (37)	$ (307)	$ (49)	$ (378)

INCOME TAXES - Components of De

INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2015
Assets
Compensation and related benefits	$ 312	$ 328
Net operating loss	90	35
Reserves and reinsurance	321	1,460
Unrealized investment gains (losses)	108	0
Investments	124	0
Tax credits	149	528
Other	0	170
Total	1,104	$ 2,521
Liabilities
DAC	1,175		$ 850
Unrealized investment gains (losses)	0		373
Investments	0		891
Other	208		0
Total	$ 1,383		$ 2,114

INCOME TAXES - Reconciliation_2

INCOME TAXES - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$ 477	$ 729	$ 802
Additions for tax positions of prior years	91	28	99
Reductions for tax positions of prior years	(29)	(247)	(172)
Additions for tax positions of current year	0	0	0
Settlements with tax authorities	0	(33)	0
Ending balance	539	477	729
Unrecognized tax benefits that, if recognized, would impact the effective rate	$ 407	$ 317	$ 485

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Components of AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized gains (losses) on investments	$ (394)	$ 830			$ 140
Defined benefit pension plans	968	955			1,055
Foreign currency translation adjustments	(72)	(35)			(77)
Total accumulated other comprehensive income (loss)	(1,434)	(160)			(992)
Less: Accumulated other comprehensive (income) loss attributable to the noncontrolling interest	(38)	(52)			(71)
Accumulated other comprehensive income (loss) attributable to Holdings	(1,396)	(108)			$ (921)
Unrealized gains (losses) on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI	113
Defined benefit pension plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI	$ (202)
ASU 2016-01 | AOCI Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Impact of new ASUs		$ (7)	$ 0	$ 0

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Components of OCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax [Abstract]
Net unrealized gains (losses) arising during the year	$ (1,952)	$ 910	$ (227)
(Gains) losses reclassified into net income (loss) during the year	60	10	(55)
Net unrealized gains (losses) on investments	(1,892)	920	(282)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	563	(230)	8
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(356), $262 and $(164))	(1,329)	690	(274)
Change in defined benefit plans:
Less: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost	189	100	34
Change in defined benefit plans (net of deferred income tax expense (benefit) of $50, $51 and $19)	189	100	34
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the year	(37)	42	(18)
(Gains) losses reclassified into net income (loss) during the year	0	0	0
Foreign currency translation adjustment	(37)	42	(18)
Total other comprehensive income (loss), net of income taxes	(1,177)	832	(258)
Less: Other comprehensive (income) loss attributable to noncontrolling interest	(15)	(19)	14
Other comprehensive income (loss) attributable to Holdings	(1,192)	813	(244)
AFS Securities, OCI, tax	356	(262)	164
Defined benefit plan, OCI, tax	50	51	19
Income tax expense (benefit)	$ 13	$ 5	$ 29

COMMITMENTS AND CONTINGENT LI_3

COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Outstanding balance at end of period	$ 3,990	$ 3,000
Issued during the period	7,980	6,762
Repaid during the period	6,990	6,000
Difference related to remaining amortization		14
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Month
Debt Instrument [Line Items]
Outstanding balance at end of period	1,490	500
Issued during the period	7,980	6,000
Repaid during the period	6,990	6,000
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Four Years
Debt Instrument [Line Items]
Outstanding balance at end of period	1,621	1,244
Issued during the period	0	324
Repaid during the period	0	0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Five Years
Debt Instrument [Line Items]
Outstanding balance at end of period	98	377
Issued during the period	0	303
Repaid during the period	0	0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years
Debt Instrument [Line Items]
Outstanding balance at end of period	781	879
Issued during the period	0	135
Repaid during the period	0	0
Federal Home Loan Bank of New York Long-Term Funding Agreements
Debt Instrument [Line Items]
Outstanding balance at end of period	2,500	2,500
Issued during the period	0	762
Repaid during the period	$ 0	$ 0

COMMITMENTS AND CONTINGENT LI_4

COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details) $ in Millions	May 02, 2018USD ($)job	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Loss Contingencies [Line Items]
Unaccrued amounts of reasonably possible range of losses		$ 95
Value of alleged damages				$ 1
Operating Leases, Future Minimum Payments, Due in 2019		212
Operating Leases, Future Minimum Payments, Due in 2020		186
Operating Leases, Future Minimum Payments, Due in 2021		181
Operating Leases, Future Minimum Payments, Due in 2022		166
Operating Leases, Future Minimum Payments, Due in 2023		155
Operating Leases, Future Minimum Payments, Due Theafter		293
Future Minimum Sublease Rentals, Sale Leaseback Transactions, 2019		59
Future Minimum Sublease Rentals, Sale Leaseback Transactions, 2020		46
Future Minimum Sublease Rentals, Sale Leaseback Transactions, 2021		44
Future Minimum Sublease Rentals, Sale Leaseback Transactions, 2022		41
Future Minimum Sublease Rentals, Sale Leaseback Transactions, 2023		40
Future Minimum Sublease Rentals, Sale Leaseback Transactions, Thereafter		27
Operating Leases, Rent Expense, Net		143	$ 143	140
Operating Leases, Rent Expense, Sublease Rentals		12	16	16
Federal home loan bank stock		190
Carrying value of collateral pledged for federal home loan bank		6,100
AXA
Loss Contingencies [Line Items]
Severance Costs		7	$ 29	$ 21
Face amount of mortgage loans		606
Commitments by the Company to provide equity financing		952
Alliance Bernstein
Loss Contingencies [Line Items]
Restructuring And Related Cost, Number Of Positions Relocated | job	1,050
New real estate charges		10
Alliance Bernstein | Minimum
Loss Contingencies [Line Items]
Restructuring and Related Cost, Expected Cost	$ 155
Alliance Bernstein | Maximum
Loss Contingencies [Line Items]
Restructuring and Related Cost, Expected Cost	$ 165
EQ AZ Life Re
Loss Contingencies [Line Items]
Letters of credit		2,500
Other Restricted Assets		1,600
CS Life RE
Loss Contingencies [Line Items]
Letters of credit		125
Other Restricted Assets		300
Affiliated Entity | AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing		304
Assets of Consolidated VIEs/VOEs | AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing		$ 12

COMMITMENTS AND CONTINGENT LI_5

COMMITMENTS AND CONTINGENT LIABILITIES - Debt Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2018	Apr. 20, 2018
Debt Instrument [Line Items]
2,020	$ 0
2,022	0
2024 and thereafter	3,350
Three Year Term Loan | Senior Debentures
Debt Instrument [Line Items]
2,021	$ 300
Senior Notes (3.90%, due 2023) | Senior Notes
Debt Instrument [Line Items]
2,023		$ 800

- Narrative (Details)

- Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statutory Accounting Practices [Abstract]
Statutory amount available for dividend payments without regulatory approval	$ 1,000
Statutory amount available for dividend payments	2,100
Insurance Groups statutory net income (loss)	3,031	$ 942	$ 656
Statutory surplus, capital stock and Asset Valuation Reserve	8,446	9,238
Shareholder dividends	1,100		$ 1,050
AB Ownership transfer	1,700
Extraordinary dividends	572
Securities on deposit with such government or state agencies	77
Subsidiary
Statutory Accounting Practices [Abstract]
Repayments of surplus notes	$ 86	$ 103

BUSINESS SEGMENT INFORMATION -

BUSINESS SEGMENT INFORMATION - Summary of Segment Operations and Assets (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Net earnings (loss)	$ 1,938	$ (496)	$ 164	$ 168	$ 483	$ 10	$ 618	$ (277)	$ 1,820	$ 834	$ 1,254
Adjustments related to:
Goodwill impairment loss									0	369	0
Non-GAAP Operating Earnings									2,166	2,035	1,391
Interest expense									231	160	174
Segment revenues	5,155	$ 1,083	2,966	2,874	2,922	$ 2,806	3,888	2,844	12,078	12,460	11,763
Long-lived assets	220,797				235,615				220,797	235,615
Investment expenses									72	72	79
Segment Reconciling Items
Segment Reporting Information [Line Items]
Net earnings (loss)									1,820	834	1,254
Adjustments related to:
Variable annuity product features									(70)	1,107	2,143
Investment (gains) losses									86	191	(1,983)
Goodwill impairment loss									0	369	0
Net actuarial (gains) losses related to pension and other postretirement benefit obligations									215	135	140
Other adjustments									299	119	(7)
Income tax expense (benefit) related to above adjustments									(111)	(644)	(93)
Non-recurring tax items									(73)	(76)	(63)
Separation costs									213	93
Revenue adjustments related to guaranteed minimum benefits									(643)	(214)	(2,132)
Revenue adjustments related to investment gains (losses)									(86)	(191)	1,983
Other adjustments to revenue									(57)	64	90
Intersegment Eliminations
Adjustments related to:
Investment expenses									67	68	60
Operating Segments
Adjustments related to:
Goodwill impairment loss									0	369	0
Corporate and Other
Adjustments related to:
Non-GAAP Operating Earnings									(356)	(213)	(181)
Interest expense									223	138	161
Segment revenues									1,148	1,212	1,256
Long-lived assets	21,464				22,110				21,464	22,110
Individual Retirement | Operating Segments
Adjustments related to:
Goodwill impairment loss									0	53	0
Non-GAAP Operating Earnings									1,555	1,252	1,167
Segment revenues									4,054	4,374	3,703
Long-lived assets	105,532				121,824				105,532	121,824
Investment Management | Operating Segments
Adjustments related to:
Long-lived assets	10,294				10,057				10,294	10,057
Group Retirement | Operating Segments
Adjustments related to:
Goodwill impairment loss									0	122	0
Non-GAAP Operating Earnings									389	283	167
Segment revenues									1,019	942	801
Long-lived assets	38,874				38,419				38,874	38,419
Investment Management And Research | Operating Segments
Adjustments related to:
Non-GAAP Operating Earnings									381	211	161
Segment revenues									3,411	3,216	2,933
Protection Solutions | Operating Segments
Adjustments related to:
Goodwill impairment loss									0	139	0
Non-GAAP Operating Earnings									197	502	77
Segment revenues									3,232	3,057	3,129
Long-lived assets	$ 44,633				43,205				44,633	43,205
Research services
Adjustments related to:
Revenues									439	450	480
Research services | Intersegment Eliminations
Adjustments related to:
Revenues									$ 94	96	$ 86
As Previously Reported
Adjustments related to:
Segment revenues			$ 2,962	$ 2,835			$ 3,882	$ 2,830
As Previously Reported | Individual Retirement | Operating Segments
Adjustments related to:
Long-lived assets					121,713					121,713
As Previously Reported | Group Retirement | Operating Segments
Adjustments related to:
Long-lived assets					38,578					38,578
As Previously Reported | Protection Solutions | Operating Segments
Adjustments related to:
Long-lived assets					$ 43,157					$ 43,157

EQUITY - Narrative (Details)

EQUITY - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Nov. 20, 2018	Nov. 09, 2018	Aug. 10, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Dividends declared (in usd per share)		$ 0.13	$ 0.13
Shares repurchased (in shares)	30,000,000			32,500,000
Share repurchase plan, authorized amount		$ 800	$ 500
Incremental increase in authorized amount		$ 300
Purchase of treasury shares				$ 648	$ 0	$ 0
Treasury stock reissued (in shares)				400,000

EARNINGS PER SHARE - Reconcilia

EARNINGS PER SHARE - Reconciliation of Numerator (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net income (loss) attributable to Holdings common shareholders:
Net income (loss) attributable to Holdings	$ 1,938	$ (496)	$ 164	$ 168	$ 483	$ 10	$ 618	$ (277)	$ 1,820	$ 834	$ 1,254
Less: Incremental dilution from AB									0	1	0
Net income (loss) attributable to Holdings common shareholders (diluted):									$ 1,820	$ 833	$ 1,254

EARNINGS PER SHARE - Weighted A

EARNINGS PER SHARE - Weighted Average Shares (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Weighted Average Shares:
Basic (in shares)	556.4	561	561
Effect of dilutive securities, employee stock awards (in shares)	0.1	0	0
Weighted average common shares outstanding - diluted (in shares)	556.5	561	561

EARNINGS PER SHARE - Basic and

EARNINGS PER SHARE - Basic and Diluted Earnings Per Share (Details) - $ / shares	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net income (loss) attributable to Holdings per common share:
Basic (in usd per share)	$ 3,570,000	$ (0.89)	$ 0.29	$ 0.30	$ 0.86	$ 0.02	$ 1.10	$ (0.49)	$ 3.27	$ 1.49	$ 2.24
Diluted (in usd per share)	$ 3,570,000	$ (0.89)	$ 0.29	$ 0.30	$ 0.86	$ 0.02	$ 1.10	$ (0.50)	$ 3.27	$ 1.48	$ 2.24

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details) shares in Millions	Apr. 24, 2018	Dec. 31, 2018shares
Earnings Per Share [Abstract]
Antidilutive securities (in shares)		2.7
Stock split ratio	459.4752645

REVISION OF PRIOR PERIOD FINA_3

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Revised Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended
		Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash long term incentive compensation expense	[1]							$ 228		$ 247		$ 213
Amortization and depreciation	[1]							257		399		758
Equity (income) loss from limited partnerships								(119)		(155)		(59)
Changes in:
Reinsurance recoverable	[1]							(191)		124		24
Capitalization of deferred policy acquisition costs	[1]							(702)		(687)		(697)
Future policy benefits								(399)		1,097		272
Current and deferred income taxes								633		(10)		(217)
Other, net	[1]							(222)		251		428
Net cash provided by (used in) operating activities								61		(243)		(236)
Cash flows from investing activities:
Short term investments	[1]							6,267		4,556		3,605
Short term investments	[1]							(5,058)		(4,897)		(4,090)
Other, net	[1]							(86)		201		384
Net cash provided by (used in) investing activities								(2,049)		(9,689)		(5,768)
Cash flows from financing activities:
Deposits								9,994		9,916		10,001
Withdrawals								(4,600)		(4,010)		(2,976)
Transfers (to) from Separate Accounts								1,724		1,486		1,432
Net cash provided by (used in) financing activities								1,655		9,070		5,111
Change in cash and cash equivalents								(345)		(840)		(903)
Cash and cash equivalents								$ 4,469	[2]	4,814	[2]	$ 5,654	$ 6,557
As Previously Reported
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash long term incentive compensation expense										185
Amortization and depreciation				$ (32)						(104)
Distributions from joint ventures and limited partnerships		$ 25	$ 26	44	$ 53	$ 63	$ 94			140
Equity (income) loss from limited partnerships		0	0	0	0	0	0			0
Changes in:
Reinsurance recoverable		32	27	20	40	92	115			0
Capitalization of deferred policy acquisition costs		15	(55)	14	(168)	(338)	(150)			(184)
Future policy benefits		(254)	296	(171)	1,516	(620)	1,587			1,599
Current and deferred income taxes		103	252	224	123	249	498			767
Other, net		(255)	(71)	(180)	333	(139)	253			127
Net cash provided by (used in) operating activities		(264)	72	(314)	666	(34)	1,044			1,021
Cash flows from investing activities:
Short term investments										0
Short term investments		876				(335)				0
Other, net		(371)	(191)	419	179	319	(133)			(342)
Net cash provided by (used in) investing activities		459	(2,899)	1,807	(5,067)	(1,057)	(6,568)			(9,689)
Cash flows from financing activities:
Deposits		2,532	2,790	5,567	4,401	8,372	6,135			10,591
Withdrawals		(1,384)	(1,342)	(2,750)	(1,724)	(4,170)	(2,765)			(6,140)
Transfers (to) from Separate Accounts		(102)	186	(307)	826	(335)	1,617			1,677
Net cash provided by (used in) financing activities		1,074	2,630	532	4,923	1,063	6,299			7,806
Change in cash and cash equivalents		1,277	(189)	2,019	533	(37)	792			(840)
Cash and cash equivalents		6,091	5,465	6,833	6,187	4,777	6,446			4,814
Presentation Reclassifications
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash long term incentive compensation expense										62
Amortization and depreciation				380						503
Distributions from joint ventures and limited partnerships		(25)	(26)	(44)	(53)	(63)	(94)			(140)
Equity (income) loss from limited partnerships		(38)	(40)	(59)	(66)	(82)	(103)			(155)
Changes in:
Reinsurance recoverable		0	0	0	0	0	0			124
Capitalization of deferred policy acquisition costs		(172)	(114)	(357)	(179)	(175)	(363)			(503)
Future policy benefits		0	0	0	0	0	0			0
Current and deferred income taxes		0	0	0	0	0	0			0
Other, net		63	66	103	119	145	197			109
Net cash provided by (used in) operating activities		0	0	0	0	0	0			0
Cash flows from investing activities:
Short term investments										4,555
Short term investments		0				139				(4,897)
Other, net		0	0	0	0	0	0			342
Net cash provided by (used in) investing activities		0	0	0	0	0	0			0
Cash flows from financing activities:
Deposits		0	0	0	0	0	0			0
Withdrawals		0	0	0	0	0	0			0
Transfers (to) from Separate Accounts		0	0	0	0	0	0			0
Net cash provided by (used in) financing activities		0	0	0	0	0	0			0
Change in cash and cash equivalents		0	0	0	0	0	0			0
Cash and cash equivalents		0	0	0	0	0	0			0
Revisions
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash long term incentive compensation expense										0
Amortization and depreciation				11						0
Distributions from joint ventures and limited partnerships		0	0	0	0	0	0			0
Equity (income) loss from limited partnerships		0	0	0	0	0	0			0
Changes in:
Reinsurance recoverable		(3)	3	9	9	(2)	10
Capitalization of deferred policy acquisition costs		0		0	0	0	0			0
Future policy benefits		6	52	(15)	(169)	(44)	(10)			(502)
Current and deferred income taxes		12	(256)	(42)	(210)	(56)	(546)			(777)
Other, net		0	0	0	0	0	15			15
Net cash provided by (used in) operating activities		17	(216)	(28)	(372)	(102)	(531)			(1,264)
Cash flows from investing activities:
Short term investments										0
Short term investments		77				0				0
Other, net		60	76	61	(173)	(5)	(230)			0
Net cash provided by (used in) investing activities		(343)	(210)	(576)	(139)	(673)	(180)			0
Cash flows from financing activities:
Deposits		(491)	(144)	(1,141)	766	(1,719)	1,283			(675)
Withdrawals		284	376	572	(158)	846	(114)			2,130
Transfers (to) from Separate Accounts		533	194	1,173	(97)	1,648	(458)			(191)
Net cash provided by (used in) financing activities		326	426	604	511	775	711			1,264
Change in cash and cash equivalents		0	0	0	0	0	0			0
Cash and cash equivalents		0	0	0	0	0	0			0
As Revised
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash long term incentive compensation expense										247
Amortization and depreciation				359						399
Distributions from joint ventures and limited partnerships		0	0	0	0	0	0			0
Equity (income) loss from limited partnerships		(38)	(40)	(59)	(66)	(82)	(103)			(155)
Changes in:
Reinsurance recoverable		29	30	29	49	90	125			124
Capitalization of deferred policy acquisition costs		(157)	(169)	(343)	(347)	(513)	(513)			(687)
Future policy benefits		(248)	348	(186)	1,347	(664)	1,577			1,097
Current and deferred income taxes		115	(4)	182	(87)	193	(48)			(10)
Other, net		(192)	(5)	(77)	452	6	465			251
Net cash provided by (used in) operating activities		(247)	(144)	(342)	294	(136)	513			(243)
Cash flows from investing activities:
Short term investments										4,555
Short term investments		953				(196)				(4,897)
Other, net		(311)	(115)	480	6	314	(363)			0
Net cash provided by (used in) investing activities		116	(3,109)	1,231	(5,206)	(1,730)	(6,748)			(9,689)
Cash flows from financing activities:
Deposits		2,041	2,646	4,426	5,167	6,653	7,418			9,916
Withdrawals		(1,100)	(966)	(2,178)	(1,882)	(3,324)	(2,879)			(4,010)
Transfers (to) from Separate Accounts		431	380	866	729	1,313	1,159			1,486
Net cash provided by (used in) financing activities		1,400	3,056	1,136	5,434	1,838	7,010			9,070
Change in cash and cash equivalents		1,277	(189)	2,019	533	(37)	792			(840)
Cash and cash equivalents		$ 6,091	$ 5,465	$ 6,833	$ 6,187	$ 4,777	$ 6,446			$ 4,814
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 23 for further information.
[2]	See Note 2 for details of balances with variable interest entities.

QUARTERLY FINANCIAL INFORMATI_3

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Summary of Quarterly Results (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								6 Months Ended		12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Revenues	$ 5,155	$ 1,083	$ 2,966	$ 2,874	$ 2,922	$ 2,806	$ 3,888	$ 2,844			$ 12,078	$ 12,460	$ 11,763
Total benefits and other deductions	2,826	1,701	2,644	2,446	2,146	2,759	3,258	2,991			9,617	11,154	9,736
Income (loss) from continuing operations, before income taxes	2,329	(618)	322	428	776	47	630	(147)			2,461	1,306	2,027
Income tax (expense) benefit	(330)	175	(61)	(91)	(149)	59	78	(37)			(307)	(49)	(378)
Net income (loss)	1,999	(443)	261	337	627	106	708	(184)			2,154	1,257	1,649
Less: net (income) loss attributable to the noncontrolling interest	(61)	(53)	(97)	(123)	(144)	(96)	(90)	(93)			(334)	(423)	(395)
Net income (loss) attributable to Holdings	$ 1,938	$ (496)	$ 164	$ 168	$ 483	$ 10	$ 618	$ (277)			$ 1,820	$ 834	$ 1,254
Earnings per share - common stock:
Basic (in usd per share)	$ 3,570,000	$ (0.89)	$ 0.29	$ 0.30	$ 0.86	$ 0.02	$ 1.10	$ (0.49)			$ 3.27	$ 1.49	$ 2.24
Diluted (in usd per share)	$ 3,570,000	$ (0.89)	$ 0.29	$ 0.30	$ 0.86	$ 0.02	$ 1.10	$ (0.50)			$ 3.27	$ 1.48	$ 2.24
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Revenues			$ 2,962	$ 2,835			$ 3,882	$ 2,830
Total benefits and other deductions			2,648	2,465			3,268	2,997
Net income (loss)			255	291			698	(197)	$ 546	$ 501
Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Revenues			4	39			6	14
Total benefits and other deductions			(4)	(19)			(10)	(6)
Net income (loss)			$ 6	$ 46			$ 10	$ 13

QUARTERLY FINANCIAL INFORMATI_4

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Revised Statements of Cash Flow (Details) - USD ($) $ in Millions		3 Months Ended										6 Months Ended		9 Months Ended		12 Months Ended
		Dec. 31, 2018		Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017		Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016	Dec. 31, 2015
Cash flow from operating activities:
Net income (loss)		$ 1,999		$ (443)	$ 261	$ 337	$ 627		$ 106	$ 708	$ (184)					$ 2,154		$ 1,257		$ 1,649
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances																1,090		995		967
Policy charges and fee income																(3,824)		(3,693)		(3,729)
Net derivative (gains) losses																231		(214)		1,848
Equity (income) loss from limited partnerships																(119)		(155)		(59)
Amortization and depreciation	[1]															257		399		758
Changes in:
Net broker-dealer and customer related receivables/payables																838		(278)		608
Reinsurance recoverable	[1]															(191)		124		24
Capitalization of deferred policy acquisition costs	[1]															(702)		(687)		(697)
Future policy benefits																(399)		1,097		272
Current and deferred income taxes																633		(10)		(217)
Other, net	[1]															(222)		251		428
Net cash provided by (used in) operating activities																61		(243)		(236)
Cash flows from investing activities:
Real estate joint ventures																139		0		136
Other																330		228		64
Short term investments	[1]															(5,058)		(4,897)		(4,090)
Cash settlements related to derivative instruments																583		(2,166)		(195)
Other, net	[1]															(86)		201		384
Net cash provided by (used in) investing activities																(2,049)		(9,689)		(5,768)
Cash flows from financing activities:
Deposits																9,994		9,916		10,001
Withdrawals																(4,600)		(4,010)		(2,976)
Transfers (to) from Separate Accounts																1,724		1,486		1,432
Net cash provided by (used in) financing activities																1,655		9,070		5,111
Change in cash and cash equivalents																(345)		(840)		(903)
Cash and cash equivalents		$ 4,469	[2]				4,814	[2]								$ 4,469	[2]	4,814	[2]	$ 5,654	$ 6,557
As Previously Reported
Cash flow from operating activities:
Net income (loss)					255	291				698	(197)	$ 546	$ 501
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income						(972)					(956)	(1,959)	(1,891)
Net derivative (gains) losses						281					235	354	(494)
Amortization of deferred sales commission						7						13		$ 18
Amortization of reinsurance cost						5						10		17
Other depreciation and amortization						(20)					(42)		(60)	(57)	$ (121)
Distributions from joint ventures and limited partnerships						25					26	44	53	63	94			140
Equity (income) loss from limited partnerships						0					0	0	0	0	0			0
Amortization and depreciation												(32)						(104)
Changes in:
Net broker-dealer and customer related receivables/payables											297
Reinsurance recoverable						32					27	20	40	92	115			0
Capitalization of deferred policy acquisition costs						15					(55)	14	(168)	(338)	(150)			(184)
Future policy benefits						(254)					296	(171)	1,516	(620)	1,587			1,599
Current and deferred income taxes						103					252	224	123	249	498			767
Other, net						(255)					(71)	(180)	333	(139)	253			127
Net cash provided by (used in) operating activities						(264)					72	(314)	666	(34)	1,044			1,021
Cash flows from investing activities:
Real estate joint ventures						0						0		0
Other												261
Short term investments						876								(335)				0
Change in short-term investments											(573)
Cash settlements related to derivative instruments						(54)					(1,400)	(333)	(1,537)	(609)	(1,722)
Other, net						(371)					(191)	419	179	319	(133)			(342)
Net cash provided by (used in) investing activities						459					(2,899)	1,807	(5,067)	(1,057)	(6,568)			(9,689)
Cash flows from financing activities:
Deposits						2,532					2,790	5,567	4,401	8,372	6,135			10,591
Withdrawals						(1,384)					(1,342)	(2,750)	(1,724)	(4,170)	(2,765)			(6,140)
Transfers (to) from Separate Accounts						(102)					186	(307)	826	(335)	1,617			1,677
Net cash provided by (used in) financing activities						1,074					2,630	532	4,923	1,063	6,299			7,806
Change in cash and cash equivalents						1,277					(189)	2,019	533	(37)	792			(840)
Cash and cash equivalents				4,777	6,833	6,091	4,814		6,446	6,187	5,465	6,833	6,187	4,777	6,446			4,814
Presentation Reclassifications
Cash flow from operating activities:
Net income (loss)						0					0	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income						0					0	0	0
Net derivative (gains) losses						0					0	0	0
Amortization of deferred sales commission						(7)						(13)		(18)
Amortization of reinsurance cost						(5)						(10)		(17)
Other depreciation and amortization						184					128		203	210	399
Distributions from joint ventures and limited partnerships						(25)					(26)	(44)	(53)	(63)	(94)			(140)
Equity (income) loss from limited partnerships						(38)					(40)	(59)	(66)	(82)	(103)			(155)
Amortization and depreciation												380						503
Changes in:
Net broker-dealer and customer related receivables/payables											0
Reinsurance recoverable						0					0	0	0	0	0			124
Capitalization of deferred policy acquisition costs						(172)					(114)	(357)	(179)	(175)	(363)			(503)
Future policy benefits						0					0	0	0	0	0			0
Current and deferred income taxes						0					0	0	0	0	0			0
Other, net						63					66	103	119	145	197			109
Net cash provided by (used in) operating activities						0					0	0	0	0	0			0
Cash flows from investing activities:
Real estate joint ventures						0						139		139
Other												(139)
Short term investments						0								139				(4,897)
Change in short-term investments											0
Cash settlements related to derivative instruments						0					0	0	0	0	0
Other, net						0					0	0	0	0	0			342
Net cash provided by (used in) investing activities						0					0	0	0	0	0			0
Cash flows from financing activities:
Deposits						0					0	0	0	0	0			0
Withdrawals						0					0	0	0	0	0			0
Transfers (to) from Separate Accounts						0					0	0	0	0	0			0
Net cash provided by (used in) financing activities						0					0	0	0	0	0			0
Change in cash and cash equivalents						0					0	0	0	0	0			0
Cash and cash equivalents				0	0	0	0		0	0	0	0	0	0	0			0
Revisions
Cash flow from operating activities:
Net income (loss)						46					13	52	23
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income						6					17	29	34
Net derivative (gains) losses						(45)					(31)	(72)	(54)
Amortization of deferred sales commission						0								0
Amortization of reinsurance cost						0						0		0
Other depreciation and amortization						(5)					(4)		(5)	0	0
Distributions from joint ventures and limited partnerships						0					0	0	0	0	0			0
Equity (income) loss from limited partnerships						0					0	0	0	0	0			0
Amortization and depreciation												11						0
Changes in:
Net broker-dealer and customer related receivables/payables											(10)
Reinsurance recoverable						(3)					3	9	9	(2)	10
Capitalization of deferred policy acquisition costs						0						0	0	0	0			0
Future policy benefits						6					52	(15)	(169)	(44)	(10)			(502)
Current and deferred income taxes						12					(256)	(42)	(210)	(56)	(546)			(777)
Other, net						0					0	0	0	0	15			15
Net cash provided by (used in) operating activities						17					(216)	(28)	(372)	(102)	(531)			(1,264)
Cash flows from investing activities:
Real estate joint ventures						140						0		0
Other												0
Short term investments						77								0				0
Change in short-term investments											308
Cash settlements related to derivative instruments						(620)					22	(637)	34	(668)	50
Other, net						60					76	61	(173)	(5)	(230)			0
Net cash provided by (used in) investing activities						(343)					(210)	(576)	(139)	(673)	(180)			0
Cash flows from financing activities:
Deposits						(491)					(144)	(1,141)	766	(1,719)	1,283			(675)
Withdrawals						284					376	572	(158)	846	(114)			2,130
Transfers (to) from Separate Accounts						533					194	1,173	(97)	1,648	(458)			(191)
Net cash provided by (used in) financing activities						326					426	604	511	775	711			1,264
Change in cash and cash equivalents						0					0	0	0	0	0			0
Cash and cash equivalents				0	0	0	0		0	0	0	0	0	0	0			0
As Revised
Cash flow from operating activities:
Net income (loss)						337					(184)	598	524
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Policy charges and fee income						(966)					(939)	(1,930)	(1,857)
Net derivative (gains) losses						236					204	282	(548)
Amortization of deferred sales commission						0						0		0
Amortization of reinsurance cost						0						0		0
Other depreciation and amortization						159					82		138	153	278
Distributions from joint ventures and limited partnerships						0					0	0	0	0	0			0
Equity (income) loss from limited partnerships						(38)					(40)	(59)	(66)	(82)	(103)			(155)
Amortization and depreciation												359						399
Changes in:
Net broker-dealer and customer related receivables/payables											287
Reinsurance recoverable						29					30	29	49	90	125			124
Capitalization of deferred policy acquisition costs						(157)					(169)	(343)	(347)	(513)	(513)			(687)
Future policy benefits						(248)					348	(186)	1,347	(664)	1,577			1,097
Current and deferred income taxes						115					(4)	182	(87)	193	(48)			(10)
Other, net						(192)					(5)	(77)	452	6	465			251
Net cash provided by (used in) operating activities						(247)					(144)	(342)	294	(136)	513			(243)
Cash flows from investing activities:
Real estate joint ventures						140						139		139
Other												122
Short term investments						953								(196)				(4,897)
Change in short-term investments											(265)
Cash settlements related to derivative instruments						(674)					(1,378)	(970)	(1,503)	(1,277)	(1,672)
Other, net						(311)					(115)	480	6	314	(363)			0
Net cash provided by (used in) investing activities						116					(3,109)	1,231	(5,206)	(1,730)	(6,748)			(9,689)
Cash flows from financing activities:
Deposits						2,041					2,646	4,426	5,167	6,653	7,418			9,916
Withdrawals						(1,100)					(966)	(2,178)	(1,882)	(3,324)	(2,879)			(4,010)
Transfers (to) from Separate Accounts						431					380	866	729	1,313	1,159			1,486
Net cash provided by (used in) financing activities						1,400					3,056	1,136	5,434	1,838	7,010			9,070
Change in cash and cash equivalents						1,277					(189)	2,019	533	(37)	792			(840)
Cash and cash equivalents				$ 4,777	$ 6,833	$ 6,091	$ 4,814		$ 6,446	$ 6,187	$ 5,465	$ 6,833	$ 6,187	$ 4,777	$ 6,446			$ 4,814
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 23 for further information.
[2]	See Note 2 for details of balances with variable interest entities.

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 14, 2019	Nov. 20, 2018	Nov. 09, 2018	Aug. 10, 2018	Jan. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Feb. 27, 2019	Jan. 01, 2019
Subsequent Event [Line Items]
Share repurchase plan, authorized amount			$ 800	$ 500
Purchase of stock						$ 648	$ 0	$ 0
Shares repurchased (in shares)		30,000,000				32,500,000
Dividends declared (in usd per share)			$ 0.13	$ 0.13
Subsequent Event
Subsequent Event [Line Items]
Share repurchase plan, authorized amount									$ 800
Dividends declared (in usd per share)	$ 0.13
ASR | Subsequent Event
Subsequent Event [Line Items]
Share repurchase plan, authorized amount					$ 150
Purchase of stock					$ 150
Shares repurchased (in shares)					6,956,522
2019 Plan | Subsequent Event
Subsequent Event [Line Items]
Common stock reserved for future issuance										5,200,000

SCHEDULE I - SUMMARY OF INVES_2

SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details) $ in Millions	Dec. 31, 2018USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	$ 82,015
Fair Value	81,396
Carrying Value	81,855
U.S. Treasury, government and agency
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	14,004
Fair Value	13,829
Carrying Value	14,004
States and political subdivisions
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	415
Fair Value	461
Carrying Value	415
Foreign Government Debt
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	524
Fair Value	530
Carrying Value	524
Public Utility, Bonds
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	5,101
Fair Value	5,046
Carrying Value	5,101
All Other Corporate Bonds
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	25,471
Fair Value	25,132
Carrying Value	25,471
Residential mortgage-backed
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	225
Fair Value	234
Carrying Value	225
Asset-backed
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	612
Fair Value	601
Carrying Value	612
Redeemable preferred stock
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	449
Fair Value	446
Carrying Value	449
Fixed maturities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	46,801
Fair Value	46,279
Carrying Value	46,801
Mortgage loans on real estate
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	11,842
Fair Value	11,494
Carrying Value	11,835
Real estate held for the production of income
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	52
Fair Value	52
Carrying Value	52
Policy loans
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	3,779
Fair Value	4,183
Carrying Value	3,779
Other Limited Partnership Interests And Equity Investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	1,293
Fair Value	1,334
Carrying Value	1,334
Trading Securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	16,211
Fair Value	16,017
Carrying Value	16,017
Other Invested Assets
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	2,037
Fair Value	2,037
Carrying Value	$ 2,037

SCHEDULE II - PARENT COMPANY -

SCHEDULE II - PARENT COMPANY - Balance Sheet (Details) - USD ($) $ / shares in Units, $ in Millions		Dec. 31, 2018		Apr. 24, 2018	Dec. 31, 2017		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
ASSETS
Fixed maturities available for sale, at fair value		$ 46,279			$ 46,941
Other equity investments	[1]	1,334			1,392
Other invested assets	[1]	2,037			4,118
Total investments		81,333			81,782
Cash and cash equivalents		4,469	[1]		4,814	[1]	$ 5,654	$ 6,557
Goodwill and other intangible assets, net		4,780			4,824
Loans to affiliates		0			1,230
Other assets	[1]	3,127			2,510
Total Assets		220,797			235,615
LIABILITIES
Short-term and long-term debt	[1]	4,955			2,408
Loans from affiliates		0			3,622
Income taxes payable		68			0
Total Liabilities		205,178			218,471
Equity attributable to Holdings:
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively		5			5
Capital in excess of par value		1,908			1,299
Treasury stock, at cost, 32,138,242 shares		640			0
Retained earnings		13,989			12,225
Accumulated other comprehensive income (loss)		(1,396)			(108)				$ (921)
Total equity attributable to Holdings		13,866			13,421
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 220,797			235,615
Amortized Cost					$ 45,256
Common stock par value (in dollars per share)		$ 0.01		$ 0.01	$ 0.01
Common stock authorized (in shares)		2,000,000,000		2,000,000,000	2,000,000,000
Common stock issued (in shares)		561,000,000			561,000,000
Common stock outstanding (in shares)		528,861,758			561,000,000
Treasury stock (in shares)		32,138,242			0
Parent
ASSETS
Other invested assets		$ 16,743			$ 13,772
Fixed maturities available for sale, at fair value		336			0
Other equity investments		23			0
Other invested assets		80			0
Total investments		17,182			13,772
Cash and cash equivalents		407			44		$ 5	$ 23
Goodwill and other intangible assets, net		1,265			0
Loans to affiliates		572			1,045
Other assets		766			1
Income taxes receivable		0			72
Total Assets		20,192			14,934
LIABILITIES
Short-term and long-term debt		4,408			0
Employee benefits liabilities		1,184			0
Loans from affiliates		600			1,484
Income taxes payable		16			0
Accrued liabilities		118			29
Total Liabilities		6,326			1,513
Equity attributable to Holdings:
Common stock, $0.01 par value, 2,000,000,000 shares authorized, 561,000,000 shares issued, 528,861,758 and 561,000,000 shares outstanding, respectively		5			5
Capital in excess of par value		1,908			1,299
Treasury stock, at cost, 32,138,242 shares		(640)			0
Retained earnings		13,989			12,225
Accumulated other comprehensive income (loss)		(1,396)			(108)
Total equity attributable to Holdings		13,866			13,421
Total Liabilities, Redeemable Noncontrolling Interest and Equity		20,192			14,934
Amortized Cost		$ 337			$ 0
Common stock par value (in dollars per share)		$ 0.01			$ 0.01
Common stock authorized (in shares)		2,000,000,000			2,000,000,000
Common stock issued (in shares)		561,000,000			561,000,000
Common stock outstanding (in shares)		528,861,758			561,000,000
Treasury stock (in shares)		32,138,242
[1]	See Note 2 for details of balances with variable interest entities.

SCHEDULE II - PARENT COMPANY _2

SCHEDULE II - PARENT COMPANY - Statement of Operations and Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
REVENUES
Investment gains (losses), net									$ (86)	$ (191)	$ 1,983
Other income									516	445	402
Total revenues	$ 5,155	$ 1,083	$ 2,966	$ 2,874	$ 2,922	$ 2,806	$ 3,888	$ 2,844	12,078	12,460	11,763
Costs and Expenses [Abstract]
Interest expense									231	160	174
Other operating costs and expenses									1,809	2,069	1,509
Income tax (expense) benefit	(330)	175	(61)	(91)	(149)	59	78	(37)	(307)	(49)	(378)
Net income (loss)	$ 1,999	$ (443)	$ 261	$ 337	$ 627	$ 106	$ 708	$ (184)	2,154	1,257	1,649
Total other comprehensive income (loss), net of income taxes									(1,177)	832	(258)
Comprehensive income (loss) attributable to Holdings									628	1,647	1,010
Parent
REVENUES
Equity in income (losses) from continuing operations of consolidated subsidiaries									2,404	863	1,293
Net investment income (loss)									30	8	7
Investment gains (losses), net									(8)	0	0
Other income									(1)	0	0
Total revenues									2,425	871	1,300
Costs and Expenses [Abstract]
Interest expense									214	31	27
Other operating costs and expenses									123	22	26
Total expenses									337	53	53
Income (loss) from continuing operations, before income taxes									2,088	818	1,247
Income tax (expense) benefit									268	(16)	(7)
Net income (loss)									1,820	834	1,254
Total other comprehensive income (loss), net of income taxes									(1,192)	816	(276)
Comprehensive income (loss) attributable to Holdings									$ 628	$ 1,647	$ 1,010

SCHEDULE II - PARENT COMPANY _3

SCHEDULE II - PARENT COMPANY - Statement of Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended											12 Months Ended
		Dec. 31, 2018		Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018		Dec. 31, 2017		Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018		Dec. 31, 2017		Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net income (loss) attributable to Holdings		$ 1,999		$ (443)	$ 261	$ 337		$ 627		$ 106	$ 708	$ (184)	$ 2,154		$ 1,257		$ 1,649
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Other, net	[1]												(222)		251		428
Net cash provided by (used in) operating activities													61		(243)		(236)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available for sale													10,631		11,339		8,606
Short term investments	[1]												6,267		4,556		3,605
Payment for the purchase/origination of:
Fixed maturities, available for sale													(12,794)		(15,166)		(10,688)
Short term investments	[1]												(5,058)		(4,897)		(4,090)
Other													(233)		(296)		(192)
Repayment of loans to affiliates													1,230		15		0
Issuance of loans to affiliates													0		0		(12)
Other, net	[1]												(86)		201		384
Net cash provided by (used in) investing activities													(2,049)		(9,689)		(5,768)
Cash flows from financing activities:
Issuance of long-term debt													4,057		0		0
Proceeds from loans from affiliates													0		731		0
Repayment of loans from affiliates													(3,000)		(56)		(1,752)
Shareholder dividends paid													(157)		0		0
Purchase of AllianceBernstein Units													(1,340)		0		0
Purchase of treasury shares													(648)		0		0
Capital contribution from parent company								8					8		318		0
Net cash provided by (used in) financing activities													1,655		9,070		5,111
Change in cash and cash equivalents													(345)		(840)		(903)
Cash and cash equivalents, beginning of year						4,814	[2]					5,654	4,814	[2]	5,654		6,557
Cash and cash equivalents, end of year		4,469	[2]					4,814	[2]				4,469	[2]	4,814	[2]	5,654
Parent
Condensed Financial Statements, Captions [Line Items]
Net income (loss) attributable to Holdings													1,820		834		1,254
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Equity in net (earnings) loss of subsidiaries													(2,404)		(863)		(1,293)
Amortization and depreciation													0		0		0
Current and deferred income taxes													111		(14)		(6)
Dividends from subsidiaries													1,838		20		0
Other, net													(264)		24		27
Net cash provided by (used in) operating activities													1,101		1		(18)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available for sale													18		0		0
Short term investments													1,038
Payment for the purchase/origination of:
Fixed maturities, available for sale													(355)		0		0
Short term investments													(1,113)
Other													(16)		0		0
Repayment of loans to affiliates													1,045		0		0
Issuance of loans to affiliates													(572)		(900)		0
Increase in cash and cash equivalents from merger of AXA Financial, Inc.													381		0		0
Purchase of shares of consolidated subsidiaries													0		(55)		0
Other, net													(5)		0		0
Net cash provided by (used in) investing activities													421		(955)		0
Cash flows from financing activities:
Issuance of long-term debt													4,057		0		0
Proceeds from loans from affiliates													(800)		(731)		0
Repayment of loans from affiliates													(200)		(56)		0
Shareholder dividends paid													(157)		0		0
Purchase of AllianceBernstein Units													(1,340)		0		0
Purchase of treasury shares													(648)		0		0
Capital contribution from parent company								8					8		318		0
Capital contribution to subsidiaries													(3,679)		0		0
Net cash provided by (used in) financing activities													(1,159)		993		0
Change in cash and cash equivalents													363		39		(18)
Cash and cash equivalents, beginning of year						$ 44						$ 5	44		5		23
Cash and cash equivalents, end of year		$ 407						$ 44					407		44		5
Non-cash transactions:
Goodwill and intangible assets													1,079		0		0
Equity investments													8		0		0
Other assets													774		0		0
Settlement of long-term debt													(349)		0		0
Employee benefit plans													(1,168)		0		0
Other liabilities													$ (20)		$ 0		$ 0
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 23 for further information.
[2]	See Note 2 for details of balances with variable interest entities.

SCHEDULE II - PARENT COMPANY _4

SCHEDULE II - PARENT COMPANY - Narrative (Details) - USD ($) $ in Millions	Apr. 23, 2018	Apr. 20, 2018	Dec. 31, 2018	Apr. 30, 2018	Mar. 31, 2018	Feb. 28, 2018	Dec. 31, 2017	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2013	Oct. 01, 2018	Mar. 30, 2018
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			$ 0				$ 3,622				$ 3,622	$ 0	$ 3,622
Proceeds from loans from affiliates												0	731	$ 0
Repayment of loans from affiliates												3,000	56	1,752
Capital contribution from parent company											8	8	318	0
Change in cash and cash equivalents												(345)	(840)	(903)
Adjustments to APIC, other	$ 17
Increase (decrease) in accrued taxes payable	174
Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			600				1,484				1,484	600	1,484
Repayment of notes payable		$ 770
Proceeds from loans from affiliates												(800)	(731)	0
Repayment of loans from affiliates												200	56	0
Interest expense, related party												48	77	71
Capital contribution from parent company											8	8	318	0
Change in cash and cash equivalents												$ 363	$ 39	(18)
Adjustments to APIC, other	17
Increase (decrease) in accrued taxes payable	$ 174
AXA Financial
Condensed Financial Statements, Captions [Line Items]
Ownership percentage by noncontrolling interest					0.50%
Payments of capital distribution					$ 66
Economic interest					100.00%	99.50%
AXA Financial | Parent
Condensed Financial Statements, Captions [Line Items]
Ownership percentage by noncontrolling interest					0.50%
Payments of capital distribution					$ 66
AXA-IM Holding U.S., Inc.
Condensed Financial Statements, Captions [Line Items]
Ownership percentage after transaction	100.00%
Purchase of interest by Parent (in shares)	41,934,582
Changes in ownership interest	$ 1,113
AXA-IM Holding U.S., Inc. | Parent
Condensed Financial Statements, Captions [Line Items]
Ownership percentage after transaction	100.00%
Purchase of interest by Parent (in shares)	41,934,582
Changes in ownership interest	$ 1,113
Alliance Bernstein
Condensed Financial Statements, Captions [Line Items]
Purchase of interest by Parent (in shares)	8,160,000
Changes in ownership interest	$ 217
Economic interest	65.00%											65.00%	47.00%
Alliance Bernstein | Parent
Condensed Financial Statements, Captions [Line Items]
Purchase of interest by Parent (in shares)	8,160,000
Changes in ownership interest	$ 217
Economic interest	65.00%
AXA S.A. term loan, three- month LIBOR 1.06%, due 2024
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			0				1,007			$ 2,727	1,007	$ 0	$ 1,007
Repayment of loans from affiliates									$ 520					1,200
AXA S.A. term loan, three- month LIBOR 1.06%, due 2024 | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates										$ 2,727
Repayment of loans from affiliates									$ 520					1,200
AXA S.A. loan, LIBOR 1.44%, due 2022
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			0				366	$ 366			366	0	366		$ 366
AXA S.A. loan, LIBOR 1.44%, due 2022 | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates								366							$ 366
Related party transaction, rate (as a percent)															1.44%
Coliseum Re loan 4.75% tranche one
Condensed Financial Statements, Captions [Line Items]
Proceeds from loans from affiliates																$ 242
Coliseum Re loan 4.75% tranche one | Parent
Condensed Financial Statements, Captions [Line Items]
Proceeds from loans from affiliates								242
Coliseum Re loan 4.75% tranche two
Condensed Financial Statements, Captions [Line Items]
Proceeds from loans from affiliates																$ 145
Coliseum Re loan 4.75% tranche two | Parent
Condensed Financial Statements, Captions [Line Items]
Proceeds from loans from affiliates								145
AXA CS loan, tranche one | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates								100							$ 100
Related party transaction, rate (as a percent)															1.86%
AXA CS loan, tranche two | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates								$ 10							$ 10
Related party transaction, rate (as a percent)															1.76%
Coliseum Reinsurance Company, 4.75%, due 2028
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			0				387				387	0	$ 387
Related party transaction, rate (as a percent)													4.75%			4.75%
Coliseum Reinsurance Company, 4.75%, due 2028 | Parent
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)								4.75%
AXA S.A. loan, LIBOR 0.439%, due 2018
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			0				622				622	0	$ 622
AXA S.A. loan, LIBOR 0.439%, due 2018 | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates							$ 622				622		$ 622
Related party transaction, rate (as a percent)							0.439%
AXA Equitable loan 3.69% | Parent
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)				3.69%
Proceeds from loans from affiliates				$ 800
Repayment of loans from affiliates			200
AXA Equity Holdings | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			572									$ 572
Related party transaction, rate (as a percent)												3.75%
Colisee | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates			$ 145									$ 145
Related party transaction, rate (as a percent)												4.75%
3-Month LIBOR | AXA S.A. term loan, three- month LIBOR 1.06%, due 2024
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)										1.06%			1.06%
3-Month LIBOR | AXA S.A. term loan, three- month LIBOR 1.06%, due 2024 | Parent
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)										1.06%
LIBOR | AXA S.A. loan, LIBOR 1.44%, due 2022
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)													1.44%		1.44%
LIBOR | AXA S.A. loan, LIBOR 0.439%, due 2018
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)													0.439%
AXA CS | AXA Holdings
Condensed Financial Statements, Captions [Line Items]
Economic interest																		78.99%
AXA CS | AXA Holdings | Parent
Condensed Financial Statements, Captions [Line Items]
Economic interest																		78.99%
Note Maturity June 2018 | AXA Holdings
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates					630		$ 622				622		$ 622
Note Maturity June 2018 | AXA Holdings | Parent
Condensed Financial Statements, Captions [Line Items]
Loans from affiliates					630		$ 622				$ 622		622
Note Maturity June 2018 | LIBOR | AXA Holdings
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)											0.439%
Note Maturity June 2018 | LIBOR | AXA Holdings | Parent
Condensed Financial Statements, Captions [Line Items]
Related party transaction, rate (as a percent)											0.439%
AXA CS
Condensed Financial Statements, Captions [Line Items]
Increase (decrease) in loans from affiliates					(622)
Change in cash and cash equivalents					8
Adjustments to APIC, other					630
AXA CS | Parent
Condensed Financial Statements, Captions [Line Items]
Increase (decrease) in loans from affiliates					(622)
Change in cash and cash equivalents					8
Adjustments to APIC, other					$ 630
Noncontrolling Interest
Condensed Financial Statements, Captions [Line Items]
Decrease in noncontrolling interest	$ 29											$ 95	$ 121	$ 128
Noncontrolling Interest | Parent
Condensed Financial Statements, Captions [Line Items]
Decrease in noncontrolling interest												$ (29)
Commercial paper | Parent
Condensed Financial Statements, Captions [Line Items]
Debt instrument, face amount																	$ 2,000

SCHEDULE II - PARENT COMPANY _5

SCHEDULE II - PARENT COMPANY - Assets Acquired and Liabilities Assumed (Details) - AXA Financial - Parent $ in Millions	Oct. 01, 2018USD ($)
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 381
Goodwill and other intangibles assets, net	1,079
Other equity investments	13
Other assets	777
Total Assets	2,250
Employee benefit liabilities	1,168
Long-term debt	349
Income taxes payable	2,106
Other liabilities	20
Total Liabilities	$ 3,643

SCHEDULE III - SUPPLEMENTARY _2

SCHEDULE III - SUPPLEMENTARY INSURANCE INFORMATION (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	$ 6,745	$ 5,919
Group Retirement	49,923	47,171
Investment Management and Research	30,998	30,330
Corporate and Other	4,918	4,817	$ 4,812
Net Investment Income (Loss)	2,462	3,296	817
Policyholders’ benefits and interest credited	4,005	5,361	4,309
Amortization of deferred policy acquisition costs	333	503	779
Other Operating Expense	5,279	5,290	4,648
Corporate and Other
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	153	60
Group Retirement	3,519	2,531
Investment Management and Research	10,360	9,682
Corporate and Other	420	458	459
Net Investment Income (Loss)	474	513	550
Policyholders’ benefits and interest credited	813	919	906
Amortization of deferred policy acquisition costs	(3)	(10)	39
Other Operating Expense	1,091	695	628
Investment Management And Research | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	0	0
Group Retirement	0	0
Investment Management and Research	0	0
Corporate and Other	0	0	0
Net Investment Income (Loss)	36	118	133
Policyholders’ benefits and interest credited	0	0	0
Amortization of deferred policy acquisition costs	0	0	0
Other Operating Expense	2,538	2,517	2,306
Protection Solutions | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	2,706	2,352
Group Retirement	13,989	13,908
Investment Management and Research	4,556	5,444
Corporate and Other	2,103	1,995	2,156
Net Investment Income (Loss)	903	850	763
Policyholders’ benefits and interest credited	2,308	1,432	1,940
Amortization of deferred policy acquisition costs	161	374	551
Other Operating Expense	561	734	600
Insurance | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	3,229	2,988
Group Retirement	20,798	19,414
Investment Management and Research	16,076	15,202
Corporate and Other	2,124	2,116	1,980
Net Investment Income (Loss)	497	1,292	(1,060)
Policyholders’ benefits and interest credited	590	2,728	1,195
Amortization of deferred policy acquisition costs	183	114	139
Other Operating Expense	764	881	818
Group Retirement | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement	657	519
Group Retirement	11,617	11,318
Investment Management and Research	6	2
Corporate and Other	271	248	217
Net Investment Income (Loss)	552	523	431
Policyholders’ benefits and interest credited	294	282	268
Amortization of deferred policy acquisition costs	(8)	25	50
Other Operating Expense	$ 325	463	$ 296
As Previously Reported | Protection Solutions | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement		2,304
As Previously Reported | Insurance | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement		2,877
As Previously Reported | Group Retirement | Operating Segments
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items]
Individual Retirement		$ 678

SCHEDULE IV - REINSURANCE (Deta

SCHEDULE IV - REINSURANCE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Life insurance in-force
Gross Amount	$ 488,431	$ 483,010	$ 485,888
Ceded to Other Companies	69,255	73,049	77,306
Assumed from Other Companies	31,249	31,886	30,688
Net Amount	450,425	441,847	439,270
Premiums
Gross Amount	1,012	1,038	998
Ceded to Other Companies	132	139	146
Assumed from Other Companies	214	225	231
Premiums	$ 1,094	$ 1,124	$ 1,083
Life Insurance In-Force, Percentage of Amount Assumed to Net	6.90%	7.20%	7.00%
Premiums, Percentage of Amount Assumed to Net	19.60%	20.00%	21.30%
Life insurance and annuities
Premiums
Gross Amount	$ 963	$ 984	$ 937
Ceded to Other Companies	100	103	106
Assumed from Other Companies	204	216	222
Premiums	$ 1,067	$ 1,097	$ 1,053
Premiums, Percentage of Amount Assumed to Net	19.10%	19.70%	21.10%
Accident and health
Premiums
Gross Amount	$ 49	$ 54	$ 61
Ceded to Other Companies	32	36	40
Assumed from Other Companies	10	9	9
Premiums	$ 27	$ 27	$ 30
Premiums, Percentage of Amount Assumed to Net	37.00%	33.30%	30.00%